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After	  three	  and	  a	  half	  years,	  I	  still	  can’t	  believe	  that	  my	  PhD	  is	  almost	  finished	  and	  I	  am	  finally	  
submitting	  my	  thesis.	  It	  has	  been	  a	  great	  few	  years	  with	  a	  lot	  of	  ups	  and	  downs	  along	  the	  way	  
and	  a	  magnificent	  journey	  which	  I	  will	  never	  forget.	  I	  have	  learned	  so	  much	  both	  on	  a	  scientific	  
and	  personal	  level	  and	  feel	  this	  journey	  has	  contributed	  significantly	  to	  my	  development	  as	  a	  
person.	  As	  I	  did	  all	  of	  the	  hard	  work	  to	  achieve	  this	  PhD	  I	  would	  like	  to	  congratulate	  myself	  and	  
acknowledge	  nobody.	  All	   joking	   aside	   there	   are	   some	   special	   people	  who	  played	  an	   integral	  
role	  in	  my	  personal	  support,	  motivation,	  development	  and	  training	  throughout	  this	  journey.	  	  
Firstly,	   I	   would	   like	   to	   pay	   enormous	   appreciation	   to	  my	   supervisor	   Dr.	   Andreas	   Heise	  with	  
which	   it	  has	  been	  a	  great	  pleasure	  to	  work	  alongside.	  Your	  knowledge,	   ideas	  and	  motivation	  
have	   really	   strengthened	   my	   scientific	   knowledge	   and	   pushed	   me	   to	   high	   standards	   in	   my	  
research.	  You	  gave	  me	  enormous	  freedom	  to	  conduct	  my	  research	  and	  provided	  me	  with	  great	  
opportunities	   to	   further	  my	  personal	  and	  career	  development	  e.g.	   collaboration	  with	   IBM	   in	  
California.	   Aside	   from	   being	   a	  mentor,	   your	   friendship	   and	   approachable	   nature	  means	   you	  
were	  always	  a	  pleasure	  to	  have	  a	  conversation	  with	  outside	  of	  a	  working	  environment	  even	  if	  
it	  involved	  your	  complaints	  about	  Irish	  weather!	  Again	  thank	  you	  for	  all	  of	  your	  support	  and	  I	  
hope	  you	  were	  pleased	  with	  my	  work	  and	  conduct	  throughout.	  	  	  
I	  would	  like	  to	  thank	  Dr.	  Andrew	  Kellet	  and	  Prof.	  Neil	  Cameron	  for	  being	  my	  internal	  /	  external	  
examiners	  and	  providing	  feedback	  with	  regards	  to	  my	  thesis.	  I	  would	  also	  like	  to	  pay	  particular	  
thanks	  the	  all	  of	  the	  guys	  at	  IBM	  notably	  Joe	  Sly,	  Bob	  Miller	  and	  Joe	  Sly	  for	  all	  of	  their	  support	  
in	  helping	  me	  to	  settle	  in	  and	  work	  effectively	  at	  IBM,	  Almaden,	  San	  Jose,	  California.	  You	  are	  all	  
very	  knowledgeable	  people	  yet	  very	  interesting	  fun	  people	  to	  be	  around.	  To	  Sally-­‐Ann	  Cryan,	  
Danielle	  Victory	  and	  Alan	  Hibbitts	  your	  tremendous	  help	  and	  support	  was	  greatly	  appreciated	  
throughout	   our	   collaboration.	   You	   all	   made	  me	   feel	   very	   welcome	   at	   RCSI	   and	   contributed	  
greatly	   to	   the	   success	   of	   our	   project	   together.	   I	  would	   also	   like	   to	   thank	   IRCSET	   for	   funding	  
thius	  research	  and	  giving	  me	  the	  opportunity	  to	  undertake	  a	  PhD	  programme.	  
The	  DCU	  chemistry	  community	  has	  been	  a	  big	  part	  of	  my	  life	  the	  past	  few	  years	  so	  I	  would	  to	  
show	  my	  gratitude	  to	  its	  members.	  In	  particular	  I	  would	  like	  to	  thank	  all	  of	  the	  technical	  staff;	  
Vinny	  –great	  ability	  to	  have	  the	  “crack”	  with	  and	  your	  help	  with	  regards	  to	  the	  pump	  systems	  
was	  greatly	  appreciated,	  Ambrose	  –	  always	  dependable	  and	  patient	  in	  providing	  consumables	  
which	  keep	  our	  labs	  running,	  Damien	  –	  always	  provided	  great	  lab	  safety	  and	  had	  a	  magnificent	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ability	  to	  have	  a	  joke	  with	  and	  not	  take	  life	  too	  seriously,	  Veronica	  –	  always	  very	  helpful	  and	  do	  
a	   great	   job	   keeping	   the	  department	   running,	   John	   –	  Mr.	  NMR	   spectroscopy	   and	   IT	  who	  has	  
generously	  provided	  IT	  help	  to	  me	  on	  numerous	  occasions,	  Catherine	  –	  always	  a	  great	  help	  in	  
ordering	  chemicals	  and	  ever	  so	  patient	  	  when	  I	  messed	  up	  my	  order,	  Brendan	  –	  great	  help	  with	  
SEM	  and	  Mary	  –	  very	  helpful	   in	  providing	  support	  to	  our	   lab	  when	  GPC	  systems	  were	  having	  
problems.	  	  
Great	  appreciation	  must	  be	  paid	  to	  my	  fellow	  group	  members	  for	  all	  of	  their	  help	  particularly	  
when	  I	   initially	   joined	  the	  group.	  Your	  knowledge	  and	  support	  really	  helped	  me	  settle	   in	  and	  
provided	  me	  with	   a	  better	   understanding	  of	   different	   cultures	   seeing	   as	   I	  was	   the	  only	   Irish	  
member!	  I	  would	  like	  to	  pay	  particular	  thanks	  to	  Dr.	  Paul	  Thornton	  or	  “Plastic	  Paddy”	  as	  he’s	  
more	  commonly	  known	  for	  his	  continued	  friendship	  and	  enormous	  help	  during	  my	  PhD.	  Your	  
expertise	   and	   novel	   ideas	   thought	   me	   a	   lot	   and	   demonstrated	   how	   research	   should	   be	  
approached.	  Your	  mindset	  of	  “working	  smart”	  really	  instilled	  a	  new	  approach	  to	  science	  in	  me.	  
I’ll	   sadly	  miss	   the	   great	   football	   banter	   we	   had	   and	   our	   discussions	   on	   all	   things	   Liverpool.	  
Hopefully	   someday	   Rotherham	   F.	   C.	   will	   make	   it	   to	   the	   Premier	   League!	   To	   Jin	   Huang,	   my	  
favourite	   Chinese	   person,	   your	   friendship	   has	   been	   greatly	   appreciated.	   It	   was	   always	   a	  
pleasure	  to	  meet	  socially	  even	   if	  your	  taste	   in	  food	  and	  movies	  was	  somewhat	  questionable.	  
Your	  vibrant	  presence	  in	  the	  lab	  was	  sadly	  missed	  when	  you	  left	  for	  better	  things	  but	  I’m	  sure	  
our	   friendship	   will	   continue	   well	   into	   the	   future.	   Your	   scientific	   knowledge,	   ideas	   and	   hard	  
working	  mentality	  really	  set	  a	  great	  example	  for	  me	  to	  follow	  and	  if	  I	  even	  achieve	  half	  of	  what	  
you	   have	   I	   will	   be	   very	   successful.	   However,	   please	   stop	   publishing	   countless	   high	   impact	  
papers	   which	   makes	   the	   rest	   of	   us	   mere	   mortals	   look	   really	   bad.	   Fabrice,	   your	   enormous	  
knowledge	  of	  polymers	  and	  GPC	  thought	  me	  a	  huge	  amount	  very	  quickly	  and	  helped	  to	  quickly	  
establish	   a	   solid	   chemical	   platform	   from	  which	   I	   could	   advance	  my	   knowledge	   and	   research	  
efforts.	   It	  was	  always	  fun	  to	  discuss	  football	  and	  the	  failures	  of	  the	  Bordeaux	  football	  team.	  I	  
would	   like	   to	   say	   thank	   you	   to	   Jacoo	  who	  provided	   some	   good	   friendship	   and	  was	   the	  only	  
member	   of	   PRG	   who	   could	   really	   drink.	   Your	   love	   of	   rugby	   was	   unfortunate	   but	   could	   be	  
overlooked	   with	   your	   ability	   to	   have	   the	   “crack”.	   Zeliha	   it	   was	   a	   great	   pleasure	   to	   work	  
alongside	  you	  and	  even	  greater	  pleasure	  to	  always	  beat	  you	  at	  squash.	  Also,	  thank	  you	  for	  all	  
of	   your	   delicious	   cakes	   at	   our	   group	  meetings.	   Claudia,	   thanks	   for	   being	   a	   good	   friend	   and	  
organizing	  all	  of	   the	  birthday	   card	  arrangements.	   Your	   Italian	   flair	  was	  great	   to	  have	  around	  
the	   lab	   but	   your	   organic	   chemistry	   and	   column	   chromatography	   skills	   were	   very	   much	  
appreciated.	  Tushar,	   thank	  you	  for	  all	  of	  your	  polypeptide	  expertise	  and	   it	  was	  a	  pleasure	  to	  
witness	  your	  great	  optimism	  with	  regards	  to	  your	  work	   i.e.	  “minimum	  JACS”.	  Anton,	   it	  was	  a	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great	  pleasure	  to	  work	  alongside	  you	  and	  some	  of	  California	  together.	   I	  wish	  you	  all	  the	  best	  
with	  your	  PhD.	  Marcello,	  I	  hope	  your	  PhD	  works	  out	  well	  and	  you	  get	  the	  job	  you	  deserve.	  To	  
Saltuk	  and	  Timo,	  although	  we	  only	  briefly	  worked	  together	  it	  was	  a	  great	  honour	  and	  you	  are	  
both	  really	  good	  guys	  who	  I	  have	  no	  doubt	  will	  do	  very	  well	  in	  their	  PhDs	  and	  future	  work.	  	  	  
To	  Declan	  Daly	  my	  good	   friend,	  your	  great	   friendship	  was	  of	  great	   support	   to	  me	  during	  my	  
PhD.	  Your	  knowledge	  of	  organic	  chemistry	  is	  tremendous	  and	  I	  am	  sure	  you	  will	  do	  very	  well	  in	  
the	  future.	  Your	  organic	  chemistry	  help	  and	  tips	  contributed	  to	  improving	  my	  chemistry	  skills	  
and	  knowledge.	  I’ll	  definitely	  miss	  our	  lunch	  time	  banter	  and	  discussions	  on	  everything	  football	  
related	  even	  if	  your	  opinions	  are	  ridiculous.	  	  	  
Finally,	  I	  owe	  tremendous	  gratitude	  to	  my	  wonderful	  girlfriend,	  Cathy	  and	  mother,	  Serena	  for	  
tolerating	  me	  particularly	  in	  the	  final	  often	  stressful	  year	  of	  my	  PhD.	  Without	  you	  guys	  I	  would	  
not	  be	  where	  I	  am	  today	  and	  owe	  you	  everything.	  Cathy,	  your	  positive	  attitude	  and	  motivation	  
to	  drive	  me	  to	  succeed	  was	  very	  supportive	  whilst	  it	  was	  comforting	  to	  know	  that	  even	  after	  a	  
bad	  day	  I	  could	  always	  depend	  on	  you	  for	  help	  and	  cheering	  up.	  Even	  after	  spending	  6	  months	  
out	  in	  California,	   	  you	  stuck	  with	  it	  and	  are	  very	  much	  a	  part	  of	  this	  success	  so	  thank	  you.	  To	  
my	  Mam,	  I	  would	  not	  be	  here	  today	  without	  you,	  your	  hard	  work	  and	  support	  has	  guided	  me	  
to	  become	  the	  person	  I	  am	  today.	  Your	  patient	  and	  sincere	  nature	  enabled	  me	  to	  give	  my	  all	  to	  
this	  PhD	  in	  spite	  of	  my	  often	  testing	  moods.	  I	  am	  sure	  I	  would	  not	  have	  been	  able	  to	  finish	  this	  
PhD	  with	  your	  unwavering	  support	  so	  thank	  you.	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  and	  Branch	  Shaped	  Polymers	  for	  Delivery	  of	  
Therapeutics	  
By	  
Mark	  Byrne	  B.Sc.	  
	  
The	  area	  of	  nanomedicine	  has	  witnessed	  a	  surge	  in	  research	  interest	  in	  recent	  years	  owing	  to	  
the	  huge	  potential	  offered	  by	  this	  domain	  to	  significantly	  impact	  on	  the	  healthcare	  industry.	  To	  
progress,	   the	   advent	   of	   novel	   materials	   capable	   of	   meeting	   the	   stringent	   demands	   of	  
conducting	  medical	  applications	  at	  a	  molecular	   level	   is	   required.	  Consequently,	  polymers	  are	  
one	   such	   nanomaterial	   attracting	   considerable	   interest.	   In	   particular,	   star	   shaped	   polymers	  
have	   emerged	   as	   strong	   candidates	   for	   the	   next	   generation	   of	   nanoparticle	   platforms	  
considering	  the	  unique	  structural	  benefits	  offered	  by	  such	  architectures;	  ability	  to	  combine	  a	  
high	  local	  density	  of	  polymeric	  arms	  and	  functionality	  within	  a	  size	  confined	  structural	  space.	  
Furthermore,	  the	  inherent	  introduction	  of	  distinctive	  nano-­‐environments	  achieved	  only	  by	  star	  
shaped	   architectures	   advocates	   the	   concept	   of	   simultaneous	   multiple	   cargo	   loading,	  
protection,	   transport	   and	   site	   specific	   delivery	   via	   the	   confines	   of	   a	   single	   star	   shaped	  
polymeric	  enclosure.	  To	  achieve	   the	  next	  generation	  of	   star	   shaped	  polymers,	  new	  synthetic	  
strategies	   for	   the	   design	   of	   well-­‐defined	   star	   polymers	   of	   biocompatible	   compositions	   is	  
required.	   	   The	   aim	   of	   this	   PhD	   was	   to	   develop	   novel	   synthetic	   star	   shaped	   polymer	   based	  
biomaterials	   capable	   of	   biomedical	   applicability	   towards	   areas	   such	   as	   drug	   delivery	   and	  
biorecogniton.	   The	   main	   synthetic	   strategies	   employed	   were	   ring	   opening	   polymerization	  
(ROP)	   of	   amino	   acid	   N-­‐carboxyanhydrides	   (NCA)	   and	   efficient	   amide	   coupling	   chemistries.	  
Three	   different	   platforms	   were	   designed	   including	   stimuli	   responsive	   star	   shaped	  
polypeptides,	  star	  shaped	  poly(lysine)	  as	  a	  vector	  for	  DNA	  and	  siRNA	  delivery	  and	  biologically	  
active	   star	   shaped	   glycopolypeptides.	   Finally	   a	   fourth	  platform	   comprising	   a	   series	   of	   hybrid	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1.1	  	  	  	  	  Ring	  Opening	  Polymerization	  (ROP)	  of	  N-­‐
Carboxyanhydrides	  (NCA)	  	  
Originally	  known	  as	  Leuchs’s	  anhydrides	  owing	  to	  their	  discovery	  by	  Hermann	  Leuchs	  in	  1906,	  
N-­‐carboxyanhydrides	  (NCA)	  are	  simply	  anhydrides	  of	  α-­‐amino	  acids.1	  Depending	  on	  the	  amino	  
acid	  selected,	  NCAs	  are	  not	   typically	  synthetically	  challenging	  and	  are	  commonly	  synthesised	  
through	   the	   use	   of	   chlorinating	   agents	   such	   as	   triphosgene	   or	   phosphorus	   pentachloride	   to	  
cyclize	  the	  amino/carboxylic	  acid	  functionality	  on	  the	  α-­‐carbon	   (Scheme	  1.1).2	  A	  prerequisite	  
of	   NCA	   formation	   is	   that	   any	   amino	   acid	   side	   chain	   possessing	   nucleophilic	   or	   acidic	  
functionality	   must	   be	   protected	   which	   otherwise	   leads	   to	   unwanted	   side	   reactions	   or	  
polymerization	  of	   the	   formed	  NCA.	  NCAs	  are	   reactive	  compounds	  owing	   to	  activation	  of	   the	  
carbonyl	   functionality	   at	   C-­‐5	   position	   of	   the	   anhydride,	   whilst	   simultaneously	   providing	  
protection	  of	  the	  amino	  group.	  Storage	  of	  NCAs	  remains	  difficult	  with	  water	  posing	  a	  particular	  
problem.	  Hydrolysis	   of	   the	  NCA	   even	   in	   solid	   state	   can	   readily	   occur	   resulting	   in	   undefined,	  
uncontrolled	  oligopeptides.3-­‐5	  
	  
Scheme	  1.1:	  Synthesis	  of	  N-­‐carboxyanhydrides	  from	  α-­‐amino	  acids	  from	  triphosgene.	  
Treated	   as	   a	   monomer,	   the	   NCA	   ring	   can	   be	   opened	   in	   a	   process	   known	   as	   ring	   opening	  
polymerization	   (ROP)	   thus	   permitting	   the	   synthesis	   of	   poly(amino	   acids)	   or	   the	   step	   wise	  
growth	   of	  more	   complex	   polypeptides.6,7	   ROP	   of	   NCAs	   occurs	   via	   two	  mechanisms:	   	  Normal	  
Amine	   Mechanism	   (NAM)	   and	   Activated	   Monomer	   Mechanism	   (AMM).
1.1.1	  	  	  	  	  Normal	  Amine	  Mechanism	  (NAM)	  
This	   mechanism	   is	   usually	   observed	   with	   initiating	   groups	   such	   as	   primary	   and	   secondary	  
amines,	  alcohols	  and	  water,	   groups	  which	  are	   stronger	  nucleophiles	   than	  bases.	   Initiation	  of	  
this	  type	  occurs	  for	  both	  types	  of	  NCA	  i.e.	  N-­‐unsubstituted	  (R2	  =	  H)	  and	  N-­‐substituted	  (R2	  ≠	  H)	  
(Scheme	   1.2).	   ROP	   initiation	   of	   the	   NCA	   occurs	   via	   nucleophilic	   attack	   on	   the	   anhydride	  
carbonyl	   group	  at	  position	  5	  owing	   to	   its	   strong	  activation.	   The	   resulting	  unstable,	   carbamic	  
acid	  readily	  decarboxylates	  to	  provide	  a	  new	  amino	  group	  which	  is	  subsequently	  free	  to	  attack	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the	  next	  molecule	  of	  NCA.	  The	  use	  of	  primary	  amines	  as	  initiators	  is	  more	  profound	  given	  they	  
are	   more	   nucleophilic	   than	   the	   propagating	   amines	   leading	   to	   a	   faster	   initiation	   rate	   than	  
propagation	  rate	  and	  therefore	  leading	  to	  well	  controlled	  polymerization	  and	  polypeptides	  of	  a	  
low	   polydispersity	   index	   (PDI	   <1.2).8,9	   	  Moreover,	   the	  NAM	   results	   in	   a	   polypeptide	  with	   the	  
amine	   initiator	   attached	   to	   the	   polypeptide	   chain	   thus	   opening	   opportunities	   for	   end-­‐group	  
engineering.	  Unwanted	  termination	  and	  kinetic	  deviations	  of	  polypeptide	  growth	  are	  apparent	  
however	   and	   are	   strongly	   dependent	   on	   reaction	   conditions	   such	   as	   type	   of	   monomer,10,11	  
monomer	   purity	   12,13	   and	   solvent.14	   One	   such	   unwanted	   side	   reaction	   involves	   nucleophilic	  
attack	  of	   the	   less	   reactive	  carbonyl	  at	  position	  2	   resulting	   in	   the	   formation	  of	  an	  ureido	  acid	  
side	  chain.6,15	  However,	  such	  a	  reaction	  is	  limited	  and	  can	  be	  further	  inhibited	  by	  the	  choice	  of	  
a	  more	  nucleophilic	  initiator.	  	  
	  
Scheme	  1.2:	  NAM	  of	  NCA	  ring	  opening	  polymerization	  via	  a	  primary	  amine	  initiator.	  
Initiation:	  Carbamic	  acid	  formation	  following	  nulceophilic	  attack	  on	  the	  anhydride	  at	  
position	  5	  by	  primary	  amine.	  Decarboxylation	  of	  unstable	  carbamic	  acid	  to	  generate	  a	  new	  
free	  amino	  group.	  Propagation:	  New	  free	  amino	  group	  capable	  of	  nulceophilic	  attack	  on	  
another	  anhydride	  molecule	  and	  the	  process	  continues	  i.e.	  polymerization.	  	  	  	  
1.1.2	  	  	  	  	  Activated	  Monomer	  Mechanism	  (AMM)	  
	  In	  contrast	  to	  NAM,	  initiation	  arises	  from	  the	  basicity	  of	  the	  initiator	  and	  not	  as	  a	  result	  of	  its	  
nucleophilicity.16,17	  Common	  initiators	  employed	  here	  include	  tertiary	  amines	  and	  the	  resultant	  
mechanism	  is	  only	  applicable	  to	  N-­‐unsubstituted	  NCAs	  due	  to	  the	  requirement	  of	  removal	  of	  a	  
proton	   from	   the	   N-­‐3	   position	   as	   part	   of	   the	   initiation.	   As	   outlined	   in	   Scheme	   1.3	   the	  
subsequent	   anion	   attacks	   the	   C-­‐5	   carbonyl	   which	   further	   reacts	   with	   another	   NCA	   anion	  
releasing	   CO2.	   Apart	   from	   its	   mechanism	   and	   terminations,18-­‐21	   this	   mechanism	   differs	   from	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NAM	   in	   that	   it	   can	   potentially	   lead	   to	   higher	  molecular	  weight	   polypeptides	   of	   often	   broad	  
PDIs	  since	  propagation	  rate	  is	  faster	  than	  initiation	  rate.22	  
	  
Scheme	  1.3:	  AMM	  of	  NCA	  ring	  opening	  polymerization.	  Preinitiation:	  Tertiary	  amine	  acts	  as	  a	  
catalyst	  (base)	  and	  abstracts	  a	  proton	  from	  the	  amine	  in	  NCA	  ring	  resulting	  in	  the	  formation	  
of	  an	  anion.	  Initiation:	  The	  resulting	  anion	  acts	  as	  the	  initiator	  and	  attacks	  the	  carbonyl	  
group	  at	  position	  5	  of	  another	  NCA	  molecule	  to	  form	  a	  dimer.	  Reaction	  with	  a	  new	  NCA	  
molecule	  results	  in	  the	  simultaneous	  decarboxylation	  and	  formation	  of	  new	  NCA	  anion.	  
Propagation:	  Reaction	  with	  the	  new	  NCA	  anion	  forms	  a	  trimer	  and	  the	  process	  continues	  
with	  the	  formation	  of	  a	  new	  NCA	  anion	  in	  each	  step.	  	  
	  
Although	  both	  mechanisms	  are	  synthetically	  effective	  in	  achieving	  polypeptides,	  only	  the	  NAM	  
can	  be	  described	  as	  controlled	  producing	  low	  polypeptide	  PDI,	  predictable	  Mn	  and	  end	  group	  
fidelity.23	   Other	   techniques	   to	   initiate	   ROP	   of	   NCAs	   have	   reported	   using	   initiators	   such	   as	  
silazane	   derivatives,24	   primary	   amine	   hydrochlorides25	   and	   Deming’s	   transitional	   metal	  







1.2	  	  	  	  	  Synthesis	  of	  Star	  and	  Branch	  Shaped	  Polypeptides	  by	  NCA	  
ROP	  	  
Star	  shaped	  or	  branched	  polypeptides	  describe	  a	  particular	  architectural	  class	  of	  polypeptides	  
consisting	  of	  a	  number	  of	  linear	  polypeptide	  chains	  or	  “arms”	  bound	  to	  a	  central	  core.	  Within	  
this	  architectural	  class	  there	  is	  great	  scope	  for	  versatility	  arising	  from	  the	  potential	  to	  control	  
the	   number	   of	   arms,	   molecular	   weight	   and	   type	   of	   polypeptidic	   arm	   and	   core	   employed.	  
Depending	   on	   the	   synthetic	   approach	   employed,	   characterization	   of	   these	   architecturally	  
diverse	   materials	   remains	   quite	   challenging.	   Two	   different	   synthetic	   methodologies	   are	  
generally	  used	  to	  generate	  these	  materials:	  divergent	  and	  convergent.	  	  
1.2.1	  	  	  	  	  Divergent	  Approach	  
The	  most	  commonly	  employed	  divergent	  method,	  generally	  describes	  the	  synthesis	  of	  a	  star	  or	  
branched	   polymer	   using	   a	   “core	   first”	   approach	   i.e.	   the	   growth	   of	   a	   polymer,	   in	   this	   case	  
polypeptide,	   from	   a	   multifunctional	   initiator	   or	   more	   simply	   a	   multi-­‐amino	  macromolecule.	  
The	   presynthesised	   core	   containing	   multiple	   initiating	   sites	   allows	   for	   the	   simultaneous	  
initiation	   and	   subsequent	   growth	   of	   linear	   polypeptide	   arms	   from	   the	   central	   core	   thus	  
creating	   star	   or	   branched	   polypeptide	   architectures.	   Such	   cores	   must	   contain	   multiple	   but	  
equally	  reactive	   initiation	  sites	  with	  a	  slower	  propagation	  rate	  than	  initiation	  rate	   in	  order	  to	  
permit	   the	   synthesis	   of	   branched	   polypeptides	   with	   controlled	   and	   well	   defined	   molecular	  
weights	   and	   architectures.	   Characterization	   of	   such	   materials	   often	   proves	   challenging	  
however,	  owing	  to	  the	  inability	  to	  measure	  the	  polypeptide	  “arm”	  directly.	  This	  drawback	  may	  
be	   overcome	   by	   utilising	   a	   cleavable	   moiety	   linking	   arm	   to	   the	   core	   but	   such	   an	   approach	  
further	   complicates	   the	   synthetic	  methodology.	   The	   determination	   of	   arm	   number	   requires	  
end	  group	  analysis	  or	  investigation	  of	  comparative	  branching	  parameters	  against	  an	  equivalent	  
linear	   polypeptide	   but	   such	   methods	   are	   often	   complex	   and	   just	   an	   approximation	   of	   arm	  
number.	  	  
1.2.1.1	  	  	  	  	  Dendrimer	  Initiated	  ROP	  of	  NCAs	  
In	  terms	  of	  cores	  and	  subsequent	  polypeptide	  growth,	  amino	  terminated	  dendrimers	  are	  one	  
of	   the	   most	   commonly	   used.	   This	   is	   related	   to	   the	   fact	   that	   dendrimers	   are	   well	   defined	  
macromolecules	   which	   are	   structurally	   versatile	   and	   possess	   unprecedented	   functionality	  
within	   a	   localised	   area.29-­‐34	  As	   the	   dendrimer	   generation	   increases,	   the	   degree	   of	   branching	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and	   subsequent	   peripheral	   functionality	   also	   increases	   generating	   macromolecules	   with	  
variable	  size,	  structural	   flexibility,	  surface	  functionality	  and	  molecular	  weight.35-­‐37	   	  Poly(amido	  
amine)	   (PAMAM)	   and	   polypropylene	   imine	   (PPI)	   dendrimers	   are	   the	   two	   most	   widely	  
employed	   dendrimers	   in	   NCA	   polymerization	   partly	   owing	   to	   their	   commercial	   availability.	  
Both	   types	   possess	   the	   inherent	   structural	   and	   functional	   versatility	   associated	   with	  
dendrimers	  but	  more	  importantly	  possess	  a	  multivalent	  primary	  amino	  periphery	  required	  for	  
controlled	  NCA	  polymerization	  (Figure	  1.1).	  
	  
Figure	  1.1:	  Structure	  of	  PPI	  and	  PAMAM	  dendrimers	  (ethylenediamine	  core).	  
The	   first	   such	   reported	   case	   of	   polypeptide	   growth	   from	   a	   dendritic	   core	   via	   NCA	  
polymerization	  was	  reported	  by	  Okada	  et	  al.,	  who	  constructed	  a	  short	  armed	  glycosylated	  star	  
polypeptide	  from	  the	  ROP	  of	  glycosylated	  NCA	  via	  generation	  3	  PAMAM	  (Scheme	  1.4).38	  The	  
polymers,	  dubbed	  “sugar	  balls”	  were	  shown	  to	  be	  well	  defined	   in	  terms	  of	  molecular	  weight	  
distribution	  with	  NCA	  ROP	  proceeding	  via	  NAM.	  13C	  NMR	  spectroscopy	  suggested	  initiation	  by	  
all	  peripheral	  primary	  amino	  groups.	  
	  
Scheme	  1.4:	  Synthesis	  of	  “sugar	  balls”	  by	  ROP	  of	  the	  NCA	  monomer	  of	  a	  glucopyranosyl-­‐L-­‐
serine	  derivative	  initiated	  with	  a	  generation	  3	  PAMAM	  dendrimer.38	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In	   addition	   to	   the	   work	   performed	   by	   Okada	   et	   al.,	   subsequently,	   numerous	   groups	   have	  
attempted	   the	   dendrimer	   initiated	   ROP	   of	   a	   variety	   of	   NCA	  monomers.39,40	   The	   G0	   and	  G3-­‐
PAMAM	   initiated	   ROP	   of	   γ-­‐benzyl-­‐L-­‐glutamate	   (BLG)	   NCA	   afforded	   star	   polypeptides	   with	   4	  
and	  32	  poly(γ-­‐benzyl-­‐L-­‐glutamate)	  (PBLG)	  arms	  respectively	  whereas	  G5-­‐PPI	  was	  employed	  to	  
generate	   a	   series	   of	   poly(sarcosine)	   decorated	   G5-­‐PPI	   dendrimers	   with	   narrow	   molecular	  
weight	  distributions.41-­‐44	  A	  series	  of	  star	  shaped	  copolymers	  of	  PBLG	  and	  poly(DL-­‐valine)	  were	  
synthesized	   using	   G1	   and	   G2-­‐PPI	   dendrimers.45	   The	   described	   polymers	   showed	   good	  
agreement	   with	   theoretical	   molecular	   weights	   and	   quantitative	   reaction	   of	   all	   dendritic	  
primary	  amino	  groups.	  	  
Aliferis	   et	   al.	   investigated	   the	   effect	   the	   type	   of	   multifunctional	   initiator	   had	   on	   ROP	   of	   ε-­‐
butyloxycarbonyl-­‐L-­‐lysine	   and	   γ-­‐benzyl-­‐L-­‐glutamate	   NCAs	   via	   G0-­‐PAMAM,	   G1-­‐PPI	   and	   2-­‐
(aminomethyl)-­‐2-­‐methyl-­‐1,3-­‐propanediamine	  (AMPDA).46	  The	  tertiary	  amine	  deficient	  AMPDA	  
resulted	   in	   star	   polypeptides	   exhibiting	   unimodality	   and	   narrow	   molecular	   distributions	  
whereas	   the	   tertiary	   amine	   proficient	   PAMAM	   and	   PPI	   dendrimers	   corresponded	   to	  
polypeptides	   with	   bimodality	   and	   were	   less	   defined	   as	   denoted	   by	   uncontrolled	   molecular	  
weights	  and	  higher	  polydispersity	   indices.	   Such	  a	   feature	   is	  explained	  by	   the	  participation	  of	  
both	   the	  NAM	  and	  AMM	   in	   the	  ROP	  of	   the	  described	  NCAs	  via	  PAMAM	  and	  PPI	   resulting	   in	  
predominantly	  primary	  amine	   initiated	  star	  polypeptides	   (NAM)	  with	  high	  molecular	  weights	  
and	   low	  molecular	  weight	   tertiary	   amine	   derived	   linear	   polypeptide	   chains	   (AMM).	   Such	   an	  
observation	  has	  not	  been	  reported	  elsewhere	  and	  may	  potentially	  be	  as	  a	  consequence	  of	  the	  
use	   of	   low	   generation	   dendrimers	   thus	   sterically	   permitting	   NCA	   monomer	   initiation	   via	  
tertiary	   amines.	   The	   employment	   of	   suitable	   deprotection	   chemistry	   of	   the	   aforementioned	  
dendrimer	   derived	   star	   polypeptides	   afforded	   amino	   and	   carboxylic	   acid	   functionalised	  
polypeptides.	  	  
Owing	   to	   the	   living	   nature	   of	   NCA	   derived	   polypeptides,	   a	   key	   feature	   of	   NCA	   ROP	   is	   the	  
potential	   to	  modify	   polypeptide	   end	   groups	   (NH2)	   via	   in	   situ	   or	   post	  modification.	  Qui	   et	   al.	  
utilised	  this	   feature	   to	  great	  effect	  by	   functionalising	   the	  polypeptide	  amino	  end	  groups	  of	  a	  
four	  armed	  PAMAM	  derived	  PBLG	  star	  polypeptide	  with	  α-­‐bromoisobutyryl	  bromide	  (Scheme	  
1.5).47	   The	   resultant	   ATRP	   proficient	   star	   polypeptide	   permitted	   controlled	   radical	  
polymerization	   of	   D-­‐gluconamidoethyl	   methacrylate	   (GAMA)	   glycomonomer	   to	   form	   star	  
shaped	  biohybrid	  polymers.	  As	  expected,	  the	  star	  shaped	  hybrids	  exhibited	  inferior	  molecular	  
weight	   distributions	   towards	   their	   linear	   counterparts,	   yet	   the	   difference	  was	   only	  minimal.	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Furthermore	   the	   distribution	   was	   unimodal	   implying	   no	   unreacted	   polypeptide	   star	   whilst	  
polypeptide	  and	  methacrylate	  block	  lengths	  could	  be	  readily	  controlled.	  	  
	  
Scheme	  1.5:	  Star	  Shaped	  PBLG-­‐b-­‐PGAMA	  biohybrid	  by	  combination	  of	  NCA	  polymerization	  
and	  ATRP.	  Initially,	  generation	  of	  star	  shaped	  PBLG	  by	  ROP	  of	  BLG	  NCA	  with	  a	  generation	  2	  
PAMAM	  dendrimer	  and	  the	  subsequent	  modification	  of	  its	  amino	  end	  groups	  with	  an	  ATRP	  
initiator.	  Polymerization	  of	  a	  glycosylated	  methacrylate	  monomer	  from	  this	  star	  polymer	  by	  
ATRP	  generated	  a	  biohybrid	  star	  polymer.47	  
	  
1.2.1.2	  	  	  	  	  NCA	  Derived	  Polypeptides	  from	  Branched	  Polymers	  
Aside	  from	  dendrimers,	  branched	  versions	  of	  poly(ethylene	  imine)	  (PEI),	  poly(ethylene	  glycol)	  
(PEG)	  and	  poly(propylene	  oxide)	  (PPO)	  have	  demonstrated	  their	  ability	  to	  successfully	  serve	  as	  
multifunctional	   initiators	   for	   the	   synthesis	   of	   star	   polypeptides.	   Like	   PAMAM	  and	   PPI,	   these	  
branched	  polymers	  possess	  peripheral	  primary	  amino	  groups	  capable	  of	  ROP	  of	  NCAs.	  Several	  
examples	  of	  PEI	  initiated	  ROP	  of	  benzyl	  protected	  histidine	  and	  BLG	  NCAs	  have	  been	  reported	  
which	  have	  recently	  been	  exhaustively	  expanded	  by	  the	  work	  of	  Liu	  et	  al.	  to	  include	  a	  series	  of	  
star	  polypeptides	  boasting	  variation	   in	  hyperbranched	  PEI	   cores	  and	  polypeptide	  peripheries	  
and	  densities.48-­‐55	  One	   such	   example	  demonstrated	   the	   formation	  of	   a	   series	   hyperbranched	  
PEI	  decorated	  with	  various	   ratios	  of	  poly(lysine)	   (PLL).56	  Size	  exclusion	  chromatography	   (SEC)	  
highlighted	  the	  absence	  of	   tertiary	  amine	   initiated	  ROP,	  however	  polydispersity	   indices	  were	  
significantly	  higher	  than	  those	  obtained	  by	  dendrimer	  initiated	  ROP	  possibly	  due	  to	  the	  inferior	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structural	   integrity	   and	   monodispersity	   of	   branched	   PEI	   as	   compared	   to	   a	   dendrimer.	   Post	  
modification	   of	   the	   “living”	   polypeptide	   amino	   end	   groups	   with	   a	   nitrophenyl-­‐carbonate	  
functionalized	  PEG	  resulted	  in	  star	  polypeptides	  with	  a	  PEG	  outer	  shell.	  1H	  NMR	  spectroscopy	  
confirmed	  the	  highly	  efficient	  quantitative	  PEG	  conjugation	  to	  polypeptide	  chains.	  	  Similarly,	  4-­‐
armed	  PEG	  led	  to	  the	  successful	  synthesis	  of	  star	  shaped	  PBLG,	  PZLL	  and	  poly(alanine)	  (PAla)	  
(Scheme	   1.6).	   Quantification	   of	   polypeptide	   conjugation	   was	   obtained	   via	   1H	   NMR	  
spectroscopy	  and	  corresponded	  well	  to	  monomer	  feed	  ratios.57-­‐59	  In	  particular	  SEC	  analysis	  of	  
(PEG-­‐b-­‐PBLG)4	   by	   Karatzas	   et	   al.	   confirmed	   star	   polymer	   with	   a	   narrow	   molecular	   weight	  
distribution	  and	  good	  agreement	  of	  molecular	  weight	  with	  the	  targeted	  value.60	  In	  contrast	  the	  
PEG	  derivative,	   PPO	   (polypropylene	  oxide)	   resulted	   in	   a	  more	  polydisperse	   range	  of	   (PPO-­‐b-­‐
PBLG)3	  star	  polypeptides	  possibly	  arising	  from	  the	  unequal	  initiation	  reactivity	  and	  subsequent	  
polypeptide	  distributions	  amongst	  the	  multiple	  amino	  sites.61	  	  
	  
Scheme	  1.6:	  ROP	  of	  alanine	  NCA	  by	  a	  4-­‐armed	  amino	  terminated	  PEG	  derivative.59	  
Well	   defined,	   tri-­‐armed	   polystyrene-­‐b-­‐PBLG	   (PS-­‐b-­‐PBLG)	   star	   polymers	   were	   reported	   by	  
Abraham	  et	  al.	  who	  sequentially	  modified	  tri-­‐functional	  PS	  to	  generate	  amino	  terminated	  PS.	  
Subsequent	   ROP	   of	   BLG	   NCA	   resulted	   in	   star	   shaped	   block	   copolymers	   boasting	   controlled	  
molecular	  weights	  and	  molecular	  weight	  distributions	  similar	  to	  a	  linear	  counterpart.62	  	  
1.2.1.3	  	  	  	  	  Miktoarm	  Star	  Polypeptides	  from	  NCA	  
A	   new	   type	   of	   star	   polypeptide,	   miktoarm	   star	   polymers,	   has	   led	   to	   considerable	   interest	  
within	   this	   area.	   Miktoarm	   star	   polymers	   are	   star	   polymers	   possessing	   numerous	   arms	   in	  
which	  the	  arms	  are	  of	  various	  compositions	  i.e.	  chemically	  and/or	  molecular	  weight	  emanating	  
from	  a	  central	  core	  (Figure	  1.2).63	  Consequently,	  such	  polymers	  are	  synthetically	  challenging.	  
However,	  the	  advent	  of	  efficient	   living	  polymerisation	  techniques	  such	  as	  ROP	  and	  ATRP	  and	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their	   sequential	   synthetic	   employment	   has	   helped	   to	   overcome	   these	   synthetic	   limitations	  
somewhat	  leading	  to	  a	  more	  diverse	  range	  of	  miktoarm	  star	  polymers.	  
	  
Figure	  1.2:	  Miktoarm	  star	  polymers	  encompassing	  various	  arm	  compositions	  and	  molecular	  
weights.	  Each	  symbol	  represents	  a	  polymeric	  arm	  wherein	  different	  arm	  compositions	  are	  
denoted	  by	  a	  change	  in	  symbol	  type,	  colour	  or	  size.	  The	  helix	  type	  symbol	  represents	  a	  
polypeptide	  arm.	  
	  Concerning	   polypeptides,	   several	   examples	   of	   miktoarm	   star	   polypeptides	   have	   been	  
divulged.64,65	  A	  miktoarm	  star	  polymer	  comprising	  3	  arms,	  two	  of	  which	  are	  PBLG	  and	  the	  other	  
PS	   were	   synthesised	   by	   initially	   employing	   ATRP	   to	   afford	   linear	   PS(Br).66,67	   Subsequent	  
modification	   of	   the	   bromine	   end	   group	   via	   nucleophilic	   substitution	   with	   1-­‐
aminotriethylenetriamine,	   followed	   by	   crude	   purification	   techniques	   afforded	   a	   diamino	  
functionalized	  PS	  polymer	  capable	  of	  ROP	  of	  BLG	  NCA.	  Molecular	  weights	  were	  verified	  by	  1H	  
NMR	   spectroscopy	   whilst	   SEC	   confirmed	   the	   well	   defined	   and	   monomodal	   nature	   of	   the	  
described	   polymers	   (PDI	   <1.3).	   The	   removal	   of	   PBLG	   protecting	   groups	   ultimately	   led	   to	  
carboxylic	   acid	   functionalized	  miktoarm	   star	  polypeptides.	  More	   recently,	   Junnila	   et	   al.	   used	  
anionic	  polymerization	  and	  ROP	   to	  generate	  3	  and	  4-­‐armed	  PLL	  miktoarm	  star	  polypeptides.	  
The	   ability	   to	   control	  molecular	  weight,	   number	   and	   type	   of	   polymeric	   arms	   in	   conjunction	  
with	  narrow	  molecular	  weight	  distributions	  demonstrated	  the	  versatility	  and	  superior	  control	  
of	   these	  materials.68,69	  Asides	   from	   PS,	   the	   versatile	   technique	   of	   “click”	   chemistry	   has	   also	  
shown	  promise	  as	  an	  efficient	  route	  towards	  miktoarm	  star	  polypeptides.70	  AB2	  type	  miktoarm	  
star	   polypeptides	  were	   prepared	  using	   an	   tri-­‐functional	   initiator	   containing	   a	   primary	   amine	  
and	  dual	  alkyne	   functionality.71	  The	  described	   initiator	  permitted	  NCA	  ROP	   from	  the	  primary	  
amine	   whereas	   alkyne	   groups	   allowed	   for	   the	   “clicking”	   on	   of	   preformed	   azide	   terminated	  
linear	   polypeptide	   chains	   (Figure	   1.3).	   The	   beauty	   of	   this	   system	   is	   the	   wide	   range	   of	   NCA	  
derived	  polypeptides	  and	  combinations	  that	  can	  be	  potentially	  attached	  thus	  readily	  creating	  a	  
vast	   library	   of	   miktoarm	   star	   polypeptides.	   The	   chemistry	   employed	   is	   not	   particularly	  
challenging	   yet	   leads	   to	   very	   well	   defined	   star	   polymers	   (PDI	   <1.2)	   with	   tunable	   molecular	  




Figure	  1.3:	  AB2	  miktoarm	  star	  polymer	  synthesized	  via	  ROP	  of	  BLG	  NCA	  with	  a	  dual	  functional	  
initiator	  (primary	  amine	  /	  azide)	  to	  form	  linear	  PBLG.	  The	  subsequent	  ROP	  of	  lysine	  NCA	  
from	  a	  pre-­‐designed	  tri	  functional	  initiator	  possessing	  a	  primary	  amine	  and	  two	  alkyne	  
functionalities	  (primary	  amine	  /	  alkyne)	  permitted	  the	  “click”	  of	  two	  azide	  terminated	  PBLG	  
chains	  and	  formation	  of	  the	  resultant	  AB2	  type	  miktoarm	  polypeptide	  based	  system.71	  	  
	  
1.2.1.4	  	  	  	  	  Polypeptides	  from	  Other	  Multifunctional	  Molecules	  
Polypeptide	  growth	  from	  amino	  functionalised	  chromophores	  has	  led	  to	  the	  facile	  preparation	  
of	   fluorescently	   labelled	   star	   polypeptides,	   a	   feature	   with	   particular	   relevance	   in	   the	  
biomedical	   field,	   namely	   materials	   for	   flourescent	   probes.72	   Perylene	   derivatives	   employing	  
four	  primary	  amines	  at	  the	  periphery	  were	  used	  to	  generate	  chromophoric	  star	  polypeptides	  
comprising	   of	   four	   PBLG	   or	   PZLL	   arms	   (Figure	   1.4).73,74	   The	   resultant	   polypetides	   however,	  
particularly	  PZLL	  had	  broad	  molecular	  weight	  distributions,	   low	  yields	  and	  molecular	  weights	  
inconsistent	  with	  the	  theoretical	  values.	  In	  particular,	  long	  polypeptide	  chains	  (number	  of	  units	  
>	  200)	  were	  uncontrolled	  and	  could	  not	  achieve	  their	  desired	  molecular	  weights.	  The	  authors	  
speculate	   this	  was	   possibly	   due	   to	   unwanted	   chain-­‐breaking,	   chain	   transfer	   and	   termination	  
reactions	   although	   the	   rigid	   atructure	   of	   this	   multifunctional	   initiator	   may	   also	   hamper	  




Figure	  1.4:	  Amino	  terminated	  perylene	  derivative	  for	  NCA	  ROP	  to	  form	  star	  shaped	  
fluorescent	  polypeptides.73,74	  
Although	   not	   as	   widely	   investigated	   as	   a	   class	   of	   initiator,	   several	   other	   examples	   of	  
multifunctional	  amino	  terminated	  molecules	  for	  NCA	  ROP	  have	  been	  reported.	  These	  initiators	  
are	   of	   a	  wide	   variety	   of	   chemical	   compositions	   and	   capable	   of	   generating	   star	   polypeptides	  
possessing	  multiple	   polypeptide	   arms	   (Figure	   1.5).	   The	   NCAs	   employed	   in	   conjunction	   with	  
these	   initiators	   include	   BLG,	   BA	   (β-­‐benzyl-­‐L-­‐aspartic	   acid)	   and	   EG2-­‐L-­‐glutamate	   (diethylene	  
glycol-­‐L-­‐glutamate).	   In	  terms	  of	  composition,	  cyclotriphosphazenes	  have	  led	  to	  the	  successful	  
polymerization	  of	  NCAs	  to	  generate	  star	  polypeptides.75,76	  Similarly,	  polypeptide	  growth	  from	  
the	   amino	   side	   chain	   of	   linear	   PLL	   produced	   densely	   branched	   materials	   comprising	   100%	  
polypeptide.77	   Although	   such	   materials	   allowed	   for	   versatility	   in	   branching	   density	   the	  
polymers	  were	   limited	   by	   their	   inferior	   structural	   control.	   Concerning	   cyclotriphosphazenes,	  
although	  polypeptide	  growth	  is	  readily	  achieved,	  these	  materials	   lack	  the	  structural	  flexibility	  
and	  synthetic	  control	  associated	  with	  a	  dendrimer	  derived	  star	  polypeptide.	  More	  recently,	  the	  
generation	  of	  anionic	  and	  cationic	  star	  shaped	  polypeptides	  derived	  from	  the	  ROP	  of	  BLG	  and	  
ZLL	   NCAs	   by	   polymerization	   from	   an	   amino	   terminated	   multifunctional	   cyclodextrin	   and	  
porphyrin	  /	  polyester	  moiety	  respectively	  were	  reported.78,79	  The	  described	  star	  polypeptides	  
exhibited	   broadened	   PDIs	   (1.3	   –	   1.5)	   whilst	   initial	   results	   demonstrated	   some	   control	   over	  
polypeptide	   density.	   Removal	   of	   protecting	   groups	   afforded	   star	   shaped	   poly(glutamic	   acid)	  





Figure	  1.5:	  Polylysine	  (left)	  and	  cyclotriphosphazene	  (right)	  based	  initiators	  for	  the	  primary	  
amine	  initiated	  ROP	  of	  NCAs.75-­‐77	  
	  
1.2.2	  	  	  	  	  Convergent	  Approach	  
The	  convergent	  or	  “arm	  first”	  approach	  generally	  describes	  the	  generation	  of	  star	  polymers	  by	  
“stitching”	   linear	   polymeric	   arms	   to	   a	   core	   via	   a	   multifunctional	   linking	   agent.	   This	  
methodology	   initially	   employs	   the	   synthesis	   of	   living	   linear	   polymeric	   arms	   which	   permit	  
further	   reactivity	   with	   a	   suitable	   linking	   agent.	   As	   a	   consequence	   of	   the	   independent	   arm	  
synthesis,	  conventional	  characterization	  of	  arm	  and	  final	  star	  product	  can	  be	  carried	  out.	  Due	  
to	  its	  often	  quantitative	  nature,	  arm	  length	  and	  star	  polymer	  functionality	  can	  be	  readily	  and	  
accurately	   determined	   whilst	   accurate	   arm	   number	   determination	   remains	   challenging	   and	  
imprecise.80-­‐82	   	  In	   spite	   of	   the	   synthetic	   ease	   and	   excellent	   control	   afforded,	   the	   convergent	  
approach	  does	  pose	  several	  difficulties	  including	  extended	  linking	  reaction	  time	  and	  the	  need	  
to	  remove	  unreacted	  linear	  arms	  often	  using	  the	  crude	  purification	  process	  of	  fractionation.	  
1.2.2.1	  	  	  	  	  Core	  Cross	  Linked	  Star	  (CCS)	  Polypeptides	  from	  NCA	  
The	  convergent	  approach	  for	  star	  polypeptide	  synthesis	  is	  an	  area	  of	  growing	  interest	  in	  recent	  
times.	   In	   particular,	   the	   Qiao	   group	   has	   intensively	   researched	   this	   area	   reporting	   star	  
polypeptides	   or	   CCS	   polymers	   based	   wholly	   on	   polypeptides	   derived	   from	   NCAs.83,84	   Their	  
approach	   involved	  the	  HMDS	   initiated	  synthesis	  of	   linear	  PZLL	  or	  PBLG	  arms	  and	  subsequent	  
crosslinking	   of	   these	   arms	   with	   L-­‐cystine	   NCA	   (Scheme	   1.7).	   Removal	   of	   the	   polypeptide	  
protecting	   groups	   afforded	  water	   soluble	   star	   polypeptides	   possessing	   amino	   and	   carboxylic	  
acid	  functionalised	  arms.	  As	  well	  as	  the	  arms,	  functionality	  is	  also	  present	  in	  the	  core	  owing	  to	  
the	   presence	   of	   unreacted	   NCA	   species	   from	   the	   core	   crosslinking	   agent.	   This	   feature	   was	  
utilised	  to	   introduce	  further	   functionality	  such	  as	  alkyne,	  alkyl	  and	  even	  fluorescent	  moieties	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into	  the	  core	  via	  an	  NCA	  reactive	  amino	  group.	  In	  terms	  of	  structural	  control,	  a	  vast	  library	  of	  
described	  CCS	  polypeptides	  were	  readily	  prepared	  boasting	  arm	  number	  (3	  –	  349),	  molecular	  
weight	   (6	   –	   15	   kDa),	   core	   size	   and	   total	   star	   molecular	   weight	   control.	   Star	   formation	   was	  
readily	   monitored	   in	   real	   time	   by	   1H	   NMR	   spectroscopy	   and	   SEC	   further	   highlighting	   the	  
absolute	  control	  offered	  by	  this	  methodology.	  As	  expected,	  CCS	  molecular	  weight	  distributions	  
(PDI:	   1.2	   –	   1.6)	   did	   broaden	   in	   comparison	   to	   linear	   polypeptide	   arms	   (PDI:	   <	   1.1)	   and	  
contained	  residual	  unreacted	  linear	  arm,	  a	  feature	  typical	  of	  CCS	  polymer	  preparation.	  The	  use	  
of	  DTT	   to	  cleave	  disulphide	  bonds	   is	  well	   known,	   therefore	   its	  use	   in	  conjunction	  with	   these	  
disulphide	  cored	  CCS	  polymers	  afforded	  star	  polymer	  degradation	  and	  in	  some	  cases	  triggered	  
the	  formation	  of	  macroscopic	  structures	  i.e.	  organogels.	  The	  beauty	  of	  this	  methodology	  is	  the	  
ample	   versatility	   permitted	   through	   the	   choice	   of	   NCA/	   polypeptide	   arm	   and	   initiator.	   For	  
example	  Qiao	   et	   al.,	   through	   their	   use	   of	   a	   bifunctional	   initiator,	   have	   further	   expanded	   on	  
their	  work	   to	   include	  CCS	  polymers	  with	  peripheral	  alkene	   functionality,	  a	   feature	   they	  have	  
utilized	   for	   thiol-­‐ene	   “click”	   chemistry	   of	   thiol	   functionalized	   poly(ethylene	   glycol)	   (PEG).85	  
Similarly,	  the	  employment	  of	  an	  amino	  functionalised	  PEG,	  served	  as	  an	  initiator	  for	  the	  ROP	  of	  






Scheme	  1.7:	  Synthesis	  of	  amino	  acid	  based	  CCS	  polymers.	  HMDS	  initiated	  ROP	  of	  lysine	  NCA	  
afforded	  linear	  poly(lysine).	  The	  cystine	  NCA	  derivative	  acted	  as	  a	  crosslinker	  resulting	  in	  the	  
formation	  of	  CCS	  polymers	  with	  an	  amino	  acid	  core	  and	  poly(lysine)	  arms.	  Core	  
functionalization	  was	  permitted	  by	  conjugation	  of	  amino	  functionalized	  moieties	  to	  any	  
unreacted	  core	  NCAs.83	  
	  
CCS	   polymers	  with	   polypeptide	   periphery	   and	   styrene	   cores	  were	   synthesized	   via	   the	   cross-­‐
linking	  of	  styrenic	  terminated	  PBLG	  arms	  with	  divinylbenzene.87	  Styrenic	  terminated	  PBLG	  was	  
generated	  using	  4-­‐vinyl	  benzylamine	  as	  initiator	  for	  BLG	  NCA	  ring	  opening	  polymerization	  and	  
the	  resultant	  arms	  were	  crosslinked	  with	  varying	  feed	  ratios	  of	  divinylbenzene	  in	  a	  free	  radical	  
polymerization	  or	  RAFT	  process.	  Star	   formation	  was	  readily	   followed	  using	  SEC	   from	  which	  a	  
range	  of	  high	  molecular	  weight	   (200	   kDa	  –	  10000	  kDa)	  CCS	  polymers	  were	   synthesised.	   The	  




1.2.2.2	  	  	  	  	  	  Multifunctional	  Linking	  of	  Linear	  Polypeptides	  
Apart	   from	   CCS	   polymers,	   the	   “arm	   first”	   approach	   towards	   star	   polypeptides,	   was	   further	  
investigated	  using	   alkyne	   terminated	  PBLG	  and	  multifunctional	   azide	   terminated	   	   polyhedral	  
oligomeric	   silsesquioxane	   (POSS).88	   Click	   chemistry	   efficiency	  was	   confirmed	  by	   1H	  NMR	  and	  
13C	   NMR	   spectroscopy,	   generating	   POSS	   decorated	   with	   multiple	   polypeptide	   arms.	  
Furthermore,	  Hadjichristidis	  et	  al.	  used	  a	  trifunctional	  isocyanate	  linking	  agent	  to	  couple	  PBLG-­‐
b-­‐PZLL	  linear	  arms	  to	  this	  small	  core	  (Scheme	  1.8).89	  The	  3-­‐armed	  polymers	  synthesized	  using	  
this	   methodology	   displayed	   unprecedented	   homogeneity	   and	   excellent	   stoichiometric	  
molecular	  weight	  agreement.	  
	  
Scheme	  1.8:	  Synthesis	  of	  a	  3-­‐armed	  PBLG-­‐b-­‐PZLL	  star	  polypeptide	  by	  coupling	  of	  preformed	  


















1.3	  	  	  	  	  NCA	  Derived	  Star	  Polypeptides	  for	  Delivery	  of	  Therapeutics	  
The	   field	   of	   nanomedicine	   and	   in	   particular	   the	   use	   of	   synthetic	   materials	   within	   this	  
biomedical	   context	   has	   promoted	   materials/polymers	   to	   the	   forefront	   of	   nanotechnology	  
research	  in	  the	  quest	  for	  the	  next	  generation	  of	  “smart”	  materials.90	  Nanomedicine	   is	   itself	  a	  
broad	   field	   encompassing	   the	   strategic	   use	   of	   nanotechnology	  within	   the	   healthcare	   sector.	  
Applications	  include	  regenerative	  medicine,91	  drug	  delivery,92	  imaging	  93-­‐95	  and	  diagnostics.96-­‐98	  
The	   idea	   of	   targeted	   drug	   delivery	   or	   Ehrlich’s	   “magic	   bullet”	   concept	   has	   generated	   great	  
interest	   in	  this	  area	  owing	  to	  the	  wealth	  of	  potential	   therapeutic	  and	  administrative	  benefits	  
involved.99	   Targeted	   drug	   delivery	   has	   the	   potential	   to	   enable	   delivery	   of	   potent	   drug	  
molecules	  which	  otherwise	  exhibit	  poor	  biodistribution	  properties,	  improve	  efficacy	  of	  existing	  
drugs,	   reduce	  adverse	   side	  effects	   and	   create	  new	  administrative	  pathways.91,100	   In	   terms	  of	  
materials,	   numerous	   types	   of	   nano	   based	  materials,	   specifically	   designed	   for	   targeted	   drug	  
delivery	  applications	  have	  been	   reported.	  Materials	   include	  dendrimers,101,102	   polymers,103,104	  




Figure	  1.6:	  Materials	  used	  for	  nano-­‐based	  drug	  delivery.90	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In	  addition	  to	  the	  conventional	  drug	  molecules	  employed	  in	  the	  treatment	  of	  disease,	  recent	  
times	  have	  witnessed	  the	  emergence	  of	  plasmid	  DNA	  (pDNA)	  and	  other	  genetic	  material	  as	  an	  
unconventional	  but	  potentially	  effective	  therapeutic	  agent	  for	  the	  treatment	  and	  prevention	  of	  
certain	  diseases.113,114	  These	  “drugs”	  are	  advantageous	  over	  the	  past	  small	  molecule	  type	  drugs	  
in	  that	  they	  could	  potentially	  treat	  all	  diseases	  whilst	  being	  disease	  specific	  therefore	  limiting	  
unwanted	   side	   effects	   observed	   for	   example,	   with	   common	   anticancer	   treatments.115,116	  
Furthermore,	   gene	   therapy	   may	   potentially	   lead	   to	   the	   prevention	   of	   a	   disease	   before	   its	  
presentation	  whereas	   conventional	   drugs	   can	   presently	   only	   aim	   to	   treat	   a	   disease	   after	   its	  
development	  and	  progression.117	  One	  of	  the	  major	  issues	  associated	  with	  gene	  therapy	  is	  the	  
actual	  delivery	  of	  the	  genetic	  therapeutic	  to	  the	  target	  site.	  Vectors	  must	  be	  able	  to	  protect,	  
deliver,	  and	  release	  their	  cargo	  at	  the	  target	  site	  without	  triggering	  an	  immunological	  response	  
themselves.	   Viral	   vectors	   although	   effective	   carry	   the	   safety	   and	   potential	   immunological	  
issues	  associated	  with	  them	  thus	  leading	  to	  intensive	  research	  into	  the	  design	  of	  effective	  non-­‐
viral	  gene	  delivery	  vectors.118	  
Numerous	   polymeric	   based	   materials	   have	   been	   considered	   for	   this	   role.	   In	   particular	  
polypeptide	  based	  materials,	  specifically	  NCA	  derived	  polypeptides	  have	  emerged	  as	  promising	  
candidates	   as	   therapeutic	   delivery	   vehicles	   owing	   to	   their	   inherent	   biocompatibility	   and	  
versatility.119,120	   This	   section,	   will	   specifically	   focus	   on	   the	   applicability	   of	   NCA	   derived	   star	  
polypeptides	  towards	  targeted	  delivery	  of	  therapeutics.	  
The	  versatile	  architectures	  and	  compositions	  of	  NCA	  derived	  star	  polypeptides	  renders	   these	  
materials	  very	  useful	  within	  a	  biomedical	  and	  in	  particular	  a	  therapeutic	  delivery	  context.	  Their	  
unique	  architecture	  and	  polypeptidic	  functionality	  presents	  unique	  opportunities	  for	  potential	  
cargo	   encapsulation,	   cargo	   binding,	   cell	   targeting,	   stimuli	   responsive	   controlled	   release	   and	  
enhanced	  biocompatibility.	  	  
1.3.1	  	  	  	  	  Drug	  Delivery	  
Star	  polypeptides	  from	  branched	  amino	  functionalised	  PEG	  have	  led	  to	  the	  development	  of	  a	  
series	   of	   materials	   capable	   of	   delivering	   a	   wide	   variety	   of	   biologically	   important	   cargoes.	  
Complexation	   of	   cationic	   drug	  molecules	   such	   as	   the	   anti-­‐cancer	   drug	   doxorubicin,	  with	   the	  
anionic	  poly(glutamic	  acid)	  (PGA)	  shell	  of	  star	  shaped	  PEI-­‐PGA-­‐PEI	  resulted	  in	  the	  formation	  of	  
doxorubicin	   loaded	  nanoparticles	  which	  exhibited	  controlled	  release	  upon	  a	  pH	  trigger	   (<	  pH	  
7.4).58	  Drug	   loading	  content	  could	  be	  controlled	  by	  configuring	  the	  PGA	  density.	  Similarly	  the	  
replacement	  of	  PGA	  with	  a	  cationic	  PLL	  afforded	  a	  star	  polypeptide	  capable	  of	  complexation	  
with	   an	   anionic	   drug	   molecule,	   in	   this	   case	   diclofenac	   sodium.59	   Elevated	   pH	   (>	   pH	   7.4)	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provided	  a	  trigger	  for	  drug	  release.	  However	  a	   limitation	  of	  the	  two	  aforementioned	  delivery	  
vehicles	  is	  the	  fragile	  stability	  of	  the	  complexes,	  as	  observed	  by	  leaking	  of	  cargos	  outside	  of	  the	  
pH	   trigger	   range.	   In	  particular	  a	  drug	  delivery	   vehicle	  employing	  a	  pH	   trigger	  of	  >	  7.4	  would	  
find	   very	   limited	   applicability,	   if	   any,	   in	   the	   human	   body.	  More	   promising	   however	  was	   the	  
complexation,	  delivery	  and	  pH	  triggered	  release	  (<	  pH	  7.4)	  of	  a	  model	  anionic	  protein	  such	  as	  
insulin	   using	   PEI-­‐PLL-­‐PEG	   star	   polymer.57	   By	   using	   the	   pH	   functionality	   of	   insulin	   (isoelectric	  
point	   (pI)	   of	   5.4),	   release	   of	   the	   cargo	   at	   a	   potentially	   applicable	   pH	   of	   <5	   was	   realised	   in	  
addition	   to	   effective	   cellular	   uptake.	   Further	   development	   of	   such	  materials	   resulted	   in	   star	  
polypeptides	   capable	   of	   the	   simultaneous	   loading	   with	   both	   hydrophobic	   and	   hydrophilic	  
moieties.	  59	  Encapsulation	  of	  the	  hydrophobic	  pyrene	  was	  permitted	  by	  the	  incorporation	  of	  a	  
poly(phenyl	  alanine)	  inner	  shell	  whereas	  PLL	  and	  PGA	  outer	  shells	  permitted	  encapsulation	  of	  
hydrophilic	  molecules	  such	  as	  doxorubicin	  and	  rose	  bengal	  respectively.	  Again	  pH,	  depending	  
on	   the	   type	   of	   polypeptide	   outer	   shell,	   provided	   the	   trigger	   for	   controlled	   release.	   No	  
hydrophobic	  cargo	  release	  mechanism	  was	  provided,	  however,	  thus	  limiting	  such	  a	  multi	  cargo	  
delivery	  platform.	  	  
PEI-­‐PBLG	   star	   polypeptides	   enabled	   the	   formation	   of	   micelles	   capable	   of	   encapsulating	   pH	  
responsive	  dyes.	  The	  efficient	  encapsulation	  resulted	   in	  the	  reversible	  phase	  transfer	  of	  dyes	  
between	   aqueous	   and	   organic	   solutions.	   Although	   encapsulation	   of	   just	   dyes	  was	   reported,	  
such	  materials	   should	   in	   theory	   be	   able	   to	   replicate	   these	   results	   for	   drug	  molecules.53	  Star	  
shaped	  poly(histidine)	   (PEI-­‐PHis-­‐PEG)	  provided	  a	  branched	  material	   capable	  of	  encapsulating	  
insulin	  with	  impressive	  encapsulation	  efficiency	  via	  the	  cationic/hydrophobic	  imidazole	  ring	  of	  
histidine	  (Figure	  1.7).51	  The	  described	  complexes	  exhibited	  superior	  stability	  towards	  high	  salt	  
concentrations	   and	   particle	   sizes	   capable	   of	   loading	   into	   poly(lactide-­‐co-­‐glycolide)	   (PLGA)	  
microspheres.	  The	  star	  shaped	  poly(histidine)	  offered	   improved	  buffering	  capacity	  within	  the	  
microsphere,	   therefore	   prolonging	  microsphere	   degradation	   to	   afford	   a	   long	   term	   sustained	  
release	  of	   insulin.	   In	  mice	  this	  material	  was	  shown	  to	  effectively	  control	  blood	  glucose	   levels	  




Figure	  1.7:	  Microsphere	  encapsulation	  of	  star	  shaped	  poly(histidine)/insulin	  nanocomplexes.	  
Sustained	  release	  of	  insulin	  was	  afforded	  by	  prolonged	  degradation	  of	  the	  poly(lactide-­‐co-­‐
glycolide)	  	  (PLGA)	  microspheres	  resulting	  in	  effective	  control	  of	  glucose.51	  
Several	  examples	  of	   the	  drug	  delivery	  potential	  of	   star	  polypeptides	  comprising	  a	  dendrimer	  
core	   and	  polypeptide	   periphery	   have	   been	   reported.	  Using	   a	   four-­‐armed	   amino	   terminated,	  
disulphide	   cored	   PAMAM	   dendrimer	   derivative	   with	   a	   diethylene	   glycol-­‐L-­‐glutamate	   outer	  
shell,	   reduction	   and	   thermo	   sensitive	  micelles	   and	   hydrogels	   were	   readily	   prepared	   (Figure	  
1.8).121	   Temperature	   (LCST	   at	   40oC)	   and	   DTT	   triggered	   reduction	   permitted	   micelle	   and	  
hydrogel	  size	  control.	  Release	  of	  doxorubicin	  from	  reduction	  sensitive	  micelles	  was	  shown	  to	  
increase	  the	  release	  rate	  by	  50%	  but	  the	  star	  polypeptide	  exhibited	  a	  more	  prolonged	  release	  
profile	   than	   a	   comparative	   linear	   analogue.	   Such	   an	   effect	   highlights	   the	   benefit	   of	   a	   star	  
architecture	  in	  controlled	  release	  applications.	  In	  spite	  of	  this	  the	  trigger	  specific	  drug	  release	  
was	  questionable	  due	  to	  nonspecific	   release	  of	  doxorubicin	  without	  DTT	   limiting	  the	  realistic	  





Figure	  1.8:	  Dual	  responsive	  micelle	  and	  hydrogel	  behaviour	  of	  star	  shaped	  diethylene	  glycol-­‐
L-­‐glutamate.	  The	  disulphide	  core	  of	  PAMAM	  dendrimer	  and	  diethylene	  glycol	  periphery	  
elicits	  both	  thermo	  and	  reduction	  responsiveness	  towards	  the	  controlled	  release	  of	  
doxorubicin.121	  
	  
The	  potential	  of	  a	  series	  of	  generation	  2	  and	  3	  PAMAM	  dendrimers	  decorated	  biodegradable	  
PGA	  were	   investigated	   as	   drug	   delivery	   vehicles.122	   Albeit	   drug	   encapsulation,	   the	   polymers	  
showed	  susceptibility	  to	  enzymatic	  degradation,	  a	  potential	  release	  stimulus,	  whilst	  selectively	  
targeting	  and	  labelling	  tumorous	  cells.	  The	  polypeptidic	  nature	  of	  these	  materials	  i.e.	  glutamic	  
acid	   rendered	   them	   enzymatically	   sensitive	   and	   the	   branched	   architecture	   prolonged	  
enzymatic	   degradation	   in	   comparison	   to	   linear	   PGA.	   Furthermore	   the	   star	   architecture	  
resulted	   in	   superior	   functionality	   arising	   from	   the	   numerous	   PGA	   arms	   and	   terminal	   amines	  
present	   on	   these	   arms.	   Consequently	   post	   modification	   of	   these	   materials	   was	   readily	  
achieved	  via	  the	  covalent	  attachment	  of	  folic	  acid,	  a	  targeting	  moiety	  for	  cancer	  cells	  typically	  
over	  expressing	  folate	  receptors,	  and	  a	  fluorescent	  moiety	  for	  diagnostic	  purposes.	  	  	  
The	   use	   of	   sugars	   as	   a	   targeting	   moiety	   was	   employed	   by	   Qiu	   et	   al.	   in	   their	   use	   of	   star	  
polypeptide/methacrylate	  hybrids	  as	  polymers	  for	  drug	  delivery.50	  The	  glycol	  moiety	  favoured	  
specific	   targeting	   to	   the	   lectin,	   Concanavalin	   A.	   As	   before	   the	   star	   architecture	   again	  
emphasized	   its	   advantages	   through	   superior	   encapsulation	   efficiency	   and	   prolonged	   drug	  
release	   profile	   as	   opposed	   to	   a	   linear	   counterpart.	   Release	   rate	   was	   triphasic	   however,	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suggesting	  initial	  uncontrolled	  release	  and	  then	  subsequent	  controlled	  release	  of	  doxorubicin	  
by	  diffusion.	  	  
Star	  polypeptides	  of	  4-­‐armed	  PEG-­‐PZLL	  could	  self	  assemble	  to	  form	  vesicles	  and	  were	  shown	  
to	   exhibit	   low	   cytotoxicity	   (cell	   viability	   up	   to	   concentration	   of	   0.5	   g/L).61	   Vesicles	   were	  
successfully	  loaded	  with	  doxorubicin	  and	  the	  anti-­‐cancer	  drug	  loaded	  polymeric	  vesicles	  were	  
effectively	   internalized	  by	  breast	  cancer	  cells.	  Such	  a	  material	   shows	  promise	  as	  an	  effective	  
anti-­‐cancer	  drug	  delivery	  vehicle.	  	  	  	  	  
Amongst	   star	   polypeptides,	   amino	   acid	   based	   CCS	   polymers	   have	   emerged	   as	   leading	  
candidates	  for	  the	  delivery	  of	  chemotherapy	  agents.	  Their	  synthetic	  design	  of	  100%	  amino	  acid	  
composition	   and	   disulphide	   functionalised	   core	   provides	   these	   materials	   with	   potentially	  
superior	   biocompatibility	   and	   specific	   but	   effective	   drug	   release	   triggers.	   Qiao	   et	   al.	   have	  
reported	  a	  CCS	  polymer	  with	  PLL	  arms	  which	  provided	  the	  cationic	  functionality	  required	  to	  aid	  
cell	   internalization.88	   Furthermore	   the	   lysine	   amino	   side	   chain	   enabled	   further	   CSS	   polymer	  
modification	   through	   pegylation,	   fluorescent	   labelling	   and	   attachment	   of	   folic	   acid	   for	   cell	  
targeting.	  Pegylation	  provided	  the	  polymers	  with	  “stealth”	  properties	  further	  enhancing	  their	  
biocompatibility	  and	  effectiveness	  as	  drug	  delivery	  vehicles.123	  The	  polymers	  were	  shown	  to	  be	  
significantly	  biocompatible	  and	  were	  shown	  to	  be	  selectively	  internalized	  by	  breast	  cancer	  cells	  
owing	  to	  the	  use	  of	  a	  folic	  acid	  targeting	  moiety.	   In	  a	  similar	  approach,	  Ding	  et	  al.	  adopted	  a	  
poly(phenylalanine)-­‐b-­‐PEG	  armed	  CCS	  polymer	  for	  the	  cellular	  delivery	  of	  doxorubicin	  (Figure	  
1.9).89	   As	   a	   result	   of	   the	   disulphide	   cross-­‐linked	   core	   a	   suitable	   reducing	   agent	   such	   as	  
glutathione,	   an	   agent	   suspected	   of	   elevated	   concentration	   levels	   in	   certain	   cancerous	   cells,	  
was	   used	   to	   trigger	   the	   release	   of	   doxorubicin.	   Release	   was	   glutathione	   concentration	  
dependent	  but	  more	   importantly,	   release	  was	  only	  observed	   in	  cells	  specifically	   treated	  with	  
glutathione	   highlighting	   the	   site	   specific	   release	   profile	   of	   such	   materials.	   This	   feature	   in	  
combination	   with	   a	   suitable	   targeting	   agent	   identifies	   these	   materials	   as	   truly	   realistic	  




Figure	  1.9:	  Synthesis,	  loading	  and	  triggered	  release	  of	  doxorubicin	  from	  CCS	  polypeptides.	  
The	  hydrophobic	  phenylalanine	  moieties	  of	  the	  CCS	  polymers	  permitted	  loading	  with	  
doxorubicin.	  Release	  was	  triggered	  by	  cleavage	  of	  the	  reduction	  sensitive	  CCS	  polymer	  cores	  
with	  glutathione.89	  
	  
1.3.2	  	  	  	  	  Gene	  Delivery	  
A	  minimum	  prerequisite	   in	   the	  design	  of	  non-­‐viral	   gene	  delivery	   vectors	   is	   that	   the	  material	  
must	   be	   able	   to	   complex	   the	   genetic	   cargo.	   The	  easiest	   and	  most	   common	  way	  of	   doing	   so	  
takes	  advantage	  of	  the	  anionic	  nature	  of	  pDNA,	  siRNA	  etc.	  therefore	  permitting	  the	  formation	  
of	  an	  electrostatic	  complex	  with	  a	  cationic	  vector.	  Complexation	  capacities	  of	  genetic	  material	  
by	   cationic	   vectors	   are	   characterised	   in	   terms	   of	   N/P	   ratio	   i.e.	   ratio	   between	   the	   molar	  
concentration	   of	   amine	   or	   cationic	   charge	   from	   the	   vector	   and	   the	  molar	   concentration	   of	  
phosphate	   or	   anionic	   charge	   from	   the	   genetic	   cargo.	   Considering	   NCA	   derived	   star	  
polypeptides,	   several	   examples	   of	   their	   use	   as	   non-­‐viral	   gene	   delivery	   vectors	   have	   been	  
reported.	   Tian	   et	   al.	   utilised	   a	   branched	   PEG-­‐b-­‐PEI-­‐b-­‐PBLG	   copolymer	   as	   proof	   of	   principle	  
(Figure	  1.10).52,53	  The	  PEI	  segment	  afforded	  complexation	  with	  pDNA	  whereas	  PBLG	  helped	  to	  
introduce	   limited	   biodegradability	   to	   the	   system	   through	   use	   of	   the	   enzyme	   trypsin.	  
Characterization	   of	   the	   complexes	   was	   limited	   however,	   thus	   highlighting	   the	   potential	   but	  
limited	   applicability	   of	   this	   material.	   Similarly	   branched	   PEI-­‐b-­‐PBLG	   successfully	   complexed	  
pDNA	   to	   form	   discrete	   adequately	   sized	   nanocomplexes	   (96	   nm).54	   The	   described	   polymers	  
were	   shown	   to	  effectively	  enhance	  protection	  of	   their	   cargo	   from	  enzymatic	  degradation	  by	  
DNase	   whilst	   also	   showing	   improved	   cytotoxicity	   over	   unmodified	   hyperbranched	   PEI.	  
Furthermore,	   these	   polymers	   displayed	   improved	   transfection	   efficiencies	   over	   PEI	   possibly	  







Figure	  1.10:	  (A)	  PEI-­‐PBLG-­‐PEG	  star	  polymer	  comprising	  a	  branched	  PEI	  core,	  PBLG	  arms	  and	  	  
and	  (B)	  cationic	  micelle	  due	  to	  protonation	  of	  PEI.52	  
	  
Lysine,	  a	  well	   known	  cationic	  amino	  acid	  has	   shown	  great	  promise	  as	  a	  gene	  delivery	  vector	  
owing	   to	   its	   cationic	   character	   and	   potential	   degradability	   and	   biocompatibility.	   The	  
polymerization	   of	   lysine	   NCA	   has	   readily	   led	   to	   the	   development	   of	   several	   poly(lysine)	  
decorated	   dendrimer	   systems	   for	   gene	   delivery.	   A	   series	   of	   G3-­‐PAMAM	   dendrimers	   with	  
variable	  poly(lysine)	  chain	   lengths	  (n	  =	  5,10,20,40)	  were	  readily	  complexed	  with	  pDNA.42	  Star	  
polypeptides	   with	   longer	   poly(lysine)	   chain	   lengths	   were	   shown	   to	   favourably	   interact	   with	  
pDNA	  to	  form	  stronger	  complexes	  as	  determined	  by	  gel	  electrophoresis.	  Cellular	  studies	  were	  
not	   provided	   whereas	   1H	   and	   13C	   NMR	   spectroscopy	   provided	   evidence	   of	   polypeptide	  
conjugation	  to	  dendrimer	  but	  no	  molecular	  weight	  distribution	  or	  size	  analysis	  was	  conducted.	  
More	   recently,	   generation	   4	   PAMAM	   dendrimers	  with	   short	   poly(lysine)	   arm	   lengths	   (2	   –	   6	  
units)	  were	  prepared	  by	  ROP	  of	  	  benzyloxycarbonyl	  lysine	  NCA.124	  Polypeptide	  conjugation	  and	  
the	   arm	   average	   degree	   of	   polymerization	   were	   confirmed	   by	   1H	   NMR	   spectroscopy	  
highlighting	  molecular	  weight	  control	  by	  controlling	  monomer/initiator	  feed	  ratio.	  Removal	  of	  
lysine	  protecting	  groups	  afforded	  cationic	  star	  polypeptides	  capable	  of	  effectively	  complexing	  
pDNA	  at	  low	  N/P	  ratios	  as	  confirmed	  by ζ-	  potential	  and	  agarose	  gel	  electrophoresis.	  DLS	  and	  
AFM	  confirmed	  the	  formation	  of	  desirably	  spherical	  and	  monodisperse	  nano-­‐complexes	  with	  a	  
size	   range	   of	   100-­‐200nm.	   The	   described	   system	   was	   shown	   to	   exhibit	   greatly	   improved	  
cytotoxicity	   and	   transfection	   efficiency	   results	   compared	   to	   linear	   poly(lysine)	   and	   an	  
unmodified	   G4-­‐PAMAM	   dendrimer	   emphasising	   the	   importance	   of	   architecture	   and	  
poly(lysine)	   functionality.	   Furthermore	   the	   stability	   of	   complexes	   towards	   the	   destabilising	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effects	  of	  serum	  was	  evaluated	  with	  star	  shaped	  poly(lysine)	  of	  arm	  length	  3.8	  monomer	  units,	  
displaying	   a	   resistance	   capability	   better	   than	   several	   commercially	   available	   transfection	  
agents.	  The	  potential	  of	  these	  materials	  as	  viable	  transfection	  agents	  was	  investigated	  through	  
the	   delivery	   of	   a	   gene	   responsible	   for	   inhibiting	   the	   development	   of	   restenosis	   in	   a	   rabbit	  
model.	   Inhibition	  of	  this	  ailment	  was	  significantly	  enhanced	  through	  the	  use	  of	  gene	  therapy	  
via	  the	  described	  transfection	  agents.	  	  	  
Star	  shaped	  PEG	  with	  8	  terminal	  amino	  groups	  led	  to	  the	  generation	  of	  a	  cationic	  star	  shaped	  
polypeptide	  through	  ROP	  of	  the	  NCA	  of	  a	  piperidinyl	  derivative	  of	  BLG	  (VB-­‐L-­‐Glu	  NCA)	  (Figure	  
1.11).125	   The	   star	   shaped	   polypeptide,	   PEG-­‐poly(γ-­‐4-­‐((2-­‐(piperidin-­‐1-­‐
yl)ethyl)aminomethyl)benzyl-­‐L-­‐glutamate)(PEG-­‐PPABLG)	   in	   comparison	   to	   suitable	  
homopolymer,	   diblock,	   triblock	   and	   graft	   architectures	   demonstrated	   an	   enhanced	   DNA	  
condensation	  capacity	  most	  likely	  attributable	  to	  a	  higher	  density	  of	  cationic	  polymeric	  arms.	  
However,	  the	  described	  polymer	  exhibited	  lower	  cytotoxicity	  whilst	  exhibiting	  overall	  superior	  
transfection	   efficiencies	   highlighted	   by	   its	   3-­‐134	   fold	   increase	   in	   transfection	   efficiency	  
performance	  over	  the	  commercially	  available	  lipofectamine.	  Such	  a	  feature	  demonstrates	  the	  
significant	   role	   of	   polymer	   architecture	   in	   the	   molecular	   design	   of	   new	   gene	   transfection	  




Figure	  1.11:	  Different	  architectures	  of	  PEG-­‐PPABLG	  conjugates	  as	  gene	  transfection	  agents.	  
Cationic	  functionality	  was	  introduced	  via	  a	  piperidinyl	  derivative	  of	  BLG	  NCA	  and	  its	  
subsequent	  polymerization	  with	  linear	  and	  branched	  amino	  terminated	  PEG	  derivatives	  
afforded	  a	  range	  of	  cationic	  star	  shaped	  architectures.	  125	  
	  
The	   growth	   of	   PBLG	   from	   a	   G2-­‐PAMAM	   dendrimer	   and	   subsequent	   aminolysis	   with	   G1-­‐
PAMAM	   dendrimers	   resulted	   in	   a	   system	   comprising	   a	   G2-­‐PAMAM	   dendrimer	   core,	  
polypeptide	   inner	   shell	   and	   a	   G1-­‐PAMAM	   periphery	   (Figure	   1.12).126	   The	   described	   vector,	  
known	  as	  ALA,	  could	  effectively	  compact	  pDNA	  into	  monodisperse	  cationic	  complexes	  <200nm	  
in	  size,	  something	  which	  the	  individual	  constituents	  of	  ALA	  could	  not.	  ALA	  displayed	  negligible	  
cytotoxicity	  but	  more	   importantly	  however	  exhibited	  unprecedented	  transfection	  efficiencies	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in	  the	  presence	  of	  serum.	  Serum	  was	  actually	  shown	  to	  improve	  the	  transfection	  efficiencies	  of	  
ALA,	   a	   feature	   particularly	   prevalent	   in	   the	   actual	   real	   world	   application	   of	   vectors	   in	   the	  
human	  body.	  Consequently	  such	  a	  feature	  differentiates	  this	  material	  from	  the	  other	  reported	  
polycationic	  gene	  delivery	  vectors.	  	  
	  
	  
Figure	  1.12:	  ALA	  as	  a	  vector	  for	  pDNA	  transfection.	  The	  generation	  of	  star	  shaped	  PBLG	  was	  
accomplished	  using	  the	  generation	  2	  PAMAM	  initiated	  ROP	  of	  BLG	  NCA.	  Aminolysis	  of	  the	  
PBLG	  arms	  with	  generation	  1	  PAMAM	  dendrimer	  moieties	  resulted	  in	  a	  star	  shaped	  
polypeptide	  with	  peripheral	  dendrimer	  functionalisation	  for	  the	  electrostatic	  mediated	  
complexation	  of	  pDNA.126	  
	  
To	  conclude,	  the	  generation	  of	  star	  shaped	  polymers	  in	  particular	  polypeptides	  can	  be	  realized	  
through	  the	  use	  of	  a	  number	  of	  different	  strategies	  to	  afford	  a	  wide	  range	  of	  novel	  functional	  
materials.	  The	  potential	  applicability	  of	  such	  materials	  towards	  the	  area	  of	  therapeutic	  delivery	  
has	   already	   been	   demonstrated	   and	   and	  will	   continue	   to	   develop	  with	   the	   advent	   of	  more	  
advanced	   novel	  materials.	   The	   aim	   of	   this	   thesis	   herein,	   is	   to	   develop	   a	   range	   of	   novel	   star	  
shaped	   polymer	   platforms,	   boasting	   versatile	   functionality,	   compostion	   and	   architecture	   for	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Well-­‐defined	   star	   polypeptides	   were	   successfully	   synthesised	   by	   initiation	   of	   γ-­‐benzyl-­‐L-­‐
glutamate	   N-­‐carboxyanhydride	   (NCA)	   from	   polypropylene	   imine	   (PPI)	   dendrimers.	   The	  
dendrimer	  generation	  and	   the	  dendrimer	   to	  NCA	   ratio	  was	   systematically	  varied	   to	  afford	  a	  
range	   of	   star	   shaped	   architectures	   with	   a	   maximum	   of	   8	   to	   64	   poly(γ-­‐benzyl-­‐L-­‐glutamate)	  
(PBLG)	   arms.	   High	  molar	   masses	   up	   to	   500	   000	   g/mol	   were	   achieved	   that	   were	   otherwise	  
unobtainable	  for	  the	  analogous	  linear	  polypeptides	  in	  the	  absence	  of	  the	  dendrimer	  core.	  By	  
deprotection	  the	  PBLG	  star	  polypeptides	  were	  converted	  into	  poly(L-­‐glutamic	  acid)	  (PGA)	  star	  
polypeptides.	   Various	   concentrations	   of	   rhodamine	   B	   could	   be	   loaded	   into	   the	   polypeptide	  
star	   architectures	   dependent	   on	   the	   number	   of	   PGA	   arms	   and	   the	   length	   of	   the	   grafted	  
polypeptide	  chain	  produced.	  Furthermore,	  the	  polypeptidic	  nature	  of	  PGA-­‐grafted	  dendrimers	  
ensures	   their	   responsiveness,	   through	   controlled	   degradation,	   to	   the	   target	   enzyme	  
thermolysin.	   An	   enzyme-­‐responsive	   release	   mechanism	   was	   devised	   and	   demonstrated	   in	  
which	   rhodamine	   B	   payload	   was	   released	   upon	   incubation	   with	   thermolysin	   but	   not	   the	  
control	  enzyme	  chymotrypsin.	  The	  rate	  and	  extend	  of	  rhodamine	  B	  release	  was	  dependent	  on	  
the	  composition	  of	  the	  hybrid	  material,	  which	  can	  be	  readily	  tuned	  to	  provide	  highly	  specific	  
temporal	  and	  spatial	  controlled	  release.	  	  
This	  work	  was	  published	  in	  Polymer	  Chemistry	  (2012),	  3(10),	  2825-­‐2831.	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2.1	  	  	  	  Introduction	  	  
N-­‐carboxyanhydride	   (NCA)	   ring-­‐opening	   polymerization	   (ROP)	   enables	   the	   creation	   of	  
synthetic	   polypeptides	   to	   a	   targeted	   molar	   mass	   in	   a	   highly	   controlled	   manner.1-­‐3	   Such	  
materials	  have	  demonstrated	  their	  potential	  biomedical	  applicability4	  in	  areas	  including	  tissue	  
engineering,5	   drug	   delivery,6,7	   medical	   adhesives,8	   antimicrobial	   agents,9	   and	   biorecognition	  
applications10-­‐14	   emphasising	   the	   significance	   of	   NCA	   polymerisation	   within	   a	   biomedical	  
context.	  Researchers	  have	  recently	  begun	  to	  further	  increase	  the	  macromolecular	  complexity	  
of	   synthetic	   polypeptides	   in	   order	   to	   stimulate	   self-­‐assembly	   into	   micelles	   and	   vesicles	  
(polymersomes)	   as	   potential	   drug	   delivery	   vehicles.15-­‐19	  However,	   the	   dynamic	   behaviour	   of	  
these	  assemblies	  puts	  some	  limitations	  on	  their	  stability	  under	  certain	  conditions.	  	  
Star	  polypeptides	  offer	  an	  attractive	  alternative	  as	  unimolecular	  nanoparticles	  in	  drug	  delivery	  
and	  offer	  a	  high	  local	  density	  of	  polypeptide	  chains	  within	  a	  single	  macromolecule.	  Following	  
synthetic	   strategies	   developed	   initially	   for	   controlled	   polymerisations20-­‐22	   nanogel	   star	  
polypeptides,	   i.e.	   polypeptides	   emanating	   from	   a	   cross-­‐linked	   core	   have	   been	   reported	  
recently.23-­‐25	  Alternatively,	  star	  shaped	  polypeptides	  can	  be	  generated	  by	  NCA	  polymerisation	  
from	   a	   multifunctional	   initiator.	   Of	   particular	   interest	   to	   our	   group	   are	   amine-­‐terminated	  
dendrimers	   that	  have	  the	  potential	   to	   initiate	   the	  ring	  opening	  polymerisation	  of	  amino	  acid	  
NCAs	   to	  generate	  high	  molar	  mass	  homopolypeptides	  grafted	   to	   the	  dendritic	  core.	  Polymer	  
grafting	  from	  a	  dendritic	  core	  enables	  the	  formation	  of	  a	  polymer-­‐dendrimer	  hybrid,	  the	  size,	  
shape,	  and	  surface	  features	  of	  which	  may	  be	  readily	  controlled	  to	  modify	  its	  payload	  capacity,	  
biodistribution	  and	  pharmacokinetic	  properties	  in	  controlled	  release	  applications.	  	  
Early	   reports	  on	   the	  concept	  of	  NCA	   initiation	   from	  multifunctional	   initiators	  were	  published	  
by	   Inoue	   for	   the	   synthesis	   of	   a	   six-­‐arm	   poly(γ-­‐benzyl-­‐L-­‐aspartate)	   from	  
cyclotriphosphazene.26,27	  Müllen	   employed	   polyphenylene	   dendrimers	   with	   up	   to	   16	   amino	  
groups	  for	  the	  polymerisation	  of	  lysine	  NCA.28	  Hyper-­‐branched	  poly(ethyleneimine)s	  (PEI)	  with	  
approximately	   15	   and	   60	   amino	   groups	   were	   used	   to	   synthesise	   star-­‐shaped	   poly(L-­‐lysine)	  
(PLL)	   and	   poly(L-­‐glutamic	   acid)	   (PLG)	   by	   Liu	   for	   drug	   encapsulation	   and	   biomineralisation	  
applications.29,30	  Appelhans	  reported	  the	  synthesis	  of	   low	  molar	  mass	  polypeptide	  shells	  from	  
dendrimers	  bearing	  eight	  amine	  initiation	  sites	  to	  form	  star	  shaped	  polypeptides	  for	  metal	  ion	  
complexation	   purposes.31	   Higashi	   utilised	   a	   third	   generation	   poly(amidoamine)	   (PAMAM)	  
dendrimer	   to	   produce	   star	   shaped	   poly(γ-­‐benzyl-­‐L-­‐glutamate)	   (PBLG)	   and	   subsequently	  
examined	   its	   applicability	   for	   amino	   acid	   encapsulation.32	   The	   same	   author	   also	   reported	  
oligo(L-­‐lysine)	   shelled	   third	   generation	   PAMAM	   for	   DNA	   binding.33	   A	   fourth	   generation	  
PAMAM	   (64	   amino	   groups)	   was	   employed	   by	   Feng	   to	   graft	   PLL	   with	   an	   average	   degree	   of	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polymerisation	  of	  6	  units	  per	  arm	  from	  the	  dendritic	  core.34	  It	  was	  shown	  that	  these	  polymers	  
act	  as	  efficient	  gene	  vectors	  for	  plasmid	  DNA.	  
Consequently,	   we	   believe	   that	   expanding	   this	   concept	   of	   polypeptide	   synthesis	   from	   a	  
dendritic	   core	   may	   enable	   the	   creation	   of	   polypeptides	   possessing	   systematically	   variable	  
architecture	  boasting	  previously	  unreported	  molar	  masses	   that	  may	  be	   tuned	  dependent	  on	  
the	  number	  of	  initiator	  sites	  present	  on	  the	  dendritic	  core,	  and	  the	  quantity	  of	  amino	  acid	  NCA	  
within	  the	  monomer	  feed.	  Furthermore,	  their	   larger	  size	  may	  result	   in	  an	  increased	  ‘payload’	  
capacity	  and	  an	  inherent	  capability	  to	  non-­‐covalently	  withhold	  a	  specific	  quantity	  of	  a	  chosen	  
molecular	  cargo	  dependent	  on	  the	  dimensions	  of	  the	  material	  produced.	  This	  hybrid	  structure	  
may	   possess	   the	   capability	   to	   actuate	   a	   designed	   material	   response	   such	   as	   pH-­‐controlled	  
swelling	  and	  enzyme	  regulated	  release	  of	  a	  molecular	  ‘cargo’,	  thereby	  providing	  bioresponsive	  
carriers.	  	  
In	   this	   chapter	  we	  present	   a	   systematic	   study	   in	  which	   homopolypeptide-­‐dendrimer	   hybrids	  
can	  be	  synthesised	  with	  a	  particularly	  low	  dispersity	  (D)	  and	  high	  molar	  masses	  irrespective	  of	  
the	   dendrimer	   generation.	   We	   further	   show	   enzyme	   responsiveness	   to	   particular,	   targeted	  
proteolytic	   enzymes;	   payload	   release	   is	   only	   instigated	   upon	   polypeptide	   degradation	  
following	   its	  reaction	  with	  a	  target	  enzyme,	  and	  the	  rate	  and	  extent	  of	  release	   is	  dictated	  by	  
















2.2	  	  	  	  Results	  and	  Discussion	  
2.2.1	  Star	  Polypeptide	  Synthesis	  
The	  use	  of	  primary	  amines	  to	  initiate	  the	  ROP	  of	  α-­‐amino	  acid	  NCAs	  to	  synthesise	  well-­‐defined	  
synthetic	   linear	   polypeptides	   is	   well	   understood.1,2,35,36	   By	   utilising	   this	   methodology	   it	   was	  
possible	   to	   combine	   NCA	   monomers	   with	   an	   amine	   terminated	   dendrimer	   to	   create	  
polypeptide	   star	  polymers	   containing	  a	  dendrimer	   core	  and	  a	  polypeptide	   shell	   (Figure	   2.1).	  
Benzyl-­‐L-­‐glutamate	  (BLG)	  was	  selected	  as	  a	  suitable	  amino	  acid	  NCA	  due	  to	  the	  carboxylic	  acid	  
functionality	  it	  presented	  upon	  side	  chain	  deprotection,	  and	  to	  highlight	  the	  versatility	  that	  the	  
system	  offers.	  PPI	  dendrimers	  of	  generation	  2	  (G2;	  8	  terminal	  amines)	  up	  to	  generation	  5	  (G5;	  
64	  terminal	  amines)	  were	  employed	  to	  generate	  star	  shaped	  polypeptides	  whose	  size,	  shape,	  
arm	  length	  and	  molar	  mass	  could	  be	  configured	  by	  varying	  the	  dendrimer	  generation	  and	  the	  
monomer	  feed	  ratio	  (Figure	  2.1).	  	  
	  
Figure	  2.1:	  Diversity	  of	  synthesized	  star	  polypeptides	  and	  reaction	  scheme	  of	  for	  the	  
synthesis	  of	  poly(L-­‐glutamic	  acid)	  star	  polypeptides	  using	  second	  generation	  PPI	  dendrimer	  




In	   the	   initial	   series	   of	   polymerisations	   the	   NCA	   to	   individual	   amino	   group	   ratio	   was	   kept	  
constant	   at	   40,	   i.e.	   the	   ratio	   of	   NCA	   was	   increased	   with	   increasing	   dendrimer	   generation	  
(entries	  4-­‐7,	  Table	  2.1).	  The	  star	  polymers	  produced	  in	  this	  series	  have	  a	  constant	  arm	  length	  
but	  with	  an	  increasing	  number	  of	  arms,	  the	  total	  molar	  mass	  increases	  systematically	  with	  the	  
increasing	  dendrimer	  generation.	  As	  can	  be	  seen	  from	  Figure	  2.2,	  excellent	   linear	  correlation	  
between	   the	   polymer	   molar	   mass	   increase	   and	   the	   number	   of	   initiating	   amino	   groups	  
(dendrimer	   generation)	   was	   found.	   This	   linearity	   indicates	   that	   monomer	   conversion	   was	  
uniform,	  which	  may	  not	  have	  been	  expected,	  given	  that	  the	  number	  of	  initiating	  arms	  differs	  
significantly	  between	  dendrimer	  generations.	  While	  the	  reactions	  were	  typically	  carried	  out	  for	  
24	  h	  it	  was	  noted	  that	  even	  after	  6	  h	  the	  maximum	  molar	  mass	  was	  obtained	  for	  the	  complete	  
range	  of	  dendrimer	  generations.	  
	  
Table	  2.1:	  Star-­‐shaped	  PBLG	  by	  initiation	  from	  PPI	  dendrimers	  (L:	  linear	  initiator	  
benzylamine;	  G1-­‐G5:	  generation	  of	  PPI	  dendrimer;	  G5(64)-­‐PBLG40	  =	  initiator	  generation	  5	  
dendrimer	  with	  maximum	  64	  arms	  and	  theoretical	  arm	  length	  of	  40	  amino	  acids)	  Dispersities	  
of	  all	  polymers	  <	  1.2	  (SEC	  MALS	  detection).	  
Entry	   Polymer	   NCA/NH2	  	   NCA/dendrimer	   Mw/g	  mol-­‐1(a)	   Mnth	  (b)/g	  mol-­‐1	  
1	   L(1)-­‐PBLG640	   640	   640	   47	  500	   140	  000	  
2	   L(1)-­‐PBLG2560	   2560	   2560	   55	  000	   500	  000	  
3	   G2(8)-­‐PBLG60	   60	   480	   91	  700	   105	  400	  
4	   G2(8)-­‐PBLG40	   40	   320	   63	  200	   70	  500	  
5	   G3(16)-­‐PBLG40	   40	   640	   110	  700	   141	  000	  
6	   G4(32)-­‐PBLG40	   40	   1280	   240	  800	   282	  500	  
7	   G5(64)-­‐PBLG40	   40	   2560	   499	  800	   565	  000	  
8	   G5(64)-­‐PBLG20	   20	   1280	   227	  300	   286	  200	  
9	   G5(64)-­‐PBLG7.5	   7.5	   480	   92	  900	   111	  400	  
10	   G2(8)-­‐PBLG12.5	   12.5	   100	   24	  900	   22	  500	  
11	   G3(16)-­‐PBLG6.3	   6.3	   100	   24	  400	   23	  500	  
12	   G4(32)-­‐PBLG3.1	   3.1	   100	   27	  800	   25	  320	  
13	   G5(64)-­‐PBLG1.6	   1.6	   100	   28	  900	   29	  000	  
	  
(a)	  determined	  by	  SEC	  (DMF)	  using	  MALS	  detection	  using	  the	  dn/dc	  of	  linear	  PBLG	  of	  0.118.	  
(b)	   calculated	   assuming	   initiation	   from	   all	   amino	   groups	   and	   quantitative	   conversion:	  




These	   results	  adhere	   to	   the	   recent	  work	  of	  Habraken	  et	  al.	  who	  concluded	  that	  a	   linear	  BLG	  
NCA	   polymerization	   reaction	   at	   20	   °C	   and	   a	   degree	   of	   polymerization	   (DP)	   of	   40	   requires	  
approximately	   3	   h	   for	   complete	   monomer	   conversion.36	   Despite	   the	   fact	   that	   a	   G2-­‐PPI	  
dendrimer	  has	  only	  8	  points	  of	  initiation	  compared	  to	  the	  64	  of	  a	  G5-­‐PPI	  dendrimer	  it	  appears	  
that	   both	   have	   similar	  monomer	   conversion	   times	   suggesting	   that	   the	   amino	   groups	   on	   the	  
dendrimer	   act	   as	   individual	   initiators	   similar	   to	   conventional	   amines.	   These	   star	   shaped	  
polypeptides	   could	   be	   synthesised	   up	   to	   very	   high	   molar	   masses,	   which	   were	   otherwise	  
unobtainable	   in	   the	   absence	   of	   the	   dendritic	   core.	   Deming	   reported	   the	   synthesis	   of	   linear	  
PBLG	   with	   molar	   masses	   as	   high	   as	   Mn	   =	   300	   000	   g/mol	   using	   metal	   based	   initiators.37	  
However,	  molar	  masses	  comparable	  to	  the	  described	  star	  shaped	  polypeptides	  of	  almost	  500	  
000	  g/mol	   for	   the	  G5	  dendrimer	   cannot	  be	   readily	   synthesised	  using	  a	   linear	  primary	  amine	  
initiator	  and	  the	  same	  NCA	  to	  amino	  group	  ratio	  in	  both	  CHCl3	  and	  DMF	  even	  after	  a	  reaction	  
time	  of	  6	  days	   (entries	   1	   and	  2,	   Table	   2.1).	  The	   fact	   that	  molar	  masses	  were	   typically	   lower	  
than	  the	  theoretical	  value	  for	  PBLG	  may	  be	  attributed	  to	  the	  use	  of	  linear	  PBLG	  dn/dc	  values.	  It	  
is	  also	  thought	  that	  the	  PPI	  core	  did	  not	  contribute	  significantly	  to	  the	  overall	  dn/dc	  values	  of	  




Figure	  2.2:	  Weight	  average	  molar	  mass	  (Mw)	  of	  star-­‐shaped	  PBLG	  obtained	  by	  initiation	  of	  
NCA	  from	  different	  generation	  PPI	  dendrimers:	  ! 	  increasing	  NCA	  to	  dendrimer	  ratio	  (Inset	  




The	  versatility	  of	  the	  polymerisation	  was	  further	  investigated	  in	  a	  series	  of	  reactions	  in	  which	  
the	   total	   ratio	   of	   NCA	   to	   PPI	   dendrimers	  was	   kept	   constant	   (entries	   10-­‐13,	   Table	   2.1).	   This	  
results	  in	  a	  decreasing	  NCA	  to	  amino	  group	  ratio	  with	  increasing	  dendrimer	  generation.	  As	  can	  
be	  seen	  in	  Figure	  2.2,	  the	  polymers	  of	  this	  series	  have	  a	  constant	  total	  molar	  mass	  with	  more	  
but	   shorter	   arms	   as	   the	   dendrimer	   generation	   increases.	   Polymers	   of	   low	  molar	  mass	  were	  
observed,	  particularly	   for	   generation	  4	  PPI	  dendrimer	   initiated	  ROP	  owing	  most	   likely	   to	   the	  
presence	  of	  a	  very	  small	  amounts	  of	  dendrimer	  molecules	  with	  reduced	  amino	  end	  groups.	  	  	  1H	  
NMR	  spectroscopy	  analysis	  (Figure	  2.3)	  confirmed	  polypeptide	  conjugation	  to	  PPI	  although	  the	  
dendrimer	  peaks	  were	  very	  difficult	  to	  observe	  due	  to	  overlapping	  with	  the	  broad	  polypeptide	  
peaks.	   Furthermore	   the	   relatively	   small	   size	   of	   the	   dendrimer	   core	   compared	   to	   the	  
polypeptide	  shell	  rendered	  the	  dendrimer	  signals	  very	  weak.	  Consequently,	  it	  was	  not	  possible	  
to	   determine	   whether	   all	   dendritic	   amino	   groups	   initiated	   polymerisation	   but	   the	   excellent	  
correlation	   of	   polymer	   molar	   masses	   with	   the	   expected	   values	   irrespective	   of	   dendrimer	  
generation	  suggest	  a	  high	  initiation	  efficiency.	  	  
	  
	  
Figure	  2.3:	  1H	  NMR	  spectra	  of	  G2(8)-­‐PBLG40	  (Top)	  (CDCl3,	  d-­‐TFA)	  and	  G2-­‐PPI	  dendrimer	  




As	  discussed,	  primary	  amines	  are	  very	  efficient	   initiators	   for	  ROP	  of	  NCAs.	  However,	   tertiary	  
amines	  are	  also	  known	  to	  act	  as	  initiators	  albeit	  via	  a	  different	  mechanism	  (activated	  monomer	  
mechanism,	  AMM)	  resulting	  in	  inferior	  control	  over	  polymerization	  conditions	  i.e.	  polymer	  Mw	  
and	  PDI.1,2	  The	  PPI	  dendrimers	  employed	  here	  possess	  numerous	  tertiary	  amines	  in	  their	  core	  
the	  number	  of	  which	  is	  dependent	  on	  dendrimer	  generation.	  Therefore	  it	  was	  very	  important	  
to	  confirm	  that	  the	  star	  shaped	  polypeptides	  synthesized	  above	  were	  generated	  via	  NCA	  ROP	  
initiated	  from	  the	  primary	  amine	  terminated	  arms	  and	  not	  the	  core	  tertiary	  amines.	  To	  achieve	  
this,	  peripheral	  primary	  amines	  of	  G2-­‐PPI	  dendrimer	  were	  protected	  using	  tert-­‐butoxycarbonyl	  
(BOC)	  protecting	  groups	  (Figure	  2.4).	  Given	  the	  dense	  steric	  environment	  of	  primary	  amines	  in	  
these	  dendrimer	  structures,	  BOC	  was	  chosen	  as	  a	  suitable	  protecting	  group	  owing	  to	  its	  small	  
size	  and	  ability	  to	  operate	  effectively	  in	  the	  presence	  of	  ROP	  of	  NCAs.	  	  	  1H	  NMR	  spectroscopy	  
confirmed	   the	   successful	   protection	   of	   all	   primary	   amines	   and	   the	   resultant	   material	   was	  
employed	  as	  an	  initiator	  for	  ROP	  of	  the	  NCA	  BLG	  (Figure	  2.5).	  
	  





Figure	  2.5:	  1H	  NMR	  spectroscopy	  analysis	  of	  BOC	  protected	  G2-­‐PPI	  (Bottom)	  (CDCl3)	  and	  G2-­‐
PPI	  dendrimer	  without	  BOC	  protection	  (Top)	  (CDCl3).	  	  
	  
	  A	   series	  of	   polymerizations	  were	   attempted	   in	  which	   the	  molar	   ratio	  of	  BOC-­‐PPI	   dendrimer	  
and	  BLG	  monomer	  were	  varied	  to	  ascertain	  the	  degree	  of	  molecular	  weight	  control	  afforded	  
by	   tertiary	   amine	   initiation.	   For	   comparative	   purposes	   a	   linear	   tertiary	   amine	   initiator,	  
diisopropylethylamine	  (DIPEA)	  was	  employed	  and	  the	  results	  are	  summarized	  in	  Table	  2.2.	  The	  
results	  showed	  that	  no	  precise	  control	  over	  polypeptide	  Mw	  was	  afforded	  by	   tertiary	  amines	  
and	   the	   resultant	   Mw	   values	   were	   dramatically	   higher	   than	   the	   corresponding	   theoretical	  
values.	   Furthermore,	   variation	   of	   the	   monomer	   feed	   ratio	   had	   no	   effect	   on	   Mw	   whilst	   PDI	  
values	  were	  somewhat	  more	  elevated	  than	  for	  primary	  amine	  derived	  polypeptides	  which	  is	  in	  
stark	  contrast	  to	  the	  well-­‐defined	  polypeptides	  described	  in	  Table	  2.1.	  The	  data	  in	  Table	  2.2	  is	  
consistent	   with	   typical	   tertiary	   amine	   derived	   polypeptide	   characteristics	   and	   thus	   confirms	  
the	  advantage	  of	  using	  primary	  amines	  as	  initiators	  as	  well	  as	  their	  overwhelming	  participation	  
in	  the	  PPI	  generated	  well-­‐defined	  star	  shaped	  polypeptides	  discussed	  above.1,2,38	  Although,	  the	  
minor	  coexistence	  of	   tertiary	  and	  primary	  amine	   initiation	  cannot	  be	  completely	   ruled	  out	   it	  
can	   be	   concluded	   that	   initiation	   from	  primary	   amines	   is	   predominant.	   In	   addition,	   it	   can	   be	  
hypothesized	  that	  as	  peripheral	  polypeptide	  growth	  proceeds,	  participation	  of	  tertiary	  amine	  
initiation	   and	   subsequent	   polymerization	  may	   be	   nullified	   due	   to	   steric	   hindrance	   from	   the	  
dense	  polypeptide	  periphery.	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Table	  2.2:	  PBLG	  obtained	  by	  initiation	  from	  BOC	  protected	  G2-­‐PPI	  dendrimers	  and	  linear	  (L)	  
initiator	  diisopropylethylamine	  (DIPEA).	  
Entry	   Polymer	   NCA/dendrimer	   Mw/g	  mol-­‐1(a)	   Mnth	  (b)/g	  mol-­‐1	   PDI	  
1	   L(1)-­‐PBLG320	   320	   333	  000	   69	  900	   1.2	  
2	   G2(8)-­‐PBLG320	   320	   288	  000	   71	  400	   1.2	  
3	   G2(8)-­‐PBLG160	   160	   271	  600	   36	  500	   1.3	  
4	   G2(8)-­‐PBLG80	   80	   280	  100	   19	  000	   1.3	  
	  
(a)	  determined	  by	  SEC	  (DMF)	  using	  MALS	  detection	  using	  the	  dn/dc	  of	  linear	  PBLG	  of	  0.118.	  
(b)	   calculated	   assuming	   initiation	   from	   all	   primary	   amino	   groups	   and	   quantitative	  
conversion:	  c(monomer)/c(BOC-­‐dendrimer)	  x	  M(monomer)	  +	  M(BOC-­‐dendrimer).	  
	  
Finally,	   FTIR	   spectroscopy	   was	   employed	   to	   elucidate	   the	   secondary	   structure	   of	   the	   star	  
polypeptides	   in	   the	   solid	   state.	   Linear	   PBLG	   and	   almost	   all	   of	   the	   PBLG	   star	   shaped	  
polypeptides	  exhibited	  an	  α-­‐helical	  secondary	  structure	  with	  characteristic	  bands	  observed	  at	  
1650	   cm-­‐1	   and	   1545	   cm-­‐1	   	   (entries	   1-­‐11,	   Table	   2.1)(Figure	   2.6,	   A	   and	   B).	   By	   decreasing	   the	  
polypeptide	   chain	   length	   to	   12	   units	   per	   arm,	   the	   presence	   of	   a	   strong	   α-­‐helix	   was	   still	  
observed	  (entry	  10,	  Table	  2.1).	  However	  by	  further	  decreasing	  the	  average	  chain	  length	  to	  ~	  2	  
units	  per	  arm	  for	  G5(64)-­‐PBLG1.6	   (entry	   13,	   Table	   2.1),	   the	  polypeptide	   lost	   its	  α-­‐helicity	  and	  
assumed	  some	  weak	  β-­‐sheet	  character	  (amide	  I	  1642	  cm-­‐1	  amide	  II	  1530	  cm-­‐1)	  (Figure	  2.6,	  C).	  
By	  varying	  the	  PBLG	  chain	  length	  thus	  it	  was	  possible	  to	  modify	  its	  secondary	  structure	  which	  is	  
consistent	   with	   the	   literature.30,39,40	   A	   more	   detailed	   study	   on	   the	   solution	   properties	   as	   a	  




Figure	  2.6:	  FTIR	  spectra	  of	  Linear	  PBLG	  (A),	  G5(64)-­‐PBLG	  with	  40	  units	  per	  arm	  (B)	  and	  2	  units	  
per	  arm	  (C).	  
	  
Consequently,	  it	  was	  possible	  to	  create	  polypeptide	  systems	  in	  which	  the	  length	  and	  density	  of	  
the	  polypeptide	  shell	  could	  be	  altered	  in	  a	  highly	  systematic	  way.	  By	  this	  method	  it	  is	  possible	  
to	   synthesise	   very	  well	   defined	  polypeptides	  of	   varying	  degrees	  of	   star	   shaped	  architectures	  
and	  molar	  mass	  with	  low	  dispersity.	  	  
	  
2.2.2	  Payload	  Loading	  /	  Enzyme	  Mediated	  Release	  
The	   high	   degree	   of	   control	   over	   the	  molar	  mass	   of	   the	   hybrid	  materials	   generated	   ensures	  
their	  particular	   relevance	   for	  use	  as	   carrier	   vehicles	   in	   targeted	  drug	  delivery	  applications.	   It	  
was	  hypothesised	   that	   the	  quantity	  of	  guest	  molecules	   loaded	   in	   the	  polypeptide-­‐dendrimer	  
structures	  is	  directly	  affected	  by	  the	  number	  and	  length	  of	  the	  polypeptide	  chains	  grafted	  from	  
the	   dendritic	   core.	   To	   facilitate	   loading	   with	   a	   water	   soluble	   molecule,	   selected	   PBLG	   star	  
polymers	   were	   deprotected	   to	   generate	   poly(L-­‐glutamic	   acid)	   (PGA)	   star	   polypeptides.	  
Quantitative	   deprotection	   was	   confirmed	   by	   1H	   NMR	   spectroscopy	   spectroscopy	   by	   the	  
disappearance	  of	   the	   aromatic	   and	  CH2	   peaks	   of	   the	   benzyl	   protecting	   group	   at	   7.2	   and	   5.0	  




Figure	  2.7:	  1H	  NMR	  spectra	  of	  deprotected	  8-­‐armed	  star	  shaped	  PGA	  (D2O).	  (Peaks	  A	  -­‐	  I	  not	  
visible.	  Labelled	  as	  where	  they	  should	  be	  expected).	  
	  
	  A	   study	   was	   conducted	   whereby	   a	   range	   of	   PGA-­‐conjugated	   dendrimers	   were	   loaded	   with	  
fluorescent	   rhodamine	   B	   solution	   and	   the	   quantity	   encapsulated	   determined	   by	   UV	  
spectroscopy.	   Dye	   loading	   was	   carried	   out	   at	   pH	   11	   to	   facilitate	   deprotonation	   of	   the	   PGA	  
carboxylic	   acid	   groups	   and	   solubility	   in	   the	   rhodamine	   B	   aqueous	   solution.39	   The	   dye	   was	  
entrapped	  in	  the	  star	  polypeptide	  by	  lowering	  the	  pH	  to	  4	  resulting	  in	  protonation	  of	  the	  PGA	  
and	  precipitation	  of	  dye	  loaded	  polymers.	  Notably,	  loading	  only	  occurred	  when	  the	  solution	  pH	  
was	  adjusted	  from	  pH	  11	  to	  pH	  4	  and	  not	  when	  the	  particles	  were	  incubated	  in	  pH	  4	  or	  pH	  11	  
rhodamine	   solutions.	   This	   supports	   the	   conclusion	   that	   the	   dye	   had	   penetrated	   the	   shell	   as	  
opposed	   to	   being	   adsorbed	   to	   the	   surface.	   The	   dye-­‐loaded	   polymers	   were	   stable	   and	   no	  









Table	  2.3:	  Rhodamine	  B	  loading	  capacity	  of	  poly(glutamic	  acid)	  (PGA)	  star	  polymers	  with	  









Star	  PGA:Rhodamine	  B	  
loading	  (molar	  ratio)	  
1	   L(1)-­‐PGA252	   252	   252	   1:0.018	  
2	   G2(8)-­‐PGA37	   37	   296	   1:0.047	  
3	   G5(64)-­‐PGA7	  	   7	   448	   1:0.024	  
4	   G5(64)-­‐PGA16	  	   16	   1024	   1:0.111	  
5	   G5(64)-­‐PGA36	  	   36	   2304	   1:0.333	  
(a)	  based	  on	  SEC	  molar	  mass.	  
	  
The	  molar	   ratio	  of	   rhodamine	  B	   loaded	  within	   linear	  PGA	  possessing	  252	  glutamic	   acid	   (GA)	  
units	  and	  a	  molar	  mass	  of	  55000	  g/mol	  was	  found	  to	  be	  1:0.018	  (polymer:rhodamine	  B)	  (entry	  
1,	   Table	   2.3).	   In	   comparison,	   the	   star	  polypeptide,	  G2(8)-­‐PGA37	  with	  37	  GA	  units	   coupled	   to	  
each	  of	  the	  8	  initiation	  sites	  of	  a	  2nd	  generation	  dendrimer	  (total	  PGA	  units	  296)	  contained	  a	  
greater	   rhodamine	  B	  content	   relative	   to	   the	  moles	  of	   the	  PGA	  polymer	  used	   (entry	   2,	   Table	  
2.3).	   This	   signifies	   the	   importance	   the	   polymer	   architecture	   has	   over	   the	   loading	   capacity.	  
Similarly,	   increasing	  the	   length	  of	  the	  polypeptide	  chain	  and	  subsequently	  the	  molar	  mass	  of	  
the	  star	  shaped	  polypeptides	  had	  a	  profound	  effect	  on	  the	  materials’	  loading	  capabilities.	  The	  
molar	  ratio	   for	  5th	  generation	  PPI	   initiators	  bearing	  a	  maximum	  of	  64	  arms	  was	   found	  to	  be	  
1:0.024	  when	  PGA	  consisting	  of	  7	  amino	  acid	  units	  was	  attached	   to	   its	  periphery.	   Increasing	  
the	  length	  of	  the	  polypeptide	  chain	  to	  consist	  of	  16	  and	  36	  PGA	  units	  per	  arm	  further	  increased	  
the	  amount	  of	  rhodamine	  loaded	  relative	  to	  the	  moles	  of	  the	  star	  polymer	  used,	  highlighting	  
the	  control	  over	  loading	  offered	  (entries	  3-­‐5,Table	  2.3).	  When	  comparing	  the	  loading	  capacity	  
of	  the	  8	  arm	  and	  the	  64	  arm	  PGA	  star	  polypeptide	  with	  comparable	  polypeptide	  chain	  lengths	  
of	  around	  37	  GA	  units	  (entries	  2	  and	  5,Table	  2.3)	  the	  latter	  was	  found	  to	  be	  about	  seven	  times	  
higher.	  This	  corresponds	  to	  the	  ratio	  of	  total	  molar	  mass	  of	  the	  two	  star	  polymers	  and	  suggests	  
that	  above	  a	  certain	  size	  and	  degree	  of	  branching	  the	   loading	  capacity	   is	  proportional	   to	  the	  
total	   molar	   mass.	   This	   highlights	   the	   advantage	   of	   using	   higher	   generation	   dendrimers	   as	  
initiators	  for	  these	  star	  polypeptides	  as	  only	  they	  give	  access	  to	  high	  molar	  mass	  unimolecular	  





Figure	  2.8:	  Rhodamine	  B	  loaded	  particles	  and	  enzyme	  triggered	  release.	  
	  
The	   same	   PGA	   star	   polypeptides	  were	   used	   in	   a	   preliminary	   study	   of	   the	   release	   profiles	   in	  
response	   to	   the	   proteolytic	   enzymes	   chymotrypsin	   and	   thermolysin	   (Figure	   2.8).	   Enzyme-­‐
responsive	  materials	  are	  a	  class	  of	  responsive	  material	  that	  are	  expected	  to	  play	  a	  key	  role	  in	  a	  
number	   of	   biomedical	   applications	   such	   as	   regenerative	  medicine,	   medical	   diagnostics,	   and	  
drug	   delivery	   due	   to	   their	   high	   selectivity	   and	   biocompatibility.40,41	   Enzymes	   offer	   key	  
advantages	   as	   release	   triggers;	   they	   are	   not	   biologically	   disruptive,	   function	   under	   mild	  
conditions,	   and	   possess	   a	   high	   degree	   of	   selectivity,	   e.g.	   at	   disease	   sites	   including	   cancer,	  
inflammation	   and	   infection.42	   Payload	   release	   of	   the	   rhodamine	   B	   loaded	   PGA	   star	   polymer	  
was	  anticipated	  to	  occur	   in	   the	  presence	  of	  an	  enzyme	  capable	  of	  hydrolytic	  cleavage	  of	   the	  
PGA.	  Thermolysin	  has	  demonstrated	  the	  capability	  to	  cleave	  peptide	  bonds	  when	  glutamic	  acid	  
is	  present	  at	  the	  P1’	  site.43	  	  Indeed	  significant	  release	  monitored	  by	  UV	  spectroscopy	  following	  
particle	  incubation	  occurred	  in	  the	  presence	  of	  thermolysin	  and	  was	  dependent	  upon	  enzyme	  
concentration	  (Figure	  2.9).	  By	  decreasing	  the	  enzyme	  concentration	  to	  0.1	  mg/ml	  the	  release	  
of	   rhodamine	   B	   from	   both	   linear	   and	   star	   shaped	   PGA	  was	   significantly	   prolonged	  whereas	  
minimal	   release	  was	   observed	   for	   chymotrypsin	   at	   both	   concentrations	   as	   expected	   (Figure	  
2.10).	   The	   low	   level	   of	   rhodamine	   release	   observed	   for	   linear	   PGA	   incubated	   with	  
chymotrypsin	  was	  most	  likely	  related	  to	  unbound	  rhodamine	  B	  dye	  molecules,	  which	  had	  not	  
been	   completely	   removed	   during	   dialysis.	   The	   control	   enzyme	   chymotrypsin	   possesses	   the	  
specificity	   to	   cleave	  amide	  bonds	   in	  which	   the	   carboxyl	   side	  of	   the	  bond	   (the	  P1	  position)	   is	  





Figure	  2.9:	  Enzymatic	  release	  profiles	  followed	  by	  UV	  spectroscopy	  at	  554nm	  of	  rhodamine	  B	  
loaded	  L(1)-­‐PGA252	  (entry	  1,	  Table	  3.2)	  and	  G2(8)-­‐PGA37	  (entry	  2,Table	  3.2)	  in	  water	  (1	  
mg/mL)	  of	  similar	  molar	  masses	  using	  1	  mg/mL	  chymotrypsin	  and	  thermolysin.	  ! :	  G2(8)-­‐




Figure	  2.10:	  Enzymatic	  release	  profiles	  followed	  by	  UV	  spectroscopy	  at	  554nm	  of	  rhodamine	  
B	  loaded	  L(1)-­‐PGA252	  (entry	  1,	  Table	  3.2)	  and	  G2(8)-­‐PGA37	  (entry	  2,Table	  3.2)	  in	  water	  (1	  
mg/mL)	  of	  similar	  molar	  masses	  using	  0.1	  mg/mL	  of	  thermolysin.	  ! :	  G2(8)-­‐PGA37,	  




	  Figure	   2.11	   shows	  the	  comparison	  of	   the	  release	  profiles	  of	  PGA	  star	  polymers	  with	  varying	  
number	  of	  arms.	  With	  the	  exception	  of	  star	  polymer	  G5(64)-­‐PGA7	  with	  short	  PGA	  arms	  (entry	  
3,	  Table	  2.3)	  the	  total	  of	  rhodamine	  B	  loading	  per	  polymer	  mass	  is	  quite	  similar	  (it	  only	  differs	  
in	   molar	   loading).	   As	   the	   same	   mass	   of	   rhodamine	   B	   loaded	   polymers	   was	   used	   in	   these	  
experiments	  a	  similar	  final	  absorbance	  is	  expected	  after	  quantitative	  release	  from	  G5-­‐PGA	  with	  
16	  and	  36	  monomers	  per	  arm	  (entry	  4	  and	  5,	  Table	  2.3).	  This	  is	  indeed	  the	  case	  but	  noticeable	  
is	   a	  dependence	  of	   the	  polymer	   architecture	  on	   the	   rate	  of	   payload	   release	  with	   the	   longer	  
PGA	  arms	  G5-­‐PGA	  (entry	  5,Table	  2.3)	  providing	  a	  slower	  release	  as	  evidenced	  by	  the	  release	  
profile	  (Figure	  2.11).	  Degradation	  of	  linear	  PGA	  occurred	  at	  a	  greater	  rate	  (24	  h	  for	  complete	  
payload	  release)	  compared	  to	  release	  from	  2nd	  generation	  PPI	  bearing	  an	  average	  of	  37	  PGA	  
units	   coupled	   to	   each	   of	   its	   8	   initiation	   sites	   using	   a	   thermolysin	   concentration	   of	   1	  mg/ml.	  
Similarly	   by	   increasing	   the	   degree	   of	   branching,	   polypeptide	   chain	   length	   and	   therefore	   the	  
polypeptide	   shell	   density	   the	   release	   rate	   can	   be	   further	   prolonged	   (Figure	   2.11).	   It	   can	   be	  
speculated	  that	  this	  difference	  results	  from	  steric	  hindrance	  inhibiting	  enzymatic	  activity	  upon	  
the	   dendrimer-­‐containing	  material.	   Azagarsmay	   et	   al.	   have	   proposed	   a	   similar	   hypothesis.45	  
These	   preliminary	   results	   suggest	   that	   architecture	   and	  molar	   mass	   may	   be	   useful	   tools	   to	  
manipulate	   the	   ‘cargo’	   loading	   and	   pharmacokinetics	   of	   star	   PGA	   based	   drug	   delivery	  
platforms.	  	  
	  
Figure	  2.11:	  Enzymatic	  release	  profiles	  followed	  by	  UV	  spectroscopy	  at	  554nm	  of	  rhodamine	  
B	  loaded	  PGA	  star	  polymers	  in	  water	  (1	  mg/mL)	  using	  1	  mg/mL	  thermolysin.	  ! :	  G2(8)-­‐PGA37	  
(296	  GA	  units,	  entry	  2,	  Table	  3.2);	  # :	  G5(64)-­‐PGA36	  (2304	  GA	  units,	  entry	  5,	  Table	  3.2);	  # :	  




2.3	  	  	  	  	  Conclusions	  
Well-­‐defined	  high	  molecular	  polypeptides	  were	  successfully	  synthesised	  by	  NCA	  ROP	  initiated	  
from	  PPI	  dendrimers	   to	  afford	  a	   range	  of	   star	   shaped	  architectures.	  Such	  high	  molar	  masses	  
were	  unobtainable	  for	  the	  analogous	  linear	  polypeptides	  in	  the	  absence	  of	  the	  dendrimer	  core.	  
The	   extensive	   control	   offered	   by	   the	   method	   of	   polymerisation	   ensures	   that	   the	   products	  
formed	   have	   applicability	   as	   use	   as	   drug	   delivery	   vehicles.	   Various	   concentrations	   of	  
rhodamine	   B	   could	   be	   loaded	   into	   the	   polypeptide	   star	   architectures	   dependent	   on	   the	  
generation	   of	   dendrimer	   utilised	   and	   the	   length	   of	   the	   grafted	   polypeptide	   chain	   produced.	  
Furthermore,	   the	   polypeptidic	   nature	   of	   PGA-­‐grafted	   dendrimers	   ensures	   their	  
responsiveness,	   through	   controlled	   degradation,	   to	   the	   target	   enzyme	   thermolysin.	   An	  
enzyme-­‐responsive	  release	  mechanism	  was	  devised	  and	  demonstrated	  in	  which	  rhodamine	  B	  
payload	   was	   released	   upon	   incubation	   with	   thermolysin	   but	   not	   the	   control	   enzyme	  
chymotrypsin.	  The	  kinetic	  of	  rhodamine	  B	  release	  could	  be	  controlled	  carefully	  dependent	  on	  
the	   composition	   of	   the	   hybrid	   material,	   which	   could	   be	   readily	   tuned.	   The	   polypeptide-­‐
dendrimer	   hybrid	   materials	   produced	   are	   created	   under	   highly	   controlled	   conditions,	   are	  
tuneable	   dependent	   on	   the	   dendrimer	   employed	   /	   extent	   of	   polypeptide	   grafted	   and	   may	  

















Star	  Polypeptide	  Synthesis	  
Materials	  
All	   air	   and	  moisture	   sensitive	   compounds	  were	   handled	   under	   a	   nitrogen	   atmosphere	   using	  
general	  Schlenk-­‐line	   techniques.	  α-­‐pinene	   (98%)	  bis(trichloromethyl)	  carbonate	   (triphosgene)	  
99%	  and	  benzylamine	  were	  purchased	  from	  Sigma	  Aldrich.	  γ-­‐Benzyl-­‐L-­‐glutamate	  was	  supplied	  
by	   Bachem.	   PPI	   (polypropylene	   imine)	   dendrimers	   generations	   2-­‐5	   were	   purchased	   from	  
SyMO-­‐Chem	   BV	   (The	   Netherlands).	   Chloroform	   (anhydrous),	   ethyl	   acetate	   (anhydrous),	  
dimethylformamide	   (anhydrous),	   tetrahydrofuran	   (anhydrous),	   n-­‐heptane,	   and	   diethylether	  
were	   supplied	   by	   Sigma	   Aldrich.	   All	   chemicals	   were	   used	   without	   any	   purification	   unless	  
otherwise	  noted.	  Chloroform	  and	  ethyl	  acetate	  were	  used	  directly	  from	  the	  bottle	  and	  stored	  
under	   an	   inert,	   dry	   atmosphere.	   γ-­‐Benzyl-­‐L-­‐glutamate	   NCA	   was	   synthesised	   following	   a	  
literature	  procedure.46	  
	  Methods	  
Nuclear	  magnetic	  resonance	  (NMR)	  spectra	  were	  recorded	  on	  a	  Bruker	  Avance	  400	  (400MHz)	  
spectrometer	  at	  room	  temperature	  in	  CDCl3	  and	  d-­‐TFA	  as	  solvents.	  The	  following	  abbreviations	  
for	  multiplicity	  are	  used:	  s,	  singlet;	  m,	  multiplet;	  br,	  broad.	  Attenuated	  Total	  Reflection	  (ATR)	  
FTIR	   spectroscopy	   measurements	   were	   performed	   on	   a	   Perkin-­‐Elmer	   Spectrum	   100	   in	   the	  
spectral	  region	  of	  650-­‐4000	  cm-­‐1	  and	  were	  obtained	  from	  4	  scans	  with	  a	  resolution	  of	  2	  cm-­‐1.	  A	  
background	   measurement	   was	   taken	   before	   the	   sample	   was	   loaded	   onto	   the	   ATR	   for	  
measurement.	  Size	  Exclusion	  Chromatography	  (SEC)	  was	  performed	  on	  an	  Agilent	  1200	  system	  
in	   conjunction	  with	   two	  PSS	  GRAM	  analytical	   (8	   x	   300	   and	   8	   x	   100,	   10	  μ)	   columns,	   a	  Wyatt	  
Dawn	  Heleos	  8	  multi	  angle	  light	  scattering	  detector	  (MALS)	  and	  Wyatt	  Optilab	  rEX	  differential	  
refractive	   index	   detector	   (DRI)	   with	   a	   658	   nm	   light	   source.	   The	   eluent	  was	   DMF	   containing	  
0.1M	  LiBr	  at	  a	  flow	  rate	  of	  1	  mL	  min-­‐1.	  The	  column	  temperature	  was	  set	  to	  40	  ºC	  with	  the	  MALS	  
detector	  at	  35	  ºC	  and	  the	  DRI	  detector	  at	  40	  ºC.	  Molar	  masses	  and	  dispersities	  were	  calculated	  
from	   the	   MALS	   signal	   by	   the	   Astra	   software	   (Wyatt)	   using	   the	   refractive	   index	   increment	  
(dn/dc)	   of	   linear	  poly-­‐benzyl-­‐L-­‐glutamate	   (PBLG)	  of	   0.118.	  All	   samples	   for	  GPC	  analysis	  were	  
prepared	  with	  a	  concentration	  of	  2	  mg/ml	  and	  were	  filtered	  through	  a	  0.45	  μm	  PTFE	  filter	  (13	  
mm,	  PP	  housing,	  Whatman)	  prior	  to	  injection.	  UV-­‐Vis	  spectra	  were	  recorded	  on	  a	  Varian	  Cary	  
50	   using	   a	   UV	   quartz	   cuvette	   in	   the	   spectral	   range	   of	   300-­‐700	   nm.	   The	   concentration	   of	  
rhodamine	  B	  was	  monitored	  by	  recording	  the	  absorbance	  at	  554	  nm,	  i.e.	  the	  peak	  of	  maximum	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absorbance	   for	   rhodamine	   B.	   A	   baseline	   correction	   using	   deionised	   water	   was	   employed	  
before	  each	  measurement.	  	  
Synthesis	  of	  linear	  poly(γ-­‐benzyl-­‐L-­‐glutamate)	  (Representative	  Procedure)	  
	  In	  a	  Schlenk	  tube	  under	  a	  nitrogen	  atmosphere,	  a	  solution	  of	  the	  NCA	  of	  γ-­‐benzyl-­‐L-­‐glutamate	  
(BLG)	   (2.0	   g,	   7.63	  mmol)	   in	   CHCl3	   (25	  ml)	  was	   prepared.	   A	   solution	   of	   benzylamine	   initiator	  
(0.32	  mg,	  2.98	  x	  10-­‐6	  mmol)	  in	  CHCl3	  was	  also	  prepared	  and	  charged	  to	  the	  reaction	  solution	  
via	   syringe.	   The	   solution	  was	   stirred	  at	   room	   temperature	  until	   no	   further	   increase	   in	  molar	  
mass	   was	   achieved.	   The	   molar	   mass	   was	   monitored	   by	   SEC	   by	   precipitating	   1	   mL	   of	   the	  
reaction	   solution	   into	   an	   excess	   of	   cold	   diethyl	   ether.	   Upon	   no	   increase	   in	  molar	  mass,	   the	  
polymer	  was	  precipitated	  into	  an	  excess	  of	  cold	  diethyl	  ether	  and	  dried	  under	  vacuum	  (Yield:	  
51%).	  
Synthesis	  of	  Star	  Shaped	  PBLG	  (Representative	  Procedure)	  
As	   a	   reference	   procedure,	   the	   NCA	   of	   γ-­‐benzyl-­‐L-­‐glutamate	   (BLG)	   (2.18	   g,	   8.3	   mmol)	   was	  
dissolved	  in	  25	  mL	  CHCl3	  in	  a	  Schlenk	  tube	  under	  a	  nitrogen	  atmosphere.	  A	  solution	  of	  G2	  PPI	  
dendrimer	  (20	  mg,	  2.59	  x	  10-­‐2	  mmol)	  in	  1	  mL	  CHCl3	  was	  quickly	  charged	  to	  the	  dissolved	  NCA	  
solution	  via	  syringe.	  The	  solution	  was	  stirred	  for	  24	  h	  at	  room	  temperature.	  Depending	  on	  the	  
type	   of	   initiator,	   the	   used	   amount	   of	   initiator	   and	   monomer	   were	   adjusted	   to	   achieve	   the	  
desired	  molar	  mass	   of	   the	   star	   shaped	   polypeptides.	   The	   polymer	   was	   precipitated	   into	   an	  
excess	  of	  cold	  diethyl	  ether	  and	  dried	  under	  vacuum	  (Yield:	  90%).	  
Benzyl	  Ester	  Hydrolysis	  of	  Poly(γ-­‐benzyl-­‐L-­‐glutamate)	  (Representative	  Procedure)	  
G5-­‐PPI-­‐PBLG	  (400	  mg)	  was	  dissolved	  in	  8	  mL	  of	  trifluoroacetic	  acid	  (TFA).	  A	  6-­‐fold	  excess	  with	  
respect	   to	   γ-­‐benzyl-­‐L-­‐glutamate	   of	   a	   33%	   solution	   of	   HBr	   in	   acetic	   acid	   (2.3	  mL)	  was	   added	  
slowly	   to	   the	   reaction.	   After	   16	   h,	   the	   solution	   was	   precipitated	   into	   diethyl	   ether.	   The	  
precipitate	  was	  redissolved	   in	  ethanol	  and	  precipitated	  twice	   into	  diethyl	  ether.	  The	  polymer	  
was	  dissolved	  in	  deionised	  water	  and	  dialyzed	  (molar	  mass	  cut-­‐off	  8,000	  g/mol)	  for	  3	  days.	  The	  
polymer	  was	   lyophilized	   (Yield:	   81%).	   Deprotection	  was	   confirmed	   by	   1H	  NMR	   spectroscopy	  
due	  to	  the	  absence	  of	  signals	  at	  7.2	  ppm	  (benzyl	  group)	  and	  5.0	  ppm	  and	  (CH2-­‐Bz).	  
Synthesis	  of	  BOC	  protected	  G2-­‐PPI	  Dendrimers	  
G2-­‐PPI	   dendrimer	   (0.15g,	   0.	   19	   mmol)	   was	   dissolved	   in	   3	   ml	   of	   anhydrous	   CHCl3	   under	   a	  
nitrogen	  atmosphere.	  Triethylamine	  (0.37	  g,	  3.7	  mmol,	  1.7	  eq.	  per	  NH2)	  was	  added	  via	  syringe	  
and	   stirred	   for	   20	   min.	   Di-­‐tert-­‐butyl	   dicarbonate	   (0.51g,	   2.3	   mmol,	   1.5	   eq.	   per	   NH2)	   was	  
dissolved	  in	  1	  ml	  of	  anhydrous	  CHCl3	  and	  added	  slowly	  via	  syringe	  to	  the	  reaction	  solution.	  The	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reaction	  was	  stirred	  for	  48	  h	  and	  then	  washed	  with	  5%	  potassium	  bisulfate	  solution	  (3	  times).	  
The	  aqueous	  solution	  was	  filtered	  and	  pH	  was	  adjusted	  to	  pH	  8	  with	  1M	  NaOH.	  The	  product	  
was	  extracted	  with	  CHCl3	  x	  3	  and	  the	  solvent	  was	  removed	  under	  reduced	  pressure	  to	  afford	  
the	  target	  compound	  as	  viscous	  material.	  (Yield:	  71%).1H	  NMR	  spectroscopy	  (400MHz,	  CDCl3):	  
δ	  (ppm)	  5.40	  (br	  s,	  NH),	  3.13	  (br	  t,	  16H),	  2.35	  (br	  m,	  36H)	  1.58	  (br	  t,	  24H),	  1.41	  (br	  s,	  72H),	  1.35	  
(br	  s,	  4H).	  
Synthesis	   of	   Star	   Shaped	   PBLG	   with	   BOC	   protected	   G2-­‐PPI	   Dendrimers	   (Representative	  
Procedure)	  
As	   a	   reference	   procedure,	   the	   NCA	   of	   γ-­‐benzyl-­‐L-­‐glutamate	   (BLG)	   (0.267	   g,	   1	   mmol)	   was	  
dissolved	   in	   5	  mL	   CHCl3	   in	   a	   Schlenk	   tube	   under	   a	   nitrogen	   atmosphere.	   A	   solution	   of	   BOC	  
protected	  G2-­‐PPI	  dendrimer	  (5	  mg,	  3.18	  x	  10-­‐2	  mmol)	  in	  1	  mL	  CHCl3	  was	  quickly	  charged	  to	  the	  
dissolved	  NCA	  solution	  via	  syringe.	  The	  solution	  was	  stirred	  for	  24	  h	  at	  room	  temperature.	  The	  
used	   amount	  of	   initiator	   and	  monomer	  were	   adjusted	   to	   attempt	  molecular	  weight	   control.	  
The	   polymer	  was	   precipitated	   into	   an	   excess	   of	   cold	   diethyl	   ether	   and	   dried	   under	   vacuum	  
(Yield:	  88%).	  
	  
Payload	  Loading	  and	  Enzyme-­‐Mediated	  Release	  
	  Loading	  of	  Linear	  and	  Star	  Shaped	  Poly(glutamic	  acid)	  (PGA)	  with	  Rhodamine	  B	  Dye	  
	  	  A	  25	  mg/ml	  solution	  of	  polymer	  (50	  mg)	  in	  pH	  11	  buffer	  was	  prepared.	  A	  0.1	  mg/ml	  solution	  
of	  rhodamine	  B	  (0.1	  mg)	  was	  prepared	  and	  charged	  to	  the	  polymer	  solution	  with	  stirring	  for	  2	  
hours.	  To	  acidify	  this	  solution	  a	  few	  drops	  of	  drops	  of	  25%	  HCl	  solution	  and	  5ml	  of	  pH	  4	  buffer	  
was	  added.	  The	  suspension	  was	  dialyzed	  (molar	  mass	  cut-­‐off	  8000	  g/mol)	  against	  pH	  4	  buffer	  
until	  the	  excess	  rhodamine	  B	  dye	  was	  removed.	  	  	  
Enzyme	  Controlled	  Release	  of	  Rhodamine	  B	  Dye	  from	  Linear	  and	  Star	  Shaped	  Polymers	  
A	  1	  mg/ml	  solution	  of	  dye	  encapsulated	  polymer	  and	  a	  desired	  concentration	  of	  Thermolysin	  
enzyme	  (50-­‐100	  units/mg	  protein)	  was	  prepared	  in	  a	  UV	  quartz	  cuvette	  using	  deionised	  water.	  
The	  UV	  spectrum	  of	  the	  solution	  was	  recorded	  at	  selected	  time	  intervals	  and	  the	  concentration	  
of	   rhodamine	   B	   was	   determined	   using	   a	   prepared	   calibration	   curve.	   The	   solution	   was	  
incubated	  in	  a	  water	  bath	  at	  37	  ºC	  between	  measurements.	  The	  enzyme	  Chymotrypsin	  (57.24	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Chapter	  3	  	  
Molecular	  Weight	  and	  Architectural	  
Dependence	  of	  Well-­‐Defined	  Star	  Shaped	  




A	   series	   of	   well-­‐defined	   star-­‐shaped	   polypeptides	   were	   successfully	   synthesised	   by	   the	   ring	  
opening	   polymerisation	   (ROP)	   of	   the	  N-­‐carboxyanhydride	   (NCA)	   of	   ε-­‐carbobenzyloxy-­‐L-­‐lysine	  
(ZLL)	  using	  a	  range	  of	  generations	  of	  polypropylene	  imine	  (PPI)	  dendrimers	  as	  multifunctional	  
initiators.	  The	  monomer	  feed	  ratio	  and	  dendrimer	  generation	  were	  varied	  to	  afford	  a	  series	  of	  
polypeptide	   dendrimer	   hybrids	   with	   superior	   structural	   versatility	   and	   functionality.	  
Subsequent	  protecting	  group	  removal	  yielded	  star-­‐shaped	  poly(lysine)	  of	  controlled	  variation	  
in	   polypeptide	   chain	   length	   and	   arm	   multiplicity.	   Star-­‐shaped	   PLL	   polymers	   were	   used	   to	  
prepare	  pDNA	  and	  siRNA	  to	  form	  “polyplexes”	  to	  determine	  their	  ability	  to	  complex	  different	  
nucleic	   acid	   cargoes	   and	   were	   compared	   with	   linear	   PLL	   polyplex	   controls.	   Significant	  
differences	   in	   size	   and	   surface	   charge	   were	   seen	   between	   star-­‐shaped	   PLL	   polyplexes	   and	  
linear	   PLL	   polyplexes	   for	   both	   cargoes.	   The	   star-­‐shaped	   polypeptides	  were	   capable	   of	  more	  
effective	   complexation	   of	   both	   nucleic	   acids	   at	   low	   N/P	   ratios	   compared	   to	   linear	   PLL	   as	  
evidenced	  by	   zeta	   potential	   and	   electrophoretic	   data.	   This	  was	   particularly	   evident	   in	   siRNA	  
polyplexes	   as	   linear	   PLL	   failed	   to	   completely	   complex	   siRNA	   into	   nanocomplexes	   of	  
appropriate	  size	  for	  cell	  transfection	  i.e.	  <200	  nm	  in	  size,	  while	  star	  poly-­‐(lysine)	  formed	  siRNA	  
polyplexes	   <100	   nm	   at	   certain	   N/P	   ratios,	   albeit	   strongly	   dependent	   on	   the	   particular	  
molecular	  weight	  and	  architecture,	  as	  analysed	  by	  dynamic	  light	  scattering	  (DLS).	  Atomic	  force	  
microscopy	   (AFM)	   identified	   discrete	   spherically	   shaped	   polyplexes	   for	   all	   star-­‐shaped	  
polypeptide-­‐based	  polyplexes	  while	   linear	  PLL	  formed	  elongated	   irregular	  shaped	  complexes.	  
This	  difference	   in	  morphology	  may	  go	  some	  way	   towards	  explaining	   the	  300-­‐fold	   increase	   in	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luciferase	  expression	  seen	  for	  star-­‐shaped	  PLL	  polyplexes	  G5(64)-­‐PLL40	  compared	  to	  linear	  PLL	  
pGLuc	  polyplexes	   in	  epithelial	   cells.	   Each	  of	   the	  PPI-­‐PLL	  polymers	  appeared	   to	  be	   capable	  of	  
protecting	   the	   nucleic	   acid	   cargoes	   from	   degradation	   by	   the	   relevant	   nuclease	   enzyme	   as	  
effectively	   as	   the	   positive	   control	   polyethyleneimine	   (PEI)	   polyplexes.	   Overall	   the	   promising	  
nucleic	  acid	  complexation,	  sizing,	  morphology	  and	  protection	  capacity	  of	  two	  different	  genetic	  
“cargoes”	  highlight	  the	  potential	  of	  polypeptide	  dendrimer	  hybrids	  as	  gene	  delivery	  vectors.	  
 
	  

























3.1 Introduction	  	  
Gene	  delivery	  is	  an	  area	  which	  has	  generated	  immense	  interest	  in	  recent	  times.1,2	  The	  ability	  to	  
use	   genetic	   material	   such	   as	   plasmid	   DNA,	   siRNA	   and	   microRNA	   to	   better	   understand	   and	  
potentially	   treat	   and	   prevent	   diseases	   that	   currently	   lack	   or	   have	   poor	   therapeutic	   or	  
prophylactic	  modalities	  is	  very	  appealing.3	  However,	  the	  inability	  to	  deliver	  these	  nucleic	  acid-­‐
based	   “drugs”	   in	   a	   safe	   and	   efficient	   manner	   remains	   a	   significant	   challenge	   to	   their	  
commerical	  and	  clinical	  translation.	  These	  biomolecules	  are	   large,	  polyanionic	  structures	  that	  
can	  be	  easily	  degraded	  by	  enzymes	  and	  do	  not	  readily	  cross	  the	  target	  cell	  membrane	  to	  reach	  
their	  intracellular	  sites	  of	  action.	  The	  use	  of	  viral	  and	  non-­‐viral	  vectors	  has	  helped	  to	  overcome	  
some	   of	   these	   hurdles	   but	   major	   obstacles	   remain.4	   Although	   very	   efficient,	   viral	   delivery	  
vectors	   possess	   the	   inherent	   immunogenic,	   safety	   and	   production	   concerns	   associated	  with	  
them.5	   Consequently	   the	   use	   of	   cationic	   non-­‐viral	   delivery	   vectors	   has	   been	   extensively	  
explored	   with	   natural	   and	   synthetic	   polymers	   including	   poly-­‐L-­‐lysine	   (PLL),6	   chitosan,7	  
dimethylaminoethyl	   methacrylate	   (DMAEMA),8	   poly(ethyleneimine)	   (PEI)9	   and	   various	  
dendrimers10,11	  being	  harnessed	  for	  nucleic	  acid	  delivery.	  	  
The	   concept	   of	   dendrimer	   facilitated	   gene	   therapy	   is	   of	   particular	   interest	   arising	   from	   the	  
unique	   properties	   associated	   with	   these	   materials.12	   Dendrimers	   are	   monodisperse	   and	   at	  
higher	  generations	  are	  globular	  macromolecules	  that	  offer	  numerous	  functional	  groups	  within	  
a	   highly	   defined	   compact	   structure.	   Some	   of	   the	   best-­‐known	   cationic	   dendrimers	   include	  
polypropylene	  imine	  (PPI)	  and	  poly(amido	  amine)	  (PAMAM)	  which	  contain	  peripheral	  ionisable	  
primary	   amino	   groups,	   the	   number	   of	  which	   can	   be	   varied	   depending	   on	   the	   generation	   of	  
dendrimer	   chosen.	   This	   cationic	   periphery	   permits	   the	   formation	   of	   electrostatically	   derived	  
nanoparticle	   complexes	   with	   nucleic	   acids	   such	   as	   pDNA,	   whilst	   the	   inner	   tertiary	   amines	  
enhance	   endosomal	   buffering	   capacity	   and	   therefore	   transfection.13	  However,	   some	   of	   the	  
major	  hurdles,	  which	  have	  limited	  their	  use	  in	  biomedical	  applications	  to-­‐date	  is	  their	  inherent	  
cytotoxicity,	  potential	  immunogenicity	  and	  size	  limitations.14	  
Star-­‐shaped	  polymers	  provide	  an	  attractive	  alternative	  as	  unimolecular	  containers	  because	  the	  
molecular	  weight	  and	  the	  number	  of	  polymeric	  arms	  can	  be	  tightly	  controlled	  by	  choice	  of	  the	  
polymerisation	  method	   and	   the	  multifunctional	   initiator.15-­‐17	   This	   facilitates	  manipulation	   of	  
the	   shape	   and	   the	   cargo	   space	   available	   for	   drug	   loading.	   Particularly	   attractive	   are	  
polypeptide	  based	  star	  polymers	  due	  to	  their	  improved	  biocompatibility,	  functionality	  and	  the	  
ability	  to	   introduce	  stimuli	  responsiveness	  when	  required	  through	  inclusion	  of	  specific	  amino	  
acid	  sequences,	  whilst	  maintaining	  a	  well-­‐defined	  globular	  shape.18,19	  A	  convenient	  method	  of	  
polypeptide	   introduction	   is	   via	   N-­‐carboxyanhydride	   (NCA)	   polymerisation	  which	   permits	   the	  
	  60	  
	  
versatile	   and	   well	   controlled	   growth	   of	   long	   chain	   polypeptides	   from	   an	   (multi)	   amino	  
terminated	  initiator.20-­‐30	  NCA	  derived	  polypeptides	  have	  already	  demonstrated	  their	  potential	  
biomedical	  applicability	   in	  areas	   such	  as	   tissue	  engineering,31	  drug/gene	  delivery,32-­‐35	  medical	  
adhesives,36	  antimicrobial	  agents,37	  and	  biorecognition	  applications.38-­‐45	  
Cationic	   polypeptides	   such	   as	   linear	   poly(lysine)	   have	   also	   been	   investigated	   as	   a	   pDNA	  
delivery	  vector	  owing	  to	  its	  cationic	  nature	  and	  potential	  biocompatibility.46,47	  Such	  complexes,	  
however,	   exhibited	   low	   transfection	   efficiencies	   and	   elevated	   cytotoxicity	   thus	   preventing	  
their	   clinical	   application.48	   The	   incorporation	   of	   poly(lysine)	   into	   a	   branched	   or	   star	   shaped	  
architecture	   may	   overcome	   these	   issues	   by	   creating	   a	   unimolecular	   nanoparticle	   with	  
increased	   cargo	   capacity	   and	   protection.	   Pan	   et.	   al	   have	   reported	   the	   growth	   of	   short	  
poly(lysine)	   chains	   from	   a	   fourth	   generation	   PAMAM	   dendrimer	   and	   their	   use	   as	   a	   pDNA	  
transfection	  agent.49	  These	  materials	  showed	  enhanced	  transfection	  efficiencies	  with	  reduced	  
cytotoxicity	   thus	   highlighting	   the	   potential	   of	   such	   polypeptide-­‐dendrimer	   hybrids.	   Dendritic	  
poly(lysine)	   has	   also	   shown	   promise	   as	   a	   pDNA	   transfection	   agent	   but	   such	   materials	   are	  
synthetically	  challenging	  and	  lack	  the	  structural	  versatility	  of	  a	  star	  shaped	  polypeptide	  derived	  
from	  the	  NCA	  /	  multifunctional	  initiator	  approach.50,51	  We	  have	  recently	  reported	  the	  versatile	  
synthesis	  of	  pH	  responsive	  star	  poly(glutamic	  acid)	  using	  various	  generations	  of	  PPI	  dendrimers	  
as	  multifunctional	   initiators	   for	  NCA	  polymerisation.30	   By	   this	   approach	   the	   number	   of	   arms	  
and	  the	  total	  molecular	  weight	  of	  the	  star	  polypeptides	  was	  systematically	  varied.	  Herein,	  we	  
report	   the	   synthesis	   and	   systematic	   study	   of	   a	   range	   of	   well-­‐defined	   star	   shaped	   lysine	  
polymers	   of	   controlled	   molecular	   weights.	   We	   further	   investigate	   the	   potential	   of	   these	  
materials	  as	  gene	  delivery	  vectors	  using	  pDNA	  and	  siRNA	  as	  suitable	  model	  cargoes.	  pDNA	  and	  
siRNA	  are	  polyanionic	  biomolecules	  that	  present	  several	  different	  challenges	  in	  terms	  of	  their	  
delivery	   to	   a	   cell.52	   Structurally,	   the	   much	   larger	   pDNA	   readily	   collapses	   into	   compact	  
nanoparticles	  with	   a	   polycationic	   vector	  whereas	   siRNA	   carrying	  much	   less	   negative	   charge,	  
tends	   to	   form	  weaker	   complexes.	  As	  a	   consequence	   it	  was	   interesting	   to	  determine	   if	   these	  
star-­‐shaped	  polypeptides	  were	  suitable	  as	  vectors	  for	  both	  cargoes	  in	  terms	  of	  their	  ability	  to	  
efficiently	   package	   and	   protect	   these	   cargoes.	   The	   size,	   shape	   and	   morphology	   of	   these	  
nanomaterials	   were	   determined	   by	   Dynamic	   Light	   Scattering	   (DLS)	   and	   Atomic	   Force	  
Microscopy	   (AFM)	   in	   conjunction	  with	   ζ-­‐potential	   and	   agarose/	   PAGE	   gel	   electrophoresis	   to	  
measure	   complexation	   efficiency	   and	   stability.	   The	   star	   shaped	  polypeptides	  were	   shown	   to	  
effectively	   package	   and	   protect	   both	   pDNA	   and	   siRNA	   and	   preliminary	   transfection	   studies	  
compared	  their	  capacity	  to	  transfect	  pDNA	  into	  cells	  compared	  to	  linear	  PL.	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3.2 Results	  and	  Discussion	  
3.2.1	  Star	  Polypeptide	  Synthesis	  
	  
	  
Figure	  3.1:	  Synthesis	  of	  poly(L-­‐lysine)	  star	  polypeptides	  by	  NCA	  polymerisation	  using	  second	  











Table	  3.1:	  Star-­‐shaped	  PZLL	  by	  initiation	  from	  PPI	  dendrimers	  (L:	  linear	  initiator	  benzylamine;	  
G5(64)-­‐PZLL40	  =	  initiator	  generation	  5	  dendrimer	  with	  maximum	  64	  arms	  and	  theoretical	  arm	  
length	  of	  40	  amino	  acids).	  Dispersities	  of	  all	  polymers	  <	  1.2	  (SEC	  MALS	  detection).	  
Entry	   Polymer	   NCA/NH2	  	   NCA/dendrimer	   Mw/g	  mol-­‐1(a)	   Mnth	  (b)/g	  mol-­‐1	  
1	   L(1)-­‐PZLL320	   320	   320	   69	  000	   83	  800	  
2	   G2(8)-­‐PZLL40	   40	   320	   96	  000	   83	  800	  
3	   G3(16)-­‐PZLL40	   40	   640	   203	  000	   167	  700	  
4	   G4(32)-­‐PZLL40	   40	   1280	   420	  000	   335	  400	  
5	   G5(64)-­‐PZLL40	   40	   2560	   765	  000	   670	  700	  
6	   G5(64)-­‐PZLL5	   5	   320	   100	  000	   83	  800	  
(a)	  determined	  by	  SEC	  (DMF)	  using	  MALS	  detection	  using	  the	  dn/dc	  of	  linear	  PZLL	  of	  0.101.	  
(b)	   calculated	   assuming	   initiation	   from	   all	   amino	   groups	   and	   quantitative	   conversion:	  
c(monomer)/c(dendrimer)	  x	  M(monomer)	  +	  M(dendrimer).	  
	  
The	   ROP	   of	   α-­‐amino	   acid	   NCAs	   via	   primary	   amines	   is	   a	   well	   understood	   method	   for	   the	  
synthesis	   of	   well-­‐defined	   synthetic	   linear	   polypeptides.53-­‐55	   Building	   on	   previous	   work	  
conducted	   in	   our	   group,	   the	   use	   of	   multifunctional	   amino	   terminated	   dendrimers	   was	  
employed	   to	   synthesise	   well	   defined	   star	   shaped	   poly(lysine).30	   By	   employing	   four	   different	  
generations	   of	   PPI	   dendrimers	   and	   varying	   the	   monomer	   feed	   ratio	   of	   ε-­‐carbobenzyloxy-­‐L-­‐
lysine	   (ZLL)	   NCA	   it	   was	   possible	   to	   create	   star	   shaped	   poly(lysine)	   whose	   size,	   shape,	   arm	  
length	  and	  molecular	  weight	  could	  be	  readily	  controlled	  (Figure	  3.1).	  To	  develop	  a	  systematic	  
library	   of	   star	   polypeptides	   and	   demonstrate	   the	   versatility	   of	   the	   system,	   polymers	   with	  
similar	   polypeptide	   arm	   length	   (40	   monomer	   units,)	   but	   different	   degrees	   of	   branching	  
(entries	  2	  -­‐	  5,	  Table	  3.1)	  were	  synthesized	  from	  the	  different	  generation	  PPI	  dendrimers	  (e.g.	  
G5(64)-­‐PZLL40).	   1H	  NMR	  spectroscopy	   (Figure	   3.2)	   confirmed	   the	   successful	   synthesis	  of	  PZLL	  
and	   its	  conjugation	  to	  the	  dendrimer	  although	  PPI	  dendrimer	  peaks	  were	  difficult	  to	  observe	  
for	   the	  higher	  molecular	  weight	  polymers	  due	   to	  overlapping	  with	   the	  broad	  polymer	  peaks	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and	  its	  low	  concentration	  in	  comparison	  to	  the	  high	  density	  of	  PZLL.	  It	  was	  thus	  not	  possible	  to	  
confirm	  NCA	   initiation	   from	  all	   of	   the	  primary	   amino	   sites	   although	   the	  agreement	  with	   the	  
expected	  linear	   increase	  of	  molecular	  weights	  with	  increasing	  dendrimer	  generation	  suggests	  
high	   initiation	  efficiency	   (Figure	  3.3).	  This	   library	  of	  materials	  was	   further	  completed	  by	  a	  64	  
arm	   PZLL	   with	   only	   5	   repeating	   units	   per	   arm	   (entry	   6,	   Table	   3.1;	   G5(64)-­‐PZLL5)	   thus	  
comparable	  to	  G2(8)-­‐PZLL40	  in	  total	  molecular	  weight	  yet	  with	  more	  and	  shorter	  arms.	  Finally,	  
a	  linear	  PZLL	  was	  synthesised	  (entry	  1,	  Table	  3.1;	  L(1)-­‐PZLL320).	  Deprotection	  of	  the	  described	  
polymers	   afforded	   linear	   and	   star	   shaped	   poly(lysine)	   possessing	   amino	   functionalities.	  
Quantitative	   deprotection	   was	   confirmed	   by	   1H	   NMR	   spectroscopy	   and	   FTIR	   spectroscopy	  
(Figures	  3.4	  and	  3.5).	  Polymers	  1	  –	  6	  were	  subsequently	  investigated	  as	  gene	  delivery	  vectors.	  	  
	  
	  
Figure	  3.2:	  1H	  NMR	  spectra	  of	  G2(8)-­‐PZLL40	  (Top)	  (CDCl3)	  and	  G2-­‐PPI	  Dendrimer	  (Bottom)	  







Figure	  3.3:	  SEC	  traces	  of	  selected	  star	  shaped	  and	  linear	  poly-­‐ε-­‐carbobenzyloxy-­‐L-­‐lysine	  (A:	  
G5(64)-­‐PZLL40;	  B:	  	  G2(8)-­‐PZLL40;	  C:	  G5(64)-­‐PZLL5)	  and	  weight	  average	  molar	  mass	  (Mw)	  of	  star-­‐
shaped	  PZLL	  obtained	  by	  initiation	  of	  NCA	  from	  different	  generation	  PPI	  dendrimers.	  The	  line	  




Figure	  3.4:	  1H	  NMR	  spectrum	  of	  deprotected	  G2(8)-­‐PLL40	  (D2O).	  (Peaks	  A	  -­‐	  H	  not	  visible)	  
	  
	  




3.2.2	  Complexation	  with	  Genetic	  Cargoes	  
Particle	  size,	  surface	  charge	  and	  morphology	  of	  pDNA-­‐PLL	  polyplexes	  
ζ-­‐potential	  analysis	  (Figures	  3.6	  and	  3.7)	  demonstrated	  that	  star	  shaped	  PLL	  could	  successfully	  
form	  cationic	  polyplexes	  with	  pDNA	  at	  N/P	  2	   -­‐	  5	  whereas	   linear	  PLL	  required	  higher	  ratios	  of	  
N/P	  10	  –	  20	   to	  neutralise	   the	  polyanionic	  charge	  of	   the	  pDNA.	  No	  noticeable	  effect	   in	  pDNA	  
complexation	  was	   observed	   between	   the	   different	   star	   shaped	   architectures.	   For	   successful	  
pDNA	  transfection	  nanoparticles	  <200nm	  are	   required.	  Nanoparticles	  with	  sizes	  greater	   than	  
200	  nm	  will	  be	  readily	  removed	  from	  the	  body	  by	  the	  reticuloendothelial	  system	  (RES)56	  and	  
will	  not	  be	  efficiently	  endocytosed	  by	  cell	  membranes.	  The	  particle	  size	  (Figures	  3.8	  and	  3.9)	  of	  
cationic	  pDNA	  polyplexes	   formed	  was	   investigated	  over	  a	   range	  of	  N/P	   ratios	  using	  dynamic	  
light	  scattering	  (DLS).	  Around	  charge	  neutrality	  i.e.	  complete	  pDNA	  neutralisation	  (as	  indicated	  
by	   a	   ζ-­‐potential	   around	   0	   mV	   in	   Figures	   3.6	   and	   3.7)	   large	   sized	   pDNA	   polyplexes	   were	  
observed	   which	   would	   be	   expected	   due	   to	   a	   lack	   of	   colloidal	   stability.	   For	   pDNA	   it	   was	  
observed	  that	  at	  N/P	  5	  –	  100,	  G2(8)-­‐PLL40	  and	  G5(64)-­‐PLL5	  could	  form	  nanoparticles	  <100nm	  in	  
size	   with	   the	   densely	   branched,	   long	   armed	   G3(16),	   G4(32)	   and	   G5(64)-­‐PLL40	   slightly	   larger	  
nanoparticles	  over	  this	  N/P	  ratio	  range.	  Linear	  PLL	  could	  also	  compact	  pDNA	  into	  nanoparticles	  
<200nm	  but	  only	  at	  higher	  N/P	  ratios	  (N/P	  >10)	  than	  star	  shaped	  PLL.	  Atomic	  force	  microscopy	  
was	  used	  to	  investigate	  the	  morphology	  of	  the	  pDNA	  polyplexes	  as	  the	  shape	  of	  the	  complexes	  
can	  impact	  on	  gene	  delivery	  efficiency.57	  It	  was	  observed	  that	  star	  shaped	  PLL	  could	  efficiently	  
complex	  pDNA	  into	  discrete,	  compact,	  spherically	  shaped	  nanoparticles	  with	  sizes	  in	  the	  range	  
50	  –	  150nm	  (Figures	  3.10	  and	  3.11).	  In	  comparison	  linear	  PLL/pDNA	  complexes	  were	  irregular	  
and	  elongated	   in	  shape.	  pDNA-­‐	  L(1)-­‐PLL320	  polyplexes	  displayed	  sizes	  >200nm,	  supporting	  the	  





Figure	  3.6:	  ζ-­‐potential	  of	  G2(8)-­‐PLL40,	  G5(64)-­‐PLL40,	  G5(64)-­‐PZLL5	  and	  L(1)-­‐PLL320	  
polypeptide/pDNA	  polyplexes	  at	  over	  a	  range	  of	  N/P	  ratios.	  
	  
	  
Figure	  3.7:	  ζ-­‐potential	  of	  G3(16)-­‐PLL40	  and	  G4(32)-­‐PLL40	  polypeptide/pDNA-­‐PLL	  polyplexes	  at	  





Figure	  3.8:	  Particle	  size	  of	  G2(8)-­‐PLL40,	  G5(64)-­‐PLL40,	  G5(64)-­‐PZLL5	  and	  L(1)-­‐PLL320	  
polypeptide/pDNA	  polyplexes	  at	  over	  a	  range	  of	  N/P	  ratios.	  
	  
	  
Figure	  3.9:	  Particle	  size	  of	  G3(16)-­‐PLL40	  and	  G4(32)-­‐PLL40	  polypeptide/pDNA-­‐PLL	  polyplexes	  at	  





Figure	  3.10:	  Atomic	  Force	  Microscopy	  of	  G5(64)-­‐PZLL5,	  G5(64)-­‐PLL40,	  and	  L(1)-­‐PLL320	  
polypeptide/pDNA	  polyplexes	  at	  N/P	  20.	  
	  
	  
Figure	  3.11:	  Atomic	  Force	  Microscopy	  of	  G2(8)-­‐PZLL40,	  G3(16)-­‐PLL40,	  and	  G4(32)-­‐PLL40	  
polypeptide/pDNA	  polyplexes	  at	  N/P	  20.	  
	  
Particle	  size,	  surface	  charge	  and	  morphology	  of	  siRNA-­‐PLL	  polyplexes	  
siRNA	   are	   much	   shorter	   chain	   oligonucleotides	   and	   therefore	   interact	   with	   and	   form	   very	  
different	   polyplexes	   to	   those	   fabricated	   with	   pDNA.	   L(1)-­‐PLL320	   failed	   to	   effectively	   complex	  
siRNA	  even	  at	  very	  high	  PLL:siRNA	  N/P	  	  ratios	  up	  to	  300	  (Figure	  3.12).	  The	  inability	  of	  linear	  PLL	  
to	  neutralise	   siRNA	  and	   form	  a	  discrete	   compact	   cationic	  nanostructure	   clearly	   relates	   to	   its	  
linear	   architecture	   as	   star	   shaped	   polypeptides	   very	   effectively	   neutralised	   the	   polyanionic	  
siRNA	  at	  low	  N/P	  ratios	  <5.	  The	  molecular	  weight	  and	  architecture	  had	  a	  significant	  impact	  on	  
the	  overall	   surface	   charge	  of	   the	   siRNA	  polyplexes	   formed	  with	  G2(8)-­‐PLL40	  and	  G5(64)-­‐PLL5,	  
with	  similar	  molecular	  weights,	  both	  forming	  cationic	  siRNA	  polyplexes	  at	  N/P	  3	  whereas	  the	  















(Figures	   3.12	   and	   3.13).	   For	   example,	   G5(64)-­‐PLL40	  overall	   possesses	  more	   lysine	   units	   than	  
G2(8)-­‐PLL40	  and	  G5(64)-­‐PLL5	  with	  a	  large	  core	  and	  up	  to	  64	  long	  lysine	  arms.	  G2(8)-­‐PLL40	  has	  a	  
small	   core	  with	  only	  up	   to	  8	   long	  arms	  and	  G5(64)-­‐PLL5	  has	  a	   large	  core	  with	  up	   to	  64	  short	  
arms,	  making	  their	  overall	  molecular	  weight	  and	  number	  of	  lysine	  residues	  smaller.	  Therefore,	  
it	   can	   be	   determined	   from	   this	   and	   the	   L(1)-­‐PLL320	   data	   that	   is	   not	   simply	   the	   number	   of	  
cationic	   lysine	   residues	   presented	   that	   impacts	   on	   siRNA	   complexation	   but	   how	   they	   are	  
presented.	   The	   large	   dendrimer	   core	   and	   dense	   polypeptide	   shell	   of	   G5(64)-­‐PLL40	  may	   limit	  
siRNA	  interaction	  with	  PPI-­‐PLL	  	  with	  the	  siRNA	  being	  retained	  upon	  the	  periphery	  of	  this	  star-­‐
shaped	  polypeptide.	   In	  contrast	  the	  long	  but	  relatively	  few	  arms	  of	  G2(8)-­‐PLL40	  and	  the	  many	  
but	   short	   arms	   of	   G5(64)-­‐PLL5	   results	   in	   a	   decreased	   polypeptide	   density,	   enabling	   greater	  
exposure	  of	  siRNA	  to	   lysine	  units	  and	  potentially	   the	  dendrimer	  core	  even	  though	  these	  star	  
shaped	   polypeptides	   have	   fewer	   overall	   cationic	   units	   than	   G5(64)-­‐PLL40.	   This	   difference	   in	  
ability	   to	   complex	   siRNA	   between	   the	   star	   shaped	   PLL	   was	   also	   evident	   in	   the	   particle	   size	  
analysis	   (Figures	   3.14	   and	   3.15).	   siRNA	  polyplexes	   composed	  of	  G2(8)-­‐PLL40	   and	  G5(64)-­‐PLL5	  
could	   form	  discrete	  nanoparticles	   <100nm	  at	  N/P	  5	   –	   100	  whereas	   those	   composed	  of	   L(1)-­‐
PLL320	  and	  G3(16),	  G4(32)	  and	  G5(64)-­‐PLL40	  could	  not	  form	  polyplexes	  <200nm	  at	  N/P	  1	  -­‐	  100.	  
AFM	  analysis	  (Figures	  3.16	  and	  3.17)	  of	  star	  shaped	  PLL	  siRNA	  polyplexes	  showed	  the	  efficient	  
complexation	   and	   subsequent	   formation	   of	   spherically	   shaped	   compact	   nanoparticles	   (50	   –	  
150nm)	  at	  N/P	  20.	  L(1)-­‐PLL320	  however,	   formed	   large	  elongated	  siRNA	  polyplexes	   (>200nm)	  a	  
feature	  which	  may	  inhibit	  efficient	  or	  complete	  siRNA	  complexation	  as	  observed	  in	  ζ-­‐potential	  
analysis	   of	   the	   described	   polyplex.	   	   A	   small	   amount	   of	   aggregation	  was	   observed	   for	   siRNA	  
polyplexes	  of	  G2(8)-­‐PLL40	  (Figure	  3.16)	  which	  may	  be	  an	  artefact	  of	  sample	  preparation	  i.e.	  as	  
the	  mica	  sheet	  was	  dried,	  the	  gradual	  loss	  of	  solvent	  may	  have	  promoted	  minor	  aggregation.	  






Figure	  3.12:	  ζ-­‐potential	  of	  G2(8)-­‐PLL40,	  G5(64)-­‐PLL40,	  G5(64)-­‐PZLL5	  and	  L(1)-­‐PLL320	  
polypeptide/siRNA	  polyplexes	  at	  over	  a	  range	  of	  N/P	  ratios.	  
	  
	  





Figure	  3.14:	  Particle	  size	  of	  G2(8)-­‐PLL40,	  G5(64)-­‐PLL40,	  G5(64)-­‐PZLL5	  and	  L(1)-­‐PLL320	  
polypeptide/siRNA	  polyplexes	  over	  a	  range	  of	  N/P	  ratios.	  	  
	  
	  
Figure	  3.15:	  Particle	  size	  of	  G3(16)-­‐PLL40	  and	  G4(32)-­‐PLL40	  polypeptide/siRNA-­‐PLL	  polyplexes	  






Figure	  3.16:	  Atomic	  force	  microscopy	  of	  G2(8)-­‐PLL40,	  G5(64)-­‐PLL40	  and	  L(1)-­‐PLL320	  
polypeptide/siRNA	  polyplexes	  at	  N/P	  20.	  
	  
	  
Figure	  3.17:	  Atomic	  force	  microscopy	  of	  G5(64)-­‐PLL5,	  G3(16)-­‐PLL40	  and	  G4(32)-­‐PLL40	  
polypeptide/siRNA	  polyplexes	  at	  N/P	  20.	  
	  	  
	  
Gel	  retardation	  assays	  of	  siRNA/pDNA	  polyplexes	  
The	  cationic	  nature	  of	  the	  star	  shaped	  polypeptides	  provides	  a	  useful	  platform	  for	  the	  delivery	  
of	  nucleic	   acids	   into	   cells.	  Gel	   retardation	  assays	  were	  used	   to	  evaluate	  and	   further	   confirm	  
(Figures	  3.6	  –	  3.17)	  the	  ability	  of	  both	  linear	  and	  three	  of	  the	  star-­‐shaped	  polypeptides	  G2(8)-­‐
PLL40,	   G5(64)-­‐PLL5	   and	   G5(64)-­‐PLL40	   to	   form	   complexes	   with	   the	   two	   different	   nucleic	   acid	  
cargoes	   under	   investigation	   i.e.	   plasmid	   DNA	   and	   siRNA.	   The	   assays	   were	   carried	   out	   at	  
different	  N/P	   ratios	   for	   pDNA	   (N/P:	   0.5,	   1,	   5,	   10,	   20)	   and	   siRNA	   (N/P:	   1,	   2,	   3,	   5,	   10,	   20,	   50)	  















From	   Figures	   3.18	   and	   3.19	   it	  was	   noted	   that	   all	   polymers,	   both	   linear	  and	   star	   shaped	   PLL	  
successfully	  complexed	  pDNA	  at	  N/P	  5.	  This	  is	  evidenced	  by	  the	  lack	  of	  a	  pDNA	  band	  seen	  on	  
the	   gels	   in	   Lanes	   6,	   7	   and	   8	   which	   represent	   N/P	   ratios	   of	   5,	   10	   and	   20	   respectively.	   This	  
observation	  corroborates	   the	  particle	   size	  and	  zeta	  potential	  data	   (Figures	   3.6	   and	   3.8).	   The	  
effective	   interaction	   seen	   for	   all	   the	   polylysines	  most	   likely	   arises	   from	   the	   large	   number	   of	  
nucleic	  acids	  presented	  by	  pDNA	  that	  enables	  effective	  electrostatic	  complexation	  with	  all	  of	  
the	   described	   polymers.	   The	   nature	   of	   the	   nanoparticle	   produced	   by	   this	   complexation,	  
however	   is	   structure	   dependent	   as	   evidenced	   in	   Figures	   3.8,	   3.9,	   3.10	   and	   3.11.	   PEI/pDNA	  
complex	  and	  uncomplexed	  pDNA	  were	  used	  as	  a	  reference	  and	  control	  respectively.	  	  	  
	  
Polypeptide	  architecture	  had	  a	  very	  significant	  effect	  on	  siRNA	  complexation	  (Figures	  3.20	  and	  
3.21).	  L(1)-­‐PLL320	  was	  unable	  to	  completely	  complex	  siRNA	  even	  at	  N/P	  50	  as	  evidenced	  by	  the	  
presence	   of	   siRNA	   band	   in	   lane	   9	   of	   gel	   in	   Fig	   3.20b.	   However,	   star-­‐shaped	   PLL	   could	  
successfully	  form	  polyplexes	  at	  ratios	  as	  low	  as	  N/P	  1	  as	  evidenced	  by	  the	  lack	  of	  siRNA	  band	  
seen	   in	   Lanes	  4-­‐9	  on	   the	   gel	   in	  Figure	   3.20a.	   Architectural	   variations	  within	   the	   star	   shaped	  
polypeptide	  family	  also	  displayed	  notable	  differences	  in	  siRNA	  complexation	  with	  G5(64)-­‐PLL5	  
demonstrating	  gel	   retardation	   i.e.	   complexation	  at	   the	   lowest	  N/P	   ratio	  of	  N/P	  2	   (Fig	   3.20a)	  
while	  G5(64)-­‐PLL40	  and	  G2(8)-­‐PLL40	  fully	   retarded	   the	  siRNA	  at	  N/P20	  and	  N/P	  10	   respectively	  
(Figure	   3.21).	   Zeta	   potential	   analysis	   showed	   a	   similar	   trend	   with	   G5(64)-­‐PLL40	   neutralising	  
siRNA	  at	  a	  slightly	  higher	  N/P	  ratio	  than	  G5(64)-­‐PLL5	  or	  G2(8)-­‐PLL40	  (Figure	  3.6)	  and	  producing	  






Figure	  3.18:	  1%	  Agarose	  gel	  electrophoresis	  of	  star	  shaped	  PLL	  and	  linear	  PLL	  complexed	  with	  
plasmid	  DNA	  to	  form	  polyplexes	  as	  a	  function	  of	  N/P	  ratio.	  (a)	  	  G5(64)-­‐PLL5;	  (b)	  L(1)-­‐PLL320;	  
Lane	  1:	  pDNA	  Ladder,	  Lane	  2:	  pDNA,	  Lane	  3:	  PEI/pDNA	  (N/P	  10),	  Lanes	  4	  –	  8:	  pDNA	  
complexes	  at	  the	  N/P	  ratios	  of	  0.5,	  1,	  5,	  10,	  20.	  
	  
	  
Figure	  3.19:	  1%	  Agarose	  gel	  electrophoresis	  of	  star	  shaped	  PLL	  complexed	  with	  plasmid	  DNA	  
to	  form	  polyplexes	  as	  a	  function	  of	  N/P	  ratio.	  (a)	  	  G2(8)-­‐PLL40;	  (b)	  G5(64)-­‐PLL40;	  Lane	  1:	  pDNA	  
Ladder,	  Lane	  2:	  pDNA,	  Lane	  3:	  PEI/pDNA	  (N/P	  10),	  Lanes	  4	  –	  8:	  pDNA	  complexes	  at	  the	  N/P	  
ratios	  of	  0.5,	  1,	  5,	  10,	  20.	  
	  
	  
Figure	  3.20:	  PAGE	  gel	  electrophoresis	  of	  star	  shaped	  PLL	  and	  linear	  PLL	  complexed	  with	  
siRNA	  to	  form	  polyplexes	  as	  a	  function	  of	  N/P	  ratio.	  (a)	  G5(64)-­‐PLL5;	  (b)	  L(1)-­‐PLL320;	  Lane	  1:	  
siRNA,	  Lane	  2:	  PEI/siRNA	  (N/P	  10),	  Lanes	  3	  –	  9:	  siRNA	  complexes	  at	  the	  N/P	  ratios	  of	  1,	  2,	  3,	  





Figure	  3.21:	  PAGE	  gel	  electrophoresis	  of	  star	  shaped	  PLL	  complexed	  with	  siRNA	  to	  form	  
polyplexes	  as	  a	  function	  of	  N/P	  ratio.	  (a)	  G2(8)-­‐PLL40;	  Lane	  1:	  siRNA	  Ladder,	  Lanes	  2	  –	  7:	  
siRNA	  complexes	  at	  the	  N/P	  ratios	  of	  1,	  2,	  3,	  5,	  10,	  20,	  Lane	  8:	  PEI/siRNA	  (N/P	  10),	  Lane	  9:	  
siRNA	  (b)	  G5(64)-­‐PLL40;	  Lane	  1:	  siRNA	  Ladder,	  Lane	  2:	  siRNA,	  Lane	  3:	  PEI/siRNA	  (N/P	  10),	  
Lanes	  4	  –	  10:	  siRNA	  complexes	  at	  the	  N/P	  ratios	  of	  1,	  2,	  3,	  5,	  10,	  20,	  50.	  
	  
Stability	  of	  polyplexes:	  DNase	  I	  and	  RNase	  I	  protection	  assays	  
Protection	  of	   the	  nucleic	  acid	  cargo	   from	  nuclease	  degradation	   is	  a	  vital	  prerequisite	   for	  any	  
potential	   gene	  delivery	  vector.	  Molecular	   therapeutics	   such	  as	  pDNA	  and	  siRNA	   in	  particular	  
are	   susceptible	   to	   hydrolysis	   and	   nuclease	   enzymes	   in	   vivo.	   Without	   sufficient	   molecular	  
“cargo”	   protection	   gene	   therapy	   is	   inefficient	   or	   can	   be	   rendered	   completely	   ineffective.	  
DNase	  and	  RNase	  degrade	  and	  nick	  pDNA	  and	  siRNA	  respectively	  resulting	  in	  extra	  banding	  or	  
no	  bands	  at	  all	   (complete	  degradation)	   in	  gel	  electrophoresis.	   	  The	  ability	  of	   the	  star	  shaped	  
polypeptide	  architectures	  (G2(8)-­‐PLL40,	  G5(64)-­‐PLL5	  and	  G5(64)-­‐PLL40),	   to	  protect	  nucleic	  acids	  
from	  this	  form	  of	  enzymatic	  breakdown	  was	   investigated	  using	  PEI	  and	   linear	  PLL	  as	  controls	  
(Figures	   3.22	   and	   3.23).	   The	   polyplexes	   were	   exposed	   to	   the	   relevant	   nuclease	   and	   then	  
disrupted	   to	   enable	   the	   nucleic	   acids	   to	   travel	   down	   the	   gel.	   The	   same	   generations	   of	   star	  
shaped	  poly(lysine)	  were	  selected	  as	  used	  in	  the	  gel	  retardation	  study.	  
	  
Naked	  pDNA	   is	  completely	  degraded	   in	   the	  presence	  of	  DNase	  emphasising	   the	  requirement	  
and	   advantage	   of	   using	   a	   gene	   delivery	   vector	   (Figure	   3.22,	   Lane	   3).	   All	   of	   the	   star	   shaped	  
poly(lysine)	  formed	  tight	  complexes	  with	  pDNA	  and	  provided	  some	  degree	  of	  protection	  to	  the	  
pDNA	  cargo	  from	  nuclease	  degradation	  similar	  to	  that	  seen	  for	  PEI	  though	  smearing	  is	  seen	  in	  
the	  pDNA	  that	  did	  not	  remain	  encapsulated	  (Figure	  3.22,	  Lanes	  6	  –	  8).	  Their	  protective	  ability	  
was	  similar	  to	  that	  of	  PEI	  at	  an	  N/P	  ratio	  of	  10	  which	  is	  known	  to	  offer	  sufficient	  protection	  in	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vitro	  and	  in	  vivo.	  Interestingly	  from	  a	  stability	  perspective	  the	  star-­‐shaped	  PLL	  was	  more	  stable	  
to	  disruption	  by	  SDS	  than	  PEI	  as	  evidenced	  by	  the	  presence	  of	  DNA	  fluorescence	  in	  the	  wells	  of	  
these	  samples	  (Figure	  3.22,	  Lanes	  5-­‐8)	  while	  very	  little	  remains	  in	  the	  PEI	  sample	  (Figure	  3.22,	  
Lane	   4).58	   Chain	   length	   and	   degree	   of	   branching	   appeared	   to	   have	   minimal	   effect	   on	   the	  
protective	   capacity	   of	   each	   family	   for	   pDNA	   with	   little	   difference	   observed	   amongst	   star	  
shaped	  PLL	  (Figure	  3.22,	  Lanes	  6	  –	  8).	  	  
	  
	  
Figure	  3.22:	  1%	  Agarose	  gel	  electrophoresis	  of	  star	  shaped	  and	  linear	  PLL	  pDNA	  polyplexes	  at	  
N/P	  10	  and	  their	  stability	  towards	  the	  enzyme	  DNase.	  Lane	  1:	  pDNA	  ladder,	  Lane	  2:	  pDNA,	  
Lane	  3:	  pDNA/DNase,	  Lane	  4:	  PEI/pDNA/DNase,	  Lane	  5:	  L(1)-­‐PLL320/pDNA/DNase,	  Lane	  6:	  
G2(8)-­‐PLL40/pDNA/DNase,	  Lane	  7:	  G5(64)-­‐PLL40/pDNA/DNase	  and	  Lane	  8:	  G5(64)-­‐
PLL5/pDNA/DNase.	  
	  
RNase	   stability	   assays	   indicated	   that	   each	   of	   the	   star	   shaped	   polypeptides	   was	   capable	   of	  
protecting	   siRNA	   from	   nuclease	   degradation	   via	   RNase	   (Figure	   3.23,	   Lanes	   1	   –	   3).	  Without	  
complexation	   with	   a	   vector,	   naked	   siRNA	   was	   completely	   degraded	   by	   RNase	   (Figure	   3.23,	  
Lane	  6).	  L(1)-­‐PLL320	   (Figure	  3.23,	   Lane	  4)	  also	  showed	  similar	  protective	  ability	   to	  that	  of	   the	  
star	   shaped	   polypeptides	   and	   PEI	   (Figure	   3.23,	   Lane	   5)	   despite	   its’	   inability	   to	   completely	  
complex	  siRNA	  at	  N/P	  10	   (Figure	  3.12).	  From	  observations	  of	  AFM	  images	  (Figure	  3.16)	  L(1)-­‐
PLL320/siRNA	  complex	  adopts	  a	  very	   large	  coiled	  morphology,	  which	  may	  promote	  protection	  
of	   the	   cargo	   by	   sterically	   hindering	   degradation	   by	   RNase.	   It	  was	   evident	   that	   disruption	   of	  
these	  polyplexes	  was	  readily	  achieved	  owing	  to	  the	  sharp	  bands	  observed	  in	  Figure	  3.23	  after	  
siRNA	   decomplexation	   from	   the	   vectors.	   Such	   a	   feature	   possibly	   arises	   from	   the	   inherently	  
small	  size	  of	  siRNA,	  allowing	  easier	  disruption	  of	  the	  polyplexes	  formed.	  The	  much	  larger	  pDNA	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however,	  containing	  more	  nucleic	  acids,	  produced	  broad	  smeared	  bands	  as	  a	  consequence	  of	  
its	   ability	   to	   form	   very	   strong	   complexes	   with	   the	   described	   polypeptides	   resulting	   in	   a	  
complex	  more	  difficult	  to	  disrupt	  (Figure	  3.22).	  	  
	  
	  
Figure	  3.23:	  PAGE	  gel	  electrophoresis	  of	  star	  shaped	  and	  linear	  PLL	  siRNA	  polyplexes	  at	  N/P	  
10	  and	  their	  stability	  towards	  the	  enzyme	  RNase.	  Lane	  1:	  G5(64)-­‐PLL5/siRNA/RNase,	  Lane	  2:	  
G5(64)-­‐PLL40/siRNA/RNase	  ,	  Lane	  3:	  G2(8)-­‐PLL40/siRNA/RNase,	  Lane	  4:	  L(1)-­‐
PLL320/siRNA/RNase,	  Lane	  5:	  PEI/siRNA/RNase,	  Lane	  6:	  siRNA/RNase	  and	  Lane	  7:	  siRNA.	  
	  
pDNA	  transfections	  of	  Calu-­‐3	  cells	  using	  linear	  and	  star-­‐shaped	  G5(64)-­‐PLL40	  polyplexes	  
Based	   on	   the	   physicochemical	   data	   outlined	   above	   one	   of	   the	   star-­‐shaped	   PLL	   generations,	  
G5(64)-­‐PLL40	   was	   optimised	   for	   transfection	   using	   a	   reporter	   plasmid	   expressing	   luciferase,	  
pGLuc	   and	   compared	   to	   linear	  PLL	  at	   its	  previously	  determined	  N/P	  optimum	  of	  2	   for	  pDNA	  
transfection.59	   Figure	   3.24	   illustrates	   the	   results	   of	   this	   study	   with	   G5(64)-­‐PLL40	  successfully	  
transfecting	   Calu-­‐3	   cells	   with	   the	   levels	   of	   expression	   dependent	   	   on	   the	   N/P	   ratio	   of	   the	  
polyplexes	   used.	   An	   optimum	   N/P	   ratio	   of	   5	   was	   determined	   for	   this	   star-­‐shaped	   polymer,	  
similar	   to	   that	   found	   for	   other	   dendrimer-­‐based	   gene	   vectors	   such	   as	   Superfect™.	   From	   the	  
particle	   size	   analysis	   (Figure	   3.8)	   N/P	   ratios	   <	   5	   for	   G5(64)-­‐PLL40	   with	   pDNA	   formed	   large	  
nanoparticles	   >300nm.	   	  Optical	   images	   taken	  of	   cells	   post	   treatment	   (Figure	   3.25)	   indicated	  
that	   at	   high	   N/P	   ratios	   e.g.	   N/P50	   (Figure	   3.25	   -­‐	   D)	   there	   were	   signs	   of	   significant	   cellular	  
toxicity,	   while	   at	   the	   optimum	   transfection	   N/P	   ratio	   of	   5	   cells	   appear	   healthy	   and	   viable	  
(Figure	   3.25	   -­‐	   C).	   The	  highest	   levels	   of	   expression	  were	   seen	   at	   day	   5	  post	   transfection	   and	  
these	  were	  significantly	  greater	  than	  for	  linear	  pLL	  at	  each	  of	  N/P	  ratios	  5,	  10	  and	  20	  (p<0.05).	  
These	   preliminary	   transfection	   studies	   indicate	   that	   the	   star-­‐shaped	   PLL	   is	   capable	   of	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protecting	   pDNA,	   enhancing	   its	   cellular	   uptake	   and	   ultimately	   facilitating	   pDNA	   expression	  
over	   prolonged	   periods,	   up	   to	   5	   days,	  which	   could	   enable	   applications	   in	   both	   conventional	  




Figure	  3.24:	  Transfection	  of	  Calu-­‐3	  cells	  with	  pLuc/pLL	  polyplexes	  composed	  of	  linear	  
pLL:pDNA	  (N/P	  2)	  and	  star-­‐shaped	  PLL	  G5(64)-­‐PLL40	  over	  range	  of	  N/P	  ratios	  (N/P	  1-­‐50).	  
Expression	  of	  luciferase	  expressed	  as	  RLUs	  (log	  scale)	  was	  assessed	  1,	  2	  or	  5	  days	  post	  
transfection	  with	  the	  polyplexes	  (n=3	  +/-­‐	  S.D.)	  Data	  are	  represented	  as	  mean	  ±	  SD	  and	  were	  
compared	  by	  t-­‐test	  (non-­‐parametric,	  one-­‐tailed)	  against	  linear	  PLL	  at	  day	  5.	  	  Differences	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Figure	  3.25:	  Optical	  images	  of	  Calu-­‐3	  cells	  treated	  with	  A)	  untreated	  cells	  B)	  pDNA-­‐Linear	  PLL	  
N/P	  2	  C)	  pDNA-­‐G5(64)-­‐pLL40	  N/P	  5	  and	  D)	  pDNA-­‐G5(64)-­‐pLL40	  N/P	  50	  polyplexes.	  
3.3 Conclusion	  
Star-­‐shaped	  polypeptides	  are	  an	  attractive	  class	  of	  molecules	  for	  use	  as	  gene	  delivery	  vectors	  
owing	  to	   their	  potential	   improved	  biocompatibility,	   structural	  characteristics	  and	  therapeutic	  
“cargo”	   capacity.	   In	   this	  paper	  we	  describe	   the	   facile	   and	   systematic	   synthesis	  of	   a	   range	  of	  
well-­‐defined,	   monodisperse	   star	   shaped	   poly(lysine)	   polymers	   boasting	   molecular	   weight,	  
branching	   and	   polypeptide	   chain	   length	   versatility.	   The	   applicability	   of	   the	   described	  
polypeptides	  as	  gene	  delivery	  vectors	  was	  subsequently	   investigated.	  From	  our	   study,	   it	  was	  
apparent	   that	   polypeptide	   architecture	   had	   a	   significant	   impact	   on	   the	   nature	   of	   the	  
polyplexes	  formed.	  In	  terms	  of	  pDNA,	  all	  star	  shaped	  polypeptides	  efficiently	  packaged	  pDNA	  
into	  discrete	  spherically	  shaped	  and	  positively	  charged	  nanocomplexes	  at	  low	  N/P	  ratios	  with	  
sizes	   as	   low	   as	   <100nm	   whereas	   the	   equivalent	   linear	   polypeptide	   required	   a	   higher	  
complexation	   ratio.	   The	   complexation	  of	   siRNA	  with	   star-­‐shaped	  PLL	  was	  greatly	   superior	   to	  
linear	  PLL.	   In	  particular	   the	  small	  armed,	   less	  densely	  branched	  star	  polypeptides	  were	  most	  
promising	   as	   both	   pDNA	   and	   siRNA	   delivery	   vectors	   owing	   to	   their	   optimum	   sizing	   and	  
complexation	  data.	  All	   star	  polypeptides	  offered	   similar	   protection	  of	   pDNA	  and	   siRNA	   from	  
nuclease	  degradation	  once	  complexed.	  However	  upon	  decomplexation	  it	  was	  noted	  that	  siRNA	  
complexes	  were	  more	   readily	   disrupted	   in	   comparison	   to	   pDNA	   complexes,	   highlighting	   the	  
differences	  in	  stability	  between	  polyplexes	  composed	  of	  the	  different	  nucleic	  acids.	  Overall	  the	  
promising	   nucleic	   acid	   complexation,	   sizing,	   morphology	   and	   protection	   capacity	   of	   two	  
different	   genetic	   “cargos”	  highlights	   the	  potential	   of	   polypeptide	  dendrimer	  hybrids	   as	   gene	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delivery	   vectors	   (GDVs).	   Their	   potential	   as	   GDVs	   was	   confirmed	   with	   preliminary	   pDNA	  
transfection	  studies	  in	  which	  one	  of	  the	  G5(64)-­‐PLL40	  was	  found	  to	  be	  capable	  of	  successfully	  
transfecting	  epithelial	  cells	  with	  pDNA,	  and	  importantly	  these	  levels	  were	  significantly	  greater	  
compared	  to	  linear	  PLL	  with	  a	  300-­‐fold	  increase	  in	  expression	  seen	  over	  the	  5	  day	  study.	  The	  
systematic	  study	  reported	  here	  may	  potentially	  lead	  to	  the	  identification	  and	  development	  of	  
an	  ideal	  polypeptide	  dendrimer	  hybrid	  material	  for	  use	  as	  a	  versatile	  platform	  in	  gene	  delivery.	  
Versatility	  may	  be	  readily	  enhanced	  through	  the	  facile	  control	  of	  polypeptide	  dimensions	  such	  
as	  branching	  and	  molecular	  weight,	  end	  group	  and	   side	   chain	  modification	  using	  pegylation,	  
glycosylation	  and	  attachment	  of	  ligands	  to	  further	  improve	  biocompatibility,	  cell	  targeting	  and	  





















All	   air	   and	  moisture	   sensitive	   compounds	  were	   handled	   under	   a	   nitrogen	   atmosphere	   using	  
general	  Schlenk-­‐line	   techniques.	  α-­‐pinene	   (98%)	  bis(trichloromethyl)	  carbonate	   (triphosgene)	  
99%	   and	   benzylamine	   were	   purchased	   from	   Sigma	   Aldrich.	   H-­‐Lys(Z)-­‐OH	   were	   supplied	   by	  
Bachem.	  PPI	   (polypropylene	   imine)	  dendrimers	  generations	  2-­‐5	  were	  purchased	   from	  SyMO-­‐
Chem	   BV	   (The	   Netherlands).	   Chloroform	   (anhydrous),	   ethyl	   acetate	   (anhydrous),	  
dimethylformamide,	   tetrahydrofuran,	   n-­‐heptane,	   and	   diethylether	   were	   supplied	   by	   Sigma	  
Aldrich.	  All	  chemicals	  were	  used	  without	  any	  purification	  unless	  otherwise	  noted.	  Chloroform	  
and	   ethyl	   acetate	   were	   used	   directly	   from	   the	   bottle	   and	   stored	   under	   an	   inert,	   dry	  
atmosphere.	   ε-­‐carbobenzyloxy-­‐L-­‐lysine	   NCA	   were	   synthesised	   following	   a	   literature	  
procedure.60	   siGENOME	   non-­‐targeting	   siRNA	   #4	   (5’	   AUGAACGUGAAUUGCUCAA	   3’)	   was	  
obtained	  from	  Dharmacon	  and	  the	  pGL3-­‐control	  vector	  plasmid	  was	  sourced	  from	  Promega.	  
Star	  poly-­‐ε-­‐carbobenzyloxy-­‐L-­‐lysine	  ((G2-­‐5)	  PPI-­‐PZLL)	  
As	  a	  reference	  procedure,	   the	  NCA	  of	  ε-­‐carbobenzyloxy-­‐L-­‐lysine	   (ZLL)	   (2.02	  g,	  6.6	  mmol)	  was	  
dissolved	  in	  25	  ml	  CHCl3	  in	  a	  Schlenk	  tube	  under	  a	  nitrogen	  atmosphere.	  A	  solution	  of	  G2	  PPI	  
dendrimer	  (30	  mg,	  2.07	  x	  10-­‐2	  mmol)	   in	  2	  ml	  CHCl3	  was	  quickly	  charged	  to	  the	  dissolved	  NCA	  
solution	  via	  syringe.	  The	  solution	  was	  stirred	  for	  24	  h	  at	  room	  temperature.	  Depending	  on	  the	  
type	  of	   initiator,	   the	  used	  molar	  amount	  of	   initiator	  and	  monomer	  were	  adjusted	  to	  achieve	  
the	  desired	  molecular	  weight	  of	   the	  star	  shaped	  polypeptides.	  The	  polymer	  was	  precipitated	  
into	  an	  excess	  of	  cold	  diethyl	  ether	  and	  dried	  under	  vacuum	  (Yield:	  95%).	  
Star	  poly-­‐L-­‐lysine	  (PPI-­‐PLL)	  
G2(8)-­‐	  PZLL40	   (1.2	  g)	  was	  dissolved	   in	  12	  ml	  of	   trifluoroacetic	  acid	   (TFA).	  A	  6-­‐fold	  excess	  with	  
respect	   to	  ε-­‐carbobenzyloxy-­‐L-­‐lysine	  of	  a	  33%	  solution	  of	  HBr	   in	  acetic	  acid	   (5ml)	  was	  added	  
slowly	   to	   the	   reaction.	   After	   16	   h,	   the	   solution	   was	   precipitated	   into	   diethyl	   ether.	   The	  
precipitate	  was	   dissolved	   in	   ethanol	   and	   precipitated	   thrice	   into	   diethyl	   ether.	   The	   polymer	  
was	   dissolved	   in	   deionised	  water	   and	   dialyzed	   (MWCO	   8,000)	   for	   3	   days.	   The	   polymer	  was	  
lyophilized.	   Yield:	   68%.	   Deprotection	   was	   confirmed	   by	   1H	   NMR	   spectroscopy	   due	   to	   the	  






Linear	  poly-­‐ε-­‐carbobenzyloxy-­‐l-­‐lysine	  (L-­‐PLL)	  
In	  a	  Schlenk	  tube	  under	  a	  nitrogen	  atmosphere,	  a	  solution	  of	  the	  NCA	  of	  ε-­‐carbobenzyloxy-­‐L-­‐
lysine	  (ZLL	  (0.92	  g,	  3	  mmol)	  in	  CHCl3	  (30	  ml)	  was	  prepared.	  A	  solution	  of	  benzylamine	  initiator	  
(1	  mg,	  9.33	  x	  10-­‐3	  mmol)	  in	  1	  ml	  CHCl3	  was	  also	  prepared	  and	  charged	  to	  the	  reaction	  solution	  
via	   syringe.	   The	   solution	   was	   stirred	   at	   room	   temperature	   until	   no	   further	   increase	   in	  
molecular	  weight	  was	  achieved.	  The	  molecular	  weight	  was	  monitored	  by	  SEC	  by	  precipitating	  1	  
ml	   (63	  mg)	  of	   the	  reaction	  solution	   into	  an	  excess	  of	  cold	  diethyl	  ether.	  Upon	  no	   increase	   in	  
molecular	  weight,	  the	  polymer	  was	  precipitated	  into	  an	  excess	  of	  cold	  diethyl	  ether	  and	  dried	  
under	   vacuum	   (Yield:	   70%).	   For	   the	   deprotection	   the	   same	   procedure	   as	   for	   PPI-­‐PZLL	   was	  
applied.	  (Yield:	  70%).	  
	  
Methods	  
Nuclear	  magnetic	  resonance	  (NMR)	  spectra	  were	  recorded	  on	  a	  Bruker	  Avance	  400	  (400MHz)	  
spectrometer	  at	  room	  temperature	  in	  CDCl3	  and	  d-­‐TFA	  as	  solvents.	  Attenuated	  Total	  Reflection	  
(ATR)	   FTIR	   spectroscopy	  measurements	  were	   performed	  on	   a	   Perkin-­‐Elmer	   Spectrum	  100	   in	  
the	  spectral	  region	  of	  650-­‐4000	  cm-­‐1	  and	  were	  obtained	  from	  4	  scans	  with	  a	  resolution	  of	  2	  cm-­‐
1.	   A	   background	   measurement	   was	   taken	   before	   the	   sample	   was	   loaded	   onto	   the	   ATR	   for	  
measurement.	  Size	  Exclusion	  Chromatography	  (SEC)	  was	  performed	  on	  an	  Agilent	  1200	  system	  
in	   conjunction	  with	   two	  PSS	  GRAM	  analytical	   (8	   x	   300	   and	   8	   x	   100,	   10	  μ)	   columns,	   a	  Wyatt	  
Dawn	  Heleos	  8	  multi	  angle	  light	  scattering	  detector	  (MALS)	  and	  Wyatt	  Optilab	  rEX	  differential	  
refractive	  index	  detector	  (DRI)	  with	  a	  658	  nm	  light	  source.	  The	  eluent	  was	  DMF	  containing	  0.1	  
M	  LiBr	  at	  a	  flow	  rate	  of	  1mL	  min-­‐1.	  The	  column	  temperature	  was	  set	  to	  40	  ºC	  with	  the	  MALS	  
detector	  at	  35	  ºC	  and	  the	  DRI	  detector	  at	  40	  ºC.	  Molar	  masses	  and	  dispersities	  were	  calculated	  
from	   the	   MALS	   signal	   by	   the	   Astra	   software	   (Wyatt)	   using	   the	   refractive	   index	   increment	  
(dn/dc)	  of	  linear	  poly-­‐(ε-­‐carbobenzyloxy-­‐L-­‐lysine)	  (PZLL)	  of	  0.101.61	  All	  samples	  for	  GPC	  analysis	  
were	   prepared	  with	   a	   concentration	   of	   2	  mg/ml	   and	  were	   filtered	   through	   a	   0.45	   μm	   PTFE	  
filter	  (13mm,	  PP	  housing,	  Whatman)	  prior	  to	  injection.	  
Plasmid	  preparation	  	  
The	   pGL3-­‐control	   vector	   plasmid	   (Promega)	   consists	   of	   5256	   bp	   and	   contains	   the	   firefly	  
luciferase	   gene	   and	   an	   ampicillin	   resistance	   gene	   that	   are	   controlled	   by	   a	   SV40	  
promoter/enhancer.	   The	   plasmids	   were	   replicated	   in	   the	   high-­‐copy	   DH5-­‐α	   Escherichia	   coli	  
strain	  grown	  in	  selective	  ampicillin	  (50	  µg/ml)	  supplemented	  Luria-­‐Bertani	  medium,	  isolated	  by	  
alkaline	   lysis	   followed	  by	  anion	  exchange	  chromatography	  using	  the	  Giga	  Qiagen	  kit	   (Qiagen)	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according	   to	   the	  manufacturer’s	  protocol.	   Purity	  of	   the	  plasmid	  and	   integrity	  of	   cDNA	   insert	  
were	  determined	  by	  agarose	  gel	  electrophoresis	   and	  UV	   spectroscopy	   (E	  260/280	  nm	  ratio).	  
After	   isolation,	   the	  pDNA	  was	  dissolved	  to	  an	  end	  concentration	  of	  1.2	  µg/ml	  Tris	  HCl	  buffer	  
(pH	  8.0).	  The	  purity	  was	  assayed	  by	  1%	  agarose	  gel	  electrophoresis.	  This	  was	  then	  used	  in	  the	  
preparation	  of	  the	  pDNA	  polyplexes.	  
	  
Preparation	  of	  siRNA	  and	  pDNA	  polyplexes	  
siGENOME	   non-­‐targeting	   siRNA	   #4	   (5’	   AUGAACGUGAAUUGCUCAA	   3’)	   was	   obtained	   from	  
Dharmacon	  and	  used	  in	  the	  preparation	  of	  the	  polyplexes.	  The	  siRNA/pDNA	  G2-­‐PLys	  (40units)	  
and	  G5-­‐PLys	  (5	  units)	  polyplexes	  were	  freshly	  prepared	  prior	  to	  use.	  The	  ratio	  of	  dendrimer	  to	  
pDNA/siRNA	  in	  the	  polyplexes	  was	  calculated	  according	  to	  the	  molar	  ratio	  of	  amino	  group	   in	  
dendrimer	  to	  phosphate	  group	   in	  pDNA/siRNA,	   i.e.,	   the	  N:P	  ratio.	  To	  prepare	  the	  polyplexes,	  
solutions	  of	  	  G2-­‐PPI-­‐PLL	  or	  G5-­‐PPI-­‐PLL	  prepared	  in	  buffer	  (Tris	  HCl	  buffer	  pH	  7.4	  -­‐	  10mM	  NaCl)	  
were	  mixed	  with	  pDNA/siRNA	  at	  various	  N:P	  ratios	  (1,	  5,	  10,	  20	  and	  100).	  These	  mixtures	  were	  
incubated	  at	  room	  temperature	  for	  30	  min	  for	  polyplex	  formation,	  diluted	  and	  analysed.	  
	  
Particle	  size	  and	  zeta	  potential	  analysis	  	  
The	  polyplexes	  were	  prepared	  in	  triplicate	  at	  various	  N:P	  ratios	  as	  described,	  and	  their	  particle	  
size	   and	   surface	   charge	   (ζ-­‐potential)	   measured	   by	   a	   Malvern	   Zetasizer	   Nano	   ZS	   (Malvern	  
Instruments,	  Ltd.,	  United	  Kingdom).	  
	  
Atomic	  Force	  Microscopy	  (AFM)	  
Particle	   size	   and	   morphology	   were	   also	   determined	   using	   Atomic	   Force	   Microscopy	   (AFM,	  
Asylum	   MFP-­‐3D-­‐BIO,	   DIT	   Focas	   Institute,	   Dublin,	   Ireland).	   For	   AFM,	   the	   polyplexes	   were	  
prepared	  at	   the	  N:P	   ratio	  of	  20	  by	  adding	   the	  polypeptide	   solution	   to	  pDNA/siRNA	   to	  give	  a	  
final	  pDNA/siRNA	  concentration	  of	  10ng/μL.	  After	  incubation	  at	  room	  temperature	  for	  30	  min,	  
2	  μL	  of	  the	  complex	  solution	  was	  diluted	   into	  198	  μL	  H2O	  and	  deposited	  onto	  the	  surface	  of	  
freshly	   cleaved	  mica	   sheets	   (Agar	   scientific,	   G250-­‐3,	   11	   x	   11mm	  mica).	   After	   3	  mins,	   excess	  
solution	   was	   removed	   by	   careful	   absorption	   onto	   filter	   paper	   (Whatman,	   Fisher	   Scientific,	  
Ireland)	  and	  the	  mica	  was	  further	  dried	  at	  room	  temperature	  for	  24	  hr	  before	  analysis	  by	  AFM.	  
Samples	   were	   imaged	   using	   a	   MFP-­‐3D	   BIO	   AFM	   (Asylum	   Research).	  	   Micromasch	  
silicon	  NSC18	  cantilevers	   were	   used.	   Tips	   were	   225	   nm	   long	   and	   had	   a	   typical	   resonant	  
frequency	  of	  75kHz.	  The	  AFM	  operated	  in	  AC	  mode	  (alternate	  contact)	  in	  order	  to	  minimise	  tip	  
samples	  interaction.	  Typical	  free	  air	  amplitudes	  were	  ~800	  mV	  and	  a	  high	  amplitude	  set-­‐point	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relative	  to	  the	  set-­‐point	  was	  maintained	  to	  minimise	  cell/tip	  damage.	  All	  samples	  were	  imaged	  
in	  air	  at	  relative	  humidity.	  The	  images	  obtained	  contained	  512	  pixels	  per	  scan	  line.	  
	  
Gel	  retardation	  assay	  
The	  pDNA	  polyplexes	  were	  prepared	  as	  outlined	  above,	  mixed	  with	  a	  6X	  loading	  dye	  (Promega	  
G190A-­‐Blue/orange	  6x)	  and	  analysed	  by	  running	  1%	  (w/v)	  agarose	  gel	  electrophoresis	  at	  100	  V	  
for	   1	   hr	   in	   TBE	   buffer	   (Tris/Borate/EDTA	   buffer,	   Gibco,	   Biosciences,	   Ireland)	   with	   0.5	   µg/ml	  
ethidium	  bromide.	  Visualisation	  was	  obtained	  by	  UV	  transillumination	  (G.	  Box,	  Syngene,	  UK).	  
The	  siRNA	  polyplexes	  were	  also	  prepared	  as	  before,	  mixed	  with	  loading	  dye	  (promega	  G190A-­‐
Blue/orange	   6x)	   and	   analysed	   by	   running	   20%	   non	   -­‐	   denaturing	   polyacrylamide	   gel	   in	   TBE	  
buffer	  at	  100V	  for	  1hr.	  The	  gel	  was	  then	  stained	  upon	  completion	  using	  Gelstar	  nucleic	  acid	  gel	  
stain	  for	  30min.	  Visualisation	  was	  then	  obtained	  by	  UV	  transillumination	  (G.	  Box,	  Syngene,	  UK).	  
	  
DNase	  I	  protection	  assay	  
DNase	   I	   protection	   assay	  was	   performed	   to	   investigate	   the	   ability	   of	   dendrimers	   to	   protect	  
pDNA	   from	   endonuclease	   degradation.	   Samples	   of	   polyplexes	  were	   prepared	   as	   before	   and	  
diluted	   to	   10	  μL,	   1.5	  μL	   of	   10X	   reaction	  buffer	   (as	   supplied)	  was	   then	   added.	   Samples	  were	  
treated	  with	  1	  μg	  of	  DNase	  I	   (1	  U/μL,	  Fermentas)	  at	  37	  °C	  for	  30	  min.	  2	  μL	  of	  EDTA	  (50	  mM)	  
and	  8	  μL	  of	  sodium	  dodecyl	  sulfate	  (SDS,	  1.25%	  w/v)	  were	  then	  added	  and	  the	  samples	  were	  
incubated	  at	  37	  °C	  for	  a	  further	  2	  hours	  to	  allow	  complete	  DNA	  dissociation	  from	  complexes.	  
Prior	   to	   running	  1%	  agarose	   gel	   electrophoresis	   as	  before,	   6X	   loading	  dye	   (promega	  G190A-­‐
Blue/orange	   6X)	   was	   added	   to	   these	   samples	   and	   the	   amount	   of	   pDNA	   released	   from	   the	  
complexes	  was	   then	   visualized	   by	   UV	   transillumination	   (G.	   Box,	   Syngene,	   UK).	   Naked	   pDNA	  
with	  or	  without	  DNase	  I	  treatment	  were	  used	  as	  positive	  and	  negative	  controls.	  	  
	  
RNase	  protection	  assay	   	  
RNase	   protection	   assay	   was	   performed	   to	   investigate	   the	   ability	   of	   dendrimers	   to	   protect	  
siRNA	   from	   endonuclease	   degradation.	   Samples	   of	   polyplexes	  were	   prepared	   as	   before	   and	  
diluted	   to	   10	  μL.	   Samples	  were	   treated	  with	   1	   μg	   of	   RNase	   (1	  U/μL,	   Fermentas)	   and	   1μL	   of	  
EDTA	  (50mM)	  at	  37	  °C	  for	  30	  min.	  8	  μL	  of	  sodium	  dodecyl	  sulfate	  (SDS,	  1.25%	  w/v)	  were	  then	  
added	  and	  the	  samples	  were	  incubated	  at	  37	  °C	  for	  a	  further	  2	  hours	  to	  allow	  complete	  siRNA	  
dissociation	   from	   complexes.	   The	   polyplexes	   were	   analysed	   using	   a	   20%	   non	   -­‐	   denaturing	  
polyacrylamide	  gel	   in	  TBE	  buffer	  at	  100V	   for	  1hr.	  The	  gel	  was	   then	  stained	  upon	  completion	  
using	   Gelstar	   nucleic	   acid	   gel	   stain	   for	   30min.	   The	   amount	   of	   siRNA	   released	   from	   the	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complexes	  was	   then	   visualized	   by	   UV	   transillumination	   (G.	   Box,	   Syngene,	   UK).	   Naked	   siRNA	  
with	  or	  without	  RNase	  treatment	  were	  used	  as	  positive	  and	  negative	  controls.	  	  
	  
pDNA	  transfections	  of	  Calu-­‐3	  cells	  using	  linear	  and	  star-­‐shaped	  G5(40)	  PLL	  polyplexes	  	  
Non	   differentiated	   airway	   epithelial	   cells	   (Calu-­‐3	   cells)	   were	   seeded	   at	   a	   density	   of	   5x104	  
cells/well	   in	  48-­‐well	  plates	  24hrs	  prior	   to	  transfection.	  The	  reporter	  gene	  pGaussia	   luciferase	  
was	  used	  for	  the	  subsequent	  transfections	  and	  the	  plasmid	  was	  isolated	  using	  a	  Qiagen	  maxi	  
prep	  kit	  as	  per	  manufacturer’s	  instructions.	  Polyplexes	  of	  linear	  PLL	  at	  N/P	  2	  and	  G5(40)	  PLL	  at	  
various	  N/P	  ratios	  were	  prepared	  by	  mixing	  the	  star	  shaped	  dendrimer	  G5	  (40units)	   in	  100μl	  
Opti-­‐MEM	   and	   incubated	   at	   room	   temperature	   for	   30min.	   The	   cells	   were	   then	   transfected	  
with	  these	  polyplexes	  for	  4	  hours.	  After	  4	  hours,	  150μL	  of	  serum-­‐containing	  media	  was	  added	  
to	  each	  well	  and	  incubated	  for	  24,	  120,	  168	  hours	  respectively	  at	  37oC	  and	  5%	  CO2.	  Following	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Chapter	  4	  	  





Well-­‐defined	  advanced	  polypeptide	  architectures	   including	  block,	  sequenced	  and	  star	  shaped	  
arrangements	  were	  synthesised	  via	  NCA	  ROP	  with	  hexylamine	  and	  various	  generations	  of	  PPI	  
dendrimers	   respectively.	   Molecular	   weight,	   arm	   length	   and	   arm	   density	   were	   readily	  
controlled	  to	  afford	  a	  series	  of	  star	  shaped	  poly(glutamic	  acid)	  derivatives	  with	  accessible	  high	  
molecular	   weights	   (500,	   000	   g/mol)	   and	   structural	   complexity.	   Analogous	   linear	   derivatives	  
were	  generated	  through	  employment	  of	  the	  NCA	  of	  glutamic	  acid	  bearing	  two	  different	  amino	  
acid	  side	  chain	  protecting	  groups	  to	  generate	  a	  block	  copolymer	  and	  the	  first	  reported	  case	  of	  
a	   sequenced	   polypeptide	   arrangement.	   The	   sequential	   deprotection	   and	   presentation	   of	  
carboxylic	   acid	   moieties	   for	   conjugation	   of	   glucosamine	   residues	   through	   amide	   coupling	  
chemistry	  resulted	   in	  the	  ability	  to	  strategically	  position	  sugars	  within	  a	  polypeptide	  scaffold.	  	  
Similarly,	  glycosylation	  of	  star	  shaped	  poly(glutamic	  acid)	  resulted	  in	  the	  formation	  of	  a	  diverse	  
range	  of	  glycopolypeptide	  architectures	  with	  tuneable	  sugar	  substitution	  and	  the	  potential	  to	  
achieve	   high	   conjugation	   efficiencies.	   The	   bioactivity	   of	   the	   described	   glycopolypeptides	  
towards	  the	  lectin	  ConA	  was	  investigated	  and	  was	  shown	  to	  be	  architecturally	  dependent.	  The	  
applicability	  of	  these	  materials	  towards	  targeted	  drug	  delivery,	  biorecognition	  applications	  and	  
the	   study	   of	   new	   more	   complex	   carbohydrate	   –	   protein	   interactions	   may	   be	   attempted	   in	  





4.1	  	  	  	  Introduction	  
Glycosylated	   polymers	   or	   glycopolymers,	   are	   an	   emerging	   polymer	   technology	   offering	  
immense	  potential	  towards	  biomedical	  applications	  and	  the	  study	  of	  more	  complex	  biological	  
processes.	   The	   importance	   of	   “glycosylation”	   and	   its	   related	   cellular	   interactions	   has	   been	  
overwhelmingly	  demonstrated	  by	  the	  vast	  array	  of	  biological	  processes	  dependent	  upon	  it	   in	  
nature.1-­‐5	  Nature	  sees	  the	  prevalent	  use	  of	  glycosylated	  cell	  components	  to	  perform	  many	  vital	  
biological	   functions	   such	   as	   cellular	   recognition,	   signalling,	   fertilization,	   inflammation	   and	  
many	  more.	   In	   particular,	   much	   attention	   has	   been	   drawn	   to	   specific	   carbohydrate-­‐protein	  
interactions	   between	   sugars	   and	   lectins	   to	   help	   better	   understand	   these	   complex	   biological	  
systems.	  Specificity	  has	  been	  made	  possible	  by	  the	  enormous	  range	  of	  possible	  constructs	  that	  
carbohydrates	  can	  form	  and	  it	  is	  this	  diversity	  and	  complexity	  which	  has	  led	  to	  coining	  of	  the	  
phrase	   “glycocode”	   thus	   highlighting	   the	   sheer	   wealth	   of	   information	   possessed	   by	  
carbohydrates.6,7	  However,	  the	  investigation	  of	  carbohydrate-­‐protein	  interactions	  requires	  the	  
synthesis	  of	  often	  complicated	  glycoprotein	  structures	  thus	  somewhat	  limiting	  research	  in	  this	  
area.8,9	   The	   synthesis	   of	   artificial	   glycoconjugates,	   in	   particular,	   glycopolymers	   may	   help	   to	  
overcome	   this	   somewhat	   and	   is	   this	   biomimicry	   which	   potentially	   affords	   materials	   for	   an	  
array	  of	  biomedical	  applications	  such	  as	  therapeutics	  and	  medical	  diagnostics.10-­‐16	  In	  terms	  of	  
polymer	  scaffolds,	  synthetic	  polypeptides	  have	  emerged	  as	  a	  strong	  candidate	  owing	  to	  their	  
inherent	   biocompatibility	   and	   close	   mimicry	   to	   natural	   peptides.	   Particularly,	   polypeptides	  
derived	  from	  the	  ring	  opening	  polymerization	  (ROP)	  of	  amino	  acid	  N-­‐carboxyanhydrides	  (NCAs)	  
are	  of	   increasing	   interest	  owing	  to	   the	  versatile	  yet	  high	  degree	  of	  control	  offered	  by	  such	  a	  
technique.17-­‐20	  Furthermore	  their	  unique	  ability	  to	  form	  secondary	  structures	  and	  potential	  to	  
utilise	  amino	  acid	   side	  chain	   functionalities	  affords	   “smart”	  polypeptide	  materials	   capable	  of	  
self-­‐assembly	  and	  stimuli	  responsive	  properties	  e.g.	  pH,	  light	  and	  enzymatic.21	  	  
Preparation	   of	   glycopeptides	   from	   NCA	   derived	   polypeptides	   can	   be	   performed	   via	   two	  
methods:	  polymerization	  of	  glycosylated	  NCA	  monomers	  and	  post	  modification	  of	  amino	  acid	  
side	  chains.	  Polymerization	  of	  glycosylated	  NCA	  monomers	  permits	  100%	  glycosylation	  of	  the	  
polypeptide	   but	   monomer	   synthesis	   can	   prove	   difficult	   whilst	   incorporation	   of	   a	   different	  
sugar	   into	   the	   polypeptide	   requires	   the	   complete	   synthesis	   of	   a	   new	  monomer.	   Rude	   et	   al	  
reported	   the	   first	   such	   synthesis	   of	   a	   glycosylated	   NCA	   through	   combination	   of	  
acetobromoglucose	  and	  N-­‐carboxybenzyl-­‐L-­‐serine	  benzyl	  ester	  via	  a	  Koenigs-­‐Knorr	  reaction.22	  
However,	   the	   resultant	  polypeptides	  were	  poorly	  defined.	  More	   recently,	   the	  Deming	  group	  
has	  extensively	  researched	  this	  synthetic	  pathway	  to	  develop,	  amongst	  others,	  several	   lysine	  
based	  glycosylated	  NCA	  monomers	  boasting	  excellent	  reactivity	  and	  ultimately	  the	  generation	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of	   a	   series	   of	   well-­‐defined	   glycopolymers.23-­‐25	   Related	   progress	   in	   this	   area	   is	   discussed	   in	  
several	   review	   articles	   and	   this	   chapter	   will	   focus	   predominantly	   on	   the	   technique	   of	   post	  
modification.26,27	  	  
Post	  modification	  of	  polypeptide	  amino	  acid	  side	  chains	  presents	  greater	  versatility	  due	  to	  the	  
diverse	  range	  of	  amino	  acids	  available	  i.e.	  different	  functionalities	  and	  therefore	  many	  efficient	  
coupling	   chemistry	   options	   in	   addition	   to	   greater	   variability	   in	   sugar	   choice.	   The	   advent	   of	  
“click”	  chemistry	  has	  offered	  a	  very	  useful	  synthetic	  tool	  for	  post	  modification	  of	  polypeptides	  
with	   sugar	   moieties	   owing	   to	   the	   highly	   efficient	   and	   selective	   nature	   of	   such	   chemistry.28	  
“Click”	   type	   reactions	   include	   thiol-­‐ene	  and	  azide-­‐alkyne	  which	  means	  sugars	  may	  be	   readily	  
adapted	  to	   include	  alkyne,29	  azide,30,31	  thiol32	  and	  alkene	  functionalities	  to	  permit	  coupling	  to	  
the	   corresponding	   “click”	   compatible	  polypeptide	   side	   chains.	   Focusing	  on	  azide-­‐alkyne	   type	  
chemistry,	  Chunsheng	  et	   al.	   employed	  an	  azide	   functionalised	  mannose	  derivative	   to	   form	  a	  
water	  soluble	  glycosylated	  homopolypeptide	  using	  the	  alkyne	  functionalised	  NCA,	  γ-­‐propargyl-­‐
L-­‐glutamate	  developed	  by	  Hammond.33,34	  Glycosylation	  proceeded	  in	  high	  efficiency	  with	  close	  
agreement	   observed	   between	   target	   and	   measured	   degrees	   of	   glycosylation.	   Similarly,	  
Donghui	  Zhang	  successfully	  clicked	  alkyne	  functionalised	  sugars	  to	  the	  pendant	  azide	  moieties	  
of	  an	  azide	   functionalised	  derivative	  of	  glutamic	  acid.35	  The	  described	  polypeptides	  although	  
synthetically	  and	  structurally	  appealing	  do	  suffer	  from	  the	  presence	  of	  an	  ester	  bond	  in	  linking	  
sugar	   to	   polypeptide	   backbone,	   thus	   introducing	   a	   hydrolytically	   susceptible	   moiety.	   To	  
overcome	  this,	  Huang	  et	  al	  utilised	  a	  non-­‐natural	  amino	  acid	  with	  pendant	  alkyne	  functionality	  
i.e.	   DL-­‐propargylglycine	   to	   first	   synthesise	   the	   novel	   NCA	   and	   subsequently	   generate	   the	  
polypeptide	  to	  elicit	  modification	  with	  azide	  terminated	  sugars.28	  However,	  homopolypeptide	  
molecular	   weight	   was	   limited	   owing	   to	   the	   ability	   of	   this	   polymer	   to	   form	   strong	   β–sheet	  
secondary	   structures.	   Copolymerization	   with	   another	   NCA	   monomer,	   such	   as	   γ-­‐benzyl-­‐L-­‐
glutamate,	  alleviated	  this	  somewhat	  and	   led	  to	  generation	  of	  a	  series	  of	  biologically	  relevant	  
polymersomes	  and	  nano-­‐assemblies.36,37	  	  
Asides	   from	   the	   fashionable	   “click”	   chemistry,	   traditional	   amine	   to	   carboxylic	   acid	   coupling	  
chemistry	   is	   another	  option	  which	  has	  demonstrated	   its	   practicality	   in	   conjugating	   sugars	   to	  
the	   side	   chain	   of	   polypeptides.	   Synthetically,	   glycopolypeptides	   obtained	   via	   this	   method	  
negate	  the	  requirement	  of	  new	  specialised	  amino	  acid	  derivatives	  observed	  in	  “click”	  reactions	  
whilst	   sugars	   are	   predominantly	   introduced	   via	   a	   hydrolytically	   stable	   amide	   linkage.	  
Furthermore,	  azide-­‐alkyne	   type	  “click”	   chemistry	   sees	   the	   formation	  of	  an	  unnatural	   triazole	  
ring	  linkage	  between	  polypeptide	  and	  sugar	  in	  which	  its	  effect	  on	  sugar	  behaviour	  have	  yet	  to	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be	  fully	  explored.	  The	  obvious	  amino	  acid	  candidates	  are	  lysine,	  glutamic	  acid	  and	  aspartic	  acid	  
as	   amine	   and	   carboxylic	   acid	   functionalities	   are	   found	   naturally	   in	   their	   side	   chain	   groups,	  
respectively.	  With	  regards	  to	  lysine,	  numerous	  attempts	  have	  been	  made	  to	  conjugate	  amine	  
reactive	  sugars	  to	  lysine	  side	  chains.38-­‐42	  The	  sugar	  gluconolactone	  was	  successfully	  employed	  
by	  Feng	  and	  co-­‐workers	   to	  attach	  ring	  opened	  sugars	   to	  an	  amphiphilic	   lysine	  based	  triblock	  
copolymer	  under	  basic	  conditions.43,44	  Sugar	  density	  was	  modified	  by	  adjusting	  the	  sugar	  feed	  
ratio	   but	  was	   limited	   to	   a	  maximum	  of	   75%,	  most	   likely	   as	   a	   result	   of	   steric	   hindrance.	   The	  
attachment	  of	   isothiocyanate	   functionalised	  mannose	   sugars	   to	  poly(L-­‐lysine)	   via	  a	   thio-­‐urea	  
linkage	   was	   recently	   reported.45	   Glycosylation	   densities	   of	   16%	   to	   23	   %	   were	   achieved	   to	  
afford	   a	   series	   of	   glycopolypeptides	  with	   pH	   and	   surfactant	   triggered	   stimuli	   responsive	   self	  
assembly	   properties.	   Concerning	   carboxylic	   acid	   functionalised	   polypeptides,	   their	   ability	   to	  
permit	   derivatization	   with	   amines	   by	   amide	   coupling	   chemistry	   has	   been	   clearly	  
demonstrated.46-­‐50	  Consequently,	  glycosylation	  of	  NCA	  derived	  polypeptides	  with	  amino	  sugars	  
should	  be	  possible.	  Recently,	  Menzel	  et	  al.	  devised	  a	  very	  effective	  strategy	  to	  achieve	  this	  by	  
employing	   the	   coupling	   reagent,	   4-­‐(4,6-­‐Dimethoxy-­‐1,3,5-­‐triazin-­‐2-­‐yl)-­‐4-­‐methylmorpholinium	  
chloride	   (DMTMM)	   to	   functionalize	   a	   series	   of	   linear	   poly(glutamic	   acid)	   precursors	   with	  
glucosamine.51	   The	  DMTMM	  used	   is	   known	   to	  be	  a	   very	  mild	   and	  efficient	   coupling	   reagent	  
applicable	  to	  both	  organic	  and	  aqueous	  solvents,	   thus	  enabling	  glycosylation	  of	  polypeptides	  
to	  be	  achieved	  in	  a	  very	  “green”	  and	  simple	  way.52,53	  Sugar	  densities	  were	  readily	  controlled	  by	  
varying	  the	  sugar	  to	  carboxylic	  acid	  loading	  ratio	  with	  impressive	  sugar	  densities	  of	  up	  to	  80%	  
achievable	   by	   this	   method.	   Complete	   glycosylation	   was	   most	   probably	   inhibited	   by	   steric	  
hindrance	  of	  neighbouring	  sugars.	  The	  beauty	  of	  this	  system	  is	  in	  its	  simplicity	  throughout	  the	  
protocol.	  Synthetically,	  the	  polypeptide	  can	  be	  derived	  from	  well	  understood	  basic	  NCAs	  such	  
as	  BLG	  (NCA	  of	  γ-­‐benzyl-­‐L-­‐glutamate)	  in	  which	  molecular	  weight	  can	  be	  readily	  controlled	  and	  
is	   not	   inhibited	   by	   the	   formation	   of	   strong	   secondary	   structures	   as	   in	   the	   case	   of	   DL-­‐
propargylglycine.	  Coupling	  of	  amino	  sugars	  is	  performed	  in	  water	  requiring	  minimal	  technical	  
skill	  whilst	  sugar	  densities	  can	  be	  easily	  controlled.	  	  
To	  expand	  on	   this	  methodology,	   its	  application	   towards	  more	  complex	  architectures	   such	  as	  
star	  shaped	  polypeptides	  may	  be	  very	  interesting.	  Star	  shaped	  polypeptides	  in	  particular	  offer	  
a	  stable	  yet	  structurally	  variable	  complex	  nanoparticle	  platform	  containing	  a	  high	  local	  density	  
of	   functionality.54-­‐56	   Consequently,	   a	   high	   local	   density	   of	   sugars	   within	   a	   size	   confined	  
structural	  space	  may	  be	  achievable	  using	  very	  simple	  post	  modification	  chemistry	  techniques.	  
The	   resultant	   structurally	   diverse	   glycopolypeptides	   may	   be	   more	   suitable	   to	   investigating	  
highly	  complex	  carbohydrate	  protein	  interactions	  such	  as	  the	  interaction	  of	  dendritic	  cells	  with	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viruses.57-­‐60	   Furthermore,	   star	   shaped	   polypeptides	   have	   become	   increasingly	   prevalent	   as	  
potential	   drug	   delivery	   vehicles	   meaning	   sugar	   conjugation	   and	   its	   inherent	   site	   specific	  
interactions	  may	  provide	  star	  polypeptides	  with	  an	  attractive	  targeting	  function.61-­‐66	  In	  addition	  
to	   the	   employment	   of	   star	   shaped	   glycopolypeptides,	   selective	   positioning	   of	   sugars	  
introduces	   further	   architectural	   variation	   and	   complexity	   to	   these	   synthetic	   glycoprotein	  
mimics.	  Such	  a	  feature	  helps	  to	  further	  probe	  advanced	  carbohydrate	  protein	  interactions	  and	  
the	  effects	  of	  sugar	  positioning	  and	  architecture.	  Haddleton	  and	  coworkers	  recently	  reported	  
the	   selective	   positioning	   of	   sugars	   along	   an	   acrylate	   based	   polymer	   through	   the	   sequence	  
controlled	   polymerization	   of	   pre-­‐synthesized	   glycosylated	   acrylate	   monomers.67	   Advanced	  
binding	  studies	  of	  these	  well	  defined	  polymers	  with	  the	  biologically	   important	  lectin	  DC-­‐SIGN	  
were	   undertaken	   and	   highlight	   the	   significant	   role	   of	   sugar	   positioning	   in	   carbohydrate	   –
protein	   interactions.	  Similarly,	   the	  effects	  of	  architecture	  and	  scaffold	  were	  shown	  to	  exhibit	  
an	  effect	  on	  the	  binding	  behavior	  of	  DC-­‐SIGN	  with	  a	  series	  of	  glycopolypeptides	  functionalized	  
with	   mixed	   ratios	   of	   mannose	   and	   galactose	   sugars	   synthesized	   via	   “click”	   chemistry.68	  
Consequently,	   architectures	   such	   as	   stars	   and	   selective	   sugar	   positioning	   will	   help	   to	  
significantly	  advance	  research	  in	  this	  field.	  	  	  	  	  	  
This	   chapter	   will	   investigate	   the	   application	   of	   Menzel’s	   methodology	   towards	   a	   series	   of	  
poly(glutamic	   acid)	   architectures,	   in	   particular	   star	   shaped	   poly(glutamic	   acid).	   Originally	  
developed	  by	  Byrne	  et	  al.,	  a	  range	  of	  well	  defined	  star	  shaped	  poly(glutamic	  acid)	  derivatives	  
with	  controllable	  molecular	  weights	  and	  architectures	  such	  as	  arm	  density	  and	  length	  will	  be	  
employed.52	  The	  subsequent	  glycosylation	  of	  these	  star	  shaped	  polymers	  will	  be	  attempted	  to	  
explore	   the	   feasibility	   of	   Menzel’s	   methodology	   towards	   these	   complex	   architectures	   in	  
addition	   to	   briefly	   investigating	   their	   resultant	   lectin	   binding	   properties.	   Furthermore,	   the	  
synthesis	   of	   linear	   glycopolypeptides	   with	   selective	   sugar	   positioning	   will	   be	   attempted	  
through	   the	   block	   copolymerization	   of	   glutamic	   acid	   NCAs	   bearing	   benzyl	   and	   tert-­‐butyl	  
carboxylic	   acid	   protecting	   groups.	   The	   sequential	   removal	   of	   these	   protecting	   groups	   in	  
tandem	  with	   selective	  glycosylation	  will	   be	  attempted	   to	  afford	  a	   simple	   route	   towards	  well	  








4.2	  	  	  	  Results	  and	  Discussion	  
4.2.1	  Advanced	  Star	  Shaped	  Polypeptides	  
4.2.1.1	  Star	  Polypeptide	  Synthesis	  
The	   technological	   advancement	   of	   NCA	   ROP	   has	   enabled	   the	   controlled	   synthesis	   of	  
structurally	   diverse	   yet	   well-­‐defined	   polypeptide	   scaffolds.69-­‐72	   Through	   the	   use	   of	   primary	  
amino	   initiators,	   the	   generation	   of	   well-­‐defined	   polypeptides	   is	   readily	   accessible.18-­‐20	   The	  
employment	  of	  more	  complex	  amino	  initiators	  such	  as	  multifunctional	  dendrimers	  introduces	  
a	   new	   avenue	   of	   structural	   complexity	   to	   NCA	   derived	   polypeptides.73-­‐76	   As	   previously	  
described,	   a	   series	   of	   star	   shaped	   polypeptide	   architectures	   were	   prepared	   via	   ROP	   of	   the	  
NCA,	   BLG	   using	   different	   generations	   of	   multifunctional	   poly(propylene	   imine)	   (PPI)	  
dendrimers.52	   The	   resultant	  materials	   consisted	  of	   a	  dendrimer	   core	  and	  a	  polypeptide	   shell	  
capable	   of	   offering	   multiple	   carboxylic	   moieties	   upon	   deprotection	   of	   the	   amino	   acid	   side	  
chain	  protecting	  groups	  (Figure	  4.1).	  	  
	  
Figure	  4.1:	  Diversity	  of	  synthesized	  star	  polypeptides	  and	  reaction	  scheme	  for	  the	  synthesis	  




As	   observed	   in	  Table	   4.1,	   a	   series	   of	   star	   shaped	  PBLG	  architectures	   and	   the	   equivalent	  Mw	  
linear	  derivatives	  were	  synthesised	  which	  boasted	  controllable	  molecular	  weights	  and	  degrees	  
of	  branching.	  Entry	  1	  and	  entries	  4	  –	  7	  of	  Table	  4.1,	  describe	  PBLG	  polymers	  with	  a	  constant	  
arm	   length	   but	   different	   degrees	   of	   branching	   due	   to	   the	   choice	   of	   initiator	   used.	   Similarly,	  
total	   molecular	   weight	   was	   maintained	   to	   afford	   a	   series	   of	   polymers	   with	   different	   arm	  
lengths	  and	  branching	  densities	  (Entries	  2	  –	  3	  and	  Entry	  8,	  Table	  4.1).	  	  
	  
Table	  4.1:	  Star-­‐shaped	  PBLG	  by	  initiation	  from	  PPI	  dendrimers	  (L:	  linear	  initiator	  hexylamine;	  
G1-­‐G5:	  generation	  of	  PPI	  dendrimer;	  G5(64)-­‐PBLG40	  =	  initiator	  generation	  5	  dendrimer	  with	  
maximum	  64	  arms	  and	  theoretical	  arm	  length	  of	  40	  amino	  acids).	  Dispersities	  of	  all	  polymers	  
<	  1.2	  (SEC	  MALS	  detection).	  
Entry	   Polymer	   NCA/NH2	  	   NCA/dendrimer	   Mw/g	  mol-­‐1(a)	   Mnth	  (b)/g	  mol-­‐1	  
1	   L(1)-­‐PBLG40	   40	   40	   10	  000	  (8	  900)(c)	   8	  700	  
2	   L(1)-­‐PBLG200	   200	   200	   41	  500	  (44	  400)(c)	   43	  600	  
3	   G2(8)-­‐PBLG27	   27	   216	   40	  100	   47	  100	  
4	   G2(8)-­‐PBLG40	   40	   320	   63	  200	   70	  500	  
5	   G3(16)-­‐PBLG40	   40	   640	   110	  700	   141	  000	  
6	   G4(32)-­‐PBLG40	   40	   1280	   240	  800	   282	  500	  
7	   G5(64)-­‐PBLG40	   40	   2560	   499	  800	   565	  000	  
8	   G5(64)-­‐PBLG3	   3.5	   224	   42	  300	   48	  800	  
	  
(a)	  determined	  by	  SEC	  (DMF)	  using	  MALS	  detection	  using	  the	  dn/dc	  of	  linear	  PBLG	  of	  0.118	  
(b)	   calculated	   assuming	   initiation	   from	   all	   amino	   groups	   and	   quantitative	   conversion:	  
c(monomer)/c(dendrimer)	   x	   M(monomer)	   +	   M(dendrimer)	   (c)	   Mn	   determined	   by	   1H	   NMR	  
spectroscopy	  using	  the	  integral	  ratio	  of	  hexylamine	  and	  PBLG.	  	  
1H	  NMR	   spectroscopy	  was	  used	   to	   elucidate	  molecular	  weight	   (Mn)	   for	   linear	   PBLG	  whereas	  
star	  shaped	  PBLG	  prevented	  accurate	  molecular	  weight	  determination	  via	  this	  method	  due	  to	  
the	   lack	   of	   visible	   PPI	   dendrimer	   peaks,	   peak	   overlap	  with	   PBLG,	   low	   composition	   and	   core	  




Figure	  4.2:	  1H	  NMR	  spectrum	  of	  L(1)-­‐PBLG200	  (CDCl3,	  d-­‐TFA).	  
The	  described	  polypeptides	  were	  analysed	  by	  SEC	  (size	  exclusion	  chromatography)	  in	  DMF	  and	  
the	  results	  are	  summarized	  in	  Table	  4.1.	  SEC	  traces	  of	  polypeptides	  with	  similar	  Mw	  (Entries	  2	  –	  
3	  and	  Entry	  8,	  Table	  4.1)	  and	  increasing	  molecular	  weight	  (Entry	  1	  and	  entries	  4	  –	  7	  of	  Table	  
4.1)	  can	  be	  observed	  in	  Figure	  4.3	  and	  Figure	  2.2,	  Chapter	  2	  respectively.	  	  
	  
	  
Figure	  4.3:	  SEC	  traces	  L(1)-­‐PBLG200	  (A),	  G2(8)-­‐PBLG27	  (B)	  and	  G5(64)-­‐PBLG3	  (C).	  
	  99	  
	  
To	  afford	  water	  soluble	  carboxylic	  acid	  functionalised	  linear	  and	  star	  shaped	  polypeptides	  for	  
eventual	  amide	  coupling	  of	  sugars,	  the	  benzyl	  protecting	  groups	  were	  removed	  using	  standard	  
TFA	  /	  HBr	  methods	  of	  acidic	  hydrolysis.	  Quantitative	  deprotection	  was	  confirmed	  by	  1H	  NMR	  
spectroscopy	   (Figure	   4.4	   and	   Figure	   2.7,	   Chapter	   2)	  due	   to	   the	  disappearance	  of	   the	  benzyl	  
peaks	  at	  7.3	  ppm.	  	  	  
	  
Figure	  4.4:	  1H	  NMR	  spectra	  of	  L(1)-­‐PBLG200	  (bottom)	  (CDCl3,	  d-­‐TFA)	  and	  L(1)-­‐PGA200	  (top)	  
(D2O).	  
	  
4.2.1.2	  Synthesis	  of	  Glycosylated	  Star	  Shaped	  Polypeptides	  
Functionalization	   of	   polypeptides	   with	   glucosamine	   was	   accomplished	   using	   DMT-­‐MM	  
medicated	   amide	   coupling	   chemistry	   (Figure	   4.5).	   Initially	   polypeptides	   were	   converted	   to	  
their	   Na	   salt	   form	   to	   facilitate	   the	   formation	   of	   an	   ammonium	   carboxylate	   salt	   with	  
glucosamine	  hydrochloride.	  The	  hydrochloride	  form	  of	  glucosamine	  was	  employed	  as	   its	  free	  
form	  is	  unstable	  in	  water.	  The	  formation	  of	  this	  ammonium	  carboxylate	  salt	  promotes	  higher	  
coupling	   efficiencies	   as	   DMTMM	   is	   known	   to	   preferentially	   react	   with	   carboxylate	   anions.50	  



















Table	  4.2:	  Results	  of	  amide	  coupling	  of	  glucosamine	  to	  star	  shaped	  poly(glutamic	  acid).	  
Entry	   Polymer	   Mnth	  (a)/g	  mol-­‐1	   GA:Amine:DMT-­‐MM(c)	   Target	  DS	  (%)(d)	  Measured	  DS	  (%)(e)	  
1	   L(1)-­‐PGA40	   5	  200(b)	   1	  :	  1	  :	  0.7	   50	   58	  
2	   L(1)-­‐PGA200	   26	  100(b)	   1	  :	  0.7	  :	  0.35	   25	   27	  
3	   L(1)-­‐PGA200	   26	  100(b)	   1	  :	  1	  :	  0.7	   50	   53	  
4	   L(1)-­‐PGA200	   26	  100(b)	   1	  :	  2	  :	  2	   100	   92	  
5	   G2(8)-­‐	  PGA	  27	   27	  600	   1	  :	  0.7	  :	  0.35	   25	   30	  
6	   G2(8)-­‐	  PGA	  27	   27	  600	   1	  :	  1	  :	  0.7	   50	   54	  
7	   G2(8)-­‐	  PGA	  27	   27	  600	   1	  :	  2	  :	  2	   100	   96	  
8	   G2(8)-­‐	  PGA	  40	   41	  000	   1	  :	  0.7	  :	  0.35	   25	   30	  
9	   G2(8)-­‐	  PGA	  40	   41	  000	   1	  :	  1	  :	  0.7	   50	   51	  
10	   G2(8)-­‐	  PGA	  40	   41	  000	   1	  :	  2	  :	  2	   100	   85	  
11	   G3(16)-­‐PGA	  40	   81	  900	   1	  :	  1	  :	  0.7	   50	   43	  
12	   G4(32)-­‐	  PGA	  40	   163	  800	   1	  :	  1	  :	  0.7	   50	   48	  
13	   G5(64)-­‐	  PGA	  40	   327	  700	   1	  :	  1	  :	  0.7	   50	   43	  
14	   G5(64)-­‐	  PGA	  40	   327	  700	   1	  :	  2	  :	  2	   100	   73	  
15	   G5(64)-­‐	  PGA	  3	   24	  600	   1	  :	  0.7	  :	  0.35	   25	   20	  
16	   G5(64)-­‐	  PGA	  3	   24	  600	   1	  :	  2	  :	  2	   100	   48	  
(a)	   calculated	   assuming	   initiation	   from	   all	   amino	   groups	   and	   quantitative	   conversion:	  
c(monomer)/c(dendrimer)	  x	  M(monomer)	  +	  M(dendrimer)	  (b)	  actual	  Mn	  as	  determined	  by	  1H	  
NMR	  spectroscopy	  using	  the	   integral	   ratio	  of	  hexylamine	  and	  PGA	  (c)	  molar	   ratio	  of	  COOH	  
from	  PGA	  :	  NH2	  of	  glucosamine	   :	  DMT-­‐MM	  coupling	  reagent	   (d)	   target	  number	  of	  glutamic	  
acid	  units	  to	  be	  functionalised	  as	  calculated	  by	  molar	  ratio	  coupling	  reagents	  to	  glutamic	  acid	  







Glycosylation	  of	  linear	  derivatives	  (Entries	  1	  –	  4,	  Table	  4.3)	  was	  expected	  to	  be	  straightforward	  
owing	  to	  its	  accessible	  architecture.	  The	  degree	  of	  substitution	  (DS)	  could	  be	  easily	  targeted	  by	  
carefully	   controlling	   the	   COOH	   :	   NH2	   :	   DMT-­‐MM	   ratio	   to	   afford	   a	   series	   of	   linear	   PGA	  
derivatives	  where	   actual	  DS	  was	   in	   close	   agreement	  with	   targeted	  DS.	   As	   determined	  by	   1H	  
NMR	   spectroscopy	   a	   DS	   of	   92%	   was	   achieved	   highlighting	   the	   excellent	   efficiency	   of	   this	  
methodology	  (Figure	  4.6).	  	  
	  
Figure	  4.6:	  1H	  NMR	  spectra	  of	  L(1)-­‐PGA200	  (Bottom)	  (D2O)	  and	  L(1)-­‐PGA200-­‐(G)	  53%	  (Top)	  
(D2O).	  
The	   subsequent	   application	   of	   this	   methodology	   towards	   the	   architecturally	   more	   complex	  
star	   polypeptides	   was	   performed.	   Glycosylation	   proved	   successful	   for	   all	   star	   shaped	  
polypeptides	   (Figure	   4.7)	   particularly	   for	   the	   less	   densely	   branched	   derivatives	   (Table	   4.2).	  
Concerning	  star	  shaped	  polypeptides	  of	  similar	  Mw	  (Entries	  5	  –	  7	  and	  15	  –	  16,	  Table	  4.2)	  and	  
therefore	   similar	   numbers	   of	   PGA	   units,	   notable	   differences	   in	   coupling	   efficacy	   were	  
observed.	  The	   less	  densely	  branched	  G2(8)-­‐PGA27	  star	  polymer	  reported	  an	  actual	  DS	  of	  96%	  
which	   is	   in	   close	   agreement	   with	   the	   targeted	   DS	   of	   100%	   and	   comparable	   to	   the	  
architecturally	   much	   simpler	   linear	   PGA	   derivative.	   However,	   the	   densely	   branched	   G5(64)-­‐
PGA3	  resulted	  in	  lower	  DS	  numbers	  (DS	  =	  20%	  and	  48%)	  particularly	  for	  the	  targeting	  of	  100%	  
glycosylation.	   This	   observation	   most	   likely	   arises	   because	   of	   the	   inaccessibility	   of	   the	   inner	  
carboxylic	   acid	   moieties	   of	   the	   densely	   branched	   G5(64)-­‐PGA3,	   and	   therefore	   inhibits	   their	  
coupling	   to	   amino	   sugars.	   Such	   an	   observation	   seems	   reasonable	   given	   the	   steric	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considerations	   of	   coupling	   sugars	   to	   functional	   groups	   within	   an	   already	   densely	   branched	  
complex	  network	  of	  polymer	  chains.	  	  
	  
Figure	  4.7:	  1H	  NMR	  spectra	  of	  G2(8)-­‐PGA27	  (Bottom)	  (D2O)	  and	  G2(8)-­‐PGA27-­‐(G)	  54%	  (Top)	  
(D2O).	  Dendrimer	  peaks	  not	  visible.	  
This	  hypothesis	  was	  further	  tested	  when	  considering	  the	  targeted	  glycosylation	  of	  star	  shaped	  
polypeptides	   of	   similar	   arm	   lengths	   but	   different	   degrees	   of	   branching	   and	   total	   number	   of	  
PGA	  units	  (Entry	  1	  and	  entries	  8	  –	  14,	  Table	  4.2).	  Controlled	  sugar	  conjugation	  was	  observed	  
for	  each	  of	  these	  star	  polymers	  with	  targeted	  DS	  of	  25%	  and	  50%	  proceeding	  quite	  efficiently	  
although	   incomplete	   glycosylation	   became	   more	   apparent	   as	   branching	   density	   increased	  
(Entries	   9	   and	   11	   –	   13,	   Table	   4.2).	   As	   with	   G2(8)-­‐PGA27	   and	   G5(64)-­‐PGA3,	   this	   feature	   was	  
emphasised	  when	  100%	  glycosylation	  was	   targeted	   resulting	   in	   a	  DS	  of	  85%	   for	  G2(8)-­‐PGA40	  
whereas	  a	  DS	  of	  73%	  was	  observed	  for	  the	  more	  densely	  branched	  G5(64)-­‐PGA40.	  As	  discussed	  
above,	   steric	   factors	   seem	   the	  most	  plausible	  explanation	   for	   these	  observations.	   In	   spite	  of	  
this,	   glycosylation	   of	   these	   complex	   architectures	   can	   be	   facilely	   achieved	   using	   this	  
straightforward	  methodology	  negating	   the	  synthetic	  challenges	  of	  designing	  challenging	  NCA	  
monomers	  and	  their	  subsequent	  application	  to	  more	  complex	  chemistries.	  Furthermore,	  sugar	  
density	  can	  readily	  controlled	  in	  which	  high	  coupling	  efficiencies	  of	  up	  to	  96%	  can	  be	  achieved	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for	   star	   shaped	   PGA	   which	   is	   comparable	   to	   the	   linear	   PGA	   analogue.	   Although	   branching	  
density	  does	   impact	  on	  sugar	  conjugation,	   its	  effect	  only	  becomes	  notable	  when	  a	  high	  DS	   is	  
targeted.	   Despite	   this,	   respectable	   DS	   values	   of	   up	   to	   48%	   and	   73%	  were	   observed	   for	   the	  
most	  densely	  branched	  of	  polypeptide	  architectures.	  	  
FTIR	   spectroscopic	   analysis	   of	   the	   described	   glycopolypeptides	   helped	   to	   elucidate	   their	  
secondary	   structures	   (solid	   state).	   All	   of	   the	   glycopolypeptides	   exhibited	  α-­‐helical	   secondary	  
structures	   irrespective	  of	  architecture	  and	   sugar	  density.	  α-­‐helical	   character	  was	  denoted	  by	  
the	  presence	  of	  strong	  Amide	  I	  and	  II	  bands	  at	  approximately	  1650	  cm-­‐1	  and	  1544	  cm-­‐1	  which	  
are	  indicative	  of	  an	  α-­‐helix	  (Figure	  4.8).77	  Furthermore	  the	  presence	  of	  sugar	  can	  be	  observed	  
at	  1036	  cm-­‐1	  providing	   further	  evidence	  of	   successful	   sugar	  conjugation.	  Circular	  dichromism	  
(CD)	  provides	  more	  detailed	  analysis	  of	  polypeptide	  secondary	  structure	  as	  sugar	  conjugation	  
and	  density	  are	  known	  to	  have	  an	  impact	  on	  secondary	  structure.49	  However,	  this	  investigation	  
was	  not	  undertaken	  and	  is	  something	  which	  will	  be	  looked	  at	  in	  future.	  	  	  
	  
Figure	  4.8:	  FTIR	  spectra	  of	  G2(8)-­‐PGA27-­‐(G)	  96%	  (A),	  G2(8)-­‐PGA27-­‐(G)	  54%	  (B),	  G2(8)-­‐PGA27-­‐(G)	  





4.2.1.3	  Lectin	  Binding	  Studies	  of	  Star	  Shaped	  Glycopolypeptides	  
The	  binding	  of	  glycoconjugates,	  such	  as	  glycopolypeptides	  to	  lectins	  is	  a	  very	  effective	  tool	  in	  
helping	   to	   ascertain	   the	   bioactivity	   of	   such	   materials.	   Lectin	   specific	   binding	   interactions	  
demonstrate	  the	  targeting	  potential	  of	  glycosylated	  materials	  for	  targeted	  drug	  delivery	  whilst	  
also	   highlighting	   their	   potential	   use	   in	   the	   study	   of	   advanced	   carbohydrate-­‐protein	  
interactions.	  The	  choice	  of	   lectin	   is	  very	   important	  due	   to	   the	  highly	  specific	  nature	  of	   these	  
carbohydrate-­‐protein	   interactions.	   Preliminary	   lectin	   binding	   studies	   were	   performed	   using	  
turbidimetric	   assays.	   Upon	   mixing	   a	   solution	   of	   glycopolypeptide	   with	   a	   solution	   of	   sugar	  
specific	   lectin,	   UV	   analysis	  was	   performed	   at	   selected	   time	   intervals.	   Successful	   sugar-­‐lectin	  
binding	  was	  denoted	  by	  an	  increase	  in	  turbidity.	  The	  lectin	  chosen	  was	  ConA,	  a	  lectin	  known	  to	  
bind	  with	  glucosamine.78	  For	  this,	  PBS	  (pH	  7.2)	  was	  employed	  as	  at	  this	  pH	  ConA	  is	  known	  to	  
exist	   as	   a	   homotetramer	   with	   four	   binding	   sites	   for	   potential	   sugar	   interactions.79	   The	  
systematic	  investigation	  of	  the	  effects	  of	  architecture	  on	  lectin	  binding	  was	  carried	  out	  at	  420	  
nm	  using	  a	  polymer	  concentration	  of	  2	  mg/ml.	  No	  immediate	  precipitation	  was	  observed	  upon	  
mixing	  of	  glycopolypeptide	  and	  lectin.	  However,	  the	  gradual	  increase	  in	  solution	  turbidity	  was	  
observed	  over	  time	  and	  was	  shown	  to	  be	  architecturally	  dependent.	  Concerning	  linear	  and	  star	  
shaped	  glycopolypeptides	  of	  similar	  Mw	  	  (Entries	  3	  –	  7	  and	  15	  –	  16,	  Table	  4.2),	   lectin	  binding	  
was	  observed	   for	   each	   (Figure	   4.9).	   The	  effects	   of	   sugar	  density	   can	  be	   clearly	   observed,	   as	  
expectedly,	  a	  higher	  DS	   results	   in	  a	  quicker	   reduction	   in	   solution	   transparency.	  For	  example,	  
the	  G2(8)-­‐PGA27	  family	  of	  star	  shaped	  glycopolypeptides	  with	  DS	  54%	  and	  96%	  sees	  the	  rapid	  
aggregation	  and	  thus	  precipitation	  of	  lectin	  (approx.	  10	  min).	  However	  a	  DS	  of	  30%	  resulted	  in	  
the	   dramatic	   decrease	   in	   the	   rate	   of	   precipitation	   and	   the	   overall	   maximum	   absorbance	  
observed	   after	   1	   h.	  Not	   notable	   further	   absorbance	   increase	  was	   observed	   even	   after	   24	   h.	  
Menzel	   and	   co-­‐workers	   noted	   that	   at	   below	   a	   DS	   of	   50%	   for	   linear	   PGA	   no	   precipitation	  
occurred	  due	  to	  unsuccessful	  binding	  or	  limited	  binding	  in	  which	  the	  aggregates	  are	  solubilised	  
by	  the	  free	  carboxylic	  acid	  moieties.51	  Although	  limited	  binding	  is	  evident	  here,	  the	  low	  sugar	  
density	   of	   this	   particular	   glycopolypeptide	   somewhat	   slows	   the	   rate	   of	   interaction	   and	   the	  
ability	   to	   form	   insoluble	   aggregates.	   A	   similar	   observation	  was	   apparent	   for	   L(1)-­‐PGA200	   and	  
G5(64)-­‐PGA3	  of	  varying	  sugar	  densities.	  The	  effect	  of	  architecture	  was	  notable	  with	  the	  general	  
trend	   being	   that	   increased	   branching	   density	   had	   a	   greater	   effect	   on	   lectin	   binding	   and	  
aggregate	  precipitation.	  Considering	  glycopolypeptides	  with	  an	  approximate	  DS	  of	  25%,	  L(1)-­‐
PGA-­‐(G)200	   27%	   and	   G2(8)-­‐PGA27-­‐(G)	   30%	   sluggishly	   form	   lectin	   aggregates	   which	   do	   not	  
become	   significantly	   insoluble	  over	   time.	   In	   contrast,	   the	  densely	  branched	  but	   short	   armed	  
G5(64)-­‐PGA3-­‐(G)	   20%	   with	   approximately	   the	   same	   number	   of	   total	   PGA	   units	   and	   sugar	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moieties	  forms	  a	  more	  turbid	  solution	  in	  a	  shorter	  time	  frame.	  At	  this	  DS	  it	  is	  suggested	  that	  a	  
very	  densely	  branched	  polymer	  network	  interacts	  more	  favourably	  with	  lectin.	  The	  multivalent	  
binding	   of	   lectins	   to	   this	   short	   armed	   highly	   branched	   polypeptide	   structure	   is	   possibly	  
promoted	  by	  a	  higher	  local	  density	  of	  sugars	  within	  this	  size	  confined	  structural	  space	  resulting	  
in	  superior	  binding	  efficiency,	  steric	  shielding	  of	  free	  carboxylic	  acid	  moieties	  and	  consequently	  
more	   pronounced	   precipitation	   of	   lectin	   aggregates.	   Furthermore,	   the	   exact	   positioning	   of	  
sugars	  in	  these	  star	  shaped	  architectures	  is	  unknown	  but	  it	  can	  be	  speculated	  that	  the	  densely	  
branched	  star	  polymers	  e.g.	  G5(64)-­‐PGA3-­‐(G)	  20%	  display	  their	  sugars	  at	  the	  periphery	  due	  to	  
inefficient	   sugar	   coupling	   at	   the	   inner	   carboxylic	   acid	   moieties	   whereas	   the	   less	   densely	  
branched	   star	   polymers	   e.g.	   G2(8)-­‐PGA27-­‐(G)	   30%	   sees	   a	   more	   even	   distribution	   of	   sugars	  
throughout	  its	  polymeric	  network.	  Consequently,	  these	  sugars	  are	  more	  accessible	  to	  lectins	  in	  
the	   case	   of	   G5(64)-­‐PGA3-­‐(G)	   20%,	   therefore	   promoting	   superior	   lectin	   binding	   interactions.	  
Glycopolypeptides	   with	   a	   DS	   of	   50%	   also	   demonstrated	   the	   effect	   of	   architecture	   on	   lectin	  
interactions	  particularly	   in	   relation	   to	   linear	   architectures.	  Although	  no	   significant	  difference	  
was	  observed	  amongst	  the	  two	  star	  shaped	  architectures	  i.e.	  G2(8)-­‐PGA27-­‐(G)	  54%	  and	  G5(64)-­‐
PGA3-­‐(G)	  48%	  a	  clear	  impact	  on	  the	  comparable	  L(1)-­‐PGA200-­‐(G)	  53%	  was	  noted.	  Precipitation	  
of	   lectin	   aggregates	   was	   slower	   and	   less	   pronounced	   for	   this	   architecture.	   Similarly,	   G2(8)-­‐
PGA27-­‐(G)	   96%	   and	   L(1)-­‐PGA200-­‐(G)	   92%	   afforded	   such	   a	   variation	   highlighting	   the	   major	  
implications	  of	  structural	  architecture	  for	  carbohydrate-­‐protein	  interactions.	  	  	  	  	  
	  
Figure	  4.9:	  Absorbance	  at	  420nm	  of	  lectin	  /	  glycopolypeptide	  (comparable	  Mw)	  solutions	  and	  
the	  effects	  of	  architecture	  and	  sugar	  density	  on	  binding.	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Related	   glycopolypeptide	   architectures	   of	   constant	   arm	   length	   i.e.	   40	   but	   varying	   branching	  
densities	  and	  molecular	  weights	  (number	  of	  PGA	  units)	  were	  investigated	  with	  regards	  to	  their	  
potential	   effects	   on	   lectin	   binding.	   Again	   lectin	   binding	   was	   observed	   throughout	   whilst	  
architecture	  was	  shown	  to	  affect	   lectin	  binding	  interactions	  (Figure	  4.10).	  Comparable	  to	  the	  
above	   results	   (Figure	   4.9),	   a	   higher	   DS	   resulted	   in	   a	   marked	   lectin	   binding	   interaction	  
difference	   such	   that	   solution	   turbidity	   increased	   more	   quickly	   and	   achieved	   a	   greater	  
absorbance	   maximum	   (G2(8)-­‐PGA40-­‐(G)	   30%,	   51%,	   85%	   and	   G5(64)-­‐PGA40-­‐(G)	   43%,	   73%,	  
Figure	   4.10).	   At	   a	   DS	   of	   approximately	   50%,	   no	   significant	   effect	   of	   architecture	   on	   lectin	  
binding	  was	  observed	  amongst	  the	  star	  shaped	  conformations	  (G2(8)-­‐PGA40-­‐(G)	  51%,	  G3(16)-­‐
PGA40-­‐(G)	   43%	   and	   G5(64)-­‐PGA40-­‐(G)	   43%,	   Figure	   4.10),	   although	  G3(16)-­‐PGA40-­‐(G)	   43%	   did	  
result	   in	   a	  higher	  overall	   absorbance	  maximum.	  Notable	  however,	  was	   the	   rapid	   increase	   in	  
turbidity	   experienced	   by	   G5(64)-­‐PGA40-­‐(G)	   73%	   in	   comparison	   to	   G2(8)-­‐PGA40-­‐(G)	   85%	   of	   an	  
equivalently	   targeted	   DS.	   Although	   G5(64)-­‐PGA40-­‐(G)	   73%	   has	   more	   sugar	   units	   overall,	   its	  
degree	  of	  substitution	  or	  ratio	  of	  sugar	  :	  COOH	  	  is	  less	  which	  in	  theory	  should	  reduce	  the	  speed	  
and	   formation	   of	   insoluble	   lectin	   aggregates.	  However,	   the	   opposite	  was	   observed	   in	  which	  
the	   densely	   branched	  G5(64)-­‐PGA40-­‐(G)	   73%	   reached	   its	  maximum	   absorbance	   after	   10	  min	  
whereas	  	  G2(8)-­‐PGA40-­‐(G)	  85%	  obtained	  the	  same	  absorbance	  max.	  after	  30	  min.	  As	  discussed	  
above,	  albeit	  at	  a	  DS	  of	  25%	  the	  densely	  branched	  G5(64)-­‐PGA	  glycopolypeptide	  architectures	  
seem	  to	  have	  a	  more	  profound	  effect	  on	  lectin	  binding	  interactions	  at	  the	  extremes	  of	  DS	  i.e.	  
30%	  >	  x	  >	  70%	  due	  to	  their	  favoured	  presentation	  of	  sugars	  at	  the	  accessible	  surface.	  
Comparing	  the	  effects	  of	  arm	  length	  using	  figures	  4.9	  and	  4.10,	  it	  is	  shown	  that	  a	  shorter	  arm	  
length	  permits	  a	  faster	   lectin	  binding	   interaction.	  For	   instance,	  G2(8)-­‐PGA40-­‐(G)	  51%	  and	  85%	  
achieve	   their	   absorbance	   max.	   at	   30	   min	   whereas	   	   G2(8)-­‐PGA27-­‐(G)	   54%	   and	   96%	   achieves	  
theirs	  at	  10	  min.	  A	  similar	  observation	  is	  made	  for	  G5(64)-­‐PGA40-­‐(G)	  43%	  and	  G5(64)-­‐PGA3-­‐(G)	  
48%.	  Although	  all	  of	  their	  DS	  are	  relatively	  similar,	   it	  seems	  that	  polypeptide	  arm	  length	  also	  
has	   a	   major	   effect	   on	   sugar	   -­‐	   lectin	   interactions.	   As	   observed	   for	   branching	   density,	   it	   is	  
hypothesised	   that	   the	   positioning	   of	   sugars	   i.e.	   positioning	   at	   accessible	   periphery	   is	   a	   key	  
factor	   for	   lectin	   binding	   interactions	   and	   it	   appears	   that	   this	   feature	   is	   favoured	   for	   star	  
polymers	   of	   short	   polypeptide	   arm	   lengths.	   Consequently,	   it	   can	   be	   concluded	   that	   sugar	  
density	   at	   the	   accessible	   surface	  which	   itself	   is	   speculated	   to	   be	   dependent	   on	   polypeptide	  





Figure	  4.10:	  Absorbance	  at	  420nm	  of	  lectin	  /	  star	  shaped	  glycopolypeptide	  (comparable	  arm	  

















4.2.2	  Advanced	  Linear	  Polypeptide	  Architectures	  
4.2.2.1	  Linear	  Polypeptide	  Synthesis	  
Aside	   from	   star	   shaped	   polypeptides,	   the	   synthesis	   of	   more	   complex	   linear	   polypeptide	  
architectures	   was	   attempted.	   Considering	   the	   eventual	   goal	   of	   polypeptide	   glycosylation	  
through	  aqueous	  mediated	  amide	  coupling	  chemistry,	  the	  targeting	  of	  linear	  polypeptides	  with	  
selectively	   positioned	   carboxylic	   acid	   moieties	   was	   envisaged.	   Therefore,	   to	   achieve	   water	  
soluble	  polypeptides	  with	  selectively	  positioned	  sugars	  a	  methodology	  involving	  the	  use	  of	  two	  
NCA	  monomers	   both	  with	   carboxylic	   acid	   side	   chain	   functionality	   but	   capped	  with	   different	  
protecting	  groups	  was	  employed.	  The	  use	  of	  two	  different	  protecting	  groups	  should	  permit	  the	  
selective	  removal	  and	  subsequent	  presentation	  of	  carboxylic	  moieties	  at	  defined	  positions	  thus	  
providing	   a	   reactive	   handle	   for	   glycosylation	   with	   amino	   functionalised	   sugars.	   Finally,	  
deprotection	   of	   the	   remaining	   robust	   protecting	   groups	   should	   afford	   a	   universally	   water	  
soluble	  polypeptide	  possessing	  sugars	  at	  well-­‐	  defined	  positions.	  	  
Concerning	   NCA	   monomers	   with	   carboxylic	   acid	   functionality,	   γ-­‐benzyl-­‐L-­‐glutamate	   was	  
chosen	   due	   its	   facile	   synthesis,	   well	   understood	   NCA	   ROP	   behaviour	   and	   robust	   protecting	  
group.18,19,80	   Similarly,	   the	   second	   NCA	   monomer	   chosen	   was	   based	   on	   glutamic	   acid	   but	  
possessed	   a	   tert-­‐butyl	   protecting	   group	   which	   permits	   side	   chain	   deprotection	   under	   mild	  
acidic	   conditions	   whilst	   in	   theory	   preserving	   the	   benzyl	   protecting	   groups.76	   Therefore,	   the	  
NCA	  monomer,	  L-­‐glutamic	  acid	  5-­‐tert-­‐butyl	  ester	  (GATBE)	  bearing	  tert-­‐butyl	  protection	  of	  the	  
carboxylic	   acid	   side	   chain	   functionality	   was	   synthesised	   using	   typical	   triphosgene	   mediated	  




Figure	  4.11:	  1H	  NMR	  spectrum	  of	  L-­‐glutamic	  acid	  5-­‐tert-­‐butyl	  ester	  (GATBE)	  NCA	  monomer	  
(CDCl3).	  
Initially,	  a	  linear	  block	  copolymer	  arrangement	  was	  attempted	  through	  polymerization	  of	  BLG	  
NCA	  at	  0oC	  and	  subsequent	  chain	  extension	  by	  GATBE	  NCA.	  The	  use	  of	  0oC	  inhibits	  unwanted	  
side	  reactions	  such	  as	  termination	  of	  the	  terminal	  polypeptide	  primary	  amine	  thus	  allowing	  for	  
the	  well	   controlled	   chain	   extension	   of	   PBLG	   chains	  with	   other	  NCAs.82	   Chain	   extension	  with	  
GATBE	  was	   not	   attempted	   until	   FTIR	   spectroscopy	   confirmed	   the	   complete	   consumption	   of	  
BLG	  monomer.	  The	  observed	   shift	   in	   retention	   time	  of	  homopolymer	   to	  block	   copolymer	  by	  
SEC	  confirmed	  the	  successful	  generation	  of	  a	  block	  copolymer	  arrangement	  (Figure	  4.12).	  The	  
presence	  of	  terminated	  homopolymer	  chains	  was	  detected	  however	  at	  an	  elution	  time	  of	  23	  
minutes	   which	   prevented	   chain	   extension	   by	   a	   second	   monomer.	   The	   Mw	   of	   the	   block	  
copolymer	  differed	  significantly	   from	  the	   theoretical	  Mw	  due	   to	   the	  unknown	  dn/dc	  value	  of	  
this	   block	   copolymer	   (Table	   4.3,	   entries	   1	   and	   2).	  However,	   the	  distinguishable	  presence	  of	  
both	  PBLG	  and	  PGATBE	  moieties	  in	  1H	  NMR	  spectroscopy	  analysis	  which	  helped	  to	  accurately	  







Table	  4.3:	  Synthesis	  of	  block	  copolymers	  by	  initiation	  from	  hexylamine	  (L:	  linear	  initiator	  
hexylamine;	  L(1)-­‐PBLG20	  =	  initiator	  with	  theoretical	  arm	  length	  of	  20	  amino	  acids).	  	  
Entry	   Polymer	   NCA/NH2	  	   Mw/g	  mol-­‐1(a)	   Mnth	  (b)/g	  mol-­‐1	   PDI	  
	  	  	  	  L(1)-­‐PBLG20-­‐b-­‐PGATBE20	  
1	   L(1)-­‐PBLG20	   20	   5	  500	  (3	  500)(c)	   4	  400	   1.1	  
2	   L(1)-­‐PBLG20-­‐b-­‐PGATBE20	   20	   17	  700	  (6	  700)(c)	   8	  100	   1.4	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  L(1)-­‐PBLG5(B)-­‐s-­‐PGATBE5(T)	   	   	  
3	   Block	  1	  (PBLG)	  -­‐	  B	   5	   2	  800	   1	  200	   1.1	  
4	   Block	  2	  (PGATBE)	  -­‐	  BT	   5	   4	  100	   2	  100	   1.2	  
5	   Block	  3	  (PBLG)	  -­‐	  BTB	   5	   7	  400	   3	  200	   1.2	  
6	   Block	  4	  (PGATBE)	  -­‐	  BTBT	   5	   8	  700	   4	  100	   1.2	  
7	   Block	  5	  (PBLG)	  -­‐	  BTBTB	   5	   14	  500	   5	  200	   1.3	  
8	   Block	  6	  (PGATBE)	  -­‐	  BTBTBT	   5	   15	  400	   6	  100	   1.2	  
9	   Block	  7	  (PBLG)	  -­‐	  BTBTBTB	   5	   18	  800	   7	  200	   1.2	  
10	   Block	  8	  (PGATBE)	  -­‐	  
BTBTBTBT	  
5	   19	  900	  (9100)(c)	   8	  100	   1.2	  
(a)	  determined	  by	  SEC	  (DMF)	  using	  MALS	  detection	  using	  the	  dn/dc	  of	  linear	  PBLG	  of	  0.118	  
(b)	   calculated	   assuming	   initiation	   from	   all	   amino	   groups	   and	   quantitative	   conversion:	  
c(monomer)/c(hexylamine)	   x	   M(monomer)	   +	   M(initiator)	   (c)	   determined	   by	   1H	   NMR	  
spectroscopy	  using	  the	  integral	  ratio	  of	  hexylamine,	  PBLG	  and	  PGATBE.	  
	  
	  




Figure	  4.13:	  1H	  NMR	  spectrum	  of	  L(1)-­‐PBLG20-­‐b-­‐PGATBE20	  (CDCl3).	  
To	  induce	  further	  complexity	  to	  this	  system	  the	  creation	  of	  an	  advanced	  block	  copolypeptide	  
was	  envisaged.	  The	   field	  of	  NCA	  ROP	  has	  developed	   immensely	   in	   recent	  years	  but	   the	  next	  
major	  hurdle	  for	  NCA	  ROP	  is	  the	  ability	  to	  sequence	  control	  amino	  acids	  within	  a	  polypeptide	  
chain.17,21,24	   Although	   not	   strictly	   sequenced	   to	   the	   individual	   amino	   acid,	   the	   selective	  
positioning	   or	   sequencing	   of	   PGATBE	   segments	   within	   a	   polypeptide	   chain	   was	   attempted	  
(Figure	   4.14).	   The	   creation	   of	   a	   polypeptide	   containing	   multiple	   short	   polypeptide	   blocks	  
positioned	   selectively	   is	   a	   step	   towards	   the	   “holy	   grail”	   of	   sequence	   controlled	   polypeptide	  
synthesis	  by	  NCA	  ROP.	  This	  is	  the	  first	  such	  reported	  case	  of	  amino	  acid	  “sequencing”	  within	  an	  
NCA	  derived	  polypeptide.	  The	  subsequent	  glycosylation	  of	  this	  polypeptide	  will	  also	  be	  the	  first	  








Figure	  4.14:	  Sequence	  controlled	  synthesis	  of	  linear	  polypeptides.	  
	  
The	   use	   of	   BLG	   and	   GATBE	   NCA	   monomers	   should	   prove	   feasible	   owing	   to	   their	   above	  
demonstrated	  ability	  to	  generate	  a	  simple	  block	  copolymer	  whilst	  polymerization	  of	  individual	  
monomers	   does	   not	   induce	   the	   formation	   of	   strong	   secondary	   structures	   which	   has	   been	  
known	  to	  limit	  polypeptide	  growth	  in	  the	  case	  of	  certain	  NCAs.28	  NCA	  ROP	  was	  carried	  out	  by	  
employing	  hexylamine	  to	  target	  short	  polypeptide	  blocks	  of	  5	  amino	  acid	  units.	  The	  reaction	  
was	   performed	   at	   0oC	   and	   monitored	   by	   FTIR	   spectroscopy	   to	   ensure	   complete	   monomer	  
consumption.	   The	   targeting	   of	   5	   amino	   acid	   units	   for	   each	   block	   enabled	   the	   use	   of	   the	  
available	  SEC	  instrumentation	  to	  monitor	  block	  formation	  and	  molecular	  weight	  characteristics	  
of	  the	  resultant	  polypeptide	  chains.	  The	  clear	  shift	  in	  retention	  time	  after	  chain	  extension	  can	  




Figure	  4.15:	  SEC	  traces	  (RI	  detector)	  of	  L(1)-­‐PBLG5	  (B)	  (Black)	  (1),	  	  L(1)-­‐PBLG5-­‐b-­‐PGATBE5	  (BT)	  
(Red)	  (2),	  L(1)-­‐BTB	  (Blue)	  (3),	  L(1)-­‐BTBT	  (Green)	  (4),	  L(1)-­‐BTBTB	  (Purple)	  (5),	  L(1)-­‐BTBTBT	  
(Orange)	  (6),	  L(1)-­‐BTBTBTB	  (Light	  Blue)	  (7)	  and	  L(1)-­‐BTBTBTBT	  (Pink)	  (8).	  
The	   molecular	   weight	   characteristics	   of	   the	   polypeptide	   after	   each	   chain	   extension	   are	  
summarized	   in	  Table	   4.3.	   The	  actual	  Mw	  values	  are	  not	  accurate	  due	   to	   the	  unknown	  dn/dc	  
value	  of	  this	  polymer	  but	  the	  retention	  time	  shifts	  in	  SEC	  do	  show	  that	  Mw	  is	  increasing	  after	  
each	   chain	   extension.	   Although	   narrow	   PDIs	   were	   obtained	   demonstrating	   the	   excellent	  
control	  observed,	  the	  SEC	  traces	  did	  exhibit	  some	  asymmetry	  due	  to	  peak	  tailing	  as	  a	  result	  of	  
the	   presence	   of	   a	   small	   amount	   of	   terminated	   polypeptide	   chains	   preventing	   further	   chain	  
extension.	   A	   broad	   SEC	   trace	   was	   observed	   for	   L(1)PBLG5-­‐b-­‐PGATBE5	   after	   initial	   chain	  
extension.	   It	   is	   postulated	   that	   this	   arose	   due	   to	   the	   low	   solubility	   issues	   associated	   with	  
PGATBE	  in	  DMF.	  However,	  with	  continued	  chain	  extension	  this	  feature	  became	  less	  apparent.	  
As	  shown	  in	  figure	  4.16,	  1H	  NMR	  spectroscopy	  analysis	  permitted	  accurate	  Mn	  determination	  
of	  the	  final	  linear	  polypeptide	  and	  was	  in	  close	  agreement	  with	  the	  overall	  targeted	  Mn.	  Such	  
excellent	  correlation	  epitomises	  the	  highly	  controlled	  nature	  of	  this	  system.	  	  	  	  	  	  	  	  	  
To	  afford	  carboxylic	  moieties	  for	  selective	  glycosylation	  of	  the	  described	  block	  and	  multi-­‐block	  
linear	   polypeptides,	   the	   tert-­‐butyl	   protecting	   groups	  of	   PGATBE	  were	   facilely	   removed	  using	  
TFA.	   1H	   NMR	   spectroscopy	   confirmed	   their	   quantitative	   removal	   (no	   tert-­‐butyl	   signal	   at	   1.3	  
ppm)	  in	  addition	  to	  confirming	  the	  preservation	  of	  the	  benzyl	  protecting	  groups	  of	  PBLG	  (7.3	  




Figure	  4.16:	  1H	  NMR	  spectrum	  of	  L(1)-­‐PBLG20-­‐b-­‐PGATBE20	  (CDCl3)	  (Bottom)	  and	  L(1)-­‐PBLG20-­‐b-­‐
PGA20	  (d-­‐TFA)	  (Top).	  
	  
4.2.2.2	  Glycosylation	  of	  Advanced	  Linear	  Polypeptide	  Architectures	  
Glycosylation	  of	   linear	  polypeptide	  derivatives	  at	  selected	  positions	  was	  attempted	  using	  the	  
same	   methodology	   as	   described	   for	   the	   star	   shaped	   derivatives	   (Figure	   4.17).	   However,	  
glycosylation	  was	  complicated	  given	  the	  inherent	  water	  solubility	   issues	  associated	  with	  such	  
amphiphilic	   systems.	  Despite	   this,	   glycosylation	  was	   attempted	   in	  water	   as	   only	   solubility	   of	  
the	  targeted	  functional	  groups	  i.e.	  carboxylic	  acid	  of	  polypeptide	  and	  amine	  of	  glucosamine	  is	  
required	  for	  effective	  sugar	  conjugation.	  An	  excess	  of	  sugar	  and	  coupling	  reagents	  were	  used	  
to	   attempt	   100%	   glycosylation	   of	   the	   available	   carboxylic	   acid	   groups.	   The	   results	   are	  




Figure	  4.17:	  Synthesis	  of	  advanced	  linear	  glycopolypeptide	  architectures	  via	  strategic	  










Table	  4.4:	  Results	  of	  amide	  coupling	  of	  glucosamine	  to	  linear	  poly(glutamic	  acid).	  
Entry	   Polymer	   Mnth	  (a)/g	  mol-­‐1	  	  GA:Amine:DMT-­‐MM(c)	   Target	  DS	  (%)(d)	   Measured	  DS	  (%)(e)	  
1	   L(1)-­‐PBLG20-­‐b-­‐
PGA20	  
6	  100	  	  
(5700)(b)	  





N/a	   100	   92	  (f)	  
3	   L(1)-­‐PBLG20-­‐s-­‐
PGA20	  
6	  100	  	  
(7700)(b)	  
1	  :	  2	  :	  2	  
	  
100	   70	  
4	   L(1)-­‐PGA20-­‐s-­‐
PGA20-­‐(G)	  
9	  900	  	  
(10400)(b)	  
N/a	   100	   94	  (f)	  
(a)	   calculated	   assuming	   initiation	   from	   all	   amino	   groups	   and	   quantitative	   conversion:	  
c(monomer)/c(dendrimer)	   x	  M(monomer)	  +	  M(dendrimer)	   (b)	   actual	  Mw	  as	  determined	  by	  
1H	  NMR	  spectroscopy	  using	  the	  integral	  ratio	  of	  hexylamine,	  PGA	  and	  Sugar.	  (c)	  molar	  ratio	  
of	  COOH	  from	  PGA	  :	  NH2	  of	  glucosamine	  :	  DMT-­‐MM	  coupling	  reagent	  (d)	  target	  number	  of	  
glutamic	   acid	   units	   to	   be	   functionalised	   as	   calculated	   by	  molar	   ratio	   coupling	   reagents	   to	  
glutamic	   acid	   units	   (e)	   determined	   by	   1H	   NMR	   spectroscopy	   using	   the	   integral	   ratio	   of	  
glucosamine	   and	   PGA	   (f)	   DS	   result	   for	   targeted	   PGA	   block	   /	   blocks	   and	   not	   DS	   for	  whole	  
polymer	  i.e.	  entry	  2	  has	  a	  total	  DS	  of	  46%	  but	  92%	  for	  glycosylation	  of	  targeted	  PGA	  block.	  	  
	  
Glycosylation	   of	   the	   block	   copolymer,	   L(1)-­‐PBLG20-­‐b-­‐PGA20,	   was	   perceived	   the	   most	  
straightforward	   owing	   to	   its	   relatively	   simple	   architecture.	   As	   confirmed	   by	   1H	   NMR	  
spectroscopy	   a	  DS	   of	   100%	  was	   achieved	   for	   this	   polypeptide	  which	   is	   impressive	   given	   the	  
amphiphilic	   nature	   of	   this	  material	   which	  may	   have	   somewhat	   inhibited	   the	   attainability	   of	  
high	   DS	   (Figure	   4.16)	   (Entry	   1,	   Table	   4.4).	   However,	   solubility	   of	   this	   material	   for	   1H	   NMR	  
spectroscopy	  analysis	  proved	  difficult	  even	  in	  d-­‐TFA	  meaning	  that	  accurate	  peak	  identification	  
and	  thus	  integral	  ratios	  were	  challenging	  to	  obtain.	  Furthermore,	  due	  to	  its	  amphiphilic	  nature	  
potential	  shielding	  of	  sugar	  moieties	  by	  the	  hydrophobic	  PBLG	  may	  be	  present.	  Consequently,	  
the	   real	  DS	  value	  may	  be	  more	  accurately	  obtained	   following	  deprotection	  of	   the	   remaining	  
benzyl	  groups	   to	  afford	  a	  material	  with	  superior	   solubility	  properties.	  FTIR	  spectroscopy	  also	  
confirmed	  conjugation	  due	  to	  the	  presence	  of	  a	  peak	  at	  1030	  cm-­‐1	  corresponding	  to	  the	  C-­‐O	  
functionality	  of	  sugar	  (Figure	  4.17,	  B).	  Glycosylation	  of	  the	  architecturally	  more	  complex,	  L(1)-­‐
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PBLG20-­‐s-­‐PGA20,	   was	   similarly	   attempted	   and	   afforded	   a	   notable	   DS	   of	   70%.	   (Entry	   3,	   Table	  
4.4).	   Given	   the	   amphiphilic	   nature	   of	   this	   material	   and	   elaborate	   positioning	   of	   carboxylic	  
moieties	   amongst	   the	   hydrophobic	   PBLG	   segments,	   the	   achievement	   of	   a	   high	  DS	   here	  was	  
somewhat	   surprising.	   However,	   as	   with	   L(1)-­‐PBLG20-­‐b-­‐PGA20,	   1H	   NMR	   spectroscopy	  may	   not	  
yet	  yield	  the	  true	  DS	  value	  until	  complete	  deprotection	  is	  achieved.	  FTIR	  spectroscopy	  analysis	  
of	  this	  material	  was	  similar	  to	  the	  aforementioned	  analysis	  of	  L(1)-­‐PBLG20-­‐b-­‐PGA20.	  Finally,	  to	  
obtain	   fully	   water	   soluble	   glycopolypeptides	   the	   benzyl	   protecting	   groups	   of	   PBLG	   were	  
removed	  using	  basic	  conditions	  as	  the	  typical	  acidic	  TFA	  /	  HBr	  conditions	  used	  to	  remove	  this	  
protecting	   group	   would	   react	   unfavorably	   with	   sugars	   to	   cleave	   their	   ether	   bonds	   and/or	  
brominate	  the	  α/β	  hydroxyl	  group.	  Sodium	  methoxide	   in	  methanol	  was	  employed	  to	  achieve	  
deprotection	   in	   1	   –	   2	   h	   with	   no	   undesirable	   effects	   on	   polypeptide	   backbone	   or	   sugars	  
observed	   as	   determined	   by	   1H	   NMR	   spectroscopy	   and	   FTIR	   spectroscopy	   (Figures	   4.16	   and	  
4.17,	  A).	  Post	  deprotection,	  the	  DS	  values	  obtained	  were	  92%	  and	  94%	  (DS	  of	  targeted	  block)	  
or	  46%	  and	  47%	  (DS	  for	  whole	  polypeptide)	  for	  L(1)-­‐PGA20-­‐b-­‐PGA20-­‐(G)	  and	  L(1)-­‐PGA20-­‐s-­‐PGA20-­‐
(G)	  respectively	  (Entries	  2	  and	  4,	  Table	  4.4).	  The	  DS	  value	  for	  L(1)-­‐PBLG20-­‐b-­‐PGA20	  was	  in	  close	  
agreement	   to	   its	   DS	   pre-­‐benzyl	   deprotection.	   However,	   the	   post	   benzyl	   deprotection	   DS	   of	  
94%	   obtained	   for	   L(1)-­‐PGA20-­‐s-­‐PGA20-­‐(G)	  was	   very	   impressive	   and	   differed	   significantly	   from	  
L(1)-­‐PBLG20-­‐s-­‐PGA20	   due	   to	   its	   improved	   solubility	   and	   nullification	   of	   the	   potential	   shielding	  
effects	  of	  PBLG.	  Such	  a	  result	  highlights	  the	  very	  effective	  nature	  of	  this	  methodology	  to	  create	  
a	  diverse	  range	  of	  glycosylated	  platforms.	  Both	  block	  and	  sequenced	  polypeptide	  derivatives	  
displayed	  α-­‐helical	  character	  (Amide	  I	  and	  II:	  1648	  cm-­‐1	  and	  1547	  cm-­‐1)	  in	  their	  solid	  state	  form	  
with	  the	  presence	  of	  sugar	  moieties	  denoted	  by	  the	  presence	  of	  an	  ether	  bond	  at	  1030	  cm-­‐1	  




Figure	  4.16:	  1H	  NMR	  spectra	  of	  L(1)-­‐PBLG20-­‐b-­‐PGA20-­‐(G)	  (Bottom)	  (d-­‐TFA)	  and	  L(1)-­‐PGA20-­‐b-­‐
PGA20-­‐(G)	  (Top)	  (D2O).	  	  
	  
	  
Figure	  4.17:	  FTIR	  spectra	  of	  L(1)-­‐PGA20-­‐b-­‐PGA20-­‐(G)	  (A),	  L(1)-­‐PBLG20-­‐b-­‐PGA20-­‐(G)	  (B)	  and	  L(1)-­‐




4.2.2.3	  Lectin	  Binding	  Studies	  of	  Advanced	  Linear	  Glycopolypeptide	  Architectures	  
The	  relationship	  between	  sugar	  positioning	  and	   its	  effects	  on	   lectin	  binding	  was	   investigated	  
using	   various	   linear	   glycopolypeptide	   architectures.	   The	   number	   of	   amino	   acid	   units	   was	  
constant	   i.e.	  40	  whereas	  sugars	  were	  strategically	  positioned	  along	  the	  polypeptide	  chain	   i.e.	  
random,	   block	   and	   sequenced	   arrangement	   of	   sugars.	   The	   targeting	   of	   linear	   polypeptides	  
with	  40	  glutamic	  acid	  residues	  was	  chosen	  as	  it	  reflects	  the	  length	  of	  one	  arm	  of	  the	  equivalent	  
star	  shaped	  polypeptides	  described	  in	  Figure	  4.10.	  As	  expected,	  the	  lectin	  binding	  interaction	  
for	  these	  linear	  derivatives	  (Figure	  4.18)	  was	  far	  slower	  than	  for	  the	  equivalents	  stars	  i.e.	  DS	  >	  
50%	  (Figure	  4.10)	  due	  to	  their	  inferior	  sugar	  density.	  With	  regards	  to	  positioning	  of	  sugars,	   it	  
was	  shown	  that	  a	  random	  arrangement	  of	  sugars	  had	  the	  greatest	  effect	  on	  lectin	  binding	   in	  
that	   the	   formation	   of	   insoluble	   lectin	   aggregates	   was	   quickest	   for	   L(1)-­‐PGA40-­‐(G)	   58%.	   The	  
reason	   for	   this	   may	   be	   due	   to	   favourable	   steric	   conditions	   for	   carbohydrate	   /	   lectin	  
interactions	  and	  screening	  of	  the	  soluble	  carboxylic	  acid	  moieties	  thus	  promoting	  the	  speedy	  
formation	   of	   insoluble	   lectin	   aggregates.	   Lectin	   interactions	   with	   the	   sequenced	   sugar	  
arrangement,	  L(1)-­‐PGA20-­‐s-­‐PGA20-­‐(G)	  47%	  was	   less	  pronounced	  and	  required	  a	   longer	  time	  to	  
achieve	   its	   maximum	   absorbance	   but	   was	   in	   fact,	   stronger	   than	   the	   block	   arrangement	   of	  
sugars,	   L(1)-­‐PGA20-­‐b-­‐PGA20-­‐(G)	   47%.	   These	   arrangements	   are	   structurally	   orientated	   in	   that	  
they	  have	   small	  but	  numerous	   (L(1)-­‐PGA20-­‐s-­‐PGA20-­‐(G))	  or	   large	  but	   few	   (L(1)-­‐PGA20-­‐b-­‐PGA20-­‐
(G))	  segments	  of	  sugars	  and	  carboxylic	  acid	  moieties	  which	  although	  elicit	  lectin	  binding,	  their	  
formation	   of	   insoluble	   lectin	   aggregates	   is	   somewhat	   quenched	   by	   the	   presence	   of	   readily	  
accessible	   segments	   of	   water	   soluble	   carboxylic	   moieties.	   In	   spite	   of	   this,	   these	   new	  
possibilities	  of	  arranging	  sugars	  within	  structurally	  diverse	  biocompatible	  polypeptide	  scaffolds	  
presents	   many	   new	   opportunities	   to	   study	   new	   and	   more	   complex	   lectin	   –	   carbohydrate	  
interactions.	   In	   addition,	   this	   methodology	   may	   be	   employed	   to	   deliver	   new	   polypeptide	  





Figure	  4.18:	  Absorbance	  at	  420nm	  of	  lectin	  /	  linear	  glycopolypeptide	  (comparable	  arm	  

















4.3	  	  	  	  Conclusion	  
A	  series	  of	  well-­‐defined	  block,	  sequenced	  and	  star	  shaped	  polypeptides	  were	  prepared	  via	  NCA	  
ROP	   initiated	   by	   hexylamine	   and	   various	   generations	   of	   PPI	   dendrimers	   respectively.	   Star	  
shaped	   polypeptides	   were	   generated	   in	   which	   their	   molecular	   weight,	   arm	   length	   and	   arm	  
density	   were	   readily	   controlled.	   The	   employment	   of	   the	   NCA	   of	   glutamic	   acid	   bearing	   two	  
different	   amino	   acid	   side	   chain	   protecting	   groups	   afforded	   a	   block	   copolymer	   arrangement	  
capable	   of	   sequential	   deprotection	   and	   presentation	   of	   carboxylic	   acid	  moieties.	   Similarly,	   a	  
sequenced	   arrangement	   of	   these	   amino	   acids	   was	   prepared	   for	   the	   first	   time	   boasting	  
excellent	  synthetic	  control	  and	  monitoring	  throughout.	  The	  subsequent	  glycosylation	  of	  these	  
materials	  with	  glucosamine	  via	  amide	  coupling	  chemistry	  presented	  a	  new	  class	  of	  star	  shaped	  
glycopolypeptide	   architectures	   with	   tuneable	   sugar	   densities	   and	   potential	   to	   achieve	   high	  
degrees	   of	   sugar	   conjugation.	   Similarly,	   linear	   block	   and	   sequenced	   polypeptide	   derivatives	  
permitted	  the	  strategic	  positioning	  of	  sugar	  moieties	  along	  a	  polypeptide	  chain.	  The	  bioactivity	  
of	  the	  described	  glycopolypeptide	  scaffolds	  towards	  the	   lectin	  ConA	  was	   investigated	  using	  a	  
turbidimetry	   assay.	   The	   carbohydrate	   –	   lectin	   interactions	  were	   shown	   to	   be	   architecturally	  
dependent	   and	   consequently	   these	   advanced	   glycopolypeptide	   architectures	   may	   find	  
applicability	  towards	  biorecognition	  applications	  and	  the	  study	  of	  more	  complex	  carbohydrate	  
















4.4	  	  	  	  Experimental	  
Materials	  
All	   air	   and	  moisture	   sensitive	   compounds	  were	   handled	   under	   a	   nitrogen	   atmosphere	   using	  
general	   Schlenk-­‐line	   techniques.	  All	   chemicals	   unless	   otherwise	   stated	  were	  purchased	   from	  
Sigma	  Aldrich.	   γ-­‐Benzyl-­‐L-­‐glutamate	   and	   L-­‐Glutamic	   Acid	   5-­‐tert-­‐Butyl	   Ester	  were	   supplied	   by	  
Bachem.	  PPI	   (polypropylene	   imine)	  dendrimers	  generations	  2-­‐5	  were	  purchased	   from	  SyMO-­‐
Chem	   BV	   (The	   Netherlands).	   Chloroform	   (anhydrous),	   ethyl	   acetate	   (anhydrous),	  
dimethylformamide	   (anhydrous),	   tetrahydrofuran	   (anhydrous),	   n-­‐heptane	   and	   diethylether	  
were	   supplied	   by	   Sigma	   Aldrich.	   All	   chemicals	   were	   used	   without	   any	   purification	   unless	  
otherwise	  noted.	  Chloroform	  and	  ethyl	  acetate	  were	  used	  directly	  from	  the	  bottle	  and	  stored	  
under	   an	   inert,	   dry	   atmosphere.	   γ-­‐Benzyl-­‐L-­‐glutamate	   NCA	   was	   synthesized	   following	   a	  
literature	  procedure.82	  
Methods	  
Nuclear	  magnetic	  resonance	  (NMR)	  spectra	  were	  recorded	  on	  a	  Bruker	  Avance	  400	  (400MHz)	  
spectrometer	  at	  room	  temperature	  in	  CDCl3	  and	  d-­‐TFA	  as	  solvents.	  Attenuated	  Total	  Reflection	  
(ATR)	   FTIR	   spectroscopy	  measurements	  were	  performed	  on	   a	   Perkin-­‐Elmer	   Spectrum	  100	   in	  
the	  spectral	  region	  of	  650-­‐4000	  cm-­‐1	  and	  were	  obtained	  from	  4	  scans	  with	  a	  resolution	  of	  2	  cm-­‐
1.	   A	   background	   measurement	   was	   taken	   before	   the	   sample	   was	   loaded	   onto	   the	   ATR	   for	  
measurement.	  Size	  Exclusion	  Chromatography	  (SEC)	  was	  performed	  on	  an	  Agilent	  1200	  system	  
in	   conjunction	  with	   two	  PSS	  GRAM	  analytical	   (8	   x	   300	   and	   8	   x	   100,	   10	  μ)	   columns,	   a	  Wyatt	  
Dawn	  Heleos	  8	  multi	  angle	  light	  scattering	  detector	  (MALS)	  and	  Wyatt	  Optilab	  rEX	  differential	  
refractive	   index	   detector	   (DRI)	   with	   a	   658	   nm	   light	   source.	   The	   eluent	  was	   DMF	   containing	  
0.1M	  LiBr	  at	  a	  flow	  rate	  of	  1	  mL	  min-­‐1.	  The	  column	  temperature	  was	  set	  to	  40oC	  with	  the	  MALS	  
detector	  at	  35oC	  and	  the	  DRI	  detector	  at	  40oC.	  Molar	  masses	  and	  dispersities	  were	  calculated	  
from	   the	   MALS	   signal	   by	   the	   Astra	   software	   (Wyatt)	   using	   the	   refractive	   index	   increment	  
(dn/dc)	   of	   linear	  poly-­‐benzyl-­‐L-­‐glutamate	   (PBLG)	  of	   0.118.	  All	   samples	   for	  GPC	  analysis	  were	  
prepared	  with	  a	  concentration	  of	  2	  mg/ml	  and	  were	  filtered	  through	  a	  0.45	  μm	  PTFE	  filter	  (13	  
mm,	  PP	  housing,	  Whatman)	  prior	  to	  injection.	  UV-­‐Vis	  spectra	  were	  recorded	  on	  a	  Varian	  Cary	  







Synthesis	  of	  NCA	  of	  L-­‐Glutamic	  Acid	  5-­‐tert-­‐Butyl	  Ester	  
L-­‐Glutamic	   Acid	   5-­‐tert-­‐Butyl	   Ester	   (4.5	   g,	   0.022	   mol)	   and	   α-­‐pinene	   (6	   g,	   0.044	   mol)	   were	  
dissolved	  in	  55	  ml	  of	  anhydrous	  ethyl	  acetate	  in	  a	  three-­‐neck	  round	  bottom	  flask.	  The	  reaction	  
was	   heated	   to	   80oC	   under	   nitrogen	   and	   then	   triphosgene	   (3.8	   	   g,	   0.013	   mol)	   in	   25	   ml	   of	  
anhydrous	  ethyl	  acetate	  was	  added	  drop	  wise	  over	  1	  h.	  The	  solution	  was	  stirred	  for	  a	  further	  5	  
h	  until	  the	  mixture	  became	  clear.	  The	  solution	  was	  allowed	  to	  cool	  and	  the	  2/3	  of	  the	  solvent	  
was	  removed	  under	  reduced	  pressure.	  The	  NCA	  was	  precipitated	  by	  the	  addition	  of	  heptane.	  
The	  crude	  product	  was	   filtered	  and	   recrystallized	   from	  ethyl	  acetate	   /	  heptane	   to	  afford	   the	  
target	  compound	  as	  a	  white	  powder.	  (Yield:	  2	  g,	  50%)	  1H	  NMR	  spectroscopy	  (400	  MHz,	  CDCl3,	  
δ,	  ppm):	  1.45	  (s,	  9H,(CH3)3),	  2.07	  (m,	  1H,	  CH-­‐CH2),	  2.24	  (m,	  1H,	  CH-­‐CH2),	  2.46	  (t,	  J=	  6.8	  Hz,	  2H,	  
CH2-­‐C=O),	  4.39	  (dd,	  J=	  5.7	  Hz,	  1H,	  CH-­‐C=O)	  6.77	  (s,	  1H,	  NH),	  13C	  NMR	  spectroscopy	  (400	  MHz,	  
CDCl3,	   δ,ppm):	   27.00	   (-­‐CH(CH2)CH2),	   28.01	   (-­‐C(CH3)3),	   30.97	   (-­‐CH2(CH2)CO),	   57.28	   (-­‐NH(CH)),	  
79.98	  (-­‐O(C)CH3)	  152.71	  (-­‐O(CO)NH-­‐),	  170.62	  (-­‐O(CO)CH),	  207.24	  (-­‐O(CO)CH2).	  	  
Synthesis	  of	  Linear	  poly(γ-­‐benzyl-­‐L-­‐glutamate)-­‐b-­‐	  poly(L-­‐glutamic	  acid	  5-­‐tert-­‐butyl	  ester)	  
In	  a	  Schlenk	  tube	  under	  a	  nitrogen	  atmosphere,	  a	  solution	  of	  the	  NCA	  of	  γ-­‐benzyl-­‐L-­‐glutamate	  
(BLG)	   (0.57	   g,	   2.22	  mmol)	   in	   anhydrous	  DMF	   (5	  ml)	  was	  prepared.	  A	   solution	  of	   hexylamine	  
initiator	  (11	  mg,	  0.11	  mmol)	  in	  DMF	  was	  also	  prepared	  and	  charged	  to	  the	  reaction	  solution	  via	  
syringe.	   The	   solution	   was	   stirred	   at	   0oC	   until	   no	   further	   NCA	   monomer	   remained	   as	  
determined	  by	  ATR.	  The	  molar	  mass	  was	  monitored	  by	  SEC	  by	  taking	  a	  sample	  (via	  syringe	  –	  
0.5ml)	  directly	  for	  analysis.	  The	  NCA	  of	  L-­‐Glutamic	  Acid	  5-­‐tert-­‐Butyl	  Ester	  (0.498	  g,	  2.22	  mmol)	  
in	  6	  ml	  of	  DMF	  was	  charged	  to	  the	  reaction	  solution	  and	  stirred	  at	  room	  temperature	  for	  48	  h.	  
ATR	   confirmed	   complete	  monomer	   consumption	   and	   the	   polymer	   was	   precipitated	   into	   an	  
excess	  of	  cold	  diethyl	  ether	  and	  dried	  under	  vacuum	  (Yield:	  93%).	  
Synthesis	  of	  Linear	  poly(γ-­‐benzyl-­‐L-­‐glutamate)-­‐s-­‐	  poly(L-­‐glutamic	  acid	  5-­‐tert-­‐butyl	  ester)	  
In	  a	  Schlenk	  tube	  under	  a	  nitrogen	  atmosphere,	  a	  solution	  of	  the	  NCA	  of	  γ-­‐benzyl-­‐L-­‐glutamate	  
(BLG)	  (71.2	  mg,	  0.27	  mmol)	  in	  anhydrous	  DMF	  (0.7	  ml)	  was	  prepared.	  A	  solution	  of	  hexylamine	  
initiator	  (5.5	  mg,	  0.054	  mmol)	  in	  DMF	  was	  also	  prepared	  and	  charged	  to	  the	  reaction	  solution	  
via	   syringe.	   The	   solution	   was	   stirred	   at	   0oC	   until	   no	   further	   NCA	   monomer	   remained	   as	  
determined	  by	  ATR.	  The	  molar	  mass	  was	  monitored	  by	  SEC	  by	  taking	  a	  sample	  (via	  syringe	  –	  
100μL)	  directly	  for	  analysis.	  The	  NCA	  of	  L-­‐Glutamic	  Acid	  5-­‐tert-­‐Butyl	  Ester	  (62.2	  mg,	  0.27	  mmol)	  
in	  0.6	  ml	  of	  DMF	  was	  charged	  to	  the	  reaction	  solution	  and	  stirred	  at	  0oC	  until	  no	  further	  NCA	  
monomer	  remained	  as	  determined	  by	  ATR.	  The	  molar	  mass	  was	  monitored	  by	  SEC	  by	  taking	  a	  
sample	   (via	   syringe	   –	   100μL)	   directly	   for	   analysis.	   This	   process	  was	   repeated	   to	   achieve	   the	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target	  polymer	  sequence.	  Finally,	  the	  polymer	  was	  precipitated	  into	  an	  excess	  of	  cold	  diethyl	  
ether	  and	  dried	  under	  vacuum	  (Yield:	  85%).	  
Deprotection	  of	  tert-­‐butyl	  Protecting	  Groups	  from	  Linear	  poly(γ-­‐benzyl-­‐L-­‐glutamate)-­‐s-­‐	  
poly(L-­‐glutamic	  acid	  5-­‐tert-­‐butyl	  ester)	  (Representative	  Procedure)	  
L(1)-­‐PBLG20-­‐b-­‐PGATBE20	   (0.3	  g,	  0.045	  mmol)	  was	  dissolved	   in	  4	  ml	  of	   trifluoroacetic	   acid	  and	  
stirred	  at	  0oC	  for	  1	  h	  and	  a	  further	  1	  h	  at	  room	  temperature.	  The	  polymer	  was	  precipitated	  into	  
diethyl	  ether	  twice	  and	  washed	  with	  an	  aqueous	  solution	  of	  saturated	  NaHCO3	  to	  form	  the	  Na	  
salt	  of	  the	  glutamic	  acid	  block.	  The	  solution	  was	  dialyzed	  (molar	  mass	  cut-­‐off	  1,000	  g/mol)	  for	  
3	   days.	   The	   polymer	   was	   lyophilized	   (Yield:	   85%).	   Deprotection	   was	   confirmed	   by	   1H	   NMR	  
spectroscopy	  due	  to	  the	  absence	  of	  signal	  at	  1.4	  ppm	  (tert-­‐butyl	  group).	  
Synthesis	  of	  Glucosamine	  Functionalized	  Linear	  poly(γ-­‐benzyl-­‐L-­‐glutamate)-­‐b-­‐	  poly(L-­‐
glutamic	  acid)	  (Representative	  Procedure)	  
Targeting	  a	  degree	  of	  substitution	  of	  100%,	  L(1)-­‐PBLG20-­‐b-­‐PGATBE20	  (150	  mg,	  0.44	  mmol	  PGA)	  
and	   glucosamine	   hydrochloride	   (67.3	  mg,	   1.1	  mol,	   2eq.	   per	   PGA)	  were	   dissolved	   in	   4	  ml	   of	  
deionized	  water	  and	  1	  ml	  of	  DMSO	  and	  stirred	  under	  a	  nitrogen	  atmosphere	  for	  30	  min.	  4-­‐(4,6-­‐
Dimethoxy-­‐1,3,5-­‐triazin-­‐2-­‐yl)-­‐4-­‐methylmorpholinium	   chloride	   (302	   mg,	   1.09	   mmol,	   2eq.	   per	  
PGA)	  in	  3	  ml	  of	  deionized	  water	  was	  added	  quickly	  via	  syringe	  and	  stirred	  at	  room	  temperature	  
for	   24	   h.	   3	   ml	   of	   0.1M	   aqueous	   NaHCO3	   solution	   was	   added	   and	   stirred	   for	   30	   min.	   The	  
solution	  was	  dialyzed	  for	  3	  days	  (molar	  mass	  cut-­‐off	  1,000	  g/mol)	  against	  deionized	  water	  and	  
later	  lyophilized	  to	  afford	  the	  target	  compound	  as	  a	  white	  fluffy	  solid.	  Yield	  190	  mg,	  DS	  =	  92%.	  	  	  
Benzyl	  Ester	  Hydrolysis	  of	  Linear	  Poly(γ-­‐benzyl-­‐L-­‐glutamate)	  -­‐b-­‐	  poly(L-­‐glutamic	  acid-­‐
glucosamine)	  (Representative	  Procedure)	  
L(1)-­‐PBLG20-­‐b-­‐PGA20-­‐Gluco	  (100	  mg,	  0.0011	  mmol)	  was	  added	  to	  1	  mL	  of	  methanol.	  300μL	  of	  a	  
25%	  w/v	  solution	  of	  NaOMe	  in	  methanol	  was	  added	  to	  the	  reaction	  solution	  and	  stirred	  for	  1	  
h.	  Deionized	  water	  was	  added	  gradually	  over	  a	  period	  of	  1	  h	  with	  stirring.	  The	  resultant	  clear	  
solution	  was	   for	   3	   days	   (molar	  mass	   cut-­‐off	   1,000	   g/mol)	   against	   deionized	  water	   and	   later	  
lyophilized	   to	   afford	   the	   target	   compound	   as	   a	   white	   fluffy	   solid.	   Yield	   60	   mg,	   DS	   =	   92%.	  
Deprotection	  was	  confirmed	  by	  1H	  NMR	  spectroscopy	  due	  to	  the	  absence	  of	  signals	  at	  7.2	  ppm	  




Synthesis	  of	  Linear	  poly(γ-­‐benzyl-­‐L-­‐glutamate)	  (Representative	  Procedure)	  
	  In	  a	  Schlenk	  tube	  under	  a	  nitrogen	  atmosphere,	  a	  solution	  of	  the	  NCA	  of	  γ-­‐benzyl-­‐L-­‐glutamate	  
(BLG)	  (2.0	  g,	  7.63	  mmol)	  in	  CHCl3	  (25	  ml)	  was	  prepared.	  A	  solution	  of	  hexylamine	  initiator	  (0.32	  
mg,	   2.98	   x	   10-­‐6	  mmol)	   in	   CHCl3	   was	   also	   prepared	   and	   charged	   to	   the	   reaction	   solution	   via	  
syringe.	   The	   solution	   was	   stirred	   at	   room	   temperature	   until	   no	   further	   NCA	   monomer	  
remained	  as	  determined	  by	  ATR.	  The	  polymer	  was	  precipitated	  into	  an	  excess	  of	  cold	  diethyl	  
ether	  and	  dried	  under	  vacuum	  (Yield:	  89%).	  
Synthesis	  of	  Star	  Shaped	  PBLG	  (Representative	  Procedure)	  
As	   a	   reference	   procedure,	   the	   NCA	   of	   γ-­‐benzyl-­‐L-­‐glutamate	   (BLG)	   (2.18	   g,	   8.3	   mmol)	   was	  
dissolved	  in	  25	  mL	  CHCl3	  in	  a	  Schlenk	  tube	  under	  a	  nitrogen	  atmosphere.	  A	  solution	  of	  G2-­‐PPI	  
dendrimer	  (20	  mg,	  2.59	  x	  10-­‐2	  mmol)	  in	  1	  mL	  CHCl3	  was	  quickly	  charged	  to	  the	  dissolved	  NCA	  
solution	  via	  syringe.	  The	  solution	  was	  stirred	  for	  24	  h	  at	  room	  temperature.	  Depending	  on	  the	  
type	   of	   initiator,	   the	   used	   amount	   of	   initiator	   and	   monomer	   were	   adjusted	   to	   achieve	   the	  
desired	  molar	  mass	   of	   the	   star	   shaped	   polypeptides.	   The	   polymer	   was	   precipitated	   into	   an	  
excess	  of	  cold	  diethyl	  ether	  and	  dried	  under	  vacuum	  (Yield:	  90%).	  
Benzyl	  Ester	  Hydrolysis	  of	  Poly(γ-­‐benzyl-­‐L-­‐glutamate)	  (Representative	  Procedure)	  
G5(64)-­‐PBLG40	  (400	  mg)	  was	  dissolved	  in	  8	  mL	  of	  trifluoroacetic	  acid	  (TFA).	  A	  6-­‐fold	  excess	  with	  
respect	   to	   γ-­‐benzyl-­‐L-­‐glutamate	   of	   a	   33%	   solution	   of	   HBr	   in	   acetic	   acid	   (2.3	  mL)	  was	   added	  
slowly	   to	   the	   reaction.	   After	   16	   h,	   the	   solution	   was	   precipitated	   into	   diethyl	   ether.	   The	  
precipitate	  was	  redissolved	   in	  ethanol	  and	  precipitated	  twice	   into	  diethyl	  ether.	  The	  polymer	  
was	  dissolved	  in	  excess	  saturated	  aqueous	  NaHCO3	  solution	  and	  stirred	  for	  30min	  to	  form	  the	  
Na	   salt.	   The	   solution	  was	  dialyzed	   (molar	  mass	   cut-­‐off	  8,000	  g/mol)	   for	  3	  days.	  The	  polymer	  
was	  lyophilized	  (Yield:	  81%).	  Deprotection	  was	  confirmed	  by	  1H	  NMR	  spectroscopy	  due	  to	  the	  
absence	  of	  signals	  at	  7.2	  ppm	  (benzyl	  group)	  and	  5.0	  ppm	  and	  (CH2-­‐Bz).	  
Synthesis	  of	  Glucosamine	  Functionalized	  Star	  Shaped	  poly(glutamic	  acid)	  (S-­‐PGA)	  
(Representative	  Procedure)	  
Targeting	   a	   degree	   of	   substitution	   of	   50%,	   G2(8)-­‐PGA40	   (40	   mg,	   3.1	   mmol	   PGA)	   and	  
glucosamine	   hydrochloride	   (67.3	   mg,	   3.1	   mol,	   1eq.	   per	   PGA)	   were	   dissolved	   in	   2	   ml	   of	  
deionized	  water	  and	  stirred	  under	  a	  nitrogen	  atmosphere	  for	  20	  min.	  4-­‐(4,6-­‐Dimethoxy-­‐1,3,5-­‐
triazin-­‐2-­‐yl)-­‐4-­‐methylmorpholinium	  chloride	   (60.5	  mg,	  2.19	  mmol,	  0.7eq.	  per	  PGA)	   in	  3	  ml	  of	  
deionized	  water	  was	  added	  quickly	  via	  syringe	  and	  stirred	  at	  room	  temperature	  for	  24	  h.	  2	  ml	  
of	  0.1M	  aqueous	  NaHCO3	  solution	  was	  added	  and	  stirred	  for	  30	  min.	  The	  solution	  was	  dialyzed	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for	   3	   days	   against	   deionized	  water	   and	   later	   lyophilized	   to	   afford	   the	   target	   compound	  as	   a	  
white	  fluffy	  solid.	  Yield	  50	  mg,	  DS	  =	  50%.	  	  	  
Carbohydrate-­‐Lectin	  Binding	  Tests	  
The	  lectin	  binding	  assay	  was	  performed	  by	  analysing	  the	  room	  temperature	  change	  in	  solution	  
turbidity	  at	  420	  nm.	  A	  2	  mg/ml	  solution	  of	  Concanavalin	  A	  (Type	  IV)	  from	  Canavalia	  ensiformis	  
(Jack	   bean)	  was	   prepared	   in	   0.01M	  phosphate	   buffered	   saline	   (PBS).	   900	  μL	   of	   this	   solution	  
was	   transferred	   separately	   to	   a	   quartz	   sample	   and	   reference	   cuvette.	   Similarly	   a	   2	   mg/ml	  
solution	  of	  polymer	  was	  prepared	  in	  PBS	  solution.	  90μL	  of	  this	  solution	  was	  transferred	  to	  the	  
sample	  cuvette	  whereas	  90	  μL	  of	  PBS	  was	  added	  to	  the	  reference	  cuvette.	  The	  solutions	  were	  
briefly	  mixed	  using	  a	  pipette	  and	  the	  absorbance	  was	  set	  to	  zero.	  The	  change	  in	  absorbance	  at	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Chapter	  5	  	  




A	   series	   of	   hybrid	   nanogel	   star	   polymers	   was	   synthesised	   using	   a	   combination	   of	  
polymerization	   techniques	   to	   afford	   polymers	   of	   mixed	   compositions.	   These	   well-­‐defined	  
polymers	   were	   synthesised	   in	   a	   highly	   controlled	   manner	   in	   which	   their	   compositions	   and	  
functionalities	  were	  readily	  adapted.	  The	  first	  group	  of	  hybrids	  were	  synthesised	  using	  anionic	  
polymerization	  to	  generate	  well-­‐defined	  poly(styrene)	  non-­‐degradable	  nanogel	  star	  polymers.	  
Post	   modification	   of	   these	   stars	   to	   introduce	   primary	   functionality	   permitted	   their	   use	   as	  
initiators	   (core	   first	   approach)	   for	   NCA	   ROP	   resulting	   in	   polypeptide	   conjugation	   to	   their	  
periphery.	   Peripheral	   functionality	   was	   readily	   adapted	   through	   choice	   of	   NCA.	   Secondly,	  
cationic	   and	   anionic	   peripheral	   functionalised	   degradable	   nanogel	   star	   polymers	   were	  
generated	   via	   the	   arm	   first	   approach.	   Linear	   polymeric	   arms	   were	   generated	   via	   RAFT	  
polymerization	  of	  functional	  methacrylate	  monomers	  which	  were	  subsequently	  utilised	  in	  the	  
organocatalytic	  ROP	  of	  cyclic	  esters	  to	  form	  the	  ester	  core.	  The	  size	  of	  these	  hybrid	  stars	  was	  
readily	   controlled	   by	   varying	   the	   arm	   to	   crosslinker	   ratio.	   The	   employment	   of	   hydroxyl	  
functionalised	   linear	   poly(ethylene	   glycol)	   of	   various	   molecular	   weights	   as	   initiators	   for	  	  	  
organocatalytic	  ROP	  of	  cyclic	  esters	  produced	  a	  series	  of	  well-­‐defined	  nanogel	  star	  structures	  
boasting	  thermo	  responsive	  behaviour.	  Star	  size,	  molecular	  weight,	  hydrophobic	  content	  and	  
arm	  length	  were	  readily	  controlled	  which	  enabled	  the	  modulation	  of	  poly(ethylene	  glycol)	  LCST	  
behaviour	  to	  a	  temperature	  more	  suitable	  to	  potential	  applications	  such	  as	  drug	  delivery.	  The	  
consolidation	   of	   several	   different	   synthetic	   approaches	   within	   the	   one	   organic	   nanoparticle	  
lead	   to	   an	   array	   of	   new	   materials	   boasting	   a	   well-­‐defined,	   multifunctional	   and	   structurally	  
versatile	  nature.	  This	  synthetic	  and	  structural	  versatility	  presents	  many	  new	  opportunities	  for	  
the	   development	   of	   a	   new	   generation	   of	   “smart”	   hybrid	   nanomaterials	  which	   can	   be	   easily	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tailored	  to	  meet	  the	  demands	  of	  specific	  biomedical	  applications	  such	  as	  drug	  delivery	  (anionic	  
/	   cationic	   star	   polymers	   for	   layer-­‐by-­‐layer	   technology),	   theranostics	   (core	   /	   shell	   type	   star	  
polymers)	  and	  antimicrobials	  (cationic	  star	  polymers).	  This	  work	  was	  carried	  out	  under	  an	  SFI	  
(Science	   foundation	   Ireland)	   STTF	   (Short	   Term	   Travel	   Fellowship)	   funded	   project	   at	   IBM,	  





















5.1	  Introduction	  	  
The	  site	  specific	  delivery	  of	  functional	  cargoes	  such	  as	  therapeutics	  and	  imaging	  agents	  in	  both	  
a	   single	   and	   dual	   mode	   is	   a	   major	   challenge	   facing	   the	   biomedical	   field.1-­‐6	   If	   achieved,	   the	  
potential	  implications	  could	  revolutionise	  the	  biomedical	  industry	  affording	  superior	  diagnosis	  
and	  treatment	  of	  disease.7-­‐9	  	  An	  insight	  into	  the	  great	  potential	  offered	  by	  such	  a	  concept	  was	  
demonstrated	  through	  the	  use	  of	  metal-­‐organic	  frameworks	  (MOFs)	  and	  functional	  nanotubes	  
for	   combined	   therapeutics	   and	   imaging	   delivery.10,11	   Aside	   from	   nanomedicine,	   organic	  
nanoparticle	  platforms	  have	  also	  shown	  their	  potential	  applicability	   in	  areas	  such	  as	  catalysis	  
and	  photonics	  highlighting	  the	  array	  of	  applications	  open	  to	  organic	  nanoparticles.12-­‐14	  In	  terms	  
of	  materials,	   dendrimers,15	  micelles,16,17	  and	   liposomes18,19	  are	   just	   some	   of	   the	  materials	   to	  
have	  achieved	  considerable	  research	  efforts	   in	  the	  pursuit	  of	  organic	  nanoparticles.	  However	  
such	  materials	   all	   have	   their	   specific	  drawbacks	   in	   terms	  of	   synthetic	  design,	   size	   limitations	  
and	  stability.	  To	  overcome	   this,	   the	  use	  of	  polymers	  has	  emerged	  as	  a	  very	  powerful	   tool	   in	  
designing	  the	  next	  generation	  of	  nanoparticle	  delivery	  systems.	  The	  excellent	  synthetic	  control	  
and	   versatility	   offered	   by	   advances	   in	   polymer	   chemistry	   presents	   many	   new	   exciting	  
opportunities	   for	  designing	  modern	  nanoparticle	  systems.20,21	  Specifically	  star	  polymers	  are	  a	  
particular	   class	  of	  polymers	  under	   consideration	  owing	   to	   the	   structural	  benefits	  offered	   i.e.	  
high	   local	   density	   of	   polymeric	   arms	   and	   functionality	   within	   a	   stable	   and	   size	   tunable	  
structural	   space.22	  Star	   polymers	   are	   typically	   derived	   	   using	   either	   the	   “core-­‐first”	   or	   “arm-­‐
first”	  approach	  but	  nanogel	  star	  polymers	  (“arm-­‐first”)	  have	  emerged	  as	  a	  strong	  nanoparticle	  
platform	   candidate	   owing	   to	   the	   unique	   structural	   and	   synthetic	   features	   offered	   by	   such	  
materials.23-­‐25	  The	   crosslinked	  nature	  of	   these	  materials	   affords	   the	   ability	   to	   generate	   large,	  
highly	  functional	  stars	  with	  discrete	  unique	  microenvironments	  whilst	  maintaining	  arm	  length	  
and	  core	  size,	  thus	  promoting	  nanogel	  star	  polymers	  to	  the	  forefront	  of	  organic	  nanoparticle	  
research.	   	   Nanogel	   star	   polymers	   consist	   of	   polymeric	   arms	   emanating	   from	   a	   cross-­‐linked	  
polymeric	   core	   and	   therefore	   present	   the	   concept	   of	   a	   core	   /	   shell	   type	   system.26-­‐28	   	   As	   a	  
consequence	  localisation	  within	  the	  one	  polymeric	  star	  polymer	  may	  be	  possible	  i.e.	  core	  and	  
interstitial	   regions	  within	  shell	  periphery.	  Such	  a	   feature	  may	  be	  utilised	  for	  cargo	   loading	  or	  
loading	   of	   more	   than	   one	   cargo	   in	   separate	   locations	   within	   the	   one	   unimolecular	   star	  
polymer.29	  The	   demands	   of	   therapeutic	   /	   imaging	   delivery	   i.e.	   cargo	   uptake,	   protection	   and	  
delivery	  should	  therefore	  be	  well	  addressed	  by	  nanogel	  star	  polymers	  owing	  to	  the	  nature	  of	  
their	  confined	  polymeric	  architecture.	  Furthermore	  the	  inherent	  control	  over	  nanogel	  star	  size	  
(10	  –	  100nm)	  promotes	  a	  tunable	  and	  greater	  cargo	   loading	  capacity	  than	  the	  typically	  small	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dendrimer	  (<10nm)	  counterparts	  highlighting	  a	  key	  restriction	  of	  dendrimers	  as	  a	  nanoparticle	  
platform.	  	  	  	  	  	  	  
The	  challenge	  is	  the	  synthesis	  of	  nanogel	  star	  polymers	  to	  enable	  the	  reproducible	  control	  of	  
structural	   features	   such	   as	   arm	  number	   and	   particles	   size.30-­‐32	  Zilliox	   et	   al.	   reported	   the	   first	  
such	   synthesis	   of	   nanogel	   star	   polymers	   employing	   anionic	   polymerization	   in	   the	   controlled	  
polymerization	   of	   polystyrene	   with	   the	   crosslinker	   divinylbenzene	   (DVB).26	   Since	   this	   early	  
breakthrough	  and	  with	  the	  advent	  of	  many	  new	  controlled	  polymerization	  techniques,33-­‐37	  the	  
development	   of	   more	   complicated	   and	   chemically	   diverse	   nanogel	   star	   polymers	   has	   been	  
made	   possible.	   Nanogel	   star	   polymers	   have	   been	   derived	   from	   RAFT	   (Reversible	   Addition-­‐
Fragmentation	   Chain	   Transfer	   Polymerization),38-­‐42	   ATRP	   (Atom	   Transfer	   Radical	  
Polymerization),43-­‐46	   NMP	   (Nitroxide	   Mediated	   Polymerization),	   GTP	   (Group	   Transfer	  
Polymerization),52,53	   ROMP	   (Ring	   Opening	   Metathesis	   Polymerization),54	   ROP	   (Ring	   Opening	  
Polymerization)	   of	   NCAs	   (N-­‐carboxyanhydrides)55,56	   and	   cyclic	   esters,57-­‐60	   cationic	  
polymerization,61,62	   anionic	   polymerization26	   and	   metal	   catalyzed	   living	   radical	  
polymerization.63	  Subsequently	  the	  range	  of	  employable	  monomers	  and	  therefore	  the	  range	  of	  
potential	  nanogel	  star	  polymer	  compositions	  is	  limitless	  rendering	  the	  tailoring	  of	  nanogel	  star	  
polymers	   for	   specific	   applications	   readily	   accessible.	   Further	   expansion	  of	   this	   idea	  means	   it	  
may	  be	  possible	  to	  combine	  different	  polymerization	  techniques	  and	  compositions	  within	  the	  
one	  nanogel	  star	  polymer	  platform.	  
Depending	  on	  the	  targeted	  application,	  properties	  such	  as	  degradability	  and	  biocompatibility	  
may	  become	  prevalent	  particularly	  for	  drug	  delivery	  applications.	  As	  a	  consequence	  the	  need	  
for	  nanogel	  star	  polymers	  of	  biocompatible	  compositions	  has	  emerged.56,64-­‐67In	  addition,	  it	  may	  
be	   desirable	   to	   include	   one	   or	   more	   than	   one	   compositional	   type	   i.e.	   hybrid	   nanogel	   star	  
polymers	  within	   the	  one	  star	  structure	   to	  control	  and	   induce	  properties	  such	  as	  degradation	  
profiles,	   functionality	   and	   stimuli	   responsiveness,	   features	  which	  may	   be	   unobtainable	   by	   a	  
single	  polymer	  type.	  	  
In	  this	  chapter,	  the	  synthesis	  of	  a	  range	  of	  hybrid	  nanogel	  star	  polymer	  systems	  boasting	  a	  high	  
degree	  of	  synthetic	  control	  and	  structural	  versatility	  is	  presented.	  All	  polymers	  comprise	  mixed	  
compositions	   achieved	   through	   the	   step-­‐wise	   combination	   of	   several	   polymerization	  
techniques.	   Detailed	   analysis	   of	   each	   synthetic	   step	   is	   presented	   emphasising	   the	   excellent	  




5.2	  Results	  and	  Discussion	  
5.2.1	  Polystyrene	  Core	  (Nondegradable)	  /	  Polypeptide	  Periphery	  (Degradable)	  
Nanogel	  Star	  Polymers	  
The	  design	  of	  well	  defined,	  size	  controlled	  nanogel	  star	  polymers	  of	  hydrophobic	  composition	  
have	  been	  reported	  by	  Sly	  et	  al.29	  Such	  materials	  are	  formed	  by	  the	  “arm	  first”	  approach	  which	  
can	  subsequently	  be	  utilised	   in	  a	  “core	   first”	  approach	  to	  afford	  core/shell	   type	  nanogel	  star	  
polymer	  architectures	  boasting	  a	  hydrophobic	  core	  and	  a	  hydrophilic	  periphery	   if	  so	  desired.	  
The	  presence	  of	  peripheral	  functionality	  i.e.	  hydroxyl	  functionalised	  end	  groups	  of	  polystyrene	  
arms	   provides	   a	   reactive	   handle	   from	   which	   further	   polymerization	   can	   be	   performed	  
depending	   on	   the	   type	   of	   modification	   employed	   at	   this	   position	   e.g.	   modification	   with	   an	  
ATRP	  type	  initiator.	  Consequently	  extension	  of	  the	  nanogel	  star	  polymer	  scaffold	  is	  achieved	  to	  
obtain	  more	   complex	   structures	   in	   terms	   of	   composition,	   functionality	   and	   overall	   material	  
properties.	  	  
The	  development	  of	  these	  materials	  towards	  potential	  applications	  is	  the	  natural	  progression	  
for	   such	   research.	  The	   identification	  of	   suitable	  applications	  may	   require	  modification	  of	   the	  
current	  nanoparticle	  platform	  to	  meet	  the	  demands	  of	  particular	  applications.	  For	  example	  an	  
application	  such	  as	  drug	  delivery	   requires	  a	  non-­‐toxic	  biocompatible	  delivery	  vehicle	  capable	  
of	   delivering	   sufficient	   cargo	   to	   a	   targeted	   site	   and	   then	   releasing	   its	   cargo	   in	   a	   controlled	  
manner.68	   Consequently,	   the	   incorporation	   of	   biocompatible/degradable	   polymer	  
compositions	   is	   imperative	   and	   provides	   for	   an	   attractive	   class	   of	   new	   hybrid	   nanogel	   star	  
polymer	  architectures.	  	  	  	  	  	  
Polypeptides,	   in	   particular	   polypeptides	   derived	   through	   ROP	   of	   NCAs	   are	   becoming	  
increasingly	  prevalent	   in	  the	  biomaterials	  field	  owing	  to	  their	  composition	  of	  natural	  building	  
blocks,	  the	  synthetic	  control	  afforded,	  scalability	  and	  their	  ability	  to	  form	  secondary	  structures	  
and	  elucidate	  a	  stimuli	  response.69	  These	  materials	  have	  already	  demonstrated	  their	  potential	  
applicability	  towards	  biomedical	  applications	  such	  as	  drug	  and	  gene	  delivery.70-­‐72	  Synthetically,	  
the	  ROP	  of	  NCAs	  can	  be	  achieved	  through	  the	  use	  of	  a	  primary	  amine	  as	  an	  initiator	  to	  obtain	  
well	   defined	   polypeptides.73,74	   Consequently,	   post	   modification	   of	   the	   hydroxyl	   terminated	  
polystyrene	  nanogel	  star	  polymers	  (S-­‐PS-­‐OH)	  towards	  primary	  amine	  terminated	  star	  polymers	  





Figure	  5.1:	  Synthesis	  of	  poly(styrene)	  nanogel	  star	  polymers	  using	  “arm-­‐first”	  approach.	  
	  
Using	   the	   expertise	   developed	   by	   Sly	   et	   al.	   a	   hydroxyl	   terminated	   polystyrene	   nanogel	   star	  
polymer	   was	   synthesized	   by	   anionic	   polymerization	   (Figure	   5.1).	   A	   nanogel	   star	   polymer	  
comprising	   an	   average	   of	   36	   arms	   each	   of	   3	   kDa	  molecular	   weight	   with	   total	   star	   polymer	  
molecular	  weight	  of	  110	  kDa	  and	  Rh	  of	  6.4	  nm	  was	  developed	  (Table	  1,	  S-­‐PS-­‐OH)	  (Figure	  5.2).	  
The	  amination	  of	  the	  nanogel	  star	  polymers	  was	  performed	  using	  Mitsonobu	  type	  chemistry.75	  
The	  methodology	  employed	  involved	  converting	  the	  hydroxyl	  terminated	  nanogel	  star	  polymer	  
to	   the	   corresponding	   azide	   using	   a	  Mitsonobu	   reaction	   and	   then	   reducing	   the	   azide	   to	   the	  
corresponding	   primary	   amine.	   Diphenylphosphoryl	   azide	   was	   successfully	   employed	   under	  
typical	  Mitsonobu	  reaction	  type	  conditions	  to	  afford	  azide	  terminated	  nanogel	  star	  polymers.	  
1H	   NMR	   spectroscopy	   confirmed	   the	   quantitative	   conversion	   of	   all	   hydroxyl	   groups	   to	   the	  
corresponding	  azide	  denoted	  by	  the	  absence	  of	  peak	  A	  at	  3.5	  ppm	  (CH2-­‐OH)	  and	  its	  complete	  
shift	   upfield	   to	   3.1	   ppm	   as	   a	   result	   of	   azide	   formation	   (CH2-­‐N3)	   (Figure	   5.3).	   Size	   exclusion	  
chromatography	   (SEC)	   showed	  no	  significant	  change	   in	  Mw,	  PDI	  and	  Rh	  after	  azide	   formation	  
(Table	   5.1,	   S-­‐PS-­‐N3).	   Subsequent	   reduction	  of	   the	  azide	   to	   the	  corresponding	  primary	  amine	  
using	  triphenylphosphine	  and	  ammonium	  hydroxide	  resulted	  in	  the	  complete	  conversion	  of	  all	  
azides	  to	  the	  primary	  amine	  functionality.	  Quantitative	  conversion	  was	  ascertained	  by	  1H	  NMR	  
spectroscopy	  highlighting	  the	  absence	  of	  peak	  A	  at	  3.1	  ppm	  and	   its	  complete	  shift	  upfield	  to	  
2.5	  ppm	  (Figure	  5.3,	  S-­‐PS-­‐NH2).	  Due	  to	  solubility	  issues	  in	  THF	  a	  comparison	  of	  SEC	  results	  with	  
the	   aforementioned	   hydroxyl	   and	   azide	   terminated	   nanogel	   star	   polymers	   could	   not	   be	  
obtained.	   However	   with	   SEC	   in	   DMF,	   the	   amine	   terminated	   star	   polymer	   displayed	   an	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apparent	   molecular	   weight	   of	   44.2	   kDa	   (dn/dc	   =	   0.187)	   and	   PDI	   of	   1.5	   with	   dynamic	   light	  
scattering	  (DLS)	  showing	  an	  Rh	  of	  4.7	  nm	  (Table	  5.1,	  S-­‐PS-­‐NH2).	  
	  
Table	  5.1:	  poly(styrene)	  derived	  nanogel	  star	  polymers	  (L:	  linear,	  S:	  Star).	  
Polymer	   Mw	  (kDa)(a)	   PDI	   Mw	  (kDa)(b)	   PDI	   No.	  Of	  Arms(c)	   Size	  Rh	  (nm)(e)	  
L-­‐PS	   3	   1.1	   N/a	   N/a	   1	   N/a	  
S-­‐PS-­‐OH	   44	   1.2	   110	   1.02	   36	   6.4	  
S-­‐PS-­‐N3	   46.3	   1.3	   109	   1.02	   36	   6.5	  
S-­‐PS-­‐NH2(d)	   44.2	   1.5	   N/a	   N/a	   N/a	   4.7(f)	  
(a)	   determined	   by	   SEC	   (THF)	   using	   RI	   detector	   and	   calibrated	   against	   linear	   poly(styrene)	  
standards	   (b)	   determined	   by	   SEC	   (THF)	   using	  MALS	   detection	   (dn/dc	   0.187).	   (c)	   calculated	  
using	  linear	  arm	  Mw	  and	  absolute	  star	  Mw	  from	  MALS	  detection	  (d)	  determined	  by	  SEC	  (DMF)	  
using	  RI	  detector	  (e)	  determined	  by	  DLS	  in	  THF	  (f)	  determined	  by	  DLS	  in	  DMF.	  
	  
	  
Figure	  5.2:	  SEC	  traces	  of	  linear	  poly(styrene)	  arm,	  Mw	  =	  3	  kDa	  (A)	  and	  star	  poly(styrene)-­‐OH,	  






Figure	  5.3:	  1H	  NMR	  spectrum	  spectrum	  of	  star	  PS-­‐OH	  (top),	  PS-­‐N3	  (middle)	  and	  PS-­‐NH2	  
(bottom)	  (CDCl3).	  
Polypeptide	   conjugation	   to	   the	   polystyrene	   nanogel	   star	   polymers	   was	   performed	   using	   a	  
“core	  first”	  approach	  i.e.	  ROP	  of	  NCAs	  initiated	  by	  terminal	  primary	  amino	  groups	  on	  the	  arms	  
of	   the	   nanogel	   star	   polymers	   (Figure	   5.4).	   Two	   different	   NCAs	   were	   employed;	   benzyl-­‐L-­‐
glutamate	  (BLG)	  and	  carbobenzyloxy-­‐L-­‐lysine	  (ZLL)	  i.e.	  protected	  versions	  of	  glutamic	  acid	  and	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lysine	  respectively	  to	  afford	  nanogel	  star	  polymers	  of	  a	  core	  shell	  type	  architecture	  boasting	  a	  
polystyrene	   core	   and	   a	   polypeptide	   periphery	   (Table	   5.2).	   Removal	   of	   the	   amino	   acid	   side	  
chain	   protecting	   groups	   presents	   nanogel	   star	   polymers	   with	   carboxylic	   acid	   and	   primary	  
amine	   functionalities	   and	   therefore	   anionic	   and	   cationic	   type	   star	   polymers.	   Polypeptide	  
conjugation	  involved	  the	  targeting	  of	  30	  units	  of	  amino	  acid	  per	  arm	  or	  per	  amino	  group	  on	  the	  
nanogel	   star	  polymers	   resulting	   in	   targeting	  approximately	  1080	  units	  overall.	  The	  successful	  
growth	  of	  polypeptide	  chains	  from	  the	  star	  polymers	  was	  confirmed	  by	  1H	  NMR,	  SEC	  and	  FTIR	  
sprectroscopy	  	  .	  Conjugation	  of	  both	  BLG	  and	  ZLL	  was	  determined	  by	  1H	  NMR	  spectroscopy	  to	  
be	  approximately	  half	  of	  the	  targeted	  number	  of	  units	  (BLG	  =	  57%	  and	  ZLL	  =	  45%)	  irrespective	  
of	  the	  reaction	  time	  (Table	  5.2).	  One	  explanation	  for	  this	  could	  be	  due	  to	  the	  high	  density	  of	  
growing	  polymeric	  arms	  within	  a	  size	  confined	  space.	  As	  the	  polypeptide	  arms	  become	  longer	  
the	  complex	  and	  dense	  nature	  of	  the	  polypeptide	  shell	  inhibits	  accessibility	  of	  the	  polypeptide	  
amino	   end	   group	   towards	   unreacted	   NCA	   monomer,	   therefore	   preventing	   further	   growth.	  
Consequently,	  a	  drawback	  of	  these	  multifunctional	  nanogel	  star	  polymers	  for	  NCA	  ROP	  may	  be	  
their	  limited	  accessibility	  for	  polypeptide	  conjugation.	  Although	  difficult	  to	  confirm	  for	  S-­‐PS-­‐b-­‐
PBLG	  due	  to	  overlapping	  peaks	  (Figure	  5.5),	  1H	  NMR	  spectroscopy	  of	  S-­‐PS-­‐b-­‐PZLL	  (Figure	  5.6)	  
confirmed	   initiation	  of	  NCA	  ROP	  by	  all	  amino	  terminated	  polystyrene	  arms	   (peak	  at	  2.5	  ppm	  
corresponding	  to	  CH2-­‐NH2)	  resulting	  in	  36	  polypeptide	  arms	  albeit	  no	  knowledge	  on	  the	  extent	  
of	  growth	  or	  length	  of	  each	  arm.	  	  
	  
Figure	  5.4:	  The	  “core-­‐first”	  use	  of	  poly(styrene)	  nanogel	  star	  polymers	  for	  the	  synthesis	  of	  
PGA	  and	  PLL	  grafted	  nanogel	  stars.	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Table	  5.2:	  Polypeptide	  functionalized	  poly(styrene)	  nanogel	  star	  polymers	  (S:	  Star).	  
Polymer(a)	   Mn	  (kDa)(b)	   PDI	   Mn	  PBLG/PZLL	  (kDa)(c)	   Theoretical	  Mn(d)	  (kDa)	   Size	  Rh	  (nm)(e)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  SEC	   NMR	   	   	  
S-­‐PS-­‐NH2	   44.0	   1.5	   N/a	   N/a	   4.7	  
S-­‐PS-­‐b-­‐PBLG30	   147.6	   1.5	   134	   235	   8.3	  
S-­‐PS-­‐b-­‐PZLL30	   193.7	   1.5	   128	   283	   9.5	  
S-­‐PS-­‐b-­‐PGA30	   N/a	   N/a	   78.7	   138	   6.5(f)	  
(a)	  The	  subscript	  number	  denotes	  the	  targeted	  number	  of	  polypeptide	  units	  per	  –NH2	  of	  star	  
poly(styrene)	  (assuming	  number	  of	  –NH2	  groups	  is	  36)	  (b)	  determined	  by	  SEC	  (DMF)	  using	  RI	  
detector	   and	   calibrated	   against	   linear	   poly(styrene)	   standards	   (c)	   determined	   by	   1H	   NMR	  
spectroscopy	  using	   integral	   ratio	   of	   CH	  of	   polypeptide	   and	  CH2	  peaks	  of	   PS	   	   (d)	   calculated	  
assuming	   initiation	   from	  all	   amino	   groups	   and	  quantitative	   conversion:	   c(monomer)/c(star	  
poly(styrene))	  x	  M(monomer)	  (e)	  determined	  by	  DLS	  in	  DMF	  (f)	  determined	  by	  DLS	  in	  H2O.	  
	  
	  




Figure	  5.6:	  1H	  NMR	  spectrum	  of	  star	  PS-­‐b-­‐PZLL30	  (CDCl3).	  
SEC	  further	  confirmed	  polypeptide	  conjugation	  owing	  to	  the	  clear	  shift	  in	  retention	  time	  of	  the	  
polypeptide	  functionalized	  nanogel	  star	  polymers	  to	  a	  higher	  molecular	  weight	  (Figure	  5.7).	  As	  
determined	  by	  DLS,	  the	  size,	  Rh	  of	  the	  star	  polymers	  increased	  after	  polypeptide	  conjugation.	  
In	   DMF,	   S-­‐PS-­‐b-­‐PBLG	   and	   S-­‐PS-­‐b-­‐PZLL	   displayed	   an	   Rh	   of	   8.3nm	   and	   9.5nm	   respectively	  
compared	   to	   4.7	   nm	   of	   the	   S-­‐PS-­‐NH2	   starting	   material.	   FTIR	   sprectroscopy	   	   	   identified	   the	  
presence	  of	  polypeptide	  and	  the	  adoption	  of	  a	  α-­‐helical	  conformation	  denoted	  by	  the	  strong	  
amide	   I	   and	   II	   peaks	   at	   approx.	   1650	   cm-­‐1	   and	   1530	   cm-­‐1	   which	   are	   typical	   of	   an	   α-­‐helical	  





Figure	  5.7:	  SEC	  traces	  of	  star	  poly(styrene)-­‐NH2	  (A),	  star	  PS-­‐b-­‐PBLG30	  (B)	  and	  star	  PS-­‐b-­‐PZLL30	  
(C).	  
	  




Figure	  5.9:	  FTIR	  spectra	  of	  S-­‐PS-­‐NH2	  (A),	  S-­‐PS-­‐b-­‐PZLL30	  (B)	  and	  S-­‐PS-­‐b-­‐PLL30	  (C).	  
Deprotection	   of	   the	   amino	   acid	   side	   chain	   protecting	   groups	  was	   performed	   using	   standard	  
HBr/AcOH	   conditions	   to	   afford	   nanogel	   star	   polymers	   with	   carboxylic	   acid	   and	   amine	  
functionalized	   polypeptide	   peripheries.	   Deprotection	   of	   the	   polypeptide	   functionalised	  
nanogel	  star	  polymers	  was	  confirmed	  by	  solid	  state	  FTIR	  sprectroscopy	  	  	  by	  the	  disappearance	  
of	  the	  carbonyl	  peak	  of	  the	  benzyl	  ester	  protecting	  group	  at	  1728	  cm-­‐1	  (Figure	  5.8).	  An	  α-­‐helical	  
conformation	  was	  retained	  by	  the	  deprotected	  poly(glutamic	  acid)	  (PGA).	  Similarly	  S-­‐PS-­‐b-­‐PZLL	  
was	   successfully	   deprotected	   using	   the	   aforementioned	   acid	   hydrolysis	   method	   with	   FTIR	  
sprectroscopy	   	   	   confirming	   the	   successful	   deprotection	   and	   the	   retention	   of	   an	   α-­‐helical	  
secondary	   structure	   (Figure	   5.9).	   Quantitative	   deprotection	   and	   analysis	   of	   the	   deprotected	  
star	   polymers	   by	   1H	   NMR	   spectroscopy	  was	   unsuccessful	   due	   to	   solubility	   issues	   associated	  
with	   these	   star	   polymers.	   Although	   polypeptides	   of	   both	   an	   anionic	   and	   cationic	   character	  
were	  successfully	  anchored	  to	  the	  polystyrene	  star	  polymer	  platform	  sufficient	  solubilization	  in	  
ideally	   water	   was	   not	   achievable.	   Furthermore	   the	   use	   of	   a	   range	   of	   polar	   and	   non-­‐polar	  
solvents	   such	   as	  DMSO,	  DMF,	   THF,	   CHCl3,	  DCM,	   acids,	   bases	   and	   solvent	  mixtures	  were	   not	  
successful	   in	   solubilising	   the	   material.	   A	   possible	   explanation	   for	   this	   could	   be	   due	   to	   the	  
amphiphilic	   nature	   (large	   hydrophobic	   polystyrene	   core	   and	   dense	   hydrophilic	   polypeptide	  
shell)	  of	  such	  a	  material	  in	  addition	  to	  its	  complex	  architecture	  and	  large	  molecular	  weight.	  By	  
anchoring	   more	   polypeptide	   to	   the	   polystyrene	   core	   it	   may	   be	   possible	   to	   induce	   more	  
hydrophilicity	   to	   the	   overall	   molecule	   and	   therefore	   enable	   better	   water	   solubilzation	   in	  
particular.	   However	   as	   described	   above	   the	   complex	   architecture	   of	   the	   polystyrene	   star	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polymers	  limits	  the	  capacity	  of	  polypeptide	  conjugation.	  By	  utilising	  the	  functional	  amino	  acid	  
side	   chains	   it	   may	   be	   possible	   to	   introduce	   water	   soluble	   moieties	   to	   these	   star	   polymers	  
therefore	   improving	   their	   overall	   water	   solubility.	   Suitable	   candidates	  may	   include	   coupling	  
polyethylene	   glycol	   or	   sugars	   through	   suitable	   traditional	   coupling	   chemistry.77,78	   Sugars	   in	  
particular	   would	   also	   introduce	   an	   interesting	   biorecogniton	   property	   to	   the	   star	   polymers.	  
The	   interaction	  of	   sugars	  with	   lectins	   and	  particularly	   their	   interaction	  with	   glycoconjugated	  
polymers	   is	   an	   intensively	   researched	   field	   with	   significant	   implications	   for	   drug	   delivery	  
research.79,80	  	  	  	  
	  
Overall	   the	   expansion	   of	   the	   polystyrene	   nanoparticle	   platform	   developed	   by	   Sly	   et	   al.	   to	  
include	   alternative	   compositions	   was	   realised.	   To	   impart	   enhanced	   biocompatibility	   and	  
degradability,	   polypeptides	   were	   chosen	   as	   a	   suitable	   alternative	   owing	   to	   their	   natural	  
composition	   and	   versatile	   functionalities.	   Post	   modification	   of	   hydroxyl	   terminated	  
polystyrene	   star	   polymers	   towards	   primary	   amines	   was	   achieved	   thus	   permitting	   their	  
potential	   utilisation	   as	   multifunctional	   initiators	   towards	   the	   controlled	   synthesis	   of	  
polypeptides	  by	  ROP	  of	  NCAs.	  The	  conjugation	  of	  polypeptides	  to	  the	  star	  polymer	  periphery	  
to	   form	  core/shell	   type	  architectures	  boasting	  a	  hydrophobic	  core	  and	  polypeptide	  shell	  was	  
successfully	  performed.	  Although	  polypeptide	  conjugation	  capacity	  was	  limited,	  it	  was	  possible	  
to	   create	   protected	   poly(glutamic	   aid)	   and	   poly(lysine)	   decorated	   nanogel	   star	   polymers	   as	  
confirmed	   by	   1H	   NMR,	   SEC	   and	   FTIR	   spectrsocopy.	   In	   this	   branched	   form	   the	   polypeptides	  
adopted	  strong	  α-­‐helical	  conformations.	  Protecting	  group	  removal	  yielded	  carboxylic	  acid	  and	  
amine	  decorated	  nanogel	  star	  polymers	  hybrids	  as	  confirmed	  by	  FTIR	  spectroscopy.	  However	  
solubilzation	  of	  the	  described	  hybrid	  materials	  was	  difficult	  potentially	  owing	  to	  the	  complex	  
architecture	   and	   amphiphilic	   nature	   of	   such	   materials.	   The	   targeting	   of	   these	   materials	  
towards	   biomedical	   applications	   such	   as	   drug	   delivery	   and	   imaging	   requires	   sufficient	  water	  
solubility	   meaning	   they	   are	   not	   currently	   suitable	   for	   the	   described	   applications.	   Further	  
modification	   to	   impart	   water	   solubility	   may	   improve	   the	   prospects	   of	   these	   materials	   for	  
biomedical	   applications.	   The	   initial	   steps	   taken	   here	   towards	   the	   creation	   of	   hybrid	   nanogel	  
star	   polymers	   may	   lead	   to	   the	   future	   development	   of	   more	   diverse	   compositions	   and	  
architectures	  with	  increased	  complexity	  and	  “intelligence”.	  	  	  	  	  





5.2.2	  Polyester	  Core	  (Degradable)	  /	  Polymethacrylate	  Periphery	  (Nondegradable)	  
Nanogel	  star	  polymers	  of	  biodegradable	  or	  biocompatible	  compositions	  are	  an	  attractive	  class	  
of	   new	   materials	   owing	   to	   their	   inherent	   applicability	   towards	   the	   biomedical	   field.	   The	  
polystyrene	   based	   nanogel	   platforms	   developed	   by	   Sly	   et	   al.	   although	   synthetically	   and	  
structurally	   versatile,	   their	   nondegradable	   nature	   and	   lack	   of	   biocompatibility	   restricts	   their	  
potential	  towards	  biomedical	  applications.29	  Despite	  efforts	  to	   impart	  biocompatible	  features	  
such	   as	   polypeptide	   conjugation	   the	  nanogel	   star	   polymer	   composition	   is	   still	   dominated	  by	  
the	   large	   hydrophobic	   polystyrene	   core	   (see	   above).	   To	   overcome	   this,	   Sly	   et	   al.	   have	  
developed	  a	  facile	  route	  towards	  polyester	  based	  nanogel	  star	  polymers	  which	  should	  exhibit	  
improved	   biodegradability	   due	   to	   the	   inherent	   properties	   of	   polyesters	   (Figure	   5.10).59,81	  
Expansion	   of	   this	   degradable	   platform	   through	   the	   introduction	   of	   new	   functionalities	   and	  




Figure	  5.10:	  Synthesis	  of	  poly(ester)	  based	  nanogel	  star	  polymers	  via	  organocatalytic	  ring	  
opening	  polymerization	  (OROP).59	  	  
Layer	  by	   layer	   (LBL)	   technology	   towards	  controlled	  drug	   release	  and	  wound	  care	   is	  one	  such	  
application	   in	  which	   these	  materials	  may	  play	   a	   significant	   role.	   LBL	   technology	   involves	   the	  
deposition	  of	  multiple	  layers	  of	  organic	  and	  inorganic	  compounds	  onto	  a	  surface	  or	  substrate	  
typically	   through	   electrostatic	   interactions	   (Figure	   5.11).	   The	   beauty	   of	   this	   system	   is	   the	  
control	   and	   versatility	   offered	   by	   such	   a	   technique	   in	   which	   the	   surface	   properties	   such	   as	  
functionality,	  wettability,	  charge,	  hydrophobicity,	  adhesion,	  morphology	  and	   loading	  capacity	  
may	  be	  configured	  by	  employing	  different	  polymer	  types	  and	  controlling	  the	  layer	  thickness.82	  
This	  technology	  has	  been	  applied	  to	  a	  range	  of	  applications	   including	  advanced	  drug	  delivery	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technology.83,84	   Concerning	   the	   polyester	   based	   nanogel	   star	   polymers	   described	   here,	  
employment	   of	   the	   hydrophobic	   polyester	   core	   for	   drug	   entrapment	   and	   the	   subsequent	  
formation	  of	  multiple	   layers	   it	  may	  be	  plausible	   to	  exhibit	   the	   controlled	   release	  of	  drugs	   in	  
addition	   to	   providing	   a	   biocompatible	   wound	   dressing.	   The	   hydrolytic	   susceptibility	   of	  
polyesters	  imparts	  degradability	  upon	  this	  system	  and	  by	  controlling	  the	  layer	  thickness	  it	  may	  
be	  possible	  to	  control	  the	  drug	  dose	  and	  the	  drug	  release	  time	  frame	  i.e.	  thicker	  layer	  means	  
higher	   overall	   drug	   dose	   and	   prolonged	   release	   time.	   Furthermore	   it	   may	   be	   possible	   to	  
introduce	  more	  than	  one	  drug	  or	  more	  than	  one	  type	  of	  cargo	  into	  this	  system	  which	  could	  be	  
released	   at	   different	   stages	   of	   the	   wound	   healing	   process	   by	   controlling	   the	   positioning	   of	  
cargoes	   within	   the	   different	   layers.	   Consequently	   such	   a	   technology	   provides	   numerous	  
advantages:	  physical	  protection	  of	  the	  wound,	  initial	  controlled	  drug	  release	  over	  a	  designated	  
time	  frame,	  the	  subsequent	  controlled	  release	  of	  other	  functional	  cargoes	  such	  as	  an	  additive	  
to	   reduce	   scarring	   therefore	   resulting	   in	  more	   efficient	   patient	   treatment	   and	   less	   stress	   on	  
hospital	  resources.	  	  
	  
	  
Figure	  5.11:	  Electrostatic	  interactions	  for	  the	  construction	  of	  layer	  by	  layer	  assemblies.82 
	  
To	  realise	  such	  an	  objective,	  the	  current	  polyester	  based	  material	  requires	  further	  modification	  
to	   enable	   layer	   by	   layer	   deposition	   through	   electrostatic	   interactions.	   To	   overcome	   this	  
challenge	  the	   introduction	  of	  anionic	  and	  cationic	  based	  polymers	  to	  this	  system	  is	  essential.	  
To	   achieve	   this,	   the	   controlled	   polymerization	   technique	   of	   RAFT	   was	   employed.	   RAFT	   was	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chosen	  as	  is	  has	  demonstrated	  its	  ability	  to	  generate	  a	  range	  of	  well	  defined	  polymers	  whilst	  in	  
comparison	   to	   techniques	   such	  as	  ATRP	   it	  does	  not	   require	   the	  use	  of	  metal	   catalysts	  which	  
can	   prove	   difficult	   to	   remove	   	   and	   therefore	   impact	   on	   the	   biocompatibility	   of	   such	  
polymers.85-­‐87	   In	   order	   to	   combine	   both	   OROP	   of	   cyclic	   esters	   for	   star	   formation	   and	   RAFT	  
polymerization	  for	  functional	  polymeric	  arms	  synthesis,	  the	  two	  typical	  approaches	  to	  nanogel	  
star	   polymer	   synthesis	   were	   considered:	   “arm	   first”	   and	   “core	   first”.	   The	   “arm	   first”	  
methodology	  was	   employed	   due	   to	   the	   greater	   synthetic	   control	   offered.	   Consequently	   the	  
design	  of	  a	  new	  dual	  purpose	  RAFT	  chain	   transfer	  agent	  was	  required	  to	  permit	  synthesis	  of	  
the	  desired	  polymers	  whilst	  also	  possessing	  a	  hydroxyl	  end	  group	  functionality	  to	  enable	  OROP	  
of	  a	  cyclic	  ester	  crosslinker	  to	  generate	  nanogel	  star	  polymers.	  	  	  
	  
Figure	  5.12:	  Synthesis	  of	  hydroxyl	  functionalized	  RAFT	  agent:	  2-­‐cyano-­‐5-­‐(3-­‐hydroxypropyl	  
amino)-­‐5-­‐oxopentanoic-­‐2-­‐yl	  benzodithioate.	  
The	   RAFT	   agent	   2-­‐cyano-­‐5-­‐(3-­‐hydroxypropyl	   amino)-­‐5-­‐oxopentanoic-­‐2-­‐yl	   benzodithioate	   was	  
synthesized	   for	   the	   first	   time	  by	  employing	  diisopropylcarbodiimide	   (DIC)	  mediated	   coupling	  
chemistry	   of	   the	   commercially	   available	   4-­‐Cyano-­‐4-­‐(phenylcarbonothioylthio)pentanoic	   acid	  
and	   3-­‐amino-­‐1-­‐propanol	   (Figure	   5.12).	   The	   carboxylic	   acid	   functionality	   of	   4-­‐cyano-­‐4-­‐
(phenylcarbonothioylthio)pentanoic	   acid	   	   provided	   a	   very	   useful	   reactive	   handle	   for	   simple	  
hydroxyl	   group	   modification	   using	   the	   dual	   functional	   3-­‐amino-­‐1-­‐propanol	   whilst	   this	  
dithiobenzoate	   type	   RAFT	   agent	   is	   known	   to	   be	   compatible	   towards	   a	   wide	   range	   of	  
monomers	  including	  methacrylates.86	  The	  ability	  of	  primary	  amines	  to	  cleave	  the	  ω-­‐end	  group	  
of	  RAFT	  agents	  through	  aminolysis	  has	  been	  well	  documented	  so	  the	  potential	  of	  3-­‐amino-­‐1-­‐
propanol	  to	  cleave	  the	  ω-­‐end	  group	  is	  a	  strong	  possibility.88	  To	  minimize	  this,	  the	  reaction	  was	  
carried	  out	  initially	  at	  0oC	  with	  the	  slow	  addition	  of	  a	  very	  small	  excess	  of	  amino	  alcohol	  to	  the	  
activated	  carboxylic	  acid	  RAFT	  agent	  solution.	  Although	  some	  aminolysis	  may	  be	  unavoidable,	  
the	   targeted	   RAFT	   agent	   was	   obtained	   in	   reasonable	   yield	   i.e.	   50%	   using	   column	  
chromatography	  with	  1H	  and	  13C	  NMR	  spectroscopy	  confirming	  its	  successful	  synthesis	  (Figures	  




Figure	  5.13:	  1H	  NMR	  spectrum	  of	  2-­‐cyano-­‐5-­‐(3-­‐hydroxypropyl	  amino)-­‐5-­‐oxopentanoic-­‐2-­‐yl	  
benzodithioate	  (CDCl3).	  
	  
Figure	  5.14:	  13C	  NMR	  spectrum	  of	  2-­‐cyano-­‐5-­‐(3-­‐hydroxypropyl	  amino)-­‐5-­‐oxopentanoic-­‐2-­‐yl	  
benzodithioate	  (CDCl3)	  (J	  -­‐	  >200	  ppm).	  
	  
The	   identification	  of	   suitable	   anionic	   and	   cationic	   type	  monomers	   capable	  of	  polymerization	  
with	  the	  synthesized	  RAFT	  agent	  was	  very	   important.	  This	  dithiobenzoate	  type	  RAFT	  agent	   is	  
known	   to	  be	  very	   compatible	   towards	  methacrylate	  monomers	  and	  given	   the	  wide	   range	  of	  
methacrylate	   based	   monomers	   available	   the	   pursuit	   of	   anionic	   and	   cationic	   methacrylate	  
based	   polymers	   was	   the	   logical	   choice.	   The	   monomers	   2-­‐(trimethylsilyl)ethyl	   methacrylate	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(TMSEM)	  and	  dimethylaminoethyl	  methacrylate	  (DMAEMA)	  were	  chosen	  to	  introduce	  anionic	  
and	  cationic	  properties	  respectively.	  Homopolymers	  of	  DMAEMA	  have	  been	  shown	  to	  exhibit	  
low	  toxicity	  whilst	  TMSEM	  provides	  a	  latent	  carboxylic	  acid	  functionality	  which	  can	  be	  revealed	  
upon	  post	   polymerization	   and	   subsequent	   star	   formation.89	   The	  polymerization	  of	  DMAEMA	  
towards	   the	   generation	   of	   cationic	   nanogel	   star	   polymers	   is	   depicted	   in	   Figure	   5.15	   with	  
results	  summarized	  in	  Table	  5.3.	  
Figure	  5.15:	  Synthesis	  of	  linear	  poly(DMAEMA)	  via	  RAFT	  polymerization	  (A),	  removal	  of	  ω-­‐
RAFT	  end	  group	  to	  form	  the	  corresponding	  hydrocarbon	  (B)	  	  and	  the	  subsequent	  formation	  
of	  poly(DMAEMA)	  functionalized	  nanogel	  star	  polymers	  via	  organocatalytic	  ring	  opening	  






Table	  5.3:	  Linear	  (L)	  and	  star	  (S)	  DMAEMA	  nanogel	  star	  polymers	  with	  polyester	  core.	  
Polymer	   Mn	  (kDa)(a)	   PDI	  Mn	  (kDa)(b)	   Target	  Mn	  (kDa)	   Size	  Rh	  (nm)(c)	   DMAEMA:BOP(d)	  
L-­‐DMAEMA-­‐
RAFT	  
4.5	   1.1	   5.2	   5.0	   N/a	   N/a	  
L-­‐DMAEMA-­‐
H	  
4.5	   1.1	   5.9	   5.0	   N/a	   N/a	  
L-­‐DMAEMA-­‐
b-­‐PVL	  
9.0	   1.2	   9.5	   10.2	   N/a	   N/a	  
S-­‐DMAEMA-­‐
H	  
144.3	   1.2	   N/a	   N/a	   40	   11.25(e)	  
S-­‐DMAEMA-­‐
H	  
74.3	   1.2	   N/a	   N/a	   22	   8.1(f)	  
S-­‐DMAEMA-­‐
H	  
37.6	   1.2	   N/a	   N/a	   11	   4.6(g)	  
(a)	  determined	  by	  SEC	  (THF)	  using	  RI	  detector	  and	  calibrated	  against	  linear	  PMMA	  standards	  
(b)	   determined	   by	   1H	   NMR	   spectroscopy	   using	   the	   integral	   ratios	   of	   poly(DMAEMA)	   and	  
RAFT	   CTA	   moieties	   (c)	   determined	   by	   DLS	   in	   THF	   (d)	   Molar	   ratio	   of	   DMAEMA	   to	   5-­‐5’-­‐
Bis(oxepanyl-­‐2-­‐one)	  BOP	  crosslinker	   (e)	  Reaction	   time	  of	  24	  h	   (f)	  Reaction	   time	  of	  16	  h	   (g)	  
Reaction	  time	  of	  4	  h.	  
	  
Initially	   the	   polymerization	   of	   DMAEMA	  was	   carried	   out	   in	   dioxane	   using	   AIBN	   as	   a	   radical	  
source.	  Excellent	  molecular	  weight	  control	  was	  observed	  generating	  a	  DMAEMA	  homopolymer	  
with	   narrow	  PDI	   (Table	   5.3	   –	   L-­‐DMAEMA-­‐RAFT).	   1H	  NMR	   spectroscopy	  was	   further	   used	   to	  
elucidate	  molecular	  weight	  but	  also	  confirmed	  the	  presence	  of	  both	  the	  hydroxyl	  (peaks	  A	  and	  
C)	   	   and	  dithiobenzoate	   (peaks	   L,	  M	  and	  N)	   end	   groups	   at	  α	   and	  ω	  positions	   of	   the	  polymer	  
respectively	  (Figure	  5.16).	  To	  avoid	  possible	  interference	  from	  the	  dithiobenzoate	  ω	  end	  group	  
in	   later	   synthetic	   steps,	   the	   dithiobenzoate	   group	   was	   cleaved	   to	   form	   the	   corresponding	  
hydrocarbon.	   End	   group	   removal	   and	   modification	   of	   RAFT	   derived	   polymers	   has	   been	  
extensively	  investigated	  but	  for	  the	  purpose	  of	  this	  work	  the	  identification	  of	  a	  simple	  cleavage	  
method	  for	  generation	  of	  the	  corresponding	  hydrocarbon	  was	  of	  vital	  importance.	  The	  use	  of	  
tributyltin	  hydride	  in	  conjunction	  with	  AIBN	  is	  a	  well	  known	  method	  to	  remove	  the	  RAFT	  ω-­‐end	  
group	  and	  form	  the	  corresponding	  hydrocarbon.90	  This	  method	  was	  successfully	  employed	  to	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generate	  hydrogen	  at	  the	  ω	  end	  group	  position	  with	  no	  notable	  changes	  in	  molecular	  weight	  
properties	   in	   addition	   to	   retention	   of	   the	   hydroxyl	   end	   group	   (Table	   5.3	   –	   L-­‐DMAEMA-­‐H).	  
Removal	   of	   the	   dithiobenzoate	   was	   confirmed	   by	   1H	   NMR	   spectroscopy	   due	   to	   the	  
disappearance	  of	  the	  aromatic	  signals	  at	  7.4	  –	  8	  ppm	  (L,	  M	  and	  N)	  and	  retention	  of	  peaks	  A	  and	  
C	  at	  3.6	  and	  3.4	  ppm	  respectively	  (Figure	  5.17).	  	  	  	  	  
	  
Figure	  5.16:	  1H	  NMR	  spectrum	  of	  L-­‐DMAEMA-­‐RAFT	  (CDCl3).	  
	  
Figure	  5.17:	  1H	  NMR	  spectrum	  of	  L-­‐DMAEMA-­‐H	  (CDCl3).	  
	  154	  
	  
To	  test	  the	   initial	   feasibility	  of	  the	  hydroxyl	  terminated	  DMAEMA	  polymer	  for	  OROP	  of	  cyclic	  
esters,	   L-­‐DMAEMA-­‐H	   was	   employed	   in	   the	   OROP	   of	   δ-­‐Valerolactone	   to	   form	   a	   linear	   block	  
copolymer	  using	  the	  catalyst	  1,5,7-­‐Triazabicyclo[4.4.0]dec-­‐5-­‐ene	  TBD	  	  (Figure	  5.18).	  Employing	  
a	   similar	  methodology	   to	   the	   original	   developed	   by	   Sly	   et	   al,	   resulted	   in	   the	   sluggish	   chain	  
extension	   of	   L-­‐DMAEMA-­‐H	   with	   poly(valerolactone)	   (PVL).59	   Although	   the	   hydroxyl	   initiator	  
should	  readily	  participate	  in	  the	  reaction,	  the	  fact	  that	  it	  is	  in	  the	  form	  of	  a	  large	  macroinitiator	  
means	   the	   reaction	   rate	  may	  be	   very	   sluggish.	   Elevating	   the	   temperature	   to	   40oC	   and	   a	   2	   h	  
reaction	   time	   resulted	   in	  a	  much	  more	  efficient	   reaction	   rate	   in	  which	  88%	  of	   valerolactone	  
was	  converted	  to	  its	  polymeric	  form	  as	  determined	  by	  1H	  NMR	  spectroscopy	  (Figure	  5.19).	  1H	  
NMR	   spectroscopy	   confirmed	   the	   presence	   of	   polyester	   denoted	   by	   the	   appearance	   of	   new	  
characteristic	  peaks	  at	  4.07,	  2.33	  and	  1.67	  ppm.	  As	  noted	  by	  Sly	  et	  al	   reaction	  time	   is	  a	  vital	  
parameter	   of	   this	   methodology	   as	   a	   prolonged	   reaction	   time	   may	   well	   result	   in	   increased	  
conversion	   rates	   but	   this	   can	   be	   offset	   by	   the	   broadening	   of	   PDI	   due	   to	   the	   TBD	   catalyst.59	  
Furthermore	  SEC	  analysis	  showed	  the	  clear	  shift	  in	  retention	  time	  of	  L-­‐DMAEMA-­‐H	  (Mn	  4.5kDa)	  
to	   a	   shorter	   retention	   time	   and	   thus	   higher	   molecular	   weight	   for	   L-­‐DMAEMA-­‐b-­‐PVL	   (Mn	  
9.0kDa)	  (Figure	  5.20	  and	  Table	  5.3).	  Consequently,	  the	  feasibility	  of	  this	  hydroxyl	  terminated	  
DMAEMA	  homopolymer	   as	   an	   effective	   initiator	   in	   the	   controlled	  OROP	  of	   cyclic	   esters	  was	  
confirmed.	  	  	  
	  
	  





Figure	  5.19:	  1H	  NMR	  spectrum	  of	  L-­‐DMAEMA-­‐b-­‐PVL	  (CDCl3).	  
	  
Figure	  5.20:	  SEC	  Traces	  of	  L-­‐DMAEMA-­‐H	  (A)	  and	  L-­‐DMAEMA-­‐b-­‐PVL	  (B).	  
	  
	  
Expanding	   this	   methodology	   to	   include	   nanogel	   star	   polymers	   with	   a	   cationic	   periphery,	   L-­‐
DMAEMA-­‐H	   was	   once	   again	   employed	   for	   OROP	   of	   the	   cyclic	   ester	   crosslinker	   5,5’-­‐
Bis(oxepanyl-­‐2-­‐one)	   (BOP).	   Employing	   a	   similar	   methodology	   to	   the	   above	   linear	   analogue	  
resulted	  in	  the	  unsuccessful	  synthesis	  of	  nanogel	  star	  polymers.	  Again	  this	  may	  be	  accounted	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for	  by	  the	  large	  macroinitiator	  present	  but	  also	  the	  cyclic	  ester	  used	  here	  may	  not	  be	  quite	  as	  
reactive	  as	  valerolactone	  due	  to	  increased	  stability	  of	  its	  7-­‐membered	  ring	  structure	  and	  whilst	  
it	   also	   suffers	   from	   low	   solubility	   in	   toluene.	   However,	   subjecting	   the	   reaction	   to	   a	  
temperature	  of	  70oC	  resulted	  in	  the	  successful	  synthesis	  of	  these	  stars.	  The	  reaction	  end	  time	  
was	  denoted	  by	  the	  formation	  of	  a	  clear	  solution	  due	  to	  the	  complete	  dissolution	  and	  reaction	  
of	  BOP.	   1H	  NMR	  spectroscopy	  analysis	   identified	  the	  L-­‐DMAEMA-­‐H	  arms	  but	  the	  presence	  of	  
polyester	   could	   not	   be	   confirmed	   due	   to	   its	   low	   concentration	   within	   overall	   nanogel	   star	  
polymer.	  As	  a	  result	  the	  number	  of	  arms	  or	  arm	  density	  could	  not	  be	  ascertained.	  Furthermore	  
the	   polyester	   composition	   constituted	   the	   core	   of	   the	   star	   polymer	   meaning	   it	   may	   be	  
somewhat	   shielded	  by	   the	  peripheral	   L-­‐DMAEMA-­‐H	  arms	  and	   therefore	  harder	   to	  detect.	   In	  
addition,	  FTIR	  spectroscopy	  could	  not	  detect	  the	  presence	  of	  the	  ester	  core	  due	  to	  the	  already	  
strong	   presence	   of	   ester	   functionality	   arising	   from	   the	   methacrylate	   arms.	   Therefore	   to	  
confirm	  the	  formation	  of	  nanogel	  star	  polymers,	  SEC	  was	  utilised	  which	  showed	  the	  clear	  shift	  
in	   retention	   time	  of	   L-­‐DMAEMA-­‐H	   to	   a	   shorter	   time	   retention	   for	   S-­‐DMAEMA-­‐H	  highlighting	  
the	  increase	  in	  molecular	  weight	  due	  to	  the	  formation	  of	  nanogel	  star	  polymers	  (Figure	  5.21).	  
The	   presence	   of	   residual	   unreacted	   arms	   was	   observed,	   a	   feature	   commonly	   observed	   in	  
nanogel	   star	   polymer	   synthesis.	   The	   purification	   or	   removal	   of	   these	   arms	   was	   performed	  
using	  fractionation	  i.e.	  the	  slow	  precipitation	  of	  the	  crude	  material	  into	  hexane	  until	  the	  higher	  
molecular	   weight	   star	   polymer	   precipitates	   first	   whereas	   the	   lower	   molecular	   weight	   arms	  
remain	  in	  solution.	  By	  varying	  the	  crosslinker	  to	  macroinitiator	  ratio	  i.e.	  BOP	  :	  L-­‐DMAEMA-­‐H	  it	  
was	   possible	   to	   control	   the	   Mn	   and	   size	   of	   the	   star	   polymers	   highlighting	   the	   excellent	  
synthetic	   and	   structural	   control	   afforded	   here.	   Furthermore,	   it	   was	   noted	   that	   a	   low	   BOP	  
concentration	   resulted	   in	   a	   shorter	   reaction	   time.	   All	   star	   polymers	   exhibited	   narrow	   PDIs	  
(<1.2)	  with	  sizes	  ranging	  from	  11	  nm	  to	  40	  nm	  as	  determined	  by	  DLS.	  A	  SEC	  comparison	  of	  all	  
three	  S-­‐DMAEMA-­‐H	  nanogel	  polymers	  shows	  the	  shift	  in	  retention	  time	  to	  a	  shorter	  retention	  
time	  as	  Mn	  increases	  thus	  providing	  a	  very	  useful	  tool	  to	  monitor	  the	  star	  polymer	  growth	  in	  





Figure	  5.21:	  SEC	  Traces	  of	  L-­‐DMAEMA-­‐RAFT	  (A),	  L-­‐DMAEMA-­‐H	  (B)	  and	  S-­‐DMAEMA-­‐H	  (C).	  
	  
Figure	  5.22:	  SEC	  Traces	  of	  S-­‐DMAEMA-­‐H-­‐11	  nm	  (A),	  S-­‐DMAEMA-­‐H-­‐22	  nm	  (B)	  and	  S-­‐





The	  synthesis	  of	  an	  anionic	   type	  nanogel	   star	  polymer	  was	  conducted	   in	  a	   similar	   fashion	   to	  
the	   above	   cationic	   nanogel	   star	   polymer.	   The	   protection	   of	   the	   carboxylic	   acid	   functionality	  
was	  necessary	  to	  prevent	  interference	  with	  the	  RAFT	  polymerization	  process	  and	  later	  the	  star	  
polymer	   formation	  process.	  The	  choice	  of	  protecting	  group	  was	  also	   important	  as	   the	  use	  of	  
typical	  methacrylic	  acid	  protecting	  groups	  such	  as	   tert-­‐butyl	  and	  benzyl	   require	  deprotection	  
conditions,	   which	   are	   not	   compatible	   with	   the	   hydrolytically	   unstable	   polyester	   core.	  
Therefore	   the	   trimethylsilyl	   ethyl	   protecting	   group	   was	   used	   as	   it	   should	   permit	   efficient	  
deprotection	   without	   the	   requirement	   for	   chemically	   harsh	   conditions.	   A	   summary	   of	   the	  
synthetic	  steps	  employed	  towards	  the	  generation	  anionic	  nanogel	  star	  polymers	  can	  be	  seen	  in	  
Figure	  5.23.	  	  
	  
Figure	  5.23:	  Synthesis	  of	  linear	  poly(TMSEM)	  via	  RAFT	  polymerization	  (A),	  removal	  of	  ω-­‐RAFT	  
end	  group	  to	  form	  the	  corresponding	  hydrocarbon	  (B)	  the	  formation	  of	  poly(TMSEM)	  
functionalized	  nanogel	  star	  polymers	  via	  organocatalytic	  ring	  opening	  polymerization	  of	  
cyclic	  esters	  (C)	  and	  deprotection	  of	  trimethylsilyl	  ethyl	  protecting	  group	  to	  afford	  carboxylic	  




The	   hydroxyl	   functionalised	   RAFT	   agent	   was	   employed	   to	   generate	   linear	   poly(TMSEM)	   (L-­‐
TMSEM-­‐RAFT).	   The	   polymer	   generated	   boasted	   a	   Mn	   in	   close	   agreement	   to	   the	   target	   Mn	  
whilst	   also	   exhibiting	   a	   narrow	   PDI	   (Table	   5.4	   –	   L-­‐TMSEM-­‐RAFT).	   Comparable	   to	   DMAEMA	  
derived	   polymers	   discussed	   above,	   1H	   NMR	   spectroscopy	   confirmed	   the	   Mn	   of	   the	   target	  
polymer	  and	  the	  presence	  of	  its	  protecting	  groups	  along	  with	  the	  dithiobenzoate	  and	  hydroxyl	  
end	   groups.	   The	   subsequent	   cleavage	   of	   the	  ω-­‐end	   group	   using	   the	   reliable	   AIBN	   /	   Bu3SnH	  
reaction	   conditions	   afforded	   the	   corresponding	   hydrocarbon	   ω-­‐end	   group	   with	   no	   notable	  
changes	  in	  Mn,	  PDI	  or	  modifications	  to	  the	  polymer	  (Table	  5.4	  –	  L-­‐TMSEM-­‐H).	  
Table	  5.4:	  Linear	  (L)	  and	  star	  (S)	  TMSEM	  nanogel	  star	  polymers	  with	  polyester	  core.	  
Polymer	   Mn	  (kDa)(a)	   PDI	   Mn	  (kDa)(b)	   Target	  Mn	   Size	  Rh	  (nm)(c)	   BOP	  /	  TMSEM(d)	  
L-­‐TMSEM-­‐
RAFT	  
5.5	   1.1	   5.6	   6.0	   N/a	   N/a	  
L-­‐	  TMSEM-­‐H	   5.3	   1.1	   6.4	   6.0	   N/a	   N/a	  
S-­‐TMSEM-­‐H	   76.0	   1.3	   N/a	   N/a	   24	   13	  (e)	  
(a)	  determined	  by	  SEC	  (THF)	  using	  RI	  detector	  and	  calibrated	  against	  linear	  PMMA	  standards	  
(b)	  determined	  by	  1H	  NMR	  spectroscopy	  using	  the	  integral	  ratios	  of	  poly(TMSEM)	  and	  RAFT	  
CTA	  moieties	  (c)	  determined	  by	  DLS	  in	  THF	  (d)	  Molar	  ratio	  of	  TMSEM	  to	  BOP	  crosslinker	  (e)	  
Reaction	  time	  of	  2	  h	  (f)	  	  
	  
The	  synthesis	  of	  the	  star	  shaped	  derivatives	  also	  required	  elevated	  temperatures	  in	  order	  for	  
the	   reaction	   to	   proceed	   effectively.	   However	   in	   comparison	   to	   the	   DMAEMA	   stars,	   it	   was	  
noted	   here	   that	   not	   only	   did	   the	   reaction	   proceeded	  more	   quickly	   but	   also	   the	   presence	   of	  
unreacted	   residual	   L-­‐TMSEM-­‐H	   arms	   was	   not	   observed	   by	   SEC	   (Figure	   5.25).	   Therefore	   the	  
reaction	  proceeded	  very	  efficiently	  and	  did	  not	  require	  a	  purification	  by	  fractionation	  step	  with	  
obvious	   benefits	   for	   time	   efficiency	   and	   yield.	   1H	   NMR	   spectroscopy	   and	   FTIR	   spectroscopy	  
again	  provided	  no	  evidence	  for	  the	  conjugation	  of	  L-­‐TMSEM-­‐H	  arms	  to	  the	  polyester	  core	  due	  
to	   the	  absence	  of	  any	  new	  polyester	  attributed	   signals	   (Figure	   5.24).	  Consequently,	   the	  arm	  
number	   could	   not	   be	   determined.	   SEC	   helped	   confirm	   nanogel	   star	   polymer	   formation	   by	  
observing	   the	   shift	   in	   retention	   time	   of	   the	   star	   shaped	   counterpart	   to	   a	   shorter	   retention	  
time,	   an	   observation	   indicative	   of	   higher	   molecular	   weight	   (Figure	   5.25).	   The	   star	   polymer	  
exhibited	  a	  narrow	  PDI	  of	  1.3	  and	  a	  size,	  Rh,	  of	  24	  nm.	  In	  comparison	  to	  the	  DMAEMA	  stars	  the	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BOP	  ratio	  here	  was	  greater	  at	  a	   ratio	  of	  13,	  but	   for	   this	   system	  a	  Rh	  of	  24	  nm	  was	  observed	  
which	  is	  surprising	  given	  that	  for	  DMAEMA	  a	  BOP	  ratio	  of	  11.25	  generated	  a	  star	  polymer	  of	  40	  
nm	  (Rh).	  Given	  the	  complete	  consumption	  of	  polymeric	  arms,	  it	  can	  be	  hypothesized	  that	  the	  
TMSEM	  derived	   nanogel	   star	   polymers	   have	   a	   greater	   number	   of	   arms	   present	   and	   a	  more	  
compact	   structure.	   Furthermore	   the	   carboxylic	   acid	   TMSEM	  side	   chain	   is	   protected	  whereas	  
the	   DMAEMA	   tertiary	   amine	   side	   chain	   is	   free	   and	   so	   may	   promote	   electrostatic	   repulsion	  
amongst	   the	   dense	   polymeric	   chains	   therefore	   exhibiting	   a	   somewhat	   more	   enlarged	  
structure.	  Deprotection	  of	  the	  TMSEM	  protecting	  group	  was	  attempted	  using	  TBAF,	  a	  reagent	  
commonly	   employed	   to	   remove	   this	   type	   of	   protecting	   group.	   Upon	   the	   attempted	  
deprotection,	   the	   polymer	   precipitated	   in	   the	  DCM	   solution,	   a	   good	   indication	   of	   successful	  
deprotection.	   However	   upon	   filtering	   and	   washing	   the	   isolated	   material	   suffered	   from	  
solubility	   issues	   in	   both	   organic	   and	   water	   based	   solvents	   rendering	   1H	   NMR	   spectroscopy	  
analysis	  unachievable.	  FTIR	   spectroscopy	   (solid	   state)	   could	  also	  not	  confirm	  deprotection	  of	  
the	  polymer	  side	  chain	  meaning	   it	   therefore	  cannot	  be	  determined	   if	  complete	  deprotection	  
was	  achieved.	  What	  can	  be	  confirmed	  is	  that	  after	  subjection	  to	  TBAF	  the	  solubility	  properties	  
of	   the	  material	  were	  altered	  drastically.	  The	  targeted	  material	  was	  expected	  to	  be	  soluble	   in	  
water	  owing	  to	  the	  poly(methacrylic	  acid)	  periphery.	  A	  possible	  explanation	  for	  these	  solubility	  
issues	  could	  be	  to	  the	  densely	  branched	  nature	  of	  these	  materials	  which	  may	  have	  promoted	  a	  
crosslinking	   effect	   i.e.	   transesterification	   of	   poly(ester)	   core	   and	   interaction	   with	   the	  
poly(methacrylic	   acid)	   periphery	   resulting	   in	   the	   formation	   of	   a	   more	   complex	   polymeric	  
system.	   Furthermore,	   the	   density	   i.e.	   number	   of	   poly(methacrylic	   acid)	   arms	   was	   unknown	  
meaning	   there	  may	   have	   been	   insufficient	  water	   soluble	  moieties	   present	   to	   permit	   overall	  
water	  solubility.	  Consequently,	  this	  amphiphilic	  star	  polymer	  could	  not	  be	  solubilized	  in	  either	  
aqueous	  or	  organic	  solvents.	  A	  possible	  solution	  to	  this	  could	  be	  the	  use	  of	  a	  copolymer	  such	  
as	  a	   low	  molecular	  weight	  PEG	  acrylate	   in	   low	  concentration	  to	   improve	  the	  solubility	  and	   in	  
particular	   the	   water	   solubility	   of	   the	   final	   product.	   Furthermore	   the	   presence	   of	   PEG	   may	  
promote	  greater	  freedom	  amongst	  the	  polymeric	  arms	  and	  therefore	  reduce	  the	  potential	  for	  




Figure	  5.24:	  1H	  NMR	  spectrum	  of	  S-­‐TMSEM-­‐H	  (CDCl3).	  
	  
	  





The	  result	  of	  this	  work	  is	  the	  successful	  expansion	  of	  a	  polyester	  based	  nanogel	  star	  polymer	  
platform	   to	   include	   new	   functionalities	   and	   the	   incorporation	   of	   biomedically	   important	  
polymers.	  The	  combination	  of	  two	  different	  polymerization	  techniques	  within	  the	  one	  organic	  
nanoparticle	  platform	  enabled	  the	  highly	  controlled	  yet	  versatile	  design	  and	  production	  of	  new	  
nanogel	   star	   polymers.	   This	   approach	   boasts	   great	   versatility	   in	   the	   types	   of	   polymers	   and	  
functionalities	  which	  can	  be	  incorporated	  onto	  the	  biodegradable	  ester	  core.	  Furthermore	  the	  
materials	   produced	   display	   numerous	   advantages	   in	   terms	   of	   molecular	   weight	   and	   size	  
control	  to	  create	  a	  new	  generation	  of	  hybrid	  nanogel	  star	  polymers.	  Although	  the	  targeting	  of	  
a	  nanogel	  star	  polymer	  with	  an	  anionic	  periphery	  requires	  some	  minor	  development	  work	   in	  
the	   future,	   the	   potential	   use	   of	   these	   materials	   for	   their	   targeted	   goal	   of	   layer	   by	   layer	  
technology	  is	  very	  achievable.	  More	  importantly	  however	  is	  the	  great	  potential	  offered	  by	  this	  
early	  developmental	  work,	  to	  incorporate	  new	  polymers	  of	  various	  compositions	  towards	  the	  
targeting	   of	   numerous	   biomedical	   applications	   such	   as	   gene	   delivery	   and	   theranostic	  
applications.	   The	   continued	   development	   of	   these	   novel	   hybrid	  materials	  will	   be	   pursued	   in	  















5.2.3	  Polyester	  Core	  (Degradable)	  /	  Polyethylene	  Glycol	  Periphery	  (Nondegradable)	  
As	  described	  above	   (5.2.2),	   the	   successful	   use	  of	  hydroxyl	   terminated	  polymers	   towards	   the	  
generation	  of	  hybrid	  nanogel	  star	  polymers	  presents	  an	  opportunity	  for	  the	  development	  of	  a	  
new	  range	  of	  nanogel	  star	  polymers.	  The	  development	  of	  novel	  hydroxyl	  terminated	  polymers	  
or	   the	   modification	   of	   existing	   polymers	   may	   afford	   a	   large	   library	   of	   new	   nanogel	   star	  
polymers	   boasting	   versatility	   in	   both	   composition	   and	   functionality.	   Consequently	   the	  
potential	  to	  readily	  tailor	  nanogel	  star	  polymers	  to	  meet	  the	  demands	  of	  specific	  applications	  
is	  somewhat	  achievable.	  	  
To	   confirm	   and	   demonstrate	   the	   versatility	   of	   this	   platform,	   a	   hydroxyl	   terminated	   form	   of	  
poly(ethylene	   glycol)	   i.e.	   poly(ethylene	   glycol)	   methyl	   ether	   (PEG-­‐OH)	   was	   proposed	   to	  
therefore	   generate	   nanogel	   star	   polymers	  with	   PEG	   arms	   and	   a	   polyester	   core.	   PEG-­‐OH	   is	   a	  
very	   cheap	   commercially	   available	   polymer	   in	   a	   range	   of	   molecular	   weights	   which	   from	   a	  
biomedical	   point	   of	   view	  has	   some	   interesting	   properties.	   PEG	   is	   known	   to	   exhibit	   excellent	  
biocompatibility	   and	   stealth	   like	   properties	   in	   the	   body	   and	   is	   therefore	   considered	   the	  
primary	  tool	  for	  the	  modification	  of	  drug	  delivery	  vehicles	  e.g.	  liposomes,	  dendrimers,	  micelles	  
and	  star	  and	   linear	  polymers	  and	  even	  drugs	   themselves	   to	   improve	   their	  biocompatibility.91	  
Furthermore	  PEG	  has	  been	  utilised	  to	  improve	  or	  control	  important	  drug	  delivery	  parameters	  
such	  as	  blood	  circulation	  time	  and	  excretion.	  The	  appeal	  of	  PEG	  towards	  the	  drug	  delivery	  field	  
is	   further	   exasperated	   by	   its	   approval	   from	   the	   FDA	   and	   demonstrated	   use	   in	   current	   drug	  
formulations	  such	  as	  Macugen	  by	  Pfizer.92	  
In	   addition	   to	   these	   favourable	   biomedical	   properties,	   PEG	   also	   has	   another	   interesting	  
property	   in	   the	   form	   of	   thermo	   responsiveness.	   Linear	   PEG	   has	   a	   lower	   critical	   solution	  
temperature	   (LCST)	   which	   simply	   means	   that	   the	   polymer	   undergoes	   a	   macroscopic	   phase	  
separation	   at	   a	   specific	   temperature.93	   The	   reason	   for	   this	   is	   that	   at	   below	   the	   LCST	   the	  
polymer	  is	  water	  soluble	  due	  to	  hydrogen	  bonding	  with	  water	  molecules.	  However,	  above	  the	  
LCST	   these	   hydrogen	   bonds	   are	   broken	  which	   induces	   greater	   hydrophobicity	   resulting	   in	   a	  
coil-­‐to-­‐globule	  transition	  and	  therefore	  a	  phase	  separation.	  This	  property	  is	  dependent	  on	  PEG	  
molecular	  weight	   and	   solvent	   type.92	   For	   example	   2	   kDa	   PEG	   has	   an	   LCST	   of	   approximately	  
165oC	   in	  water.	   Furthermore,	   LCSTs	   have	   been	   shown	   to	   be	   affected	   by	   a	   number	   of	   other	  
polymer	  properties	  such	  as	  composition	   (hydrophobicity	  /	  hydrophilicity),	  polydisperisity	  and	  
architecture.94-­‐96	  Concerning	   2	   kDa	   PEG	   for	   example,	   at	   present	   its	   LCST	   of	   165oC	   renders	   it	  
unsuitable	  for	  any	  real	  world	  applications.	  However,	  by	  modifying	  the	  structural	  properties	  of	  
PEG	  such	  as	  the	  architecture	  e.g.	  star	  shaped	   it	  may	  be	  possible	  to	   induce	  a	   lower	  LCST	  thus	  
affording	  a	  more	  applicable	   thermoresponsive	  PEG	  derived	  polymer.	   Such	  a	  phenomena	  has	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been	   reported	   for	   hyperbranched	   star	   polymers	   comprising	   a	   poly[3-­‐ethyl-­‐3-­‐
(hydroxymethyl)oxetane](HBPO)	  core	  and	  hydrophilic	  polyethylene	  oxide	   (PEG)	  arms.97	  These	  
hyperbranched	   polymers	   exhibited	   broad	   PDIs	   and	   formed	   very	   large	   macromolecular	  
structures	   i.e.	   vesicles	   in	   water	   (>	   300	   nm	   –	   112	   μm)	   thus	   inhibiting	   their	   potential	   for	  
biomedical	  applications.	  The	  ability	  to	  control	  the	  LCST	  behaviour	  of	  these	  polymeric	  vesicles	  
through	  varying	  the	  PEO	  arm	  length	  and	  overall	  hyperbranched	  polymer	  molecular	  weight	  was	  
demonstrated.	   Although	   LCST	   was	   tunable,	   such	   a	   platform	   lacks	   the	   superior	   structural	  
versatility	   and	   control	   offered	   by	   the	   polyester	   /	   PEG	   based	   nanoparticle	   platform.	  
Furthermore,	   the	  nanoparticles	  described	  here	  are	  considerably	  smaller	  yet	  retain	  the	  ability	  
to	   exhibit	   strong	   thermoresponsive	   behaviour,	   a	   feature	   which	   improves	   their	   potential	  
biomedical	  applicability.	  	  	  	  	  	  	  
The	  following	  work	  will	  investigate	  the	  feasibility	  of	  employing	  PEG	  in	  the	  OROP	  of	  cyclic	  esters	  
for	  the	  generation	  of	  nanogel	  star	  polymers.	  The	  LCST	  behaviour	  of	  these	  materials	  will	   then	  
be	  investigated	  as	  a	  function	  of	  PEG	  molecular	  weight	  and	  hydrophobic	  nanogel	  core	  density.	  	  	  
As	   described	   in	   Figure	   5.26,	   hydroxyl	   terminated	   PEG	   (2	   kDa	   and	   5	   kDa)	   was	   used	   as	   an	  
initiator	   for	   the	   OROP	   of	   the	   cyclic	   ester	   crosslinker	   BOP	   using	   metal	   free	   conditions	   (TBD	  
catalyst)	   to	   form	   new	   nanogel	   star	   polymers	  with	   PEG	   arms	   and	   a	   polyester	   core.	   Similarly,	  
linear	  block	  copolymers	  were	  synthesised	  through	  the	  use	  of	   the	  cyclic	  ester	  δ-­‐valerolactone	  
which	  could	  subsequently	  be	  used	  to	  afford	  nanogel	  star	  polymers	  of	   increased	  hydrophobic	  
character	  owing	  to	  the	  block	  copolymer	  nature	  of	  the	  arms	  (Figure	  5.27).	  	  	  
	  
Figure	  5.26:	  Synthesis	  of	  nanogel	  star	  polymers	  comprising	  PEG	  arms	  and	  crosslinked	  




Figure	  5.27:	  Synthesis	  of	  nanogel	  star	  polymers	  with	  PEG-­‐b-­‐PVL	  arms	  and	  crosslinked	  
polyester	  core	  via	  organocatalytic	  ring	  opening	  polymerization	  of	  cyclic	  esters.	  
A	  series	  of	  nanogel	  star	  polymers	  were	  synthesized	  with	  excellent	  control	  observed	  over	  arm	  
molecular	  weight	  and	  composition	  and	  overall	  nanogel	  star	  polymer	  molecular	  weight	   (Table	  
5.5).	   Initially	   PEG-­‐OH	   (2	   kDa)	  was	   successfully	   employed	   to	   generate	   a	  well	   defined	  nanogel	  
star	  polymer	  boasting	  a	  very	  low	  PDI	  of	  1.1,	  apparent	  Mn	  of	  28.7	  kDa	  and	  size	  (Rh)	  of	  8.6	  nm	  in	  
THF.	  The	  reaction	  required	  a	  prolonged	  reaction	  time	  of	  approximately	  20	  h	  compared	  to	  the	  4	  
h	  required	  by	  a	  small	  initiator	  such	  as	  benzyl	  alcohol	  due	  to	  2	  kDa	  PEG	  being	  a	  macroinitiator.	  
The	  number	  of	  arms	  could	  not	  be	  determined	  due	  to	  the	  absence	  of	  any	  polyester	  signals.	  The	  
reason	   for	   this	   is	   due	   to	   the	   polyester	   portion	   of	   the	  molecule	   being	   positioned	   in	   the	   core	  
therefore	   shielding	   it	   in	   1H	   NMR	   spectroscopy	   analysis.	   Furthermore,	   the	   whole	   molecule	  
predominantly	  consists	  of	  PEG	  chains	  whereas	  the	  polyester	  core	  only	  contributes	  a	  very	  small	  
fraction	   to	   the	   overall	   composition.	   SEC	   analysis	   identified	   the	   presence	   of	   unreacted	   linear	  
PEG-­‐OH	   arm	   (approx.	   30%)	   but	   the	   clear	   shift	   in	   retention	   time	   to	   higher	  molecular	  weight	  
confirmed	  the	  synthesis	  of	  a	  nanogel	  star	  polymer	  (Figure	  5.28).	  To	  remove	  the	  crude	  arm,	  the	  
mixture	   was	   purified	   by	   a	   fractionation	   process	   to	   yield	   the	   homo	   star	   polymer.	   The	  
fractionation	   process	   worked	   very	   well	   in	   purifying	   these	   polymers	   although	   yield	   was	  
sacrificed	  somewhat.	  SEC	  confirmed	  the	  absence	  of	  any	  crude	  PEG-­‐OH	  arm	  post	  fractionation	  
(Figure	   5.28,	   (C)	   Inset).	   FTIR	   spectroscopic	   analysis	   indentified	   the	   presence	   of	   ester	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functionality	   at	   1725	   cm-­‐1	   therefore	   confirming	   the	   presence	   of	   polyester	   within	   the	   star	  
polymer	  platform	  (Figure	  5.29).	  
Table	  5.5:	  PEG	  functionalized	  polyester	  nanogel	  star	  polymers	  and	  their	  LCST	  behavior.	  
Mn	  PEG	   Target	  Mn	  VL	  	   Mn	  VL(a,b)	   PDI	  Mn	  Star	  (kDa)(a)	  PDI	   No.	  Arms(c)	   Size	  Rh	  (nm)(d)	   LCST	  (oC)(e)	  
2	  kDa	   n/a	   n/a	   1.1	   28.7	   1.1	   n/a	   8.6	   75	  
2	  kDa	   1.5	  kDa	   1.8	  kDa	  (GPC)	  
1.1	  kDa	  
(NMR)	  
1.1	   48.8	   1.5	   9	   13	   70	  
2	  kDa	   3	  kDa	   3.2	  kDa	  (GPC)	  
2.5	  kDa	  
(NMR)	  
1.1	   55.8	   1.4	   10	   14	   65	  
2	  kDa	   4.5	  kDa	   5.0	  kDa	  (GPC)	  
3.2	  kDa	  
(NMR)	  
1.1	   61.1	   1.5	   8	   14	   60	  
2	  kDa	   6.0	  kDa	   5.9	  kDa	  (GPC)	  
4.8	  kDa	  
(NMR)	  
1.1	   84.5	   1.4	   8	   14.4	   40	  
2	  and	  5	  
kDa	  
n/a	   n/a	   n/a	   51.6	   1.1	   n/a	   10.8	   n/a	  
5	  kDa	   n/a	   n/a	   n/a	   51.1	   1.1	   n/a	   9.6	   n/a	  
5	  kDa	   3.0	  kDa(f)	   n/a	   n/a	   58.2	   1.3	   n/a	   21	   n/a	  
(a)	  determined	  by	  SEC	  (THF)	  using	  RI	  detector	  (b)	  determined	  by	  1H	  NMR	  spectroscopy	  using	  
integral	  ratio	  of	  PEG	  to	  polyester	  moieties	  (c)	  determined	  by	  1H	  NMR	  spectroscopy	  using	  the	  
integral	  ratio	  of	  linear	  PEG-­‐b-­‐PVL	  arm	  and	  star	  (d)	  determined	  by	  DLS	  in	  THF	  (e)	  performed	  in	  






Figure	  5.28:	  SEC	  trace	  of	  L-­‐PEG-­‐2	  kDa	  (A),	  the	  corresponding	  polyester	  nanogel	  star	  polymer,	  
S-­‐PEG-­‐2	  kDa	  (B)	  and	  S-­‐PEG-­‐2	  kDa	  after	  fractionation	  (C).	  
	  
Figure	  5.29:	  FTIR	  spectra	  of	  L-­‐PEG-­‐2	  kDa	  (A)	  and	  S-­‐PEG-­‐2	  kDa	  (B).	  
Expanding	  on	  this,	  the	  monomer	  δ-­‐valerolactone	  was	  used	  in	  conjunction	  with	  the	  same	  PEG	  
initiator	   to	  generate	  a	  series	  of	   linear	  block	  copolymers	   in	  which	  polyester	  molecular	  weight	  
was	   readily	   controlled	   by	   varying	   the	   δ-­‐valerolactone	   to	   PEG-­‐OH	  molar	   ratio	   (Table	   5.5).	   1H	  
NMR	  spectroscopy	  was	  used	  to	  determine	  the	  polyester	  molecular	  weight	  and	  thus	  monomer	  
conversion	  due	   to	   the	   clear	  distinction	  of	  PEG	  and	  ester	   signals	   (Figure	   5.30).	   Typically	   70	  –	  
80%	   conversion	   of	   δ-­‐valerolactone	   monomer	   was	   observed	   and	   molecular	   weights	   were	   in	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close	   agreement	   with	   the	   target	   molecular	   weight.	   SEC	   analysis	   showed	   a	   low	   PDI	   of	   1.1	  
highlighting	   the	   excellent	   control	   observed	   in	   such	   a	   reaction	   with	   apparent	   Mn	   in	   good	  
agreement	  with	  the	  target	  Mn.	  To	  synthesize	  the	  nanogel	  stars,	  the	  reaction	  was	  performed	  in	  
two	  steps	   i.e.	  generation	  of	   the	   linear	  arm,	   in	  situ	  sampling	  and	  subsequent	  addition	  of	  BOP	  
crosslinker.	  This	  approach	  provides	  an	  excellent	  level	  of	  control	  over	  each	  step.	  The	  resultant	  
stars	   showed	  the	  presence	  of	  weak	  ester	   signals	  which	  permitted	  elucidation	  of	   the	  average	  
arm	  number	  (AAN)	  by	  comparing	  the	   integral	  values	  of	  the	  ester	  peaks	  before	  and	  after	  star	  
formation	   (Figure	   5.30).	   The	   weak	   nature	   of	   the	   ester	   peaks	   confirms	   the	   synthesis	   of	   a	  
molecule	  with	   increased	  PEG	  composition	  i.e.	  several	  PEG	  arms	  and	  peripheral	  positioning	  of	  
these	  PEG	  arms	  i.e.	  shielding	  of	  polyester	  core.	  It	  was	  noted	  that	  all	  of	  these	  block	  copolymer	  
derived	  stars	  produced	  nanogel	  stars	  with	  8	  –	  10	  arms	  and	  all	  approximately	  13	  –	  14	  nm	  in	  size	  
(Rh)	   (Table	   5.5).	   Therefore	   the	   only	   apparent	   effect	   of	   increasing	   polyester	   arm	  Mn	  was	   the	  
increase	   in	   overall	   nanogel	   star	   polymer	   Mn.	   Although	   the	   star	   polymer	   with	   a	   4.8	   kDa	  
polyester	  arm	  Mn	  	  (largest)	  did	  show	  a	  small	  increase	  in	  size	  (Rh)	  no	  significant	  increase	  in	  size	  
was	   observed	   amongst	   the	   block	   copolymer	   stars	  which	  may	  have	   been	   expected	   given	   the	  
differing	   star	   molecular	   weights.	   Such	   an	   observation	   may	   be	   accounted	   for	   by	   the	   similar	  
average	   arm	   number	   (AAN)	   or	   degree	   of	   branching	   for	   each	   star	   resulting	   in	   a	   similar	  
hydrodynamic	  volume	  and	  therefore	  size.	  The	  degree	  of	  branching	  of	  star	  polymers	  is	  known	  
to	   have	   a	   large	   impact	   on	   their	   hydrodynamic	   volume.98-­‐100	   The	   clear	   shift	   in	   SEC	   retention	  
times	   of	   both	   arms	   and	   their	   respective	   stars	   could	   be	   readily	   followed	   highlighting	   the	  
excellent	   synthetic	  control	  afforded	  here	   (Figure	   5.31).	  The	   increase	   in	  Mn	  of	  both	  arms	  and	  
stars	   was	   reflected	   in	   a	   retention	   time	   shift	   to	   lower	   retention	   time	   thus	   confirming	   Mn	  
increase.	   	  The	  PDIs	  of	  the	  generated	  stars	   increased	  to	  1.4	  –	  1.5	  which	  was	   interesting	  when	  
compared	  to	  the	  low	  PDI	  (1.1)	  observed	  for	  the	  homo	  PEG	  derived	  star.	  The	  block	  copolymer	  
arm	   introduces	   further	   complexity	   to	   the	   system	   and	   greater	   transesterification	   possibilities	  
which	   may	   account	   for	   the	   observed	   PDI	   difference.	   FTIR	   sprectroscopy	   	   	   confirmed	   the	  
presence	  of	   ester	   functionality	  within	  both	   the	  block	   copolymer	   arms	  and	   the	   resultant	   star	  




Figure	  5.30:	  1H	  NMR	  spectrum	  of	  L-­‐PEG-­‐2k	  Da	  (A),	  L-­‐PEG-­‐2	  kDa-­‐b-­‐PVL-­‐1.5	  kDa	  (B)	  and	  S-­‐PEG-­‐2	  
kDa-­‐b-­‐PVL-­‐1.5	  kDa	  (C)	  (CDCl3).	  
	  
Figure	  5.31:	  SEC	  Traces	  of	  linear	  PEG-­‐b-­‐PVL	  block	  copolymers	  and	  their	  corresponding	  
nanogel	  star	  polymers:	  (A)	  L-­‐PEG-­‐2	  kDa-­‐b-­‐PVL-­‐1.5	  kDa,	  (B)	  L-­‐PEG-­‐2	  kDa-­‐b-­‐PVL-­‐3	  kDa,	  (C)	  L-­‐
PEG-­‐2	  kDa-­‐b-­‐PVL-­‐4.5	  kDa,	  (D)	  L-­‐PEG-­‐2	  kDa-­‐b-­‐PVL-­‐6	  kDa,	  (E)	  S-­‐PEG-­‐2	  kDa,	  (F)	  S-­‐PEG-­‐2	  kDa-­‐b-­‐





Figure	  5.32:	  FTIR	  spectra	  of	  L-­‐PEG-­‐2	  kDa	  (A),	  L-­‐PEG-­‐2	  kDa-­‐b-­‐PVL-­‐1.5	  kDa	  (B)	  and	  S-­‐PEG-­‐2	  kDa-­‐
b-­‐PVL-­‐1.5	  kDa	  (C).	  
A	  different	   PEG	  derivative	   i.e.	   PEG	  5	   kDa	   also	   permitted	   the	   successful	   synthesis	   of	   nanogel	  
star	  polymers	  (Table	  5.5).	  As	  with	  PEG-­‐2	  kDa,	  the	  PEG-­‐5	  kDa	  initiator	  produced	  a	  small	  (Rh	  =	  9.6	  
nm),	   well	   defined,	   monodisperse	   (PDI	   =	   1.1)	   nanogel	   star	   polymer.	   The	   simultaneous	  
combination	  of	   both	  PEG-­‐2	   kDa	  and	  PEG-­‐5	   kDa	   in	   equal	  molar	   ratio	   generated	   a	  mixed	  PEG	  
star	  polymer	  very	  similar	  in	  apparent	  Mn	  and	  PDI	  to	  the	  homo	  PEG-­‐5	  kDa	  star.	  The	  size	  of	  this	  
star	   polymer	   was	   slightly	   larger	   with	   an	   Rh	   of	   10.8	   nm.	   As	   described	   above,	   1H	   NMR	  
spectroscopy	  analysis	  of	  the	  homo	  PEG	  star	  polymers	  could	  not	  determine	  the	  AAN	  due	  to	  the	  
absence	  of	  any	  ester	  peaks.	  FTIR	   sprectroscopy	   	   	  did	  however	  confirm	  the	  presence	  of	  ester	  
functionality	  (Figure	  5.33).	  The	  use	  of	  PEG-­‐5	  kDa	  within	  a	  block	  a	  copolymer	  arrangement	  was	  
attempted.	   The	   OROP	   of	   δ-­‐valerolactone	   was	   performed	   using	   a	   1	   pot	   reaction	   approach	  
containing	   both	  monomer	   and	   BOP	   crosslinker.	   The	   rapid	   polymerization	   of	   δ-­‐valerolactone	  
and	  slow	  polymerization	  and	  solubility	  of	  BOP	  permits	  the	  use	  of	  such	  an	  approach	  therefore	  
negating	  the	  two	  step	  approach	  employed	  for	  PEG-­‐2	  kDa	  block	  copolymers.	  However	  the	  use	  
of	  such	  an	  approach	  reduces	  the	  ability	  to	  monitor	  and	  control	  each	  structural	  component	  i.e.	  
Mn	   and	   PDI	   of	   arm	   and	   star.	   The	   determination	   of	   AAN	   by	   1H	   NMR	   spectroscopy	   proved	  
impossible	   due	   to	   the	   lack	   of	   visible	   signals	   attributable	   to	   polyester	   star	   and	   lack	   of	   a	  
comparative	   1H	   NMR	   spectroscopy	   analysis	   of	   the	   linear	   block	   copolymer	   arm.	   FTIR	  
sprectroscopy	  did	  confirm	  the	  presence	  of	  ester	   functionality	  at	  1725	  cm-­‐1	  (Figure	  5.33).	  The	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star	  generated	  via	  this	  1	  pot	  reaction	  approach	  yielded	  an	  apparent	  Mn	  of	  58	  kDa,	  Rh	  of	  21	  nm	  
and	  PDI	  of	  1.3	  which	  was	  lower	  than	  the	  comparative	  2	  step	  approach	  for	  the	  PEG-­‐2	  kDa	  block	  
copolymer	  stars	  highlighting	  the	  effectiveness	  of	  a	  1	  pot	  approach.	  The	   large	  size	  of	  this	  star	  
compared	  to	  the	  others	  was	  due	  to	  the	  large	  PEG-­‐OH	  initiator	  (5	  kDa)	  employed	  in	  conjunction	  
with	  the	  presence	  of	  extra	  ester	  functionality	  in	  the	  form	  of	  δ-­‐valerolactone	  with	  a	  target	  Mn	  
of	  3	  kDa.	  SEC	  analysis	  of	  the	  described	  5	  kDa	  nanogel	  star	  polymer	  derivatives	  showed	  the	  shift	  
in	   retention	   time	   after	   star	   polymer	   formation	   owing	   to	   an	   increase	   in	   molecular	   weight	  
(Figure	   5.34).	  Purification	  was	  again	  performed	  using	   fractionation	   to	  remove	  any	  unreacted	  
residual	   arms	   resulting	   in	   the	   unimodal	   distribution	   of	   nanogel	   star	   polymer	   molecular	  
weights.	   The	   SEC	   trace	   of	   PEG-­‐5	   kDa	   block	   copolymer	   star	   (C	   -­‐	   Figure	   5.34)	   highlights	   the	  
broadening	  of	  PDI	  compared	  to	  the	  equivalent	  homo	  PEG-­‐5	  kDa	  stars	  (A	  and	  B	  -­‐	  Figure	  5.34).	  	  	  	  
	  







Figure	  5.34:	  SEC	  traces	  of	  L-­‐PEG-­‐5	  kDa	  (A),	  S-­‐PEG-­‐2/5	  kDa	  (B)	  and	  S-­‐PEG-­‐5	  kDa-­‐b-­‐PVL-­‐3	  kDa	  
(C).	  
As	  mentioned,	   linear	   PEGs	   have	   LCSTs	   but	   which	   are	   too	   high	   to	   be	   applicable	   to	   any	   real	  
biomedical	   application.	   The	   incorporation	   of	   numerous	   PEG	   arms	   into	   a	   star	   conformation	  
results	   in	   a	   high	   local	   density	   of	   PEG	   arms	   within	   a	   size	   confined	   structural	   space.	   Such	   a	  
feature	  may	  promote	   increased	   interaction	  amongst	  PEG	  arms	   therefore	  permitting	  a	  coil	   to	  
globule	   transition	   at	   a	   lower	   temperature	   or	   LCST.	   Furthermore,	   the	   presence	   of	   a	   small	  
hydrophobic	  polyester	  core	  which	  can	  be	  tuned	  by	  the	  incorporation	  of	  block	  copolymers	  will	  
help	  to	  promote	  greater	  hydrophobic	  interactions	  resulting	  in	  a	  lower	  LCST.	  The	  combination	  
of	   these	   tunable	   density	   and	   hydrophobic	   properties	  may	   be	   enough	   to	   reduce	   the	   LCST	   of	  
PEG	  to	  a	  more	  applicable	  temperature	  whilst	  also	  potentially	  enabling	  the	  tailoring	  of	  LCSTs	  to	  
meet	  the	  demands	  of	  a	  variety	  of	  applications.	  	  
The	  LCST	  behaviour	  of	  the	  described	  nanogel	  star	  polymers	  was	  investigated	  on	  a	  temperature	  
controlled	   spectrometer.	   The	   identification	   of	   a	   LCST	   was	   denoted	   by	   a	   strong	   increase	   in	  
absorbance	  due	  to	  the	  phase	  separation	  induced	  by	  the	  thermoresponsiveness	  of	  the	  polymer.	  
The	  results	  are	  summarized	   in	  Table	  5.5.	   It	   is	  known	  that	  PEG-­‐2	  kDa	  has	  an	  LCST	  of	  165oC	   in	  
water	   (using	   a	   sealed	   system)	   whereas	   the	   S-­‐PEG-­‐2	   kDa	   synthesised	   here	   had	   an	   LCST	   of	  
70oC.92	  The	  LCST	  of	  the	  nanogel	  stars	  was	  performed	  in	  PBS	  to	  crudely	  mimic	  the	  human	  body	  
environment.	  By	  simply	  incorporating	  numerous	  PEG	  arms	  into	  a	  star	  conformation	  containing	  
a	  small	  hydrophobic	  core	  the	  LCST	  of	  PEG-­‐2	  kDa	  was	  reduced	  by	  a	  substantial	  90oC.	  The	  effects	  
of	   sample	   concentration	   were	   negligible	   as	   a	   20	  mg/ml	   sample	   concentration	   resulted	   in	   a	  
LCST	  of	  68oC	  whereas	  5	  mg/ml	  and	  10	  mg/ml	  sample	  concentrations	  both	  generated	  a	  LCST	  of	  




Figure	  5.35:	  LCST	  behavior	  of	  PEG	  derived	  polyester	  nanogel	  star	  polymers:	  (A)	  S-­‐PEG-­‐2kDa	  5	  
mg/ml,	  (B)	  S-­‐PEG-­‐2kDa	  10	  mg/ml	  and	  (C)	  S-­‐PEG-­‐2kDa	  20	  mg/ml.	  
The	  potential	   to	   reduce	   the	   LCST	   further	   by	   increasing	   the	   hydrophobic	   content	   on	   the	   star	  
polymers	   was	   investigated.	   A	   simple	   way	   to	   do	   this	   was	   through	   the	   formation	   of	   block	  
copolymer	  arms	  with	  PEG-­‐OH	  and	  δ-­‐valerolactone.	  The	  PEG-­‐2	  kDa	  block	  copolymer	  stars	  each	  
with	   controlled	   increments	   of	   increased	   arm	   hydrophobicity	   demonstrated	   the	   ability	   to	  
control	  the	  LCST	  behaviour.	  This	  facile	  modulation	  of	  the	  arm	  hydrophilic	  /	  hydrophobic	  ratio	  
resulted	  in	  the	  incremental	  decrease	  in	  LCST	  to	  70oC,	  65oC,	  60oC	  and	  40oC	  for	  S-­‐PEG-­‐2	  kDa-­‐b-­‐
PVL-­‐1.5	   kDa,	   S-­‐PEG-­‐2	   kDa-­‐b-­‐PVL-­‐3	   kDa,	   S-­‐PEG-­‐2	   kDa-­‐b-­‐PVL-­‐4.5	   kDa	   and	   S-­‐PEG-­‐2	   kDa-­‐b-­‐PVL-­‐6	  
kDa,	  respectively	  (Figure	  5.36).	  All	  of	  these	  star	  polymers	  exhibited	  a	  similar	  AAN	  (8	  -­‐	  10)	  and	  
size	   (Rh	   =	   13	   -­‐	   14	   nm)	   ruling	   out	   the	   possibility	   of	   arm	   density	   and	   star	   size	   contributing	  
significantly	  to	  these	  LCST	  differences.	  The	  subsequent	  hydrophobicity	  increases	  amongst	  the	  
block	   copolymer	   stars	   did	   contribute	   to	   a	   decreased	   LCST.	   Such	   a	   feature	   highlights	   the	  
significant	   contribution	   made	   by	   the	   hydrophilic	   /	   hydrophobic	   ratio	   towards	   the	   LCST	  
behaviour	   of	   a	   polymer.	   A	   major	   problem	   with	   increasing	   the	   hydrophobic	   content	   is	   the	  
inherent	  water	  solubility	   issues	  associated	  with	  such	  hydrophobic	  entities.	  The	  star	  polymers	  
initially	   required	   10%	   THF	   in	   PBS	   for	   solubility	   which	   could	   later	   be	   removed	   by	   rotary	  
evaporation.	   However,	   S-­‐PEG-­‐2	   kDa-­‐b-­‐PVL-­‐4.5	   kDa	   and	   S-­‐PEG-­‐2	   kDa-­‐b-­‐PVL-­‐6	   kDa	   were	   not	  
soluble	   in	  neat	  PBS	  due	   to	   their	   large	  hydrophobic	   character.	   The	  hydrophilic	  PEG	  periphery	  
could	   not	   permit	   enough	   solubility	   in	   just	   PBS	   and	   so	   the	   final	   solution	   for	   LCST	   analysis	  
required	  a	  little	  THF	  (5%)	  to	  aid	  solubility.	  The	  presence	  of	  THF	  could	  potentially	  influence	  the	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final	  LCST	  value	  but	  as	  there	  is	  only	  a	  small	  volume	  of	  THF	  present	  the	  deviation	  from	  the	  real	  
LCST	   value	   was	   expected	   to	   be	  minimal.	   Consequently,	   the	  modulation	   of	   the	   hydrophobic	  
character	   for	   lowering	  of	   LCSTs,	   although	   very	   effective,	   is	   limited	  with	   regards	   to	   inhibiting	  
water	   solubility	   of	   the	   final	   star	   polymer.	   Upon	   cooling,	   the	   LCST	   behaviour	   for	   all	   star	  
polymers	  was	  shown	  to	  be	  reversible.	  Cooling	  resulted	  in	  the	  transition	  from	  a	  turbid	  solution	  
at	  >LCST	  to	  a	  transparent	  solution	  <LCST.	  To	  confirm	  this,	  the	  samples	  were	  analysed	  using	  a	  
heating	  cycle	  and	  an	  immediate	  cooling	  cycle	  which	  resulted	  in	  an	  identical	  LCST	  trace	  for	  the	  
cooling	  cycle.	  
	  
Figure	  5.36:	  LCST	  behavior	  of	  PEG	  derived	  polyester	  nanogel	  star	  polymers:	  (A)	  S-­‐PEG-­‐2	  kDa	  
5mg/ml,	  (B)	  S-­‐PEG-­‐2	  kDa-­‐b-­‐PVL-­‐1.5	  kDa,	  (C)	  S-­‐PEG-­‐2	  kDa-­‐b-­‐PVL-­‐3	  kDa,	  (D)	  S-­‐PEG-­‐2	  kDa-­‐b-­‐
PVL-­‐4.5	  kDa,	  (E)	  S-­‐PEG-­‐2	  kDa-­‐b-­‐PVL-­‐6	  kDa.	  
The	   LCST	   behaviour	   of	   PEG	   is	   known	   to	   be	   strongly	   dependent	   on	   molecular	   weight.92	   By	  
increasing	   PEG	   molecular	   weight	   or	   length	   of	   the	   PEG	   chains	   used	   it	   should	   in	   theory	   be	  
possible	  to	  further	   lower	  the	  LCST	  of	  the	  above	  nanogel	  star	  polymers.	  Linear	  PEG-­‐5	  kDa	  has	  
an	  LCST	  of	  145oC	  which	  upon	  incorporation	  into	  a	  star	  shaped	  architecture	  should	  result	  in	  an	  
even	  lower	  LCST.	  However,	  S-­‐PEG-­‐5	  kDa	  did	  not	  result	  in	  an	  LCST	  at	  <85oC.	  Such	  an	  observation	  
was	  unexpected	  given	  the	  large	  shift	  observed	  for	  S-­‐PEG-­‐2	  kDa.	  Similarly,	  the	  incorporation	  of	  
a	  mixture	  of	  PEG-­‐2	  kDa	  and	  PEG-­‐5	  kDa	  as	  arms	  did	  not	  result	  in	  a	  measurable	  LCST	  i.e.	  <85oC.	  
By	  mixing	  two	  different	  arm	  lengths	  the	  amount	  of	  disorder	  within	  the	  system	  should	  increase	  
and	  as	  S-­‐PEG-­‐2	  kDa	  was	  shown	  to	  elicit	  a	   lower	  LCST,	  the	  resultant	  material	  was	  expected	  to	  
exhibit	   a	   lower	   LCST	   at	   <85oC.	   Finally	   an	   increase	   in	   hydrophobic	   character	   through	   block	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copolymer	   arms	   was	   attempted	   to	   achieve	   desirable	   LCST	   behaviour	   for	   S-­‐PEG-­‐5	   kDa.	   As	  
described	   previously	   the	   synthetic	   approach	   involved	   a	   1	   pot	   procedure	   which	   should	   not	  
impact	  on	  the	  hydrophobic	  properties	  of	  the	  final	  star	  polymer.	  A	  molecular	  weight	  of	  3	  kDa	  
was	  targeted	  for	  the	  block	  copolymer	  arm	  which	  should	  impact	  on	  the	  LCST	  behaviour	  of	  the	  
nanogel	  star.	  However,	  no	  LCST	  at	  <85oC	  was	  observed	  in	  spite	  of	  its	  comparatively	  large	  size	  
(Rh)	  of	  21	  nm.	  One	  possible	  explanation	  for	  these	  PEG-­‐5	  kDa	  observations	  is	  related	  to	  the	  arm	  
density	  of	  these	  stars.	  As	  this	  PEG	  macroinitiator	  is	  larger	  than	  the	  corresponding	  PEG-­‐2	  kDa	  it	  
is	  likely	  to	  have	  a	  significant	  impact	  on	  the	  arm	  density.	  For	  example	  a	  larger	  arm	  means	  it	   is	  
very	  likely	  that	  it	  is	  not	  possible	  to	  incorporate	  as	  many	  arms	  into	  the	  same	  star	  structure	  due	  
to	  steric	   issues	  associated	  with	  a	   larger	  arm.	  The	  consequence	  of	  this	   is	  reduced	  arm	  density	  
resulting	  in	  fewer	  favourable	  interactions	  amongst	  PEG	  arms	  which	  are	  a	  key	  feature	  required	  
to	   drive	   the	   reduction	   in	   LCST	   for	   this	   particular	   nanoparticle	   platform.	   Ideally,	   the	  
determination	   of	   AAN	   for	   all	   star	   polymers	   would	   help	   to	   confirm	   this	   hypothesis.	   The	  
apparent	  Mw	   of	   these	   S-­‐PEG-­‐5	   kDa	   polymers	   was	   approximately	   50	   kDa	   even	   for	   the	   block	  
copolymer	   star	   (S-­‐PEG-­‐5	   kDa-­‐b-­‐PVL-­‐3	   kDa)	   indicating	   that	   overall	   star	  molecular	  weight	  was	  
restricted	  due	  to	  AAN	  limitations	  as	  a	  result	  of	  the	  large	  size	  of	  the	  PEG-­‐5	  kDa	  macroinitiator.	  
In	  theory	  a	  larger	  PEG	  arm	  should	  have	  a	  greater	  effect	  on	  LCST	  but	  in	  reality	  this	  was	  not	  the	  
case	  due	  to	  structural	  restrictions	  of	  the	  nanoparticle	  platform.	  	  
The	   successful	  employment	  of	  hydroxyl	   terminated	  PEG	  as	  an	   initiator	   in	   the	  OROP	  of	   cyclic	  
esters	  for	  nanogel	  star	  polymer	  synthesis	  further	  demonstrated	  the	  versatility	  of	  this	  polyester	  
based	  platform.	  Nanogel	  star	  polymers	  comprising	  PEG	  arms	  and	  a	  hydrophobic	  polyester	  core	  
were	   thus	   generated	   boasting	   narrow	   PDIs.	   The	   incorporation	   of	   two	   different	   molecular	  
weight	   PEGs	   and	  development	   of	   block	   copolymer	   arms	   further	   demonstrated	   the	   ability	   to	  
readily	   control	   both	   arm	   and	   core	   properties.	   Investigation	   of	   the	   LCST	   behaviour	   of	   the	  
described	  materials	  highlighted	  the	  significant	  impact	  of	  architecture	  on	  the	  LCST	  behaviour	  of	  
linear	  PEG.	  Furthermore,	  the	  ability	  to	  modulate	  hydrophobic	  density	  of	  arms	  and	  subsequent	  
stars	  offered	  a	  nanoparticle	  platform	  with	  LCST	  tunable	  capabilities.	  Initial	  studies	  hypothesise	  
that	  arm	  density	  also	  plays	  a	  vital	  role	  in	  regulating	  LCSTs	  due	  to	  the	  absence	  of	  any	  LCST	  for	  
PEG-­‐5	   kDa	   star	   polymers.	   Through	   future	   development	   it	   may	   be	   possible	   to	   create	   a	   PEG	  
functionalised	   nanogel	   star	   polymer	   with	   a	   body	   temperature	   LCST	   rendering	   it	   potentially	  
useful	   for	   biomedical	   applications	   such	   as	   drug	   delivery	   and	   theranostics.	   In	   addition	   the	  
incorporation	   of	   other	   thermoresponsive	   polymers	   such	   as	   PNIPAM	   or	   polymers	   with	  




Nanogel	  star	  polymers	  have	  emerged	  as	  an	   interesting	  class	  of	  organic	  nanoparticle	  platform	  
due	  to	  the	  superior	  structural	  and	  synthetic	  features	  afforded.	  Herein,	  an	  array	  of	  well	  defined	  
hybrid	   nanogel	   star	   polymer	   systems	  was	   designed	   and	   synthesised	   using	   a	   combination	   of	  
various	   polymerization	   methodologies.	   Anionic	   polymerization	   and	   ROP	   of	   NCAs	   were	  
employed	   to	   generate	   a	   series	   of	   well	   defined	   polystyrene	   nanogel	   stars	   polymers	   with	  
biocompatible	   polypeptide	   peripheries.	   The	   resultant	   materials	   exhibited	   narrow	   PDIs	   but	  
suffered	   from	   limited	   water	   solubility	   owing	   to	   the	   presence	   of	   a	   large	   hydrophobic	  
polystyrene	   core.	   Expansion	   of	   this	   platform	   to	   include	   a	   degradable	   polyester	   core	   with	  
functional	   methacrylate	   peripheries	   was	   realised.	   The	   OROP	   of	   cyclic	   esters	   via	   hydroxyl	  
terminated	   methacrylate	   polymers	   derived	   by	   RAFT	   polymerization	   afforded	   a	   series	   of	  
nanogel	  star	  polymers	  exhibiting	  excellent	  control	  over	  constituent	  arms	  and	  star	  properties.	  
Well	   defined	   linear	   cationic	   and	   protected	   carboxylic	   acid	   methacrylate	   polymers	   were	  
incorporated	   into	  a	  polyester	  nanogel	  star	  conformation	   in	  which	  the	  size	  of	   these	  stars	  was	  
readily	   tuned.	   Removal	   of	   the	   carboxylic	   acid	   protecting	   group	   led	   to	   undesirable	   solubility	  
issues	   requiring	   the	   future	   development	   of	   an	   alternative	   polymer.	   The	   versatility	   of	   this	  
degradable	  platform	  was	  further	  demonstrated	  through	  the	  use	  of	  hydroxyl	  terminated	  PEG	  of	  
two	  different	  molecular	  weights	  to	  afford	  PEG	  functionalised	  nanogel	  star	  polymers.	  Structural	  
parameters	   such	   as	   arm	  molecular	  weight,	   composition	   and	   overall	   hydrophobic	   content	   of	  
stars	   were	   facilely	   controlled.	   The	  modulation	   of	   these	   parameters	   permitted	   the	   tuning	   of	  
PEG	   LCST	   behaviour	   to	   afford	   the	   drastic	   decrease	   in	   PEG	   LCST	   to	   a	   temperature	   more	  
applicable	   to	  biomedical	  applications.	  Overall	   the	  consolidation	  of	   several	  different	   synthetic	  
approaches	  within	  the	  one	  organic	  nanoparticle	  platform	  afforded	  a	  series	  of	  hybrid	  materials	  
boasting	  well-­‐defined,	  multifunctional	  and	  structurally	  versatile	  properties.	  This	  synthetic	  and	  
structural	   versatility	   presents	   many	   new	   opportunities	   for	   the	   development	   of	   a	   new	  
generation	  of	  “smart”	  hybrid	  nanomaterials	  which	  can	  be	  easily	  tailored	  to	  meet	  the	  demands	  
of	   specific	  biomedical	  applications	   such	  as	  drug	  delivery	   (anionic	   /	   cationic	   star	  polymers	   for	  
layer-­‐by-­‐layer	   technology),	   theranostics	   (core	   /	   shell	   type	   star	   polymers)and	   antimicrobials	  






Polystyrene	  Core	  (Nondegradable)	  /	  Polypeptide	  Periphery	  (Degradable)	  Nanogel	  Star	  
Polymers	  Materials	  
General	  Methods	  
Infrared	   (IR)	  spectra	  were	  obtained	   from	  chloroform	  solutions	  using	  a	  Thermo	  Nicolet	  Nexus	  
670	  FTIR	   spectrophotometer	   in	   transmission	  mode	  with	   samples	  prepared	  as	   thin	   films	  on	  2	  
mm	   thick	   NaCl	   plates.	   Similarly,	   Attenuated	   Total	   Reflection	   (ATR)	   FTIR	   spectroscopy	  
measurements	  were	  performed	  on	  a	  Perkin-­‐Elmer	  Spectrum	  100	  in	  the	  spectral	  region	  of	  650	  -­‐	  
4000	   cm-­‐1	   and	   were	   obtained	   from	   4	   scans	   with	   a	   resolution	   of	   2	   cm-­‐1.	   A	   background	  
measurement	  was	   taken	   before	   the	   sample	  was	   loaded	   onto	   the	   ATR	   for	  measurement.	   1H	  
NMR	   spectroscopy	   spectra	   were	   obtained	   on	   a	   Bruker	   Avance	   2000	   spectrometer	   (1H,	   400	  
MHz)	  using	  5	  mm	  o.d.	  tubes	  and	  were	  referenced	  to	  internal	  solvent	  residue	  (CDCl3:	  1H	  =	  7.26	  
ppm).	  The	  following	  abbreviations	  for	  multiplicity	  are	  used:	  s,	  singlet;	  m,	  multiplet;	  br,	  broad.	  
Analytical	  Gel	  Permeation	  Chromatography	  (GPC)	  using	  Waters	  high	  resolution	  columns	  HR1,	  
HR2,	  HR4E	  and	  HR5E	  (flow	  rate	  1	  mL	  /	  min,	  THF)	  in	  conjunction	  with	  a	  Waters	  996	  photodiode	  
array	   and	   /	   or	   a	   Waters	   411	   differential	   refractometer	   was	   used	   to	   determine	   molecular	  
weight	  distributions,	  Mw/Mn	  of	  polymer	  samples	  with	  respect	  to	  linear	  polystyrene	  or	  PMMA	  
standards	  depending	  on	  the	  type	  of	  polymer	  being	  analysed..	  GPC	  using	  DMF	  as	  solvent	  was	  
performed	  using	   a	   similar	   set	   up	  with	   a	  Waters	   differential	   refractometer	   and	   linear	   PMMA	  
standards.	  	  SEC	  with	  a	  light	  scattering	  detection	  (QELS	  quasi	  elastic	  light	  scattering	  detector)	  in	  
conjunction	  with	  a	  Optilab	  intraferometric	  refractometer	  were	  used	  to	  determine	  Mw,	  Mw/Mn,	  
and	   average	   hydrodynamic	   radii,	   Rh.	  A	   dn/dc	   value	   of	   0.187	   was	   used.	   For	   all	   other	   sizing	  
measurements,	   analysis	  was	   performed	   by	  DLS	   using	   a	  Malvern	   Zetasizer	  Nano	   ZS	   (Malvern	  
Instruments,	  Ltd.,	  United	  Kingdom).	  The	  appropriate	  concentration	  was	  determined	  by	  starting	  
at	  a	  1	  mg/ml	  sample	  concentration	  and	  then	  performing	  a	  series	  of	  dilutions	  to	  obtain	  suitable	  
sizing	   characteristics.	   Samples	   were	   filtered	   using	   a	   0.4	   μm	   Acrodisc	   filter	   prior	   to	  
measurement.	  LCST	  behavior	  was	  recorded	  on	  a	  Cary-­‐100	  spectrophotometer	  equipped	  with	  a	  
Peltier	  heated	  multi-­‐cell	  holder	  with	  a	  Cary	  temperature	  controller	  and	  probe.	  Samples	  were	  
heated	  at	  a	  rate	  of	  5oC	  per	  min	  and	  held	  at	  that	  temperature	  for	  a	  further	  1	  minute.	  A	  repeat	  
cycle	   of	   cooling	   was	   performed	   to	   check	   the	   reversibility	   of	   the	   polymer	   solutions.	   Sample	  
preparation	  involved	  dissolution	  of	  the	  polymer	  in	  10%	  THF	  in	  PBS	  solution	  and	  then	  removal	  
of	   the	  THF	  under	   reduced	  pressure.	  Samples	  were	  diluted	  accordingly	   to	   the	  desired	  sample	  





All	   air	   and	  moisture	   sensitive	   compounds	  were	   handled	   under	   a	   nitrogen	   atmosphere	   using	  
general	  Schlenk-­‐line	   techniques.	  α-­‐pinene	   (98%)	  bis(trichloromethyl)	  carbonate	   (triphosgene)	  
99%	  and	  benzylamine	  were	  purchased	  from	  Sigma	  Aldrich.	  γ-­‐Benzyl-­‐L-­‐glutamate	  and	  H-­‐Lys(Z)-­‐
OH	  were	  supplied	  by	  Bachem.	  Chloroform	  and	  ethyl	  acetate	  were	  used	  directly	  from	  the	  bottle	  
and	   stored	   under	   an	   inert,	   dry	   atmosphere.	   ε-­‐carbobenzyloxy-­‐L-­‐lysine	   NCA	   and	   γ-­‐benzyl-­‐L-­‐
glutamate	   NCA	   were	   synthesised	   following	   a	   literature	   procedure.101	   3-­‐(tert-­‐
Butyldimethylsilyloxy)-­‐1-­‐propyl	   lithium	  (20	  wt%	  solution	   in	  cyclohexane)	  was	  purchased	  from	  
FMC	   Lithium	   Division	   and	   used	   as	   received.	   Styrene,	   para-­‐benezenedicarboxaldehyde	   and	  
para-­‐divinylbenzene	  (p-­‐DVB)	  were	  purchased	  from	  Sigma	  Aldrich	  and	  either	  used	  as	  received	  
or	  purified	  by	  standard	   literature	  procedures.	  Additional	  p-­‐DVB	  was	  synthesized	  according	  to	  
standard	  literature	  procedures	  from	  p-­‐benzenedicarboxaldehyde.	  Solvents	  were	  either	  used	  as	  
obtained	   from	  a	  Pure	   Solv	   solvent	  dispenser	  purchased	   from	   Innovative	   Technology,	   Inc.,	   or	  
purchased	   from	   Sigma	   Aldrich	   and	   purified	   by	   standard	   literature	   procedures.	   All	   other	  
chemicals	  were	  used	  as	  obtained	  from	  commercial	  sources	  and	  used	  as	  received	  
	  
Synthesis	   of	   “protected”	   3-­‐(tert-­‐Butyldimethylsilyloxy)-­‐1-­‐propyl-­‐functionalized	   polystyrene	  
star-­‐polymers	  
Star	   polymers	   were	   synthesised	   according	   to	   the	   procedure	   by	   Sly	   et	   al.59	   Briefly,	   3-­‐(tert-­‐
Butyldimethylsilyloxy)-­‐1-­‐propyl	  lithium	  (8.8	  mL,	  20	  wt	  %	  solution	  in	  cyclohexane)	  was	  added	  to	  
a	   stirred	   solution	   of	   styrene	   (16.0	   mL),	   cyclohexane	   (250	   mL)	   and	   THF	   (16.0	   mL)	   under	   an	  
argon.	  After	  20	  min	  a	  sample	  (4	  mL)	  was	  taken,	  quenched	  in	  degassed	  MeOH	  (approx.	  150	  mL)	  
and	  a	   representative	   sample	  of	   the	   “free”	  polystyrene	  arm	   collected	  by	   filtration	   as	   a	  white	  
amorphous	  powder	  (data	  for	  free	  arm:	  1H	  NMR	  spectroscopy	  (400	  MHz,	  CDCl3,	  δ)	  =	  7.12	  (br	  s,	  
90	  H),	  6.50-­‐6.70	  (br	  m,	  60	  H),	  3.45	  (br	  s,	  2	  H),	  1.90	  (br	  s,	  30	  H),	  1.46	  (br	  s,	  60	  H),	  1.03	  (br	  s,	  4	  H),	  
0.87	  (br	  s,	  9H),	  0.00	  (br	  s,	  6H).	  Analytical	  GPC:	  Mn	  =	  3000,	  Mw/Mn	  =	  1.07.	  This	  data	  implied	  an	  
average	   degree	   of	   polymerization	   =	   30).	   A	   solution	   of	   p-­‐divinylbenzene	   (0.17.	   mL)	   in	  
cyclohexane	  (1.0	  mL)	  was	  added	  to	  the	  remaining	  solution	  which	  was	  then	  stirred	  for	  a	  further	  
40	   min.	   The	   reaction	   solution	   was	   then	   quenched	   by	   its	   slow	   addition	   to	   a	   rapidly	   stirred	  
solution	  of	  degassed	  MeOH	  and	  EtOH	  (1.5	  L,	  1:1).	  The	  precipitate	  was	  isolated	  by	  filtration	  and	  
dried	  under	  vacuum	  (16.1	  g).	  The	  crude	  polymer	  was	  purified	  by	  fractionation.	  Briefly,	  the	  star	  
polymer	  was	  dissolved	  in	  DCM	  (100	  ml)	  before	  the	  slow	  addition	  of	  acetone	  (150	  ml)	  and	  then	  
isopropyl	   alcohol	   (30	   ml).	   The	   solution	   was	   allowed	   to	   stand	   until	   the	   product	   formed	   a	  
substantial	   oily	   layer	   on	   the	   bottom	   of	   the	   container.	   The	   mixture	   was	   decanted	   allowing	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isolation	  of	  the	  oil	  which	  was	  then	  dissolved	  in	  DCM	  (50	  mL)	  and	  the	  solution	  added	  to	  MeOH	  
(1	  L).	  The	  precipitate	  thus	  formed	  was	  isolated	  by	  filtration	  and	  dried	  under	  vacuum	  to	  afford	  
the	  nanogel	  star-­‐polymer	  (12.1	  g)	  as	  a	  white	  amorphous	  powder.	   1H	  NMR	  spectroscopy	  (400	  
MHz,	  CDCl3,	  δ)	  =	  7.12	  (br	  s,	  90H),	  6.50-­‐6.70	  (br	  m,	  60H),	  3.45	  (br	  s,	  2H),	  1.90	  (br	  s,	  30H),	  1.46	  
(br	   s,	   60H),	   1.03	   (br	   s,	   4H)	   0.87	   (br	   s,	   9H),	   0.00	   (br	   s,	   6H).	  DLS	   (THF):	  Mw	   =	   111,	   000	   g/mol,	  
Mw/Mn	  =	  1.2,	  Rh	  =	  6.4	  nm.	  	  
	  
Synthesis	  of	  “deprotected”	  hydroxyl	  functionalised	  polystyrene	  star	  polymer:	  S-­‐PS-­‐OH	  
Butyldimethylsilyloxy)-­‐1-­‐propyl-­‐	   terminated	   polystyrene	   nanogel	   star-­‐polymer	   (10.0	   g)	   was	  
dissolved	  in	  THF	  (15.0	  mL)	  and	  tetrabutylammonium	  fluoride	  (1.0	  M	  solution	  in	  THF,	  15.0	  mL)	  
was	   added.	   The	   reaction	   solution	   was	   stirred	   for	   24	   h	   at	   room	   temperature	   before	   being	  
warmed	  to	  50	  oC	  for	  1	  h.	  The	  solution	  was	  allowed	  to	  cool	  to	  room	  temperature	  before	  it	  was	  
slowly	  added	  to	  MeOH	  (1	  L)	  with	  rapid	  stirring.	  The	  precipitate	  was	   isolated	  by	  filtration	  and	  
dried	   under	   vacuum	   to	   afford	   the	   “deprotected”	   nanogel	   star-­‐polymer	   (9.8	   g)	   as	   a	   white	  
amorphous	  powder.	  1H	  NMR	  spectroscopy	  (400	  MHz,	  CDCl3,	  δ)	  =	  7.12	  (br	  s,	  90H),	  6.50-­‐6.70	  (br	  
m,	   60H),	   3.45	   (br	   s,	   2H),	   1.90	   (br	   s,	   30H),	   1.46	   (br	   s,	   60H),	   1.03	   (br	   s,	   4H).	   DLS	   (THF):	  Mw	   =	  
110,000	  g/mol,	  Mw/Mn	  =	  1.2,	  Rh	  =	  6.4	  nm.	  	  
	  
Synthesis	  of	  azide	  functionalized	  polystyrene	  nanogel	  star	  polymer:	  S-­‐PS-­‐N3	  
S-­‐PS-­‐OH	   (0.4	  g)	   in	  30ml	  benzene	  was	  distilled	  using	  Dean-­‐Stark	  apparatus.	  Under	  N2	  and	   ice,	  
Dry	  THF	  (8	  ml)	  was	  added	  to	  the	  reaction	  vessel	  followed	  by	  triphenylphosphine	  (0.7	  g	  –	  2eq.)	  
and	  DIAD	  (diisopropyl	  azodicarboxylate)	  (0.054	  g	  –	  2eq.).	  Diphenylphosphoryl	  azide	  (0.073	  g	  –	  
2eq.)	  in	  approx.	  1	  ml	  THF	  was	  added	  and	  stirred	  at	  room	  temperature	  for	  14	  h	  and	  70oC	  for	  2	  
h.	  Reaction	  was	  cooled	  and	  precipitated	  into	  methanol.	  Product	  was	  reprecipitated	  twice	  from	  
DCM	   into	   methanol	   to	   obtain	   the	   product	   as	   a	   white	   amorphous	   powder.	   1H	   NMR	  
spectroscopy	  (400	  MHz,	  CDCl3,	  δ)	  =	  7.12	  (br	  s,	  90H),	  6.50-­‐6.70	  (br	  m,	  60H),	  3.11	  (br	  s,	  2H),	  1.90	  
(br	  s,	  30H),	  1.46	  (br	  s,	  64H),	  1.03	  (br	  s,	  4H).	  DLS	  (THF):	  Mw	  =	  109,000	  g/mol,	  Mw/Mn	  =	  1.3,	  Rh	  =	  
6.5	  nm.	  
	  
Synthesis	  of	  amino	  functionalized	  polystyrene	  nanogel	  star	  polymer:	  S-­‐PS-­‐NH2	  
S-­‐PS-­‐N3	   (0.2	   g)	   and	  0.035	  g	  of	   triphenylphosphine	   (1.5eq.)	   in	   4	  ml	  of	  dry	   THF	  was	   stirred	  at	  
70oC	   for	   4	   h.	   4	   drops	   of	   NH4OH	   were	   added	   and	   stirred	   at	   50oC	   for	   4	   h.	   The	   solution	   was	  
precipitated	  into	  hexane	  and	  purified	  by	  reprecipitation	  into	  methanol.	  The	  product	  was	  freeze	  
dried	   from	  benzene	  as	  a	  white	   solid.	   1H	  NMR	  spectroscopy	   (400	  MHz,	  CDCl3,	  δ)	  =	  7.12	   (br	   s,	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90H),	  6.50-­‐6.70	  (br	  m,	  60H),	  2.5	  (br	  s,	  2H),	  1.90	  (br	  s,	  30H),	  1.46	  (br	  s,	  60H),	  1.03	  (br	  s,	  4H).	  DLS	  
(THF):	  Mw	  =	  44,200	  g/mol,	  Mw/Mn	  =	  1.5,	  Rh	  =	  4.7	  nm.	  
	  
Synthesis	  of	  star	  shaped	  PBLG:	  S-­‐PS-­‐b-­‐PBLG	  
As	   a	   reference	   procedure,	   the	   NCA	   of	   γ-­‐benzyl-­‐L-­‐glutamate	   (BLG)	   (0.52	   g,	   2	   mmol)	   was	  
dissolved	   in	  5	  mL	  DMF	   in	  a	  Schlenk	   tube	  under	  a	  nitrogen	  atmosphere.	  S-­‐PS-­‐NH2	  (0.2	  g,	  MW:	  
approx.	   109kDa,	   no.	   arms:	   36)	   in	   dry	   DMF	   (1	   ml)	   was	   added	   to	   the	   reaction	   solution.	   The	  
solution	   was	   stirred	   for	   72	   	   h	   at	   room	   temperature.	   The	   polymer	   was	   precipitated	   into	   an	  
excess	  of	  cold	  diethyl	  ether	  and	  dried	  under	  vacuum	  (Yield:	  90%).	   1H	  NMR	  spectroscopy	  (400	  
MHz,	  CDCl3,	  δ)	  =	  7.35	  (br	  s,	  85H),	  7.12	  (br	  s,	  90H),	  6.50-­‐6.70	  (br	  m,	  60H),	  5.18	  (br	  m,	  34H),	  4.70	  
(br	  s,	  17H)	  2.50	  (br	  s,	  2H),	  2.50	  (br	  s,	  34H),	  1.85-­‐2.25	  (br	  s,	  34H),	  1.85-­‐2.25	  (br	  s,	  30H),	  	  1.55	  (br	  
s,	  60H),	  1.46	  (br	  s,	  60H),	  1.03	  (br	  s,	  4H).	  DLS	  (THF):	  Mw	  =	  44,200	  g/mol,	  Mw/Mn	  =	  1.5,	  Rh	  =	  4.7	  
nm.	  
	  
Synthesis	  of	  star	  shaped	  PZLL:	  S-­‐PS-­‐b-­‐PZLL	  
As	  a	  reference	  procedure,	   the	  NCA	  of	  γ	  ε-­‐carbobenzyloxy-­‐L-­‐lysine	   (ZLL)	   (0.61	  g,	  2	  mmol)	  was	  
dissolved	   in	  6	  mL	  DMF	   in	  a	  Schlenk	   tube	  under	  a	  nitrogen	  atmosphere.	  S-­‐PS-­‐NH2	  (0.2	  g,	  MW:	  
approx.	   109kDa,	   no.	   arms:	   36)	   in	   dry	   DMF	   (1	   ml)	   was	   added	   to	   the	   reaction	   solution.	   The	  
solution	   was	   stirred	   for	   72	   h	   at	   room	   temperature.	   The	   polymer	   was	   precipitated	   into	   an	  
excess	  of	  cold	  diethyl	  ether	  and	  dried	  under	  vacuum	  (Yield:	  90%).	   1H	  NMR	  spectroscopy	  (400	  
MHz,	  CDCl3,	  δ)	  =	  7.35	  (br	  s,	  68H),	  7.12	  (br	  s,	  90H),	  6.50-­‐6.70	  (br	  m,	  60H),	  5.18	  (br	  s,	  27H),	  4.50	  
(br	  s,	  13H)	  3.15	  (br	  s,	  27H),	  1.25-­‐2.25	  (br	  m,	  237H)	  DLS	  (THF):	  Mw	  =	  44,200	  g/mol,	  Mw/Mn	  =	  1.5,	  
Rh	  =	  4.7	  nm.	  
	  
Synthesis	  of	  star	  shaped	  PGA:	  S-­‐PS-­‐b-­‐PGA	  
S-­‐PS-­‐b-­‐PBLG	   (0.5	   g)	  was	   dissolved	   in	   5	  mL	   of	   trifluoroacetic	   acid	   (TFA).	   A	   6-­‐fold	   excess	  with	  
respect	  to	  γ-­‐benzyl-­‐L-­‐glutamate	  of	  a	  33%	  solution	  of	  HBr	  in	  acetic	  acid	  was	  added	  slowly	  to	  the	  
reaction.	   After	   16	   h,	   the	   solution	   was	   precipitated	   into	   diethyl	   ether.	   The	   precipitate	   was	  
washed	   with	   ethanol	   and	   diethyl	   ether.	   The	   polymer	   was	   dissolved	   in	   deionised	   water	   and	  
dialyzed	  (molar	  mass	  cut-­‐off	  8,000	  g/mol)	  for	  3	  days.	  The	  polymer	  was	  lyophilized	  (Yield:	  90%).	  
Deprotection	  was	  confirmed	  by	  1H	  NMR	  spectroscopy	  due	  to	  the	  absence	  of	  signals	  at	  7.2	  ppm	  
(benzyl	  group)	  and	  5.0	  ppm	  and	  (CH2-­‐Bz).	  1H	  NMR	  spectroscopy	  (400	  MHz,	  D2O,	  δ)	  =	  8.15	  (br	  s,	  
90H),	  7.20	  (br	  m,	  60H),	  5.75	  (br	  m,	  17H),	  3.55	  (br	  s,	  34H)	  2.75-­‐3.25	  (br	  m,	  66H),	  2.50	  (br	  s,	  64H)	  





Synthesis	  of	  star	  shaped	  PLL:	  S-­‐PS-­‐b-­‐PLL	  
S-­‐PS-­‐b-­‐PBLG	   (0.5	   g)	   was	   dissolved	   in	   5	  ml	   of	   trifluoroacetic	   acid	   (TFA).	   A	   6-­‐fold	   excess	   with	  
respect	  to	  ε-­‐carbobenzyloxy-­‐L-­‐lysine	  of	  a	  33%	  solution	  of	  HBr	  in	  acetic	  acid	  was	  added	  slowly	  
to	   the	   reaction.	   After	   16	   h,	   the	   solution	  was	   precipitated	   into	   diethyl	   ether.	   The	   precipitate	  
was	  washed	  with	  ethanol	  and	  diethyl	  ether	  (Yield:	  85%).	  Deprotection	  was	  confirmed	  by	  FTIR	  
sprectroscopy	   	   	  due	  to	  the	  absence	  of	  the	  carbonyl	  functionality	  of	  the	  Z	  protecting	  group	  at	  
1693	  cm-­‐1.	  
	  
Polyester	  Core	  (Degradable)	  /	  Polymethacrylate	  Periphery	  (Nondegradable)	  
Materials	  
1,5,7-­‐triaza-­‐bicyclo[4.4.0]dec-­‐5-­‐ene	  (TBD)	  was	  purchased	  from	  the	  Sigma	  Aldrich	  and	  purified	  
by	   sublimation.	   Solvents	   were	   either	   used	   as	   obtained	   from	   a	   Pure	   Solv	   solvent	   dispenser	  
supplied	   by	   Innovative	   Technology,	   Inc.,	   or	   purchased	   from	   Sigma	   Aldrich	   and	   purified	   by	  
standard	  literature	  procedures.	  2-­‐(trimethylsilyl)ethyl	  methacrylate	  was	  synthesized	  following	  
a	  literature	  procedure.102	  All	  other	  chemicals	  were	  used	  as	  obtained	  from	  commercial	  sources	  
and	  used	  as	  received.	  	  
	  
Synthesis	  of	  5,5’-­‐Bis(oxepanyl-­‐2-­‐one)	  (BOP)	  	  
	  4,4’-­‐Bicyclohexanone	   (20.0	   g,	   102.8	  mmol)	  was	   added	   slowly	   over	   approx.	   30	  minutes	   to	   a	  
solution	  of	  urea-­‐hydrogen	  peroxide	  (CO(NH2)2.H2O2)	  (40.0	  g,	  424.0	  mmol)	  in	  formic	  acid	  (99%,	  
200	  mL)	   and	   stirred	  at	   room	   temperature	   for	   4hr.	   The	   solution	  was	  diluted	  with	  water	   (200	  
mL)	  and	  extracted	  with	  chloroform	  (3	  x	  200	  mL).	  The	  organic	  fractions	  were	  combined,	  washed	  
with	  an	  aqueous	  solution	  of	  Na2CO3	   (3	  x	  100	  mL,	  10	  wt%),	  dried	  over	  anhydrous	  MgSO4	  and	  
the	   solvent	   removed	   under	   reduced	   pressure.	   The	   residue	   was	   recrystallized	   (ethyl	  
acetate/acetone)	  to	  afford	  the	  title	  compound	  as	  a	  white	  crystalline	  solid	  (10.0	  g,	  43%),	  m.p	  =	  
167-­‐169	  oC,	  lit.103=	  174	  oC.	  1H	  NMR	  spectroscopy	  (400MHz,	  CDCl3):	  δ	  (ppm)	  4.39-­‐4.34	  and	  4.21-­‐
4.15	   (m,	   4H,	   -­‐CH2OCO-­‐	   (R,R)	   and	   (R,S)),	   2.78-­‐2.72	   and	   2.65-­‐2.58	   (m,	   4H,	   -­‐CH2COO-­‐(R,R)	   and	  
(R,S)),	  1.94-­‐1.84	  (m,	  4H,	  -­‐	  CH2CH2OCO-­‐),	  1.71-­‐1.61	  (m,	  4H,	  -­‐	  CH2CH2COO-­‐),	  1.55-­‐1.46	  (q,	  2H,	  J	  =	  
12	  Hz,	  -­‐CH-­‐).	  	  
	  




4-­‐Cyano-­‐4-­‐(phenylcarbonothioylthio)pentanoic	   acid	   (1	   g,	   3.6	   mmol)	   and	   DIC	   (diisopropyl	  
carbodiimide)	  (0.55	  g,	  4	  mmol)	  were	  dissolved	  in	  15	  ml	  dry	  DCM	  under	  nitrogen	  atmosphere.	  
3-­‐amino-­‐1-­‐propanol	  (0.3	  g	  –	  4	  eq.)	  in	  1	  ml	  dry	  DCM	  was	  added	  dropwise	  via	  syringe	  at	  0oC.	  The	  
solution	  was	  stirred	  at	   room	  temperature	   for	  24	  h.	  The	  solvent	  was	  removed	  under	  reduced	  
pressure	  and	  purified	  using	  column	  chromatography	  (8:2	  ethyl	  acetate:ethanol)	  (Yield:	  50%).1H	  
NMR	  spectroscopy	  (400MHz,	  CDCl3):	  δ	  (ppm)	  7.93	  (d,	  2H),	  7.58	  (t,	  1H),	  7.41	  (t,	  2H)	  6.43	  (br	  s,	  
NH),	  3.66	  (br	  t,	  2H),	  3.43	  (q,	  2H),	  3.21	  (br	  s,	  OH),	  2.45-­‐2.57	  (m,	  4H),	  1.95	  (s,	  3H),	  1.72	  (m,	  2H).	  
13C	  NMR	  spectroscopy	   (400MHz,	  CDCl3):	  δ	   (ppm)	  171.52	   (C=O),	  144.39	   (C-­‐C=S),	  133.10	   (-­‐CH),	  
128.56(2C,-­‐CH),	  126.68(2C,-­‐CH),	  118.68	  (C=N),	  59.58	  (-­‐CH2-­‐OH),	  45.94	  (-­‐C-­‐S),	  36.69	  (-­‐CH2-­‐NH),	  
34.18	  (-­‐CH2),	  31.67	  (-­‐CH2-­‐C=O),	  31.66	  (-­‐CH2-­‐C),	  23.99	  (-­‐CH3-­‐C).	  	  
	  
Synthesis	  of	  linear	  poly(DMAEMA):	  L-­‐DMAEMA-­‐RAFT	  
RAFT-­‐OH	   (0.4	  g,	  1.2	  mmol),	  DMAEMA	  (6	  g,	  38.2	  mmol)	  and	  AIBN	   (58	  mg,	  0.035	  mmol)	  were	  
dissolved	  in	  22	  ml	  of	  dry	  1,4	  dioxane	  in	  a	  Schlenk	  flask.	  The	  reaction	  was	  degassed	  by	  3	  cycles	  
of	  freeze,	  pump,	  thaw.	  The	  solution	  was	  stirred	  at	  85oC	  for	  22	  h.	  The	  solution	  was	  allowed	  to	  
cool	  to	  room	  temperature	  and	  precipitated	  into	  hexane.	  The	  product	  was	  reprecipitated	  once	  
more	   to	   obtain	   the	   product	   as	   a	   red	   coloured	   solid	   (Yield:	   90%).	   1H	   NMR	   spectroscopy	  
(400MHz,	  CDCl3):	  δ	  (ppm)	  7.85	  (d,	  2H),	  7.49	  (t,	  1H),	  7.34	  (t,	  2H),	  4.02	  (br	  s,	  64H),	  3.66	  (t,	  2H),	  
3.37	  (br	  s,	  2H),	  2.53	  (br	  s,	  64H),	  2.25	  (br	  s,	  192H),	  1.79-­‐1.88	  (br	  m,	  67H),	  1.1-­‐1.5	  (br	  m,	  6H),	  0.9-­‐
1.06	  (br	  d,	  96H).	  
	  
Removal	  of	  ω-­‐RAFT	  end	  group:	  L-­‐DMAEMA-­‐H	  
L-­‐DMAEMA-­‐RAFT	  (3.5	  g,	  0.69	  mmol)	  Bu3SnH	  (5	  g,	  17.1	  mmol)	  and	  AIBN	  (525	  mg,	  3	  mmol)	  were	  
dissolved	  in	  22	  ml	  dry	  1,4	  dioxane.	  The	  solution	  was	  degassed	  by	  3	  freeze,	  pump,	  thaw	  cycles.	  
The	  solution	  was	  stirred	  at	  60oc	   for	  1	  h	  or	  until	   the	  solution	  became	  colourless.	  The	  solution	  
was	  allowed	  to	  cool	  to	  room	  temperature	  and	  precipitated	  into	  cold	  hexane.	  The	  product	  was	  
reprecipitated	  twice	  more	  from	  acetone	  into	  hexane.	  The	  polymer	  was	  redissolved	  in	  acetone	  
and	  dialyzed	  against	  15%	  acetone/H2O	  for	  18	  h	  and	  then	  against	  acetone	  for	  24	  h.	  The	  solvent	  
was	  removed	  under	  reduced	  pressure.	  The	  product	  was	  freeze	  dried	  from	  benzene	  to	  obtain	  
the	  product	  as	  a	   colorless	   solid	   (Yield:	  70%).1H	  NMR	  spectroscopy	   (400MHz,	  CDCl3):	  δ	   (ppm)	  
4.02	  (br	  s,	  64H),	  3.66	  (t,	  2H),	  3.37	  (br	  s,	  2H),	  2.53	  (br	  s,	  64H),	  2.25	  (br	  s,	  192H),	  1.79-­‐1.88	  (br	  m,	  
67H),	  1.1-­‐1.5	  (br	  m,	  6H),	  0.9-­‐1.06	  (br	  d,	  97H).	  
	  
Synthesis	  of	  linear	  poly(DMAEMA)	  /	  polyester	  block	  copolymer:	  L-­‐DMAEMA-­‐b-­‐PVL	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L-­‐DMAEMA-­‐H	  (0.15	  g,	  0.03	  mmol)	  was	  dissolved	  in	  2	  g	  of	  dry	  toluene.	  TBD	  (2.8	  mg,	  0.2	  mmol)	  
in	  0.5	  ml	  of	  dry	  toluene	  and	  δ-­‐Valerolactone	  (0.15	  g,	  1.5	  mmol)	  were	  added	  and	  stirred	  at	  40oC	  
for	  2	  h	  under	  a	  nitrogen	  atmosphere.	  The	   reaction	  was	  quenched	  with	  benzoic	  acid	  and	   the	  
product	   was	   precipitated	   into	   cold	   diethyl	   ether.	   The	   product	   was	   filtered	   and	   dried	   under	  
vacuum	  (Yield:	  90%).1H	  NMR	  spectroscopy	  (400MHz,	  CDCl3):	  δ	  (ppm)	  4.02	  (br	  s,	  152H),	  3.66	  (t,	  
2H),	  3.37	  (br	  m,	  2H),	  2.53	  (br	  s,	  64H),	  2.33	  (br	  m,	  88H),	  2.25	  (br	  s,	  192H),	  1.79-­‐1.88	  (br	  m,	  67H),	  
1.67	  (br	  m,	  172H),	  1.1-­‐1.5	  (br	  m,	  6H),	  0.9-­‐1.06	  (br	  d,	  97H).	  
	  
Synthesis	  of	  poly(DMAEMA)	  nanogel	  star	  polymers:	  S-­‐DMAEMA-­‐H	  
L-­‐DMAEMA-­‐H	   (0.8	   g,	   0.16	  mmol)	   was	   dissolved	   in	   8.5	   g	   of	   dry	   toluene.	   TBD	   (13	  mg,	   0.094	  
mmol)	   in	   0.2	  ml	   dry	   toluene	   and	   BOP	   (0.3	   g,	   1.3	  mmol)	   were	   added	   and	   the	   reaction	   was	  
stirred	  for	  16	  h	  at	  70oc	  under	  N2.	  The	  solution	  was	  allowed	  to	  cool	  to	  room	  temperature	  and	  
quenched	  with	  benzoic	  acid.	  The	  product	  was	  precipitated	  into	  cold	  hexane.	  The	  product	  was	  
purified	  by	  fractionation	  to	  remove	  residual	  L-­‐DMAEMA	  arms.	  Briefly,	  200	  mg	  of	  polymer	  was	  
dissolved	  in	  2	  ml	  of	  acetone	  and	  hexane	  (2	  ml)	  was	  added	  slowly	  to	  form	  a	  cloudy	  suspension	  
which	   was	   allowed	   to	   settle	   over	   time.	   The	   remaining	   solution	   was	   decanted	   off	   and	   the	  
product	  precipitated	  from	  minimal	  acetone	  into	  hexane.	  The	  product	  was	  dried	  under	  reduced	  
pressure	  to	  afford	  a	  white	  solid	  (Yield:	  48%).	  1H	  NMR	  spectroscopy	  (400MHz,	  CDCl3):	  δ	  (ppm)	  
4.02	  (br	  s,	  64H),	  3.66	  (t,	  2H),	  2.53	  (br	  s,	  64H),	  2.25	  (br	  s,	  192H),	  1.79-­‐1.88	  (br	  m,	  67H),	  1.1-­‐1.5	  
(br	  m,	  6H),	  0.9-­‐1.06	  (br	  d,	  97H).	  
	  
Synthesis	  of	  linear	  poly(TMSEM):	  L-­‐TMSEM-­‐RAFT	  
RAFT-­‐OH	   (0.15	  g,	  0.45	  mmol),	  TMSEM	  (2.7	  g,	  14.5	  mmol)	  and	  AIBN	   (22	  mg,	  0.3	  mmol)	  were	  
dissolved	  in	  8	  ml	  of	  dry	  1,4	  dioxane	  in	  a	  Schlenk	  flask.	  The	  reaction	  was	  degassed	  by	  3	  cycles	  of	  
freeze,	  pump,	  thaw.	  The	  solution	  was	  stirred	  at	  85oC	  for	  22	  h.	  The	  solution	  was	  allowed	  to	  cool	  
to	  room	  temperature	  and	  precipitated	  into	  hexane.	  The	  product	  was	  reprecipitated	  once	  more	  
to	   obtain	   the	   product	   as	   a	   red	   coloured	   solid	   (Yield:	   86%).	   1H	   NMR	   spectroscopy	   (400MHz,	  
CDCl3):	  δ	  (ppm)	  7.85	  (d,	  2H),	  7.49	  (t,	  1H),	  7.34	  (t,	  2H),	  	  4.02	  (br	  s,	  60H),	  3.66	  (t,	  2H),	  3.37	  (br	  s,	  
2H),	  1.75-­‐1.85	  (br	  m,	  63H),	  1.10-­‐1.35	  (br	  m,	  6H),	  0.83-­‐0.93	  (br	  d,	  150H),	  0.01	  (br	  s,	  270H).	  
	  
Removal	  of	  ω-­‐RAFT	  end	  group:	  L-­‐TMSEM-­‐H	  
L-­‐TMSEM-­‐RAFT	   (2.2	   g,	   0.39	  mmol)	   Bu3SnH	   (2.8	   g,	   9.6	  mmol)	   and	   AIBN	   (262	  mg,	   1.6	  mmol)	  
were	  dissolved	   in	  7	  ml	  dry	  1,4	  dioxane.	  The	   solution	  was	  degassed	  by	  3	   freeze,	  pump,	   thaw	  
cycles.	   The	   solution	  was	   stirred	   at	   60oc	   for	   1	   h	   or	   until	   the	   solution	   became	   colourless.	   The	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solution	   was	   allowed	   to	   cool	   to	   room	   temperature	   and	   precipitated	   into	   cold	   hexane.	   The	  
product	   was	   reprecipitated	   twice	   more	   from	   acetone	   into	   hexane.	   The	   polymer	   was	  
redissolved	   in	   acetone	   and	   dialyzed	   against	   15%	   acetone/H2O	   for	   18	   h	   and	   then	   against	  
acetone	  for	  24	  h.	  The	  solvent	  was	  removed	  under	  reduced	  pressure.	  The	  product	  was	  freeze	  
dried	   from	   benzene	   to	   obtain	   the	   product	   as	   a	   colorless	   solid	   (Yield:	   67%).1H	   NMR	  
spectroscopy	  (400MHz,	  CDCl3):	  δ	  (ppm)	  4.02	  (br	  s,	  60H),	  3.66	  (t,	  2H),	  3.37	  (br	  s,	  2H),	  1.75-­‐1.85	  
(br	  m,	  63H),	  1.10-­‐1.35	  (br	  m,	  6H),	  0.83-­‐0.93	  (br	  d,	  151H),	  0.01	  (br	  s,	  270H).	  
	  
Synthesis	  of	  poly(TMSEM)	  nanogel	  star	  polymers:	  S-­‐TMSEM-­‐H	  
L-­‐TMSEM-­‐H	   (0.4	   g,	   0.067	   mmol)	   was	   dissolved	   in	   4.5	   g	   of	   dry	   toluene.	   TBD	   (10	   mg,	   0.072	  
mmol)	   in	   0.2	  ml	   dry	   toluene	   and	   BOP	   (0.2	   g,	   0.88	  mmol)	  were	   added	   and	   the	   reaction	  was	  
stirred	   for	   2	   h	   at	   70oc	   under	   N2.	   The	   solution	   was	   allowed	   to	   cool	   to	   room	   temperature	  
quenched	  with	  benzoic	  acid.	  The	  product	  was	  precipitated	  into	  cold	  hexane.	  The	  product	  was	  
dried	   under	   reduced	   pressure	   to	   afford	   a	   white	   solid	   (Yield:	   87%).	   1H	   NMR	   spectroscopy	  
(400MHz,	  CDCl3):	  δ	  (ppm)	  4.02	  (br	  s,	  60H),	  3.66	  (t,	  2H),	  3.37	  (br	  s,	  2H),	  1.75-­‐1.85	  (br	  m,	  63H),	  
1.10-­‐1.35	  (br	  m,	  6H),	  0.83-­‐0.93	  (br	  d,	  151H),	  0.01	  (br	  s,	  270H).	  
	  
Removal	  of	  ethyl	  (trimethylsilyl)	  protecting	  group:	  S-­‐MA-­‐H	  
S-­‐TMSEM-­‐H	   (0.2	  g)	  was	  dissolved	   in	  2	  ml	  of	  dry	  THF.	  TBAF	   solution	   (1M	   in	  THF,	  0.1	  ml)	  was	  
added	  and	  the	  reaction	  was	  stirred	  under	  N2	  overnight.	  The	   turbid	  solution	  was	  precipitated	  
into	  hexane.	  The	  filtered	  product	  was	  dried	  under	  reduced	  pressure	  to	  yield	  the	  product	  was	  
as	  an	  off	  white	  solid.	  The	  solubility	  of	   the	  product	  was	  problematic	  post	  deprotection	   (Yield:	  
80%).	  	  	  
	  
Polyester	  Core	  (Degradable)	  /	  Polyethylene	  Glycol	  Periphery	  (Nondegradable)	  
	  
Materials	  
1,5,7-­‐triaza-­‐bicyclo[4.4.0]dec-­‐5-­‐ene	   	   was	   purchased	   from	   the	   Sigma	   Aldrich	   and	   purified	   by	  
sublimation.	   Solvents	   were	   either	   used	   as	   obtained	   from	   a	   Pure	   Solv	   solvent	   dispenser	  
supplied	   by	   Innovative	   Technology,	   Inc.,	   or	   purchased	   from	   Sigma	   Aldrich	   and	   purified	   by	  
standard	   literature	  procedures.	  All	  poly(ethylene)	  glycol	  was	  dried	  by	   lyophilization.	  All	  other	  
chemicals	  were	  used	  as	  obtained	  from	  commercial	  sources	  and	  used	  as	  received.	  	  
	  
Synthesis	  of	  5,5’-­‐Bis(oxepanyl-­‐2-­‐one)	  (BOP)	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  4,4’-­‐Bicyclohexanone	   (20.0	   g,	   102.8	  mmol)	  was	   added	   slowly	   over	   approx.	   30	  minutes	   to	   a	  
solution	  of	  urea-­‐hydrogen	  peroxide	  (CO(NH2)2.H2O2)	  (40.0	  g,	  424.0	  mmol)	  in	  formic	  acid	  (99%,	  
200	  mL)	  and	  stirred	  at	  room	  temperature	  for	  4	  h.	  The	  solution	  was	  diluted	  with	  water	  (200	  mL)	  
and	   extracted	  with	   chloroform	   (3	   x	   200	  mL).	   The	   organic	   fractions	  were	   combined,	  washed	  
with	  an	  aqueous	  solution	  of	  Na2CO3	  (3	  x	  100	  mL,	  10	  wt%),	  dried	  over	  anhydrous	  Na2SO4	  and	  
the	   solvent	   removed	   under	   reduced	   pressure.	   The	   residue	   was	   recrystallized	   (ethyl	  
acetate/acetone)	  to	  afford	  the	  title	  compound	  as	  a	  white	  crystalline	  solid	  (10.0	  g,	  43%),	  m.p	  =	  
167-­‐169	  oC,	  lit.105	  =	  174	  oC.	  1H	  NMR	  spectroscopy	  (400MHz,	  CDCl3):	  δ	  (ppm)	  4.39-­‐4.34	  and	  4.21-­‐
4.15	   (m,	   4H,	   -­‐CH2OCO-­‐	   (R,R)	   and	   (R,S)),	   2.78-­‐2.72	   and	   2.65-­‐2.58	   (m,	   4H,	   -­‐CH2COO-­‐	   (R,R)	   and	  
(R,S)),	  1.94-­‐1.84	  (m,	  4H,	  -­‐	  CH2CH2OCO-­‐),	  1.71-­‐1.61	  (m,	  4H,	  -­‐	  CH2CH2COO-­‐),	  1.55-­‐1.46	  (q,	  2H,	  J	  =	  
12	  Hz,	  -­‐CH-­‐).	  	  
	  
Synthesis	  of	  linear	  PEG-­‐b-­‐PVL	  (Representative	  Procedure)	  
Poly(ethylene)	  glycol-­‐2	  kDa	  (0.4	  g,	  0.2	  mmol)	  was	  dissolved	   in	  4	  g	  of	  dry	  toluene.	  TBD	  (5	  mg,	  
0.036	  mmol)	   in	   0.5	  ml	   of	   dry	   toluene	   and	   δ-­‐Valerolactone	   (0.3	   g,	   3	  mmol)	  were	   added	   and	  
stirred	   at	   room	   temperature	   for	   30	   min	   under	   a	   nitrogen	   atmosphere.	   The	   reaction	   was	  
quenched	   with	   benzoic	   acid	   and	   the	   product	   was	   precipitated	   into	   cold	   diethyl	   ether.	   The	  
product	   was	   filtered	   and	   dried	   under	   vacuum	   (Yield:	   90%).1H	   NMR	   spectroscopy	   (400MHz,	  
CDCl3):	  δ	  (ppm)	  4.02	  (br	  t,	  20H),	  3.62	  (br	  s,	  193H),	  3.35	  (s,	  3H),	  2.33	  (br	  s,	  20H),	  2.11	  (br	  s,	  OH),	  
1.67	  (br	  m,	  40H).	  
	  
Synthesis	  of	  PEG	  nanogel	  star	  polymers:	  S-­‐PEG	  (Representative	  Procedure)	  
Poly(ethylene)	  glycol-­‐2	  kDa	   (0.25	  g,	  0.125	  mmol)	  was	  dissolved	   in	  6	  g	  of	  dry	   toluene.	  TBD	   (5	  
mg,	  0.036	  mmol)	  in	  0.5	  ml	  of	  dry	  toluene	  and	  BOP	  (0.19	  g,	  0.84	  mmol)	  were	  added	  and	  stirred	  
at	  room	  temperature	  for	  20	  h	  under	  a	  nitrogen	  atmosphere.	  The	  reaction	  was	  quenched	  with	  
benzoic	   acid	   and	   the	   product	   was	   precipitated	   into	   cold	   diethyl	   ether.	   Briefly,	   200	   mg	   of	  
polymer	  was	  dissolved	  in	  2	  ml	  of	  acetone	  and	  diethyl	  ether	  (3.5	  ml)	  was	  added	  slowly	  to	  form	  a	  
cloudy	   suspension	   which	   was	   allowed	   to	   settle	   over	   time.	   The	   remaining	   solution	   was	  
decanted	  off	  and	  the	  product	  precipitated	  from	  minimal	  acetone	   into	  cold	  diethyl	  ether.	  The	  
product	   was	   filtered	   and	   dried	   under	   vacuum	   (Yield:	   75%).1H	   NMR	   spectroscopy	   (400MHz,	  
CDCl3):	  δ	  (ppm)	  4.12	  (br	  t,	  4H),	  3.62	  (br	  s,	  150H),	  3.53	  (t,	  2H	  from	  core)	  3.35	  (s,	  3H),	  2.51	  (br	  t,	  
4H),	  2.11	  (br	  s,	  OH),	  1.63	  (br	  m,	  8H).	  
	  
Synthesis	  of	  PEG-­‐b-­‐PVL	  nanogel	  star	  polymers:	  S-­‐PEG-­‐b-­‐PVL	  (Representative	  Procedure)	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Poly(ethylene)	  glycol-­‐2	  kDa	  (0.4	  g,	  0.2	  mmol)	  was	  dissolved	   in	  4	  g	  of	  dry	  toluene.	  TBD	  (5	  mg,	  
0.036	  mmol)	   in	   0.5	  ml	   of	   dry	   toluene	   and	   δ-­‐Valerolactone	   (0.3	   g,	   3	  mmol)	  were	   added	   and	  
stirred	  at	  room	  temperature	  for	  30	  min	  under	  a	  nitrogen	  atmosphere.	  A	  sample	  was	  taken	  for	  
SEC	   and	   1H	   NMR	   spectroscopy	   analysis.	   To	   the	   reaction	   solution	   was	   added	   1.5	   g	   of	   dry	  
toluene,	  TBD	  (3	  mg,	  0.021	  mmol)	   in	  0.5	  ml	  of	  dry	   toluene	  and	  BOP	  (0.15	  g,	  0.66	  mmol).	  The	  
solution	  was	  stirred	  at	  room	  temperature	  overnight.	  The	  reaction	  was	  quenched	  with	  benzoic	  
acid	  and	  the	  product	  was	  precipitated	  into	  cold	  diethyl	  ether.	  200	  mg	  of	  polymer	  was	  dissolved	  
in	  2	  ml	  of	  acetone	  and	  diethyl	  ether	   (3.5	  ml)	  was	  added	  slowly	   to	   form	  a	  cloudy	  suspension	  
which	   was	   allowed	   to	   settle	   over	   time.	   The	   remaining	   solution	   was	   decanted	   off	   and	   the	  
product	  precipitated	   from	  minimal	   acetone	   into	   cold	  diethyl	   ether.	   The	  product	  was	   filtered	  
and	  dried	  under	  vacuum	  (Yield:	  65%).1H	  NMR	  spectroscopy	  (400MHz,	  CDCl3):	  δ	  (ppm)	  4.12	  (br	  
t,	  4H),	  3.62	  (br	  s,	  150H),	  3.53	  (t,	  2H	  from	  core)	  3.35	  (s,	  3H),	  2.51	  (br	  t,	  4H),	  2.11	  (br	  s,	  OH),	  1.63	  
(br	  m,	  8H).	  
	  
1	  pot	  synthesis	  of	  PEG-­‐b-­‐PVL	  nanogel	  star	  polymers:	  S-­‐PEG-­‐5kDa-­‐b-­‐PVL-­‐3kDa	  
Poly(ethylene)	  glycol-­‐5	  kDa	  (0.5	  g,	  0.1	  mmol)	  was	  dissolved	   in	  7	  g	  of	  dry	  toluene.	  TBD	  (5	  mg,	  
0.036	  mmol)	   in	   0.5	  ml	   of	   dry	   toluene,	   δ-­‐valerolactone	   (0.3	   g,	   3	  mmol)	   and	  BOP	   (0.2	   g,	   0.88	  
mmol)	  were	  added	  and	  stirred	  at	  room	  temperature	  overnight	  under	  a	  nitrogen	  atmosphere.	  
The	   reaction	   was	   quenched	   with	   benzoic	   acid	   and	   the	   product	   was	   precipitated	   into	   cold	  
diethyl	  ether.	  200	  mg	  of	  polymer	  was	  dissolved	  in	  2	  ml	  of	  acetone	  and	  diethyl	  ether	  (3.5	  ml)	  
was	   added	   slowly	   to	   form	   a	   cloudy	   suspension	  which	  was	   allowed	   to	   settle	   over	   time.	   The	  
remaining	  solution	  was	  decanted	  off	  and	  the	  product	  precipitated	  from	  minimal	  acetone	  into	  
cold	   diethyl	   ether.	   The	   product	   was	   filtered	   and	   dried	   under	   vacuum	   (Yield:	   70%).1H	   NMR	  
spectroscopy	  (400MHz,	  CDCl3):	  δ	  (ppm)	  4.12	  (br	  t,	  4H),	  3.62	  (br	  s,	  198H),	  3.53	  (t,	  2H	  from	  core)	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Chapter	  6	  	  
Conclusion	  and	  Outlook	  
	  
Star	  shaped	  polymers,	  in	  particular	  star	  shaped	  polypeptides	  are	  of	  great	  interest	  owing	  to	  the	  
unique	   structural	   features	   and	   inherent	   biocompatibility	   associated	   with	   such	   materials.	  
Consequently,	  the	  next	  generation	  of	  nanoparticle	  platforms	  may	  stem	  from	  this	  area	  to	  afford	  
materials	  which	   offer	   great	   potential	   towards	   biomedical	   applications	   such	   as	   drug	   delivery,	  
medical	  diagnostics	  and	  therapeutics.	  The	  aim	  of	  this	  thesis	  was	  the	  development	  of	  novel	  star	  
shaped	  polymers	  and	  to	  investigate	  their	  potential	  towards	  the	  biomedical	  field.	  ROP	  of	  NCAs	  
was	  the	  predominant	  synthetic	  tool	  employed	  in	  conjunction	  with	  amide	  coupling	  chemistries	  
for	  post	  modification	  of	  star	  shaped	  polypeptides.	  Furthermore,	  the	  synthetic	  expertise	  of	  IBM	  
was	  engaged	  to	  further	  the	  development	  of	  advanced	  star	  shaped	  polymeric	  architectures.	  To	  
summarize,	   platform	   one	   saw	   the	   development	   of	   a	   range	   well-­‐defined	   star	   shaped	  
poly(glutamic	   acid)	   capable	   of	   tunable	   loading	   capacities	   and	   enzyme	   triggered	   controlled	  
release.	  Although	  the	  cargo	  encapsulated	  was	  a	  simple	  dye,	  notable	  features	  of	  this	  platform	  
towards	  the	  delivery	  of	  real	   therapeutics	  may	  be	  considered	  for	  the	  design	  of	  more	  complex	  
delivery	   platforms.	   The	   introduction	   of	   sugars	   (targeting	   function),	   pegylation	   (modulate	  
pharmokinetics)	   and	   a	   fluorescent	   moiety	   (imaging	   /	   diagnostics)	   may	   impart	   further	  
intelligence	   to	   this	   platform	   enabling	   the	   simultaneous	   site	   specific	   controlled	   release	   of	  
therapeutics	  and	  diagnostic	  imaging.	  	  Platform	  two	  involved	  the	  employment	  of	  a	  lysine	  NCA	  
derivative	  to	  generate	  cationic	  star	  shaped	  poly(lysine)	  which	  exhibited	  superior	  complexation,	  
“polyplex”	   sizing,	   cargo	   protection	   and	   transfection	   efficiencies	   compared	   to	   the	   analogous	  
linear	   poly(lysine).	   More	   advanced	   cellular	   studies	   are	   currently	   being	   undertaken	   and	  
preliminary	   results	   show	   superior	   transfections	   efficiencies	   compared	   commercially	   gene	  
transfection	  products.	  As	  with	  platform	  1,	  the	  ability	  to	  readily	  use	  the	  functional	  amino	  acid	  
side	  chain	  to	  conjugate	  functional	  moieties	  may	  help	  to	  promote	  the	  biomedical	  applicability	  
of	  these	  materials.	  The	  formation	  of	  advanced	  glycopolypeptide	  architectures	  was	  performed	  
(platform	  3)	  to	  achieve	  materials	  boasting	  well-­‐defined	  star	  shaped	  architectures	  and	  potential	  
to	   strategically	   position	   sugar	   moieties	   within	   a	   polypeptide	   chain.	   These	   materials	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demonstrated	  their	  bioactivity	  through	  a	  lectin	  specific	  binding	  interaction	  and	  may	  find	  great	  
use	   in	   biorecogniton	   applications	   and	   the	   study	   of	   more	   advanced	   carbohydrate	   –	   protein	  
interactions.	   More	   advanced	   studies	   may	   be	   undertaken	   to	   ascertain	   the	   effects	   of	  
architecture	   /	   sugar	   positioning	   on	   these	   interactions.	   Finally,	   platform	   4	   saw	   collaborative	  
research	   efforts	   with	   IBM	   devise	   a	   series	   of	   novel	   hybrid	   nanogel	   star	   polymers	   through	   a	  
combination	  of	  various	  controlled	  polymerization	  techniques.	  These	  materials	  were	  of	  mixed	  
compositions	   but	   boasted	   well-­‐defined,	   multifunctional	   and	   structurally	   versatile	   properties	  
permitting	   their	   facile	   tailoring	   towards	   specific	   biomedical	   applications.	   The	   continued	  
development	  of	   these	  materials	   towards	   targeted	  applications	   is	   currently	  being	  undertaken	  
and	   the	   array	   of	   platforms	   developed	   provides	   a	   solid	   base	   from	  which	   alterations	  may	   be	  
made.	  	  
The	  outlook	  for	  this	  field	  is	  very	  positive	  given	  the	  immense	  array	  of	  synthetic	  tools	  available.	  
The	   ability	   to	   readily	   introduce	   novelty	   and	   “smart”	   features	   to	   these	   materials	   should	  
hopefully	   lead	   to	   the	  development	  of	  more	  advanced	  and	  applicable	  nanoparticle	  platforms.	  
Advanced	   biological	   studies	   are	   the	   next	   major	   hurdle	   in	   taking	   these	   materials	   from	   the	  
benchtop	  to	  the	  eventual	  goal	  of	  commercialization.	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